Page last updated: 2024-08-24

triazoles and voriconazole

triazoles has been researched along with voriconazole in 2443 studies

Research

Studies (2,443)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's63 (2.58)18.2507
2000's1179 (48.26)29.6817
2010's1114 (45.60)24.3611
2020's87 (3.56)2.80

Authors

AuthorsStudies
Andriole, VT; George, D; Miniter, P1
Barry, AL; Brown, SD1
Hitchcock, CA; Martin, MV; Yates, J1
Ruhnke, M; Schmidt-Westhausen, A; Trautmann, M1
Armstrong, D; Bernard, EM; Ishimaru, T; Murphy, M1
Johnson, EM; Radford, SA; Warnock, DW1
Gage, R; Stopher, DA2
Milatovic, D; Schwartz, S; Thiel, E1
Cooper, CR; Fothergill, AW; McGinnis, MR; Pasarell, L; Rinaldi, MG; Sutton, DA2
Belanger, P; Fratti, R; Ghannoum, M; Nast, CC; Sanati, H1
Belanger, P; Fratti, R; Ghannoum, M; Sanati, H1
Haberreiter, A; Paule, I; Seidl, HP; Wildfeuer, A1
Espinel-Ingroff, A2
Jones, RN; Marco, F; Messer, S; Pfaller, MA1
Nguyen, MH; Yu, CY2
Belanger, PH; Fratti, RA; Ghannoum, MA; Sanati, H1
Brummer, E; Purimetla, N; Stevens, DA; Vora, S1
de Sévaux, RG; Kullberg, BJ; Meis, JF; van de Nes, JA; van der Meer, JW; Verweij, PE1
Girmenia, C; Luzi, G; Martino, P; Monaco, M1
Kauffman, CA; Zarins, LT2
Meis, JF; van 't Hek, LG; van Dalen, R; Verweij, PE; Weemaes, CM; Yntema, JB1
McGinnis, MR; Pasarell, L1
Hitchcock, CA; Koltin, Y1
Denning, DW; Moore, CB; Oakley, KL1
Brummer, E; Chauhan, S; Stevens, DA; Vora, S1
Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE1
Brummer, E; Kamei, K; Miyaji, M2
Denning, DW; Donnelly, JP; Meis, JF; Mensink, M; Rijs, AJ; Verweij, PE1
Baquero, F1
Clancy, CJ; Nguyen, MH1
Chandrasekar, PH; Cutright, JL; Manavathu, EK3
Cuenca-Estrella, M; Martínez-Suárez, JV; Mellado, E; Monzón, A; Rodríguez-Tudela, JL1
Diehl, V; Fätkenheuer, G; Hegener, P; Ruhnke, M; Troke, PF1
Brandt, ME; Doern, GV; Hajjeh, RA; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Brandt, ME; Ghannoum, MA; Hajjeh, RA; Jessup, CJ; Mbidde, EK; Messer, SA; Pfaller, MA; Tumberland, M; Zhang, J1
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O1
Chandrasekar, PH; Cutright, J; Manavathu, EK1
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ1
Abraham, OC; Chandrasekar, PH; Cutright, JL; Manavathu, EK1
Johnson, EM; Szekely, A; Warnock, DW1
Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE1
Bhat, N; Ghannoum, MA; Okogbule-Wonodi, I; Sanati, H1
Jones, RN; Marco, F; Messer, SA; Pfaller, MA1
Hoban, DJ; Karlowsky, JA; Zhanel, GG1
Fothergill, AW; Revankar, SG; Rinaldi, MG; Sanche, SE; Sutton, DA1
Cuenca-Estrella, M; Martínez-Suárez, JV; Monzón, A; Rodríguez-Tudela, JL; Ruiz-Díez, B1
Matsushima, T; Nakajima, M; Niki, Y1
Amalfitano, G; Concia, E; Kwon-Chung, KJ; Luzzati, R; Mondon, P; Petter, R; Polacheck, I1
Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL1
Anaissie, EJ; Arikan, S; Lozano-Chiu, M; Paetznick, VL; Rex, JH1
Ghannoum, M; Koul, A; Reyes, G; Vitullo, J1
Berridge, JC; Coleman, MW; Fell, AF; Owens, PK1
Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A1
Arikan, S; Lozano-Chiu, M; Nangia, S; Paetznick, V; Rex, JH1
Del Moral, F; García, MT; Lima, JE; Llorente, MT; Mínguez, F; Prieto, J1
Patterson, TF1
Fothergill, AW; Modak, A; Pennick, GJ; Perea, S; Rinaldi, MG; Sheehan, DJ; Sutton, DA1
Chiou, CC; Groll, AH; Walsh, TJ1
Chandrasekar, PH; Cutright, J; Manavathu, E1
Ciblak, MA; Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW1
Fothergill, AW; Rinaldi, MG; Saracli, MA; Yildiran, ST1
Ernst, EJ; Klepser, ME; Lewis, RE; Malone, D; Pfaller, MA1
Kappe, R2
Arnadóttir, M; Asmundsson, P; Bödvarsson, M; Hilmarsdóttir, I; Thorsteinsson, SB1
Cerón, A; Montoya, J; Poza, G; Redondo, C; Rodriguez-Tudela, JL; Ruiz, J; Simarro, E; Vila, N1
Liu, XP; Sugar, AM2
Niki, Y1
Chandrasekar, PH; Cutright, JL; Loebenberg, D; Manavathu, EK1
Agostini, H; Althaus, C; Jensen, HE; Reis, A; Sundmacher, R; Tintelnot, K1
Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C1
Abdel-Rahman, SM; Sabo, JA1
Fothergill, AW; Kirkpatrick, WR; McAtee, RK; Patterson, TF; Rinaldi, MG1
Bolmstrom, A; Houston, A; Jones, RN; Messer, SA; Mills, K; Pfaller, MA1
Bretagne, S; Curfs, JH; Meis, JF; Verweij, PE; Weemaes, CM1
McDougal, EC; Nesky, MA; Peacock, JE1
Arikan, S; Kocagöz, S; Sancak, B; Unal, S; Uzun, O1
Lee, JK; Noskin, GA; Obias, AA; Peters, D; Peterson, LR1
Bouza, E; Marín, M; Martín Rabadán, P; Muñoz, P; Rodríguez-Creixéms, M; Tornero, P1
Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B1
Dierich, MP; Lass-Flörl, C; Nagl, M; Speth, C; Ulmer, H; Würzner, R1
Fothergill, AW; Perea, S; Rinaldi, MG; Sutton, DA1
Müller, FM; Weig, M1
Leitner, I; Ryder, NS1
Karlsson, I; Kronvall, G1
Kämmerer, R; Klempien, I; Kujath, P; Muhl, E1
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ1
Abraham, OC; Chandrasekar, PH; Manavathu, EK1
Girija, R; Hwang, YK; Joo, NH; Tan, L; Tan, P; Tee, GY1
Carrillo, AJ; Guarro, J1
Bacigalupo, A; Machetti, M; Mordini, N; Paola, D; Van Lint, MT; Veroni, L; Viscoli, C; Zotti, M1
Boyle, K; Espinel-Ingroff, A; Sheehan, DJ1
Crego, AL; Gómez, J; Lavandera, JL; Marina, ML1
Diekema, DJ; Fluit, AC; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA; Sader, HS1
Li, RK; McGinnis, MR; Nordoff, N; Pasarell, L; Warnock, DW1
Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P1
Gigliotti, F; Wellington, M1
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A1
Denning, DW; Griffiths, CE1
Diemert, D; Kunimoto, D; Rennie, R; Sand, C1
Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL1
Denning, DW; Mosquera, J1
Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K1
Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S1
Marr, KA1
Dixon, CA; Goldberger, MJ; Powers, JH1
Caillot, D; Denning, DW; Haas, A; Herbrecht, R; Lode, H; Milpied, N; Ribaud, P; Ruhnke, M; Thiel, E1
Higashiyama, Y; Iwakawa, J; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomono, K; Yanagihara, K1
Griffiths, PD1
Brummer, E; Chiller, T; Farrokhshad, K; Stevens, DA1
Hoffman, HL; Rathbun, RC1
De Roux, A; Grassot, A; Grysczyk, H; Lode, H; Mauch, H1
Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S1
Le Pogamp, P; Nilsson, LG; Romero, AJ; Wood, N1
Drew, RH; Perfect, JR; Pound, MW1
Colebunders, R; Ieven, M; Noë, A; Ostyn, B; Swinne, D1
Boyken, L; Diekema, DJ; Hollis, RJ; Huynh, H; Messer, SA; Pfaller, MA1
Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA1
Dismukes, WE; Lee, J; Walsh, TJ1
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ1
DE Carolis, E; Loranger, L; Marcotte, H; Pelletier, R1
Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA2
Espinel-Ingroff, A; Rezusta, A1
Johnson, JR1
Cornely, OA; Heussel, CP; Ullmann, AJ1
Apisarnthanarak, A; Little, JR; Tebas, P1
Ghannoum, MA; Kuhn, DM1
Gil-Lamaignere, C; Maloukou, A; Mosquera, J; Roilides, E; Walsh, TJ1
Barry, A; Brown, S; Traczewski, M1
Bernhardt, H; Bernhardt, J; Knoke, M; Zimmermann, K1
De Vries-Hospers, HG; Meis, JF; Rijs, AJ; Te Dorsthorst, DT; Verweij, PE1
Habel, F; Hoban, D; Laverdiere, M; Restieri, C1
Bastide, JM; Dannaoui, E; Grillot, R; Mallie, M; Meletiadis, J; Piens, MA; Rigoni, AL; Tortorano, AM; Viviani, MA1
Allen, MJ; Ghahramani, P; Greenhalgh, K; Kleinermans, D; Purkins, L; Wood, N1
Coco, BJ; Kirkpatrick, WR; Patterson, TF; Perea, S1
Chen, N; Glickman, RD; Graybill, JR; Lam, KW; Sponsel, WE; Zhou, L1
Bennett, JE; Caillot, D; Chandrasekar, PH; de Pauw, B; Denning, DW; Durand, C; Greene, RE; Herbrecht, R; Hodges, MR; Kern, WV; Lortholary, O; Marr, KA; Oestmann, JW; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Stark, P; Sylvester, R; Thiel, E; Troke, PF; Wingard, JR1
Fothergill, AW; Gonzalez, G; Kirkpatrick, WR; Patterson, TF; Perea, S; Rinaldi, MG1
Gayowski, T; Singh, N; Venkataramanan, R; Zang, S1
Greenberg, RN; Martin, CA; Roberts, S1
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Paphitou, NI; Rex, JH; Rodriguez, JR1
Chryssanthou, E; Cuenca-Estrella, M2
Garbino, J; Hirschel, B1
Baglivo, E; Baligvo, E; Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Ondrusova, A; Rohner, P1
Darouiche, RO; Kontoyiannis, DP; Lewis, RE; Prince, RA; Raad, II1
Brown, NE; Chow, L; Kunimoto, D1
Brown, J; Potoski, BA1
Fothergill, AW; Rinaldi, MG; Sutton, DA; Yildiran, ST1
Goa, KL; Muijsers, RB; Scott, LJ1
Bacigalupo, A; Ferrua, MT; Gallamini, A; Ghirardo, D; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Viscoli, C1
Danielsen, R; Einarsdóttir, HM; Gottfredsson, M1
Blot, F; Edé, C; Nitenberg, GM1
Karthaus, M2
Meis, JF; Meletiadis, J; Mouton, JW; Verweij, PE1
Jones, DB; Shah, KB; Wilhelmus, KR; Wu, TG1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA1
Diekema, DJ; Hollis, RJ; Maxwell, MJ; Messer, SA; Pfaller, MA1
Matsunaga, T; Nagino, K; Uchida, K; Yamaguchi, H1
Deplus, S; Dombret, H; Feuillhade, M; Fournier, S; Molina, JM; Pavageau, W; Verola, O; Zagdanski, AM1
Falk, R; Polacheck, I; Shapiro, M; Wolf, DG1
Johnson, LB; Kauffman, CA1
Kottom, TJ; Limper, AH; Morales, IJ; Puri, V; Thomas, CF; Vohra, PK1
Ullmann, AJ2
Herbrecht, R2
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A1
Boyken, L; Diekema, DJ; Hollis, RJ; Maxwell, MJ; Messer, SA; Pfaller, MA; Tendolkar, S1
Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, JB; Pfaller, MA1
Howden, BP; Mijch, AM; Schwarer, AP; Slavin, MA1
Adderson, EE; Andreansky, M; Luján-Zilbermann, J; Rodriguez, CA; Woodard, P1
Dierch, MP; Gunsilius, E; Kofler, G; Lass-Flörl, C; Speth, C; Würzner, R1
Chapman, SW; Cleary, JD; Pearson, MM; Rogers, PD1
Anghilieri, M; Cafro, AM; Carrafiello, G; Cesana, C; D'Avanzo, G; Marbello, L; Morra, E; Nosari, A1
Burt, C; de Groot, MJ; Filler, SG; Fukuoka, T; Hitchcock, CA; Johnston, DA; Winslow, CA1
Chan, J1
Kamei, K1
Lipp, HP2
Holzgrabe, U; Schäfer-Korting, M1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA2
Hodges, MR; Lutsar, I; Tomaszewski, K; Troke, PF; Wood, ND1
Allen, S; Pai, MP1
Bayer, A; Edwards, JE; Rieg, G; Spellberg, B1
Ruhnke, M1
Hyland, R; Jones, BC; Smith, DA1
Chen, E; Matar, MJ; Ostrosky-Zeichner, L; Paetznick, VL; Rex, JH; Rodriguez, JR1
de la Torre-Cisneros, J; DuPont, B; Espinel-Ingroff, A; Greenberg, RN; Johnson, E; Just-Nübling, G; Lutsar, I; Marr, KA; Perfect, JR; Schlamm, HT; Walsh, TJ1
Mori, T1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Tendolkar, S3
Eggink, C; Nulens, E; Rijs, AJ; Verweij, PE; Wesseling, P1
Johnson, PD; Korman, TM; Stratov, I1
Belmatoug, N; de Lastours, V; Dufour, V; Fantin, B; Lefort, A; Zappa, M1
Harris, GJ; Kim, JE; Perkins, SL1
Bocanegra, R; Gonzalez, GM; Graybill, JR; Hernandez, S; Najvar, LK1
Hamza, SH; Mercado, PJ; Skelton, HG; Smith, KJ1
Cole, S; Comby, P; Gibson, D; Jezequel, SG; Nedderman, AN; Roffey, SJ; Smith, DA; Walker, DK; Wood, N1
Feldmesser, M; Pamer, EG; Van Epps, HL1
Chehade, M; Esmail-Zaden, R; Galanopoulas, A; Lai, TF; Malhotra, R; Selva, D1
Ellis, DH; Gosbell, IB; Kuo, RS; Perrie, RC; Toumasatos, V; Yong, J1
Bennett, JE; Cortez, KJ; Walsh, TJ1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL2
del Palacio, A; Garau, M; Pereiro, M1
Clark, M; Pennick, GJ; Rinaldi, MG; Sutton, DA1
Sutton, DA1
Alvarez, ME; Fortún, J; Martín-Dávila, P; Moreno, S; Pintado, V; Sánchez, MA; Sánchez-Sousa, A1
Choquet, S; Chosidow, O; Consigny, S; Datry, A; Dhedin, N; Leblond, V1
Walson, PD1
Fung, HB; Jeu, L; Lyakhovetskiy, AG; Piacenti, FJ1
Girmenia, C; Martino, P1
Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ1
Biert, J; Bosma, F; de Sévaux, RG; Kullberg, BJ; Melchers, WG; van Hamersvelt, HW; Verweij, PE; Voss, A1
Arrese, JE; Piérard, GE; Piérard-Franchimont, C; Quatresooz, P1
Lutsar, I; Roffey, S; Troke, P1
Almela, M; Danés, C; de la Bellacasa, JP; Espasa, M; Jiménez de Anta, MT; Jurado, A; Marco, F; Martínez, JA; Mensa, J1
Hilhorst, MI; Kuijpers, TW; Scherpbier, HJ1
Schäfer-Korting, M1
Gupta, AK; Tomas, E1
Giles, SS; Kurtzberg, J; Perfect, JR; Schell, WA; Steinbach, WJ; Trinh, JV1
Cook, C; Fernandez, C; Fraser, R; McCully, B; Schmidt, M; Shouldice, E1
Benito, R; Gil, J; Ramírez de Ocáriz, I; Rezusta, A; Rubio Calvo, MC1
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L1
Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL2
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Rinaldi, MG; Serena, C; Sutton, DA1
Andes, D; Conklin, R; Marchillo, K; Stamstad, T1
Dromer, F; Lamer, C; Le Guillou, JL; Le Jouan, M; Martinez, V; Tod, M1
Klopfenstein, KJ; Powell, D; Rosselet, R; Termuhlen, A1
Auner, HW; Dornbusch, HJ; Eibl, M; Linkesch, W; Sill, H; Zinke-Cerwenka, W1
Alfandari, S; Bauters, F; Benchikh, Z; Camus, D; Catteau, B; Cordevant, C; De Botton, S; Dei-Cas, E; Delhaes, L; Durand-Joly, I; Espinel-Ingroff, A; Rodrigue, M1
Garbino, J; Kolarova, L; Lew, D; Ondrusova, A; Rohner, P1
Kullberg, BJ; Ostrosky-Zeichner, L; Oude Lashof, AM; Rex, JH1
Denning, D; Guiver, M; Sambatakou, H1
Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A1
Kontoyiannis, DP; Lewis, RE; Lionakis, MS; Liu, W; May, GS; Wiederhold, N1
Chaturvedi, V; Gangwar, M; Ramani, R1
Chávez, M; Claro, R; Espinel-Ingroff, A; Mazuelos, EM; Morilla, D; Ramírez, M; Serrano, MC; Valverde, A1
Johnston, A1
Eve, MD; Greenhalgh, K; Nichols, D; Oliver, SD; Purkins, L; Wood, N1
Allen, MJ; Greenhalgh, K; Oliver, SD; Purkins, L; Wood, N1
Greenhalgh, K; Kleinermans, D; Nichols, D; Purkins, L; Wood, N1
Kleinermans, D; Nichols, D; Purkins, L; Wood, N3
Ghahramani, P; Kleinermans, D; Layton, G; Nichols, D; Purkins, L; Wood, N1
Eve, MD; Fielding, A; Ghahramani, P; Love, ER; Purkins, L; Wood, N1
Hamlin, J; Kleinermans, D; Layton, G; Nichols, D; Purkins, L; Tan, K; Wood, N1
Kleinermans, D; Love, ER; Purkins, L; Wood, N1
Bernhardt, H; Bernhardt, J; Knoke, M2
Bliss, JM; Gigliotti, F; Wellington, M1
Jacobs, RF; Maples, HD; Saccente, SL; Stowe, CD1
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ; Serena, C1
Gallamini, A; Lo Nigro, C; Mattei, D; Mordini, N; Osenda, M; Pugno, F; Viscoli, C1
Sims-McCallum, RP1
Ehlert, K; Groll, AH; Kolve, H; Paulussen, M; Vormoor, J1
Baron, EJ; Colombo, AL; de Bedout, C; del Palacio, A; Gibbs, DL; Girmenia, C; Hazen, KC; Sanchez-Sousa, A1
Bilger, K; D'incan, E; Damaj, G; Doglio, MF; Faucher, C; Gastaut, JA; Ivanov, V; Le Brigand, B; Vey, N1
Martin, PL; Miller, JL; Perfect, JR; Schell, WA; Steinbach, WJ1
Bonner, D; Fung-Tomc, J; Huczko, E; Minassian, B; Washo, T1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S1
Chow, E; Moore, T; Nielsen, K1
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH1
Denning, DW; Hope, WW1
Chi, J; Gao, H; Hariprasad, SM; Holz, ER; Kim, JE; Mieler, WF; Prince, RA1
Baboor, M; Diaz, MC; Fica, A; Luppi, M; Olivares, R; Saez, L; Vasquez, P1
Alangaden, GJ; Baskaran, I; Chandrasekar, PH; Manavathu, EK; Varanasi, NL1
Maertens, JA1
De Pauw, BE; Donnelly, JP1
Burgos San José, A; Hernández Prats, C; Llinares Tello, F; Ordovás Baines, JP; Selva Otaolaurruchi, J1
Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I1
Casal, M; Charriel, G; Linares, MJ; Solís, F1
Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Perez, A; Sevilla, J1
Gao, H; Hariprasad, SM; Holz, ER; Mieler, WF; Pennesi, M; Qiao, X; Shah, K; Wu, SM1
Caliandro, R; Girard, P; Stern, JB1
Baden, LR; Cosimi, LA; Marty, FM1
Gothard, P; Rogers, TR1
Cappelli, B; Castagnola, E; Dodero, P; Faraci, M; Machetti, M; Molinari, AC; Morreale, G; Tomà, P1
Dupont, B1
Boyken, L; Diekema, DJ; Hollis, RJ; Messer, SA; Pfaller, MA; Rice, C; Tendolkar, S2
Bastié, JN; Bretagne, S; Castaigne, S; Chehata, S; Cordonnier, C; Kuentz, M; Maury, S; Pautas, C; Ribaud, P1
Abidi, MH; Chandrasekar, PH; Ibrahim, RB; Vishnubhotla, P1
Contu, L; La Nasa, G; Ledda, A; Littera, R; Maccioni, A; Vacca, A1
Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T1
Aliyeva, SE; Frising, M; Kottler, UB; Schwenn, O; Ullmann, AJ1
Schwartz, S; Thiel, E3
Höhl, R1
Almeida, C; Chávez, M; Claro, R; Espinel-Ingroff, A; Fernández, A; Martín-Mazuelos, E; Morilla, D; Ramírez, M; Serrano, MC; Valverde, A1
Smilack, JD; Sohail, MR1
Barry, A; Bille, J; Brown, S; Ellis, D; Meis, JF; Pfaller, MA; Rennie, R; Rinaldi, M; Rogers, T; Traczewski, M1
Clement, A; De Arévalo, BF; Figueroa, MS; Fortun, J1
García-Bustínduy, M; Guimerá-Martín-Neda, F; Montelongo, RG; Noda-Cabrera, A; Sánchez-González, R1
Blankenship, JR; Heitman, J; Onyewu, C; Perfect, JR; Schell, WA; Steinbach, WJ1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR1
Innes, JR; Moss, PJ; Thaker, HR; Varma, D; Wedgwood, K1
Bethell, D; Goodman, TR; Hall, G; Klein, N; Pollard, AJ1
Kamei, K; Nishimura, K; Zeng, J; Zheng, Y1
Rubin, ZA; Somani, J1
Alfonso, EC; Giaconi, JA; Marangon, FB; Miller, D2
Danaher, PJ; Walter, EA1
Miller, J; Perlroth, MG1
Adou-Bryn, KD; Buisson, Y; Chandenier, J; Douchet, C; Kombila, M; Richard-Lenoble, D; Sar, B; Swinne, D; Thérizol-Ferly, M1
Ausin, I; Badia, X; Carreras, E; Herrera, L; Roset, M1
Casadevall, A; Cleare, W; Nosanchuk, JD; van Duin, D; Zaragoza, O1
Adamson, P; Arguedas, AG; Arrieta, AC; Blumer, J; Driscoll, T; Karlsson, MO; Lutsar, I; Milligan, P; Saez-Llorens, X; Vora, AJ; Walsh, TJ; Wood, N1
Proia, LA; Tenorio, AR1
Basso, C; Biffanti, R; Milanesi, O; Stellin, G; Thiene, G; Vida, V1
Buclin, T; Liaudet, L; Marchetti, O; Padoin, C; Robatel, C; Rusca, M1
Ikeda, Y; Kondo, K; Miyoshi, S; Nakashima, M; Sekiguchi, K; Umemura, K1
Lohr, L1
Alaggio, R; Calore, E; Cesaro, S; Cusinato, R; Messina, C; Pillon, M; Toffolutti, T; Zanesco, L1
Nolard, N; Swinne, D; Van der Flaes, M; Watelle, M1
Friedrich, W; Gahr, M; Hahn, G; Koch, A; Roesler, J; Rösen-Wolff, A1
Mattner, F; Strueber, M; Weissbrodt, H1
Bocanegera, R; Colombo, AL; Gonzalez, GM; Graybill, JR; Hernandez, S; McCarthy, DI; Najvar, LK1
Chang, CS; Chang, HW; Chang, WN; Chien, CC; Huang, CR; Lee, PY; Lei, CB; Lu, CH1
Anderson, KL; Mitra, S; Pham, TA; Salouti, R; Taylor, HR1
Antoniades, A; Giotakis, J; Imbrios, G; Manesis, EK; Tsiodras, S; Zafiropoulou, R1
Peetermans, WE; Van Wijngaerden, E; Vandecasteele, SJ1
Drago, M; Morace, G; Scaltrito, MM1
Holyoake, TL; McQuaker, IG; Osborne, WL; Parker, AN1
Aoun, M1
Germaud, P; Morin, O1
Benjamin, DK; Jafri, H; Kontoyiannis, DP; Lionakis, MS; Lutsar, I; Marr, KA; Perfect, JR; Steinbach, WJ; Torres, HA; Walsh, TJ1
Bernhardt, H; Bernhardt, J; Knoke, M; Ludwig, K1
Cheng, HH; Lo, HJ; Yang, YL1
Al-Fattani, MA; Douglas, LJ1
Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E1
Balajee, SA; Englund, JA; Fredricks, DN; Imhof, A; Marr, KA1
Bartelt, LA; de Magalhaes-Silverman, M; Diekema, DJ; Dodgson, KJ; Hoth, PL; Kilborn, SB; Pfaller, MA; Siwek, GT1
Bouteille, B; Debette-Gratien, M; Denes, E; Gaulier, JM; Pichon, N1
Bigley, VH; Duarte, RF; Gosling, RD; Kibbler, CC; Potter, M; Seaton, S1
Bonatti, H; Dierich, MP; Freund, MC; Gastl, G; Gschwendtner, A; Gunsilius, E; Kropshofer, G; Lass-Flörl, C; Petzer, A1
Castro, C; Espinel-Ingroff, A; Flores, B; Martín-Mazuelos, E; Serrano, MC1
Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N1
Bruneel, F; Chevret, S; de Broucker, T; Lellouche, F; Régnier, B; Tattevin, P; Wolff, M1
Karlsson, MO; Milligan, PA; Thomson, AH; Wählby, U1
Kleinpeter, MA1
Bannwarth, B; Jarry, C; Péhourcq, F1
Capilla, J; Guarro, J1
Kuijper, EJ; Kullberg, BJ; van 't Wout, JW; Verweij, PE1
Gavaldá, J; Lumbreras, C1
del Palacio, A; Garau, M; Garcí, J; Gené, J; Molina, L; Perkins, A1
Klastersky, J1
Chryssanthou, E; Sjölin, J1
Espinel-Ingroff, A; Jones, RN; Pfaller, MA1
Azzola, A; Bubendorf, L; Eich, G; Gratwohl, A; Habicht, JM; Passweg, JR; Tamm, M1
Alkan, Y; Burhenne, J; Haefeli, WE; Shalit, I; Stein, J; Yaniv, I1
Boeckh, M; Carter, RA; Corey, L; Kim, HW; Marr, KA1
Viscoli, C1
Bonnell, M; Currier, BL; Orenstein, R; Prabhu, RM1
Wark, P1
Blazes, DL; Dolan, CK; Hall, MA; Norwood, CW1
Boyd, AE; Denning, DW; Howard, SJ; Keevil, BG; Modi, S; Moore, CB1
Drusano, GL2
Andreadis, D; Antoniades, D; Arsenis, G; Belazi, M; Destouni, E; Eliopoulou, C; Hini, S; Koussidou-Eremondi, T; Velegraki, A1
Jones, AL; Pai, MP1
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I1
Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S1
Fujisaki, G; Kami, M; Kishi, Y; Kobayashi, K; Mitamura, T; Murashige, N1
Gao, H; Hariprasad, SM; Holz, ER; Mieler, WF; Pennesi, ME; Qiao, X; Shah, K; Wu, SM1
Chadwick, EG; Guzman-Cottrill, JA; Zheng, X1
Wingard, JR1
Balajee, SA; Gribskov, JL; Imhof, A; Marr, KA1
Vervaeren, J1
Comair, Y; Kanafani, ZA; Kanj, SS1
Benjamin, DK; Heitman, J; Miller, JL; Perfect, JR; Schell, WA; Singh, N; Steinbach, WJ1
Cariani, L; Drago, M; Morace, G; Scaltrito, MM1
Beltramo, D; Levin, T; Samuel, R; Suh, B1
Denning, DW; Howard, SJ; Keevil, BG; Lockhart, S; Moore, CB; Newman, S1
Carrilero, MJ; Granados, JM; Puerto, N1
Burn, AK; Coco, BJ; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Patterson, TF; Redding, SW; Rinaldi, MG1
Huang, DB; Lahart, CJ; Wu, JJ1
Mastromarino, A; Polizzi, A; Saccà, SC; Siniscalchi, C1
Alexander, BD; Brennan, K; Forrest, G; Husain, S; Muñoz, P; Singh, N; Somani, J; Wagener, MM1
Friedman, GS; Mathis, AS; Shah, NK1
Agrawal, AK; Sherman, LK1
Aebi, C; Aebischer, CC; Ammann, RA; Gugger, M; Jaton, K; Ritz, N; Schmid, RA1
Bansal, M; Fealy, S; Khazzam, M1
Casal, M; Charriel, G; Ibarra, A; Linares, MJ; Rodriguez, F; Solís, F1
Egle, H; König, A; Kümmerer, K; Trittler, R1
Demponeras, C; Kanta, E; Karandreas, N; Manesis, EK; Tsiodras, S; Zafiropoulou, R1
Perfect, JR2
Marr, K1
Breit, SM; Grand, MG; Hariprasad, SM; Mieler, WF; Mills, MD; Shah, GK1
Birnbaum, DE; Jagiello, M; Liebold, A; Retzl, G; Wieland, T1
Mehta, J; Ortiz, R; Pennick, G; Pi, J; Stosor, V; Trifilio, S; Verma, A; Zembower, T1
Clezy, K; van Hal, SJ1
Han, XY; Hassan, SA; Matsuda, SP; May, GS; Tarrand, JJ; Wilson, WK; Xiong, Q1
Danaher, PJ1
Lowry, CM; Marty, FM1
Soto, J1
Balwierz, W1
Azanza, JR; Campanero, MA; Quetglas, EG; Sádaba, B1
Berry, GJ; DiGiulio, DB; Fothergill, AW; McClenny, NM; Mirels, LF; Montoya, JG; Rinaldi, MG; Schaenman, JM1
Lien, YH; Peng, LW1
Belohradsky, BH; Führer, M; Graubner, UB; Kammer, B; Moelter, C; Schmid, I; Schuster, F1
Gehrig, AK; Hoppe-Tichy, T; Nguyen, H; Wenzel, S1
García-Agudo, L; García-Martos, P; Gutiérrez-Calzada, J; Marín, P; Ruiz-Aragón, J; Saldarreaga, A1
Chevallier, P; Dubruille, V; Guillaume, T; Harousseau, JL; Mahé, B; Méchinaud, F; Milpied, N; Moreau, P; Morin, O; Morineau, N; Vigouroux, S1
Oren, I1
Del Favero, A; Kibbler, C; Marciniak, A; Mauskopf, J; Morris, S; Rogers, T; Rotstein, C; Schlamm, H; Troke, P; Wenzel, R1
Klepser, ME; Lewis, RE; Wiederhold, NP1
Alcazar-Fuoli, L; Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL1
Cuvelier, C; Goffin, E; Kirch, L; Pochet, JM; Tintillier, M1
Benito, R; de Ocáriz, IR; Gil, J; Rezusta, A; Rubio, MC1
Chen, A; Sobel, JD1
Horstkotte, MA; Rohde, H; Sobottka, I; Steininger, C; Stellbrink, HJ; van Lunzen, J1
Burkhardt, O; Köhnlein, T; Pletz, M; Welte, T1
Bailly, E; Bastides, F; Ehrmann, S; Gissot, V; Legras, A; Magro, P; Mercier, E1
Bastide, JM; Blancard, A; Bonnin, A; Bretagne, S; Cambon, M; Chandenier, J; Chauveau, V; Couprie, B; Datry, A; Feuilhade, M; Grillot, R; Guiguen, C; Lavarde, V; Letscher, V; Linas, MD; Mallié, M; Michel, A; Morin, O; Paugam, A; Piens, MA; Raberin, H; Tissot, E; Toubas, D; Wade, A1
Dupont, B; Fain, O; Herbrecht, R; Lescure, FX; Lortholary, O; Lutsar, I; Mouas, H1
Cudillo, L; de Fabritiis, P; Dentamaro, T; Girmenia, C; Picardi, A; Santilli, S; Tendas, A1
Fabry, K; Nelen, G; Verheyden, F1
Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Viudes, A1
Yasuda, MA1
Kontoyiannis, DP; Lionakis, MS1
Nolard, N; Swinne, D; Watelle, M1
Dinser, R; Grgic, A; Kim, YJ; Pfreundschuh, M; Schubert, J1
Irving, H; Labrom, R; Nissen, M; O'Regan, P; Siebert, D; Whyte, M1
Garbino, J; Lew, D; Rohner, P; Uckay, I; Van Delden, C1
Chandrasekar, PH; Krishnan, S; Manavathu, EK1
Ballesta, S; García, I; Pascual, A; Perea, EJ1
Cesaro, S; Visintin, G1
Aksamit, AJ; Bakleh, M; Marshall, WF; Tleyjeh, IM1
Chaberny, IF; Fischer, S; Gastmeier, P; Gottlieb, J; Haubitz, B; Mattner, F; Mattner, L; Strueber, M; Weissbrodt, H1
Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W1
Hansen, R; Mendelson, D; Park, A; Racette, AJ; Roenigk, HH1
Casal, M; Linares, MJ; Solís, F1
Mohammedi, I; Padoin, C; Piens, MA; Robert, D1
Gil-Lamaignere, C; Hess, R; Heyn, K; Kappe, R; Müller, FM; Salvenmoser, S1
de Kerviler, E; Derouin, F; Feuilhade de Chavin, M; Lacroix, C; Morel, P1
Christmann, D; Eisenmann, B; Forestier, E; Hansman, Y; Lesens, O; Martinot, M; Remy, V1
Cuenca-Estrella, M; Elia, M; Gutierrez, F; Masia, M; Ramos, JM; Rodriguez-Tudela, JL1
Leather, H1
Antachopoulos, C; Bibashi, E; Dotis, J; Koliouskas, D; Papakonstantinou, E; Roilides, E; Tamiolaki, M1
Baltch, AL; Bopp, LH; Carlyn, CJ; Michelsen, PB; Ritz, WJ; Smith, RP1
Brown, J; Freeman, BB1
Eggink, CA; Klont, RR; Rijs, AJ; Verweij, PE; Wesseling, P1
Böhme, A; Haas, A; Maschmeyer, G1
Dierich, MP; Lass-Flörl, C; Leitner, S; Rief, A; Speth, C; Würzner, R1
Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D1
Boisseau-Garsaud, AM; Calès-Quist, D; Desbois, N; Diedhou, A; Dutriaux, C; Saint-Cyr, I1
Steinbach, WJ2
Ambegaonkar, AJ; Boucher, HW; Day, DL; Lewis, JS; Lubowski, TJ; Patterson, TF1
Jacobs, RF; Maples, HD; Muldrew, KM; Stowe, CD1
Jang, GJ; Kim, KS; Lee, WK; Shin, WS1
Alsultan, A; Goldman, FD; Lubner, S; Williams, MS1
Kofla, G; Ruhnke, M1
Auvrignon, A; Boccon-Gibod, L; Landman-Parker, J; Leverger, G; Moissenet, D; Petit, A; Tabone, MD1
Keady, S; Thacker, M1
Corey, L; Cornely, OA; Driscoll, T; Lutsar, I; Ribaud, P; Ruhnke, M; Schuler, U; Schwartz, S; Thiel, E; Troke, P1
Banfield, M; Burhenne, J; Haefeli, WE; Mikus, G; Rengelshausen, J; Riedel, KD; Thomsen, T; Walter-Sack, I; Weiss, J1
Fothergill, AW; González, GM; Loebenberg, D; Rinaldi, MG; Sutton, DA1
Horn, TD; Sharp, MT1
McCluskey, P; Singh, RP1
Athanassiadou, F; Kalogera, A; Kourti, M; Papageorgiou, T; Tragiannidis, A; Velegraki, A1
Fruehwirth, F; Khoschsorur, G; Zelzer, S1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J1
Morace, G; Polonelli, L1
Bedini, A; Cocchi, S; Codeluppi, M; Esposito, R; Guaraldi, G; Squillace, N; Venturelli, C1
Barton, TD; McGarvey, M; Milas, B; Pochettino, A; Reboli, A; Reis, LJ; Schuster, MG; Velazquez, O1
Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE1
Jagirdar, J; Scott, RS; Sutton, DA1
Cetinkaya, Z; Kiraz, N1
Kotamarthi, V; Shankar, J; Sharma, V1
Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM1
Cárdenes, CD; Carrillo-Muñoz, AJ; Carrillo-Orive, B; Casals, JB; Del Valle, O; Ezkurra, PA; Quindós, G; Rodríguez, V1
Costa-de-Oliveira, S; Mårdh, PA; Pina-Vaz, C; Ricardo, E; Rodrigues, AG1
Bullock, PR; Chakraborty, A; Workman, MR1
Debets-Ossenkopp, YJ; van Furth, AM; van Groeningen, I; van Well, GT; Zwaan, CM1
MacCallum, DM; Odds, FC; Whyte, JA1
Aguado, JM; Cisneros, JM; Díaz Pedroche, C; Lumbreras, C1
Azar, DT; D'Amico, DJ; Durand, ML; Kieval, SJ; Kim, IK; Loewenstein, JI; Lujan, BJ; Martin, SS; Miller, FS; Miller, JW; Tobin, EH1
Barchiesi, F; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Pfaller, MA; Rinaldi, M; Rodriguez-Tudela, JL; Verweij, PE1
Costa-de-Oliveira, S; Espinel-Ingroff, A; Pina-Vaz, C; Rodrigues, AG1
Bergeron, A; Dromer, F; Ferry, C; Feuilhade, M; Gluckman, E; Hermoso, DG; Lacroix, C; Molina, JM; Pavie, J; Ribaud, P; Robin, M1
Bagg, J; Brailsford, S; Davies, AN; Jackson, MS; Sweeney, MP1
Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM1
Allepuz-Palau, A; Alvarez-Lerma, F; Díaz-Regañón, J; García-López, F; Nicolás-Arfelis, JM; Rodríguez-Borregán, JC; Sa-Borges, M1
Fianchi, L; Gleissner, B; Pagano, L1
Bishara, J; Peled, N; Samra, Z; Yardeni, M1
Kontoyiannis, DP; Lewis, RE2
Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V1
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A1
Blair, JE; Leslie, KO; Lyons, MK1
Niwa, T; Shiraga, T; Takagi, A1
Schiel, X; Spöhrer, U; Vogeser, M1
Espinel-Ingroff, A; Fothergill, A; Ghannoum, M; Manavathu, E; Ostrosky-Zeichner, L; Pfaller, M; Rinaldi, M; Schell, W; Walsh, T1
Alexander, BD; Long, GD; Miller, JL; Perfect, JR; Schell, WA1
Chan-Tack, KM1
Baker, CJ; Pannaraj, PS; Walsh, TJ1
Barak, A; Bash, E; Loewenstein, A; Neudorfer, M; Siegman-Igra, Y; Zayit-Soudry, S1
Colombo, GL; Morlotti, L; Serra, G1
Argaud, L; Martin, O; Mohammedi, I; Piens, MA; Robert, D; Thiebaut, A1
Bennett, JE; Boucher, HW; Denning, DW; DePauw, B; Herbrecht, R; Lortholary, O; Patterson, TF; Ribaud, P; Rubin, RH; Schlamm, HT; Troke, P; Wingard, JR1
Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW1
Blijlevens, NM; Jansen, JP; Meis, JF; van't Wout, JW1
Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M1
Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F1
Blatny, J; Burgetova, D; Kren, L; Mudry, P; Prochazka, J; Skotakova, J; Sterba, J; Valik, D; Ventruba, J1
Schoeni, MH1
Bertz, H; Finke, J; Kern, WV; Sander, A; Wagner, D1
Bennett, MT; Sirrs, S; Smith, CA; Yeung, JK1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G1
Devouassoux, G; Freymond, N; Harf, R; Le Loch, JB; Pacheco, Y; Rakotomalala, A1
Nagino, K; Shirasawa, H1
Decosterd, LA; Duchosal, MA; Gambillara, E; Kovacsovics, T; Laffitte, E; Panizzon, RG; Widmer, N1
Chamilos, G; Kontoyiannis, DP1
Baruch, A; Dowell, JA; Foster, G; Schranz, J1
Adams, HP; Apostolova, LG; Johnson, EK1
Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY1
Barfield, RC; Behm, FG; Burnette, K; Eldridge, P; Hale, GA; Handgretinger, R; Knapp, K1
Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA1
Heyn, K; Müller, FM; Salvenmoser, S; Tredup, A1
Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM1
Cutler, JE; Hazen, KC; Wetter, TJ1
Barnes, R; Diekema, DJ; Gibbs, DL; Hu, B; Nagy, E; Pfaller, MA; Rinaldi, MG; Tiraboschi, N; Veselov, AV1
Burhenne, J; Foell, JL; Reiss, T; Rengelshausen, J; Staege, MS; Stiefel, M; Wawer, A1
Fulcher, T; Hannan, M; O'Doherty, M1
Cohen, EJ; Hammersmith, KM; Kang, S; Ozbek, Z; Rapuano, CJ; Sivalingam, J1
Chamilos, G; Kontoyiannis, DP; Lewis, RE1
Chen, N; Dang, D; Glickman, R; Graybill, J; Lam, KW; Najvar, LK; Paris, G; Scribbick, F; Sponsel, W; Zhou, L1
Al-Agha, OM; Mooty, M; Salarieh, A1
Carpenter, J; Howell, A; Hurley, D; Midturi, J; Sierra-Hoffman, M; Winn, R1
Curigliano, G; de Braud, F; De Pas, T; Fazio, N; Formica, V; Goldhirsch, A; Pietri, E; Spitaleri, G1
Araujo, R; Pina-Vaz, C; Rodrigues, AG2
Chang, SC; Chen, YC; Hsieh, SM; Lee, HT; Pan, SC1
Kumar, R; Naithani, R1
Denning, DW; Jain, LR1
Brayshaw, N; Tan, K; Tomaszewski, K; Troke, P; Wood, N1
Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Bosch, M; Cantón, E; Gobernado, M; Pemán, J; Viudes, A1
Marik, PE; Raman, T1
Clode, AB; Davis, JL; Gilger, BC; Michau, TM; Salmon, J1
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T1
Alarcón L, P; Camacho A, J; Cruces R, P; Donoso F, A1
Ellis, D; Harkness, J; Kwong, T; Marriott, D1
Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV1
Baccari, P; Fumagalli, L; Lazzarin, A; Magnani, P; Prigitano, A; Sagnelli, C1
Aguado, JM; Del Busto, R; Fisher, RA; Forrest, G; Houston, S; Husain, S; Klintmalm, GB; Kontoyiannis, DP; Lewis, RE; Limaye, AP; Miller, R; Montoya, JG; Muñoz, P; Patton, P; Pursell, K; Rosso, F; Safdar, N; Singh, N; Wagener, MM1
Droll, A; Krähenbühl, S; Wenk, M1
Carde, A; Faure, P; Papy, E; Ribaud, P; Touratier, S1
Casadevall, A; Martinez, LR1
Delikou, S; Kitra, V; Miyakis, S; Papadakis, V; Papadatos, I; Parcharidou, A; Polychronopoulou, S; Velegraki, A1
Carmichael, JK1
Bal, AM2
Andes, D; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Ghannoum, MA; Johnson, EM; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG; Sheehan, DJ; Troke, P; Walsh, TJ; Warnock, DW1
Appelgren, P; Farnebo, F; Hedblad, MA; Petrini, B1
Dombrowski, F; Franke, A; Jentsch-Ullrich, K; Koenigsmann, M; Mohren, M; Schalk, E1
Al-Attar, A; Redett, RJ; Williams, CG1
Fernández Ballesteros, A; Flox Benítez, G; Quero Escalada, M; Rondón Fernández, P1
Badet, M; Bayle, F; Guérin, C; Lemasson, S; Philit, F; Poupelin, JC; Richard, JC1
de Marie, S; den Hollander, JG; Levin, MD; Lugtenburg, PJ; Rijnders, BJ; van Arkel, C1
Herbrecht, R; Jehl, F; Levêque, D; Nivoix, Y1
Kamani, N; Panicker, J; Walsh, T1
Coco, BJ; Kirkpatrick, WR; Patterson, TF1
Ambrose, PG; Andes, D; Bhavnani, SM; Knasinski, V; Safdar, N; Simmons, W; Smith, J1
Laine, K; Leino, K; Neuvonen, PJ; Olkkola, KT; Saari, TI; Valtonen, M3
Agostinelli, C; Arpinati, M; Baccarani, M; Bandini, G; Bonifazi, F; Giannini, B; Paolini, S; Ricci, P; Stanzani, M; Vianelli, N1
Allamani, M; Falagas, ME; Michalopoulos, A; Vassiloyanakopoulos, A1
Le Tulzo, Y; Tattevin, P1
Croxo, C; Darras, A; Mulliez, P; Roy-Saint Georges, F1
Castro-Orjales, MJ; Collell-Llach, MD; de la Torre-Fernández, MJ; Díaz-López, MD; León, C; López-Ciudad, V; Pérez de Juan-Romero, MA; Sanz-Rodríguez, C1
Ada, E; Avkan Oğuz, V; Balci, P; Ceylan, E; Gülşen, A; Güngör, O; Kargi, A; Sanli, A; Tertemiz, KC; Uçan, ES; Uğural Sezak, N1
Brakhage, AA; da Silva Ferreira, ME; Goldman, GH; Goldman, MH; Kim, HS; Malavazi, I; Nierman, WC; Savoldi, M1
Cobb, S; Diekema, DJ; Hoth, P; Magalheas-Silverman, M; Pfaller, MA; Polgreen, PM; Siwek, GT1
Hasan, Y; Stableforth, P; Wandroo, F1
Antin, JH; Baden, LR; Campbell, BJ; Cutler, CS; Fiumara, K; Lowry, CM; Marty, FM1
Capitano, B; Husain, S; McCurry, KR; Paterson, DL; Potoski, BA; Studer, SM; Venkataramanan, R; Zhang, S1
Alcalá, L; Bouza, E; Guinea, J; Peláez, T3
Crum-Cianflone, N; Dull, M; Teneza-Mora, N1
Gribskov, JL; Kirby, KA; Marr, KA; Panackal, AA; Rinaldi, M; Staab, JF1
Bosch, M; Cantón, E; de Llanos, R; Jarque, I; Molina, A; Pemán, J; Salavert, M1
Denis, O; Estenne, M; Jacobs, F; Knoop, C; Nolard, N; Schrooyen, M; Symoens, F1
Amorosa, V; Bridges, CR; Isidro, AM; Pentz, WH; Rutenberg, HL; Stopyra, GA1
Braun-Falco, M; Ring, J1
Jarque, I; Salavert, M1
Bosch, M; Calabuig, E; Cantón, E; Gobernado, M; Pemán, J; Valentí, A; Viudes, A1
Axer-Siegel, R; Bishara, J; Blau, H; Kramer, M; Kramer, MR; Weinberger, D1
Berry, A; Cassaing, S; Hajj, LE; Khatibi, S; Linas, MD; Magnaval, JF; Marchou, B; Massip, P; Porte, L; Sans, N1
Hynninen, VV; Laine, K; Leino, K; Lundgren, S; Neuvonen, PJ; Olkkola, KT; Rane, A; Valtonen, M; Vyyryläinen, H1
Black, TA; Hare, R; Loebenberg, D; Mann, PA; McNicholas, PM; Mendrick, CA; Norris, CC; Patel, R; Sabatelli, F1
Gilgado, F; Guarro, J; Mariné, M; Pastor, FJ; Serena, C1
Buitrago, MJ; Cuenca-Estrella, M; Garcia-Effron, G; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL1
Akova, M; Sahin, GO1
Aperis, G; Mylonakis, E1
Amrein, C; Auffret, N; Chevalier, P; Guillemain, R; Janssen, F; Le Beller, C1
Davis, JL; Papich, MG; Salmon, JH1
Denning, DW; Dupont, B; Lode, H; Sambatakou, H1
Brandenburg, VM; Floege, J; Guetgemann, A; Ketteler, M; Riehl, J1
Blijlevens, NM; Donnelly, JP; Klont, RR; van der Velden, WJ; Verweij, PE1
Clemons, KV; Martinez, M; Parmar, R; Stevens, DA1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP2
Antony, SJ; Brumble, L; Jurczyk, P1
Kujath, P; Scheele, J1
Agarwal, R; Singh, N1
Claes, K; Evenepoel, P; Kuypers, DR; Vanrenterghem, Y1
Farina, C; Goglio, A; Gotti, E; Suter, F1
Colson, YL; Marty, FM; Paul, S1
Edwards, C; Garcia, RJ; Troya, P1
Craven, DE; Gorman, SR; Magiorakos, AP; Zimmerman, SK1
Derendorf, H; Ihle, F; Theuretzbacher, U1
Blackwood, RA; Klein, KC1
Ghannoum, M; Isham, N; Sheehan, D1
Lee, GA; McDougall, R; Whitehead, K1
Carby, M; Hall, AV; Zoumot, Z1
Almyroudis, NG; Bhatti, Z; Segal, BH; Shaukat, A1
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H1
Chiadmi, F; Cisternino, S; Fontan, JE; Sahraoui, L; Schlatter, J; Toledano, A1
Pemán, J; Zaragoza, R1
Bäsecke, J; Glass, B; Perske, C; Rüchel, R1
Arechavala, A; Bianchi, MH; López Daneri, G; Negroni, R; Robles, AM; Santiso, G1
Björkholm, M; Cherif, H; Kalin, M1
Eifinger, F; Frankenbusch, K; Kribs, A; Rengelshauseu, J; Roth, B1
Buzina, W; Feierl, G; Haas, D; Holl, A; Kleinert, R; Marth, E; Reichenpfader, B; Reinthaler, FF; Roll, P1
Burhenne, J; Ding, R; Drzewinska, M; Haefeli, WE; Mikus, G; Rengelshausen, J; Riedel, KD; Schöwel, V; Thomsen, T; Weiss, J1
Chaturvedi, V; Cole, R; Gangwar, M; Ramani, R; Sheehan, DJ1
Casadevall, A; Mavrogiorgos, N; Nosanchuk, JD; Zaragoza, O1
Burhenne, J; Cornely, OA; Elter, T; Fätkenheuer, G; Gossmann, A; Kuchta, J; Riedel, KD; Schröder, U; Seifert, H; Sieniawski, M; Wickenhauser, C1
Dikman, S; Huprikar, S; Linden, E; Murphy, B; Restrepo, D1
Gottfredsson, M; Steingrímsdóttir, H1
Rokicka, M1
Selleslag, D1
Burhenne, J; Egerer, G; Geist, MJ; Mikus, G1
Kadota, J; Tokimatsu, I1
Hapuarachchi, S; Jayasinghe, S; Perera, KN; Ranwala, R; Rodrigo, N; Warnakulasuriya, A1
Bailey, TA; Di Somma, A; Silvanose, CD1
Cepero de García, MC; Espinel-Ingroff, A; Rincón, S1
Barcs, I; Dóczi, I; Mestyán, G; Nagy, E; Nikolova, R; Puskás, E1
Chusid, MJ; Destino, L; Havens, PL; Helon, AL; Sutton, DA; Thometz, JG; Willoughby, RE1
Klastersky, J; Paesmans, M1
Lill, H; Voigt, C1
Cornely, OA; Glöckner, A1
Burhenne, J; von Mach, MA; Weilemann, LS1
Bodkin, J; Bubb, WA; Coen, M; Himmelreich, U; Kuchel, PW; Power, D; Sorrell, TC1
Aperis, G; Mylonakis, E; Spanakis, EK1
Akiyama, H; Honma, M; Ito, T; Muramatsu, T; Negishi, K; Ohashi, K; Sakai, M; Sakamaki, H; Shitara, M; Suzuki, T; Ueki, T; Yamashita, T1
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S1
Bouges-Michel, C; Dannaoui, E; Garcia-Hermoso, D; Lortholary, O; Meneau, I; Naccache, JM; Sanglard, D; Valeyre, D1
Manfredi, R; Sabbatani, S1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Chang, SC; Diekema, DJ; Erzsebet, P; Gibbs, DL; Kibbler, C; Mendez, M; Newell, VA; Pfaller, MA1
Colombo, AL; Diekema, DJ; Gibbs, DL; Kibbler, C; Newell, VA; Ng, KP; Pfaller, MA1
Beck, R; Kaben, U; Tintelnot, K1
Alvarez-Lerma, F; Grau, S; Marín-Casino, M; Mateu-De, AJ; Torres-Rodríguez, JM1
Gopal, L; Sen, P; Sen, PR1
De Stefano, V; Fianchi, L; Leone, G; Murri, R; Pagano, L; Rossi, E1
Denning, DW; Gardiner, RE; Howard, SJ; Moore, CB; Park, S; Perlin, DS; Webster, I1
Chambers, D; Chin, W; Gabbay, E; Murray, R; Musk, M1
Alegre, M; Alomar, A; Dalmau, J; Gurgui, M; Pimentel, CL; Roé, E; Sanchez, F1
Burhenne, J; Haefeli, WE; Kaufmann, C; Thiel, MA; Zinkernagel, AS1
Crespo, M; Husain, S; Johnson, B; Kwak, EJ; McCurry, KR; Pakstis, DL; Paterson, DL; Pilewski, J; Shutt, K; Studer, S; Zaldonis, D; Zeevi, A1
Borgia, SM; El-Helou, P; Fuller, JD; Sarabia, A1
Demchok, JP; Meletiadis, J; O'Shaughnessy, EM; Stergiopoulou, T; Walsh, TJ1
Denning, DW; Heep, M; Mosquera, J; Schmitt-Hoffmann, A; Sharp, A; Spickermann, J; Warn, PA1
Donati, A; Gabbanelli, V; Nataloni, S; Pantanetti, S; Pelaia, P; Rossi, R1
Foster, G; Labadie, R; Liu, P; Sharma, A; Somoza, E1
Garbino, J; Roberts, C; Schnetzler, G1
Honda, M; Ichiyasu, H; Kohrogi, H; Matsumoto, M; Okamoto, S; Okamoto, T; Sato, K; Tsumori, K; Yamamura, A1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Decosterd, LA; Majcherczyk, PA; Marchetti, O; Nieth, V; Pascual, A; Sanglard, D1
Barrao, ME; García-Gil, FA; Jiménez, B; Larraga, J; Luque, P; Serrano, MT; Tomé-Zelaya, E1
König, B; König, W; Krause, H; Seibold, M; Tammer, I; Tintelnot, K1
Dierich, MP; Lass-Flörl, C; Lugger, H; Perkhofer, S1
Alak, A; Buell, D; Holum, M; Keirns, J; Sawamoto, T; Wisemandle, W1
Galluzzo, ML; Holland, SM; Piontelli, E; Rosenzweig, SD; Santos, PE; Shea, YR; Zelazko, ME1
Boggild, AK; Mohan, S; Ostrowski, MA; Poutanen, SM1
Macura, AB; Pawlik, B; Szul, A1
Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C1
Patel, R; Piper, KE; Shuford, JA; Steckelberg, JM1
Fukuoka, N; Houchi, H; Ishida, T; Kawazoe, H; Ohnishi, H; Takiguchi, Y; Tanaka, H1
Damle, B; Dodds Ashley, ES; Fang, AF; Perfect, JR; Zaas, AK1
Baumann, A; Caversaccio, M; Hausler, R; Zimmerli, S1
Belousov, DIu; Veselov, AV1
Dallot, A; Dannaoui, E; Dupont, B; Hot, A; Lortholary, O; Loulergue, P; Poirée, S1
Borrego, L; Hernández, J; Hernández-Machín, B; Islas, D; Martín, AM; Peñate, Y1
Ioannidis, J; Likartsis, C; Orfanou, A; Paliogianni, F; Roilides, E; Simitsopoulou, M; Walsh, TJ1
Imhof, A; Schaer, DJ; Schanz, U; Schwarz, U1
Kalivas, J1
Ayres, BD; Bunya, VY; Cohen, EJ; Hammersmith, KM; Rapuano, CJ1
Carratalà, J; Garcia-Vidal, C1
Campbell, C; Johnson, E; Lamagni, TL; Pezzoli, L1
Canton, E; Espinel-Ingroff, A; Gibbs, D; Wang, A1
Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS1
Alcoba-Flórez, J; Arévalo, MP; Arias, A; Moragues, MD; Pontón, J; Quindós, G; Salgado-Parreño, FJ1
Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K1
Corbett, JR; McKeown, PP; Tolland, JP1
Bandrés Gimeno, R; Muñoz Martínez, MJ1
Benjamin, DK; Cotten, CM; Perfect, JR; Schell, WA; Smith, PB; Steinbach, WJ; Walsh, TJ1
Arena, G; Bongiorni, MG; Doria, R; Germenia, C; Giannola, G; Leonildi, A; Menichetti, F; Soldati, E; Tascini, C1
Looke, DF; McCarthy, KL; Playford, EG; Whitby, M1
Scott, LJ; Simpson, D1
Del Castillo, A; Díaz, S; Domínguez-Gil, A; García Vargas, M; Martín, I; Sánchez, C1
Barchiesi, F; Borowski, E; Milewski, S; Morschhäuser, J; Prasad, R; Wakieć, R1
Chhun, S; Jullien, V; Lortholary, O; Pons, G; Rey, E; Tran, A1
Bennett, CL; Blum, W; Chamilos, G; Evens, A; Kennedy, L; Kontoyiannis, DP; McKoy, JM; Mehta, J; Mullane, K; Palella, F; Parada, J; Scheetz, MH; Tallman, MS; Trifilio, SM; Yarnold, PR1
Maesaki, S2
Baden, LR; Katz, JT; Koplan, BA; Marty, FM; Philips, JA; Stone, RM1
Booton, GC; Doyle, RL; Montoya, JG; Visvesvera, GS; Walia, R1
Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH1
Kofteridis, D; Koutsopoulos, A; Krasagakis, K; Maraki, S; Samonis, G; Sfakianakis, A; Stefanidou, M; Tosca, A1
Boumediene, A; Darde, ML; Denes, E; Durox, H; Gaulier, JM; Oksman, A; Saint-Marcoux, F1
da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J1
Araújo, CR; Costa, CR; e Souza, LK; Fernandes, Ode F; Nascimento, ES; Passos, XS; Sales, WS; Silva, Mdo R1
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J1
Collins, CD; DePestel, DD; Stevenson, JG; Stuntebeck, ER1
Avci, B; Cetinkaya, Z; Ermis, SS; Inan, UU; Kusbeci, T; Ozturk, F; Yavas, G1
Bhat, SV; Paterson, DL; Rinaldi, MG; Veldkamp, PJ1
Kalavsky, E; Krcmery, V; Liskova, A; Shahum, A1
Beschorner, R; Freudenstein, D; Koerbel, A; Tatagiba, M1
Cars, O; Johansson, A; Lignell, A; Löwdin, E; Sjölin, J1
Lambert, JS; Poulton, MB; Scott, CJ; Taylor, CB1
Meletiadis, J; O'Shaughnessy, EM; Peter, J; Stergiopoulou, T; Walsh, TJ1
Sellart-Altisent, M; Torres-Rodríguez, JM1
Bergeron, A; Cadranel, J; Camuset, J; Dauriat, G; Dombret, MC; Henno, P; Mangiapan, G; Nunes, H; Philippe, B; Rabbat, A1
Ayadi, A; Ben Salah, S; Ben Zina, Z; Cheikrouhou, F; Colin, J; Feki, J; Makni, F; Mlik, M1
Mylona, S; Ntai, S; Pomoni, M; Thanos, L; Tzavara, V1
Melchers, WJ; Mellado, E; Verweij, PE1
Dahl, P; Hu, DN; Koplin, RS; Meskin, SW; Perez, W; Ritterband, DC; Seedor, JA; Shah, MK; Yang, R1
James, C; Moore, MH; Murphy, D1
Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ1
Kohl, S; Madariaga, MG1
Coates, PT; Grove, DI; Li, JY; Yong, TY1
Arthington-Skaggs, B; Ellis, D; Espinel-Ingroff, A; Fothergill, A; Gibbs, DL; Iqbal, N; Messer, S; Pfaller, MA; Rinaldi, M; Wang, A1
Handa, H; Irisawa, H; Karasawa, M; Matsushima, T; Murakami, H; Nojima, Y; Saitoh, T; Shimizu, H; Tsukamoto, N; Yokohama, A1
Imai, N; Murayama, N; Nakane, T; Shimizu, M; Yamazaki, H1
Carrillo-Munoz, AJ; Casals, JB; Eraso, E; Quindos, G; Rementeria, A; Rodriguez Andres, C; Sanchez-Vargas, LO; Villar, M1
Arnold, S; Chen, F; Connolly, P; Freifeld, A; Lemonte, A; Meyer, T; Ooi, W; Smedema, M; Wheat, LJ1
Alvarado-Ramírez, E; Torres-Rodríguez, JM1
DeRemer, D; Fain, H; Farrow, S; Jillella, AP; Ustun, C1
Colombo, AL; Diekema, DJ; Fu, W; Gibbs, DL; Gould, IM; Meis, JF; Newell, VA; Pfaller, MA; Rodriguez-Noriega, E1
Alvárez-Espejo, T; Cobo, M; Fernández, I; Muñez, E; Muñoz, M; Ramos, A; Toquero, J1
Ajisawa, A; Honma, M; Imamura, A; Negishi, M; Suganuma, A; Suzuki, T; Takeshita, N; Yanagisawa, N1
Colby, K; Jurkunas, UV; Langston, DP1
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C2
Blayac, JP; Cociglio, M; Djezzar, S; Eiden, C; Hansel, S; Hillaire-Buys, D; Peyrière, H1
Lee, YF; Shen, YC; Tsai, HY; Tsai, TC; Wang, CY; Wang, MY; Wei, LC1
Bonatti, H; Lass-Floerl, C; Lechner, M; Lorenz, I; Piza, H; Rieder, J; Rieger, M1
Jhanji, V; Mannan, R; Sharma, N; Titiyal, JS; Vajpayee, RB1
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S1
Harada, AS; Lau, W1
Ho, DY; Lee, JD; Montoya, JG; Rosso, F1
Amedro, P; Blayac, JP; Cociglio, M; Eiden, C; Hillaire-Buys, D; Margueritte, G; Peyrière, H; Tichit, R1
Alonso, N; Bajo, R; Casado, MS; de la Llana, FG; Fajardo, M; Garcia-Dominguez, M; Sanz-Rodriguez, C; Vagace, JM; Zarallo, L1
Aller, AI; Castro, C; Claro, R; Colom, MF; Martín-Mazuelos, E; Serrano, C1
Hay, RJ1
Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH1
Gupta, A; Mao, Q; Unadkat, JD1
Germaud, P; Pipet, A1
Fincher, T; Fulcher, SF1
Eichhorn, ME; Hartl, WH; Jauch, KW; Joka, M; Küchenhoff, H; Wolf, H1
Araujo, BV; Conrado, DJ; Dalla Costa, T; Palma, EC1
Arendrup, MC; Denning, DW; Diekema, DJ; Pfaller, MA; Rex, JH1
Keynan, Y; Sprecher, H; Weber, G1
Cárdenes, CD; Carrillo-Muñoz, AJ; del Valle, O; Estivill, D; Giusiano, G; Guardia, C; Guarro, J; Quindós, G; Rodríguez, V1
Ament, AJ; de Groot, R; Donnelly, JP; Hübben, MW; Severens, JL; van 't Wout, J; Verweij, PE; Warris, A1
Bocanegra, R; Graybill, JR; Kirkpatrick, WR; Najvar, LK; Patterson, TF1
Acharya, NR; Chidambaram, JD; Fothergill, AW; Hong, KC; Lalitha, P; Lietman, TM; Maxey, KJ; McLeod, SD; Prajna, NV; Ruiz, J; Shapiro, BL; Srinivasan, M1
Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A1
Arisaka, O; Fujisawa, M; Fukushima, K; Hagisawa, S; Kurosawa, H; Matsunaga, T; Nakajima, D; Sugita, K1
Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y1
Arendrup, MC; Frimodt-Moller, N; Haedersdal, M; Kloft, C; Saunte, DM; Simmel, F; Stolle, LB; Svejgaard, EL1
Antachopoulos, C; Meletiadis, J; Pournaras, S; Roilides, E; Stergiopoulou, T; Walsh, TJ1
Dannaoui, E; Datry, A; Dromer, F; Hoinard, D; Lacroix, C; Lortholary, O; Paugam, A; Poirot, JL; Raoux, D1
Ishida, H; Kanda, F; Kuga, A; Oishi, K1
Chacko, B; David, VG; Deepti, AN; John, GT; Tamilarasi, V1
Evens, A; Frankfurt, O; Gordon, L; Mehta, J; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J1
Collins, CD; DePestel, DD; Erba, HP; Mackler, ER; Shehab, N; Welch, K1
Maida, CM; Milici, ME; Oliveri, S1
Barnes, RA; Kuriyama, T; Lewis, MA; Noake, T; Potts, AJ; White, PL; Williams, DW1
Braverman, RM; Davis, CM; Dishop, MK; Noroski, LM; Paul, ME; Rosenblatt, HM; Sutton, DA1
Cantón, E; Chirivella, M; Crespo, M; Frasquet, J; Gobernado, M; Ortiz, R; Osseyran, F; Pemán, J; Pérez-Bellés, C; Quesada, A1
Eschertzhuber, S; Hoefer, D; Hoermann, C; Lass-Florl, C; Velik-Salchner, C1
Freifeld, A; Iwen, PC; Kalil, A; Lesiak, B; Sutton, DA; Van Schooneveld, T1
Herbrecht, R; Marciniak, A; Mauskopf, J; Roberts, CS; Schlamm, HT; Wingard, JR1
Handke, R; Peleg, AY; Slavin, M; Szer, J; Tong, SY; Yoong, J1
Choe, L; Guglielmo, BJ; Inciardi, J; Martin, T; Riedel, A; Yuen, C1
Burhenne, J; Egerer, G; Geist, MJ; Mikus, G; Riedel, KD1
Bellmann, R; Bellmann-Weiler, R; Graziadei, I; Joannidis, M; Vogel, W; Weiler, S; Zoller, H1
Hall, GS; Jeng, BH; Meisler, DM; Schoenfield, L1
Abgrall, S; Bouchaud, O; Bouges-Michel, C; Brauner, M; Karoubi, P; Lortholary, O; Martin, A; Martinod, E; Padoin, C; Pizzocolo, C1
Kaye, SB; Neal, TJ; Quah, SA; Stewart, RM1
Esmore, DS; Griffiths, AP; Levvey, BJ; Oto, T; Rowland, M; Snell, GI; Williams, TJ1
Hamanaka, N; Hiroi, N; Homma, S; Isobe, K; Kikuchi, N; Kimura, K; Muraoka, S; Shibuya, K; Shimizu, K; Sugino, K; Takai, Y; Yamazaki, Y1
Allison, MJ; Foster, G; Gandelman, K; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A1
Drees, M; Gupta, M; Hadley, S; Wickes, BL1
Bongiovanni, M; Chalandon, Y; Meyer, M; Pache, JC; Van Delden, C; Waldvogel, S1
Haas, A; Maschmeyer, G1
Calderone, R; Chauhan, N; Kruppa, M1
Granowitz, E; Iarikov, D; Robertson, D; Skiest, D1
Aydin, S; Ertugrul, B; Gultekin, B; Kir, E; Uyar, G1
Bertilsson, L; Laine, K; Neuvonen, PJ; Olkkola, KT; Saari, TI1
Bertilsson, L; Hynninen, VV; Kurkinen, K; Laine, K; Neuvonen, PJ; Olkkola, KT1
Schlamm, HT; Supparatpinyo, K1
Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C1
Foo, H; Gottlieb, T1
Dotis, J; Katragkou, A; Kotsiou, M; Roilides, E; Tamiolaki, M1
Bailey, T; Demiraj, F; Di Somma, A; Krautwald-Junghanns, ME; Schmidt, V; Ungemach, FR1
Park, AJ; Tu, EY1
Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H1
Gubler, C; Imhof, A; Müllhaupt, B; Schneemann, M; Wildi, SM1
Kauffman, CA; Malani, AN1
Cheng, S; He, J; Huang, J; Qiu, F1
Kontoyiannis, DP; Lewis, RE; Mulanovich, V; Raad, II1
Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M1
Arenz, D; Böhme, A; Buchheidt, D; Cornely, OA; Drzisga, I; Frommolt, P; Harnischmacher, U; Heussel, CP; Hummel, M; Mousset, S; Ullmann, AJ; Vehreschild, JJ; Wassmer, G1
den Hollander, JG; Levin, MD; Rijnders, BJ; Sonneveld, P; van der Holt, B; van Schaik, RH; van Vliet, M1
Blumenkranz, MS; Egbert, P; Jain, A; McCulley, TJ; Moshfeghi, DM1
Fuhrmann, V; Holzinger, U; Jaeger, W; Kitzberger, R; Kneidinger, N; Miksits, M; Schenk, P; Thalhammer, F; Warszawska, J1
Del Palacio, A; Pontón, J; Quindós, G1
Cantón, E; Carrillo-Muñoz, AJ; Eraso, E; Pemán, J; Quindós, G1
Alvarez Lerma, F1
Jarque, I; Sanz, MA1
Salavert, M; Solé, A1
Guarro, J; Pastor, FJ1
Denning, DW1
Cesur, S; Kaynak, F; Ozçelik, B; Sipahi, B; Sultan, N1
Jain, A; Sun, Y; Ta, CN1
Calvo, C; de Andoin, NG; Guerrero, R; Landa, J; Nogues, A; Onate, E; Uriz, J1
Guest, S; Zarkovic, A1
Chen, SC; Sorrell, TC1
Cetinkaya, Z; Ermis, SS; Inan, UU; Kiraz, N; Küsbeci, T; Oztürk, F; Yavas, GF1
Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG2
Chan, KK; Cheng, H; Colitz, CM; Latimer, FG; Pennick, GJ; Reed, SM1
Casadevall, A; Gácser, A; Martinez, LR; Nosanchuk, JD; Ntiamoah, P1
Al-Tawfiq, JA; Amr, SS1
Caira, M; Fianchi, L; Maviglia, R; Montini, L; Pagano, L; Posteraro, B; Voso, MT1
Boakye-Agyeman, F; Langman, LJ1
Gahn, B; Gramatzki, M; Repp, R; Schub, N1
Kaya, AD; Kiraz, N1
Chanakul, K; Clongsusuek, P; Leechawengwongs, M; Liengudom, A; Milindankura, S; Viranuvatti, K1
Dambrin, C; Durand, D; Garrouste, C; Kamar, N; Linas, MD; Rostaing, L; Tall, P; Wéclawiak, H1
Chang, CL; Kim, MN; Kim, SH; Lee, HS; Lee, JS; Lee, K; Lee, WG; Ryang, DW; Shin, BM; Shin, JH; Shin, MG; Suh, SP; Uh, Y1
Hsu, S; Kwong, WT1
Hamada, S; Iwasaki, Y; Izumi, N; Kamoshima, Y; Okugawa, S; Sawamura, Y1
Laine, K; Neuvonen, M; Neuvonen, PJ; Olkkola, KT; Saari, TI1
Feldberg, E; Halperin, D; Lahav, J; Warman, M1
Espinel-Ingroff, A; Goldani, LZ; Goodrich, JM; Queiroz-Telles, F; Schlamm, HT; Shikanai-Yasuda, MA1
Awaya, Y; Murakami, I; Nagao, Y; Okimasa, S; Shibata, S; Shigetou, E1
Foster, G; Gutierrez, MJ; LaBadie, RR; Liu, P; Sharma, A1
Anten, S; Heddema, ER; Visser, O; Zweegman, AS1
Bergeron, A; de Latour, RP; Devergie, A; Ferry, C; Ghannoum, M; Gluckmana, E; Lacroix, C; Lapalu, J; Madureira, A; Ribaud, P; Robin, M; Rocha, V; Socié, G1
Hynninen, VV; Laine, K; Leino, K; Lundgren, S; Neuvonen, PJ; Olkkola, KT; Rane, A; Valtonen, M1
Stratakos, G; Zakynthinos, S1
Khakoo, RA; Khan, FA; Slain, D1
Brusca, MI; Finquelievich, JL; Gliosca, LA; Jewtuchowicz, VM; Lovannitti, CA; Mujica, MT; Rosa, AC1
Jin, LH; Kong, QF; Kostulas, N; Li, HL; Liu, XJ; Lv, GX; Peng, HS; Sun, B; Wang, DD; Wang, GY; Wang, Q; Zhai, DX; Zhao, W1
Dunand, J; Paugam, A1
Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M1
Abrantes, R; Córdoba, S; Davel, G; Rodero, L; Vitale, RG; Vivot, W1
Alves, SH; Argenta, JS; Cavalheiro, AS; Ferreiro, L; Pereira, DI; Santurio, JM; Spanamberg, A1
Greene, RE; Mauskopf, J; Roberts, CS; Schlamm, HT; Zyczynski, T1
Mian, P; Pagani, L; Spoladore, G; Vedovelli, C1
Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW1
Liu, Y; Zou, H1
Conti, S; Drago, M; Fanti, F; Morace, G; Polonelli, L; Scaltrito, MM1
Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P1
Blaich, A; Hopt, UT; Kaffarnik, M; Utzolino, S1
Ang, BS; Lim, PL; Lye, DC; Vasoo, S; Yeo, SB1
Andrew, S; Fitzgerald, D; Singh, MN1
Endo, I; Matsuo, K; Morioka, D; Moroboshi, T; Sekido, H; Shimada, H; Takeda, K; Togo, S1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA1
Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT1
Erwin, GE; Fitzgerald, JE1
Buadi, FK; McClune, B; Przepiorka, D1
Bonini, A; Caira, M; Fianchi, L; Girmenia, C; Leone, G; Pagano, L; Rossi, G; Sanguinetti, M; Valentini, CG1
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E1
Davis, JL; Dillard, SL; Flammer, K; Foster, LE; Nettifee Osborne, JA; Webb, DJ1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Marchetti, O; Pascual, A1
Lewis, RE1
Alffenaar, JW; Doedens, RA; Groninger, E; Kosterink, JG1
Fujishima, T; Hashimoto, M; Honda, Y1
Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE1
Clauss, H; Samuel, R1
Hariprasad, SM; Mieler, WF; Prince, RA; Shah, GK; Van Gelder, RN; Vemulakonda, GA1
Barnes, R; Colombo, A; Diekema, DJ; Finquelievich, J; Gibbs, DL; Newell, VA; Ng, KP; Pfaller, MA; Wadula, J1
Fozza, C; La Nasa, G; Longinotti, M; Nieddu, R; Paglietti, B; Podda, L; Sanna, S; Vacca, A1
Bouza, E; Guinea, J; Peláez, T; Recio, S; Torres-Narbona, M2
Aguirrebengoa, K; Arteaga, C; Chen, SC; Ellis, D; Heath, CH; Lutsar, I; Nguyen, Q; Rovira, M; Slavin, M; Troke, P1
Cheng, S; Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Schmidt, S; Zhong, L1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Troke, P1
Arnaud, P; Desmonts, JM; Lasocki, S; Massias, L; Montravers, P; Papy, E; Quintard, H1
Arthington-Skaggs, BA; Chaturvedi, V; Ghannoum, MA; Holliday, N; Iqbal, NJ; Killian, SB; Knapp, C; Messer, SA; Ostrosky-Zeichner, L; Pfaller, MA; Ramani, R; Rex, JH; Sein, T; Vazquez, JA; Walsh, TJ1
Boot, B; Danho, C; Huynh, A; Mejdoubi, M1
Jones, A; Muhtaseb, M1
Denning, DW; Pasqualotto, AC; Shah, M; Wynn, R1
Gil-Lamaignere, C; Maloukou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ1
Fabré, G; Maes, B; Peetermans, WE; Van Dorpe, J; Vanacker, A1
Akhaddar, A; Albouzidi, A; Boucetta, M; Elmostarchid, B; Gazzaz, M; Lmimouni, B1
de la Fuente-Trabado, M; Díaz, MA; González-Vicent, M; Lassaletta, A; López-Pino, MA; Romero-Tejada, JC1
Amrein, C; Bergé, MM; Billaud, EM; Boussaud, V; Chevalier, P; Daudet, N; Guillemain, R; Le Beller, C; Lillo-Le Louet, A1
Conlon, JD; Dauenhauer, M; Drolet, BA; Fairley, JA; Margolis, D; Talano, J; Tonkovic-Capin, V1
Golinval, O; Louis, R1
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ1
Andrews, E; Crownover, P; Damle, BD; Fang, A; Foster, G; Glue, P; LaBadie, R1
Crownover, P; Damle, B; Glue, P; LaBadie, R1
Lu, HZ; Shen, YZ; Wang, JR1
Kobayashi, H; Kusuhara, Y; Mitsumoto, S; Nakagawa, S; Ohta, S; Shimoeda, S; Suzuki, R; Yamato, S; Yamazaki, R1
Hariprasad, SM; Lin, RC; Sanduja, N1
Almeida, C; Martín-Mazuelos, E; Méndez, CC; Pemán, J; Serrano, MC; Valverde, A1
Imhof, A; Misselwitz, B; Schneemann, M1
Daniell, M; Davies, G; Fedinands, M; Fullinfaw, R; Kong, D; Lau, D; Leung, L1
Ali, S; Whittle, AM1
Bahari, IS; Deris, ZZ; Harun, A; Ravichandran, M; Roziawati, Y; Shareef, BT1
Chandler, A; Greene, JN; Houston, SH; Silapunt, S; Sriaroon, C; Vincent, AL1
Herbrecht, R; Ribaud, P; Schlamm, HT; Wingard, JR1
Michael, C; Preiss, R; Teichert, J1
Ergon, C; Metin, DY; Ozkutuk, A; Polat, SH; Yucesoy, M1
Allepuz-Palau, A; Alvarez-Lerma, F; Angeles Leon, M; Garcia, MP; Iruretagoyena, JR; Luque-Gomez, P; Navarro, A; Sanchez-Ruiz, H1
Dierich, MP; Jost, D; Lass-Flörl, C; Perkhofer, S1
Bailey, T; Di Somma, A; Garcia-Martinez, C; Silvanose, C1
Chirch, L; Fuhrer, J; Roche, P1
Annaert, PP; Augustijns, P; Benjamin, DK; Bridges, A; Gao, Y; Thakker, DR; Yanni, SB1
Can, MF; Cetiner, S; Gorenek, L; Ozerhan, I; Tozkoparan, E; Yagci, G1
Chryssanthou, E; Loebig, A; Sjölin, J1
Joshi, R; Kohli, V; Sachdev, P; Taneja, V1
Andes, D; Smith, J1
Arsene, S; Bastides, F; Chaumais, MC; Le Guellec, C; Morange, V; Nochez, Y; Pisella, PJ1
Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M1
Alvarado-Ramírez, E; Murciano, F; Sellart, M; Torres-Rodríguez, JM1
Athan, E; Campbell, P; Chang, CC; Cheng, AC; Devitt, B; Hughes, AJ; Low, J; Styles, K1
Araujo, BV; Dalla Costa, T; Haas, SE; Silva, CF1
Datry, A; Delabesse, E; Dhédin, N; Etienne, A; Gaspar, N; Lmimouni, B; Morel, V; Vernant, JP1
Barale, PO; Chaumeil, C; Errera, MH; Guez, A; Nourry, H; Sahel, JA; Warnet, JM; Zamfir, O1
Baldelli, F; Costantini, V; Giovenale, P; Gurdo, G; Lapalorcia, LM; Lignani, A; Pasticci, MB; Pitzurra, L; Terenzi, A; Verzini, F1
Cars, O; Lignell, A; Löwdin, E; Sjölin, J1
Kasahara, K; Konishi, M; Maeda, K; Mikasa, K; Nakagawa, C; Uno, K; Yonekawa, S; Yoshimoto, E1
Foisy, MM; Hughes, CA; Yakiwchuk, EM1
Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA1
Aragane, N; Fukuno, Y; Fukuoka, M; Hayashi, S; Kawaura, F; Kobayashi, H; Matsuishi, E; Sano, A; Tanaka, M1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J1
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN1
Brunel, AS; Fraisse, T; Lechiche, C; Mauboussin, JM; Pinzani, V; Sotto, A1
Goel, M; Prakash, G; Sharma, N; Titiyal, JS; Vajpayee, RB1
Akşit, F; Kiraz, N; Kiremitçi, A; Oz, Y1
Kohno, S; Kurashima, A; Maesaki, S; Niki, Y; Ogawa, K1
Chu, CC; Hsueh, PR; Ruan, SY1
Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S1
Lortholary, O1
Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Cuenca-Estrella, M; Mellado, E; Monzon, A; Rodriguez-Tudela, JL1
Bocanegra, R; Fothergill, AW; Graybill, JR; Herrera, ML; Kinney, MC; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Vallor, AC; Wickes, BL1
Ooi, WW; Srinivasan, J1
Mavinkurve-Groothuis, AM; van Die, LE; van't Hek, LG; Verweij, PE; Warris, A; Zwitserloot, AM1
Lahat, Y; Sandovsky-Losica, H; Segal, E; Shwartzman, R1
Behrens-Baumann, W; Binder, L; Knop, C; Streit, F; Tuchen, S; Vorwerk, CK1
Bennett, JE; Childs, R; Gea-Banacloche, J; Zonios, DI1
Guarro, J; Mariné, M; Ruíz-Cendoya, M1
Antoniadis, A; Braimi, M; Dermitzakis, E; Kioumi, A; Papadakis, E; Tsitouridis, I; Vyzantiadis, TA1
Carver, PL; DePestel, DD; Surowiec, D1
Ananda-Rajah, MR; Grigg, A; Slavin, MA1
Ikeda, T; Ishikawa, S; Kobayashi, K; Takeyama, H; Tokuda, Y; Wakabayashi, K; Yano, S1
Chellamma, T; Cherian, KM; Verghese, S1
Dey, P; Gupta, A; Gupta, P; Gupta, V; Kaur, J; Sachdev, N1
Abel, S; Allan, R; Gandelman, K; Tomaszewski, K; Webb, DJ; Wood, ND1
Ben-Ami, R; Kontoyiannis, DP; Lamaris, GA; Lewis, RE1
Kulpraneet, M; Panichchob, P; Prayongratana, K; Tantisiriwat, W1
Akdogan, E; Aksoy, F; Altunayoglu, V; Aydin, K; Koksal, I; Omay, SB; Sozen, EE; Yilmaz, M1
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M1
Imataki, O; Ishida, T; Kitanaka, A; Kubota, Y; Ohnishi, H; Tanaka, T1
Graybill, JR; Hariprasad, SM; Lin, TK; Mieler, WF; Sponsel, WE1
Annemans, L; Derde, MP; Marbaix, S; Van Campenhout, H1
Benesch, M; Dornbusch, HJ; Lackner, H; Schwinger, W; Sovinz, P; Strenger, V; Urban, C1
Ioannidis, J; Kanellou, K; Likartsis, C; Paliogianni, F; Roilides, E; Simitsopoulou, M; Walsh, TJ1
Ak, Ö; Batırel, A; Demirhan, G; Gençer, S; Özer, S1
Ayala, J; Elizondo, M; González, GM1
Aarnoutse, RE; Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Mouton, JW; Verweij, PE; Warris, A1
Dolande, M; Panizo, MM; Reviákina, V; Selgrad, S1
Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A1
Iseman, MD; Peloquin, CA; Schwiesow, JN1
Barcia, M; De-Domingo-Barón, B; Pardo-Sánchez, F; Rodríguez-Ares, T; Romero-Jung, P; Touriño-Peralba, R1
Aprato, A; DE Rosa, FG; Di Perri, G; Garazzino, S; Maiello, A1
Kloft, C; Radke, J; Simmel, F; Soukup, J; Zoerner, A1
Baert, K; Beernaert, LA; Chiers, K; De Backer, P; Marin, P; Martel, A; Pasmans, F1
Auberger, J; Bellmann, R; Buzina, W; Clausen, J; Gastl, G; Lass-Flörl, C; Nachbaur, D1
Bosch, M; Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A1
Farmen, S; Kaul, DR; Khaled, YA; Lowe, L; Visvesvara, GS; Yanik, GA1
Mircus, G; Osherov, N; Shadkchan, Y; Shalit, I1
Hollenbach, E1
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L1
Alangaden, GJ; Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK1
Hynninen, VV; Laine, K; Neuvonen, PJ; Olkkola, KT1
Bernhardt, H; Knoke, M1
Espinel-Ingroff, A; Hockey, H; Johnson, E; Szekely, A; Troke, P1
Albermann, N; Ebinger, F; Haefeli, WE; Hafner, V1
Bouadma, L; Da Silva, D; Massias, L; Nataf, P; Papy, E; Ruiz, S; Wolff, M1
Aronoff, DM; Malani, AN1
Adani, GL; Baccarani, U; Baraldo, M; Cojutti, P; Franceschi, L; Furlanut, M; Londero, A; Pea, F; Tavio, M; Viale, P1
Agee, S; Ford, JG; Greenhaw, ST1
Alves, AF; Anjos, J; de Hoog, GS; Estevão, H; Faria, E; Gonçalves, T; Hipolito, E; Morais, PV1
Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH1
Jones, B; Lang, S; McCulloch, E; Mowat, E; Ramage, G; Williams, C1
Ghannoum, MA; Mukherjee, PK; Shehata, AS1
Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Saari, TI2
Buchta, V; Vale-Silva, LA; Vejsova, M1
Albano, EA; Carver, AE; Porter, CC1
Cordier, JF; Cottin, V; Cristea, D; Meyronet, D; Persat, F1
Chandrasekar, PH; Krishnan-Natesan, S; Manavathu, EK; Revankar, SG1
Chen, JQ; Huang, MM; Li, J; Sun, MX; Yao, MC; Ye, CT1
Imai, K; Kobayashi, D; Kogawa, K; Nonoyama, S; Nozaki, M; Sugita, T; Tokimatsu, I; Tsuji, Y1
Anderson, R; Steel, HC; Tintinger, GR1
Hayabuchi, T; Konishi, T; Kurai, J; Shimizu, E1
Brusca, MI; Iovannitti, CA; Jewtuchowicz, VM; Malzone, MC; Mujica, MT; Pola, SJ; Rosa, AC; Sordelli, N1
Fothergill, AW; Patterson, TF; Thompson, GR; Vallor, AC; Wickes, BL; Wiederhold, NP1
Cervera, C; Crespo, G; Marco, F; Michelena, J; Moreno, A; Navasa, M1
Caira, M; Fianchi, L; Pagano, L1
Brown, TA; Grooters, AM; Hosgood, GL1
Chen, Y; Fan, L; Guo, D; Hu, DL; Lei, HP; Li, Z; Tan, ZR; Wang, D; Wang, G; Zhou, HH1
Doorduijn, JK; el Barzouhi, A; Lugtenburg, PJ; Polinder, S; Rijnders, BJ; Slobbe, L; Steyerberg, EW1
De Kaspar, HM; Kampik, A; Kernt, M; Neubauer, AS1
Donders, AR; Kuijpers, J; Melchers, WJ; Mellado, E; Rijs, AJ; Samson, RA; Snelders, E; van der Lee, HA; Varga, J; Verweij, PE1
Dupuis, A; Le Moal, G; Tournier, N; Venisse, N1
Al-Badriyeh, D; Kong, DC; Liew, D; Stewart, K2
Bijie, H; Diekema, DJ; Dzierzanowska, D; Gibbs, DL; Klimko, NN; Letscher-Bru, V; Lisalova, M; Muehlethaler, K; Newell, VA; Pfaller, MA; Rennison, C; Zaidi, M1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Hazar, V; Ogunc, D; Ongut, G; Ozhak-Baysan, B; Rodriguez-Tudela, JL; Tezcan, G; Yildiran, ST1
Denning, DW; Majithiya, J; Parmar, A; Sharp, A; Warn, PA1
da Silva, CF; Dalla Costa, T; de Araujo, BV; Haas, SE1
Cubillos, GF; Kett, DH1
Burhenne, J; Haefeli, WE; Hess, M; Scope, A1
Bertilsson, L; Hynninen, VV; Korhonen, T; Kurkinen, KJ; Laine, K; Neuvonen, PJ; Olkkola, KT1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Touw, DJ; Verweij, PE1
Barbabietola, G; Barker, K; Flynn, E; Marciniak, A; Oppenheim, BA; Roberts, C1
Hoffman, J; Howard, A; Sheth, A1
Chang, BP; Chen, YC; Huang, FY; Lee, MD; Lin, CC; Sheu, JC; Sun, PL; Tsai, JD; Tsai, TC1
Desta, Z; Jeong, S; Nguyen, PD1
Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S; Sakurai, M1
Bearman, G; Pakyz, A1
Burhenne, J; Haefeli, WE; Hoffmann, MM; Mikus, G; Rengelshausen, J; Ten Hoevel, MM; Walter-Sack, I; Weiss, J1
Okuda, A; Okuda, T; Takao, M; Takayanagi, K; Watanabe, N1
van Rijswijk, J; van Tol, A1
Antonius, T; Brüggemann, RJ; Burger, DM; Heijst, Av; Hoogerbrugge, PM; Warris, A1
Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H1
Niimi, K; Niimi, M; Tanabe, K1
Maesaki, S; Tarumoto, N1
Fujii, Y; Inase, N; Yoshizawa, Y1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S1
dos Santos Lazéra, M; Guarro, J; Pastor, FJ; Pujol, I1
Karlsson, MO; Lutsar, I; Milligan, PA1
Pea, F; Viale, P1
Fujita, N; Oyake, M; Sugai, A; Umeda, M; Umeda, Y1
Tu, EY1
Alffenaar, JW; Daenen, SM; de Vos, T; Uges, DR1
Bienvenu, B; Bougnoux, ME; Chandesris, MO; Herman, P; Lanternier, F; Lecuit, M; Lortholary, O; Mamzer, MF; Méchai, F; Mimoun, M; Parize, P; Poirée, S; Viard, JP1
Kisac, P; Krcmery, V; Liskova, A1
Fothergill, AW; Rinaldi, MG; Sutton, DA1
Anaissie, E; Chang, C; Fishman, J; Horn, D; Marr, K; Neofytos, D; Olyaei, A; Pfaller, M; Steinbach, W; Webster, K1
Nawrot, U; Nowicka, J; Wlodarczyk, K1
Azuma, E; Hosoki, K; Iwamoto, S; Komada, Y; Kumamoto, T1
Andes, D; Arnold, S; Baddour, LM; Blair, J; Freifeld, A; Lentnek, A; Proia, L; Spellberg, B; Wheat, LJ1
Guggemos, W; Hecht, A; Rüdisser, K; Seilmaier, M1
Kanazawa, K; Niki, Y; Takemoto, K; Ueda, Y; Yamamoto, Y; Yoshida, K1
de Mol, P; Meis, JF1
Fatuzzo, F; Iacobello, C; La Rosa, R; Larocca, L; Montineri, A; Nigro, L1
Aralikatti, A; Dean, S; Mitra, A; Savant, V; Shah, S1
Enache-Angoulvant, A; Girard, A; Hennequin, C; Poirot, JL1
Chan, RC; Pinto, A1
Danner, RL; Elinoff, J; Gea-Banacloche, J; Moriyama, B; Pennick, G; Rinaldi, MG; Walsh, TJ1
Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM1
Alp, S; Arikan, S; Hascelik, G; McNicholas, P; Sancak, B1
Allizond, V; Banche, G; Carlone, N; Cuffini, AM; Fucale, G; Malabaila, A; Mandras, N; Roana, J; Robbiano, F; Scalas, D; Tullio, V1
Guarro, J; Mariné, M; Rodríguez, MM; Ruíz-Cendoya, M1
Arsenis, G; Kafetzis, D; Lebessi, E; Pasparakis, D; Stripeli, F; Tsolia, M; Velegraki, A1
Baltadakis, I; Karakasis, D; Liapis, K; Manaka, K1
Chandy, R; Chehadeh, W; Chowdhary, A; Khan, ZU; Kowshik, T; Randhawa, HS1
Baird, K; Cowen, EW; Gea-Banacloche, J; Mitchell, S; Patel, AR; Pavletic, SZ; Turner, ML; Wise, B1
Alaggio, R; Alessia, B; Cesaro, S; Gamba, P; Marinello, S; Putti, MC; Rossi, L; Toffolutti, T1
Anderson, AM; Diazgranados, CA; Gongora, MC; Hidron, AI1
Annaert, P; Hermans, G; Meersseman, P; Meersseman, W; Spriet, I; Verbesselt, R; Willems, L1
Adams, AI; Bergold, AM; Meneghini, LZ; Morimoto, LN1
Sung, VW1
Calvo, E; Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C1
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR1
Marti, J1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W1
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F1
Horn, D; Neofytos, D; Sae-Tia, S1
Beernaert, LA; Dorrestein, GM; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L; Vercammen, F; Verstappen, F1
Lee, HN; Shen, YC; Tsai, HY; Tsai, TC; Wang, CY; Wang, MY; Wei, LC1
Baba, T; Endo, T; Enomoto, T; Hagiwara, E; Kato, T; Komatsu, S; Matsushima, A; Nishihira, R; Ogura, T; Sekine, A; Shiihara, J; Shinohara, T; Sogo, Y; Tagawa, A; Takahashi, H; Tsuchiya, N1
Abematsu, K; Fukamizu, T; Fukunaga, N; Ikawa, K; Matsumoto, K; Morikawa, N; Nishida, K; Shimodozono, Y; Takeda, Y; Yamada, K1
Aisa, Y; Ikeda, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S1
Maertens, J; Meersseman, W; Van Bleyenbergh, P1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M1
Jadoul, M; Labriola, L; Swinne, D; V, B1
Adel, N; Harnicar, S; Jurcic, J1
Elnazir, B; Glackin, L; Greally, P; Leen, G1
Deng, SX; Hollander, DA; Kamal, KM1
Matsumoto, Y; Nagai, A; Oh-I, T; Ohyama, F; Ooishi, T; Tsuboi, R1
Bocanegra, R; Coalson, JJ; Graybill, JR; McConville, JT; Najvar, LK; Patterson, TF; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO1
Chen, MH; Crespo, M; Humar, A; Husain, S; Kumar, D; Manuel, O; McCurry, KR; Moussa, G; Pilewski, J; Studer, SM1
Fanci, R1
Bandettini, R; Calvillo, M; Castagnola, E; Conte, M; Cuzzubbo, D; Faraci, M; Lanino, E; Manzitti, C; Miano, M; Micalizzi, C; Morreale, G; Pescetto, L; Ravegnani, M; Ricagni, L; Soro, O1
Chen, H; Fan, L; He, YJ; Lei, HP; Li, Q; Ou-yang, DS; Tan, ZR; Wang, G; Wang, LS; Zhang, W; Zhou, HH1
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH1
Ayats, J; Fernández, N; Gasch, O; Santin, M1
Avila, NA; Bacher, J; Cotton, MP; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Meletiadis, J; Mickiene, D; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Stergiopoulou, T; Walsh, TJ1
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC1
Joukhadar, C; Joukhadar, SM; Konz, KH; Kovar, F; Pöppl, W; Thallinger, C; Traunmüller, F1
Kim, SD; Lee, JJ; Lee, SJ1
Clancy, CJ; Derendorf, H; Li, Y; Nguyen, MH; Schmidt, S; Zhong, L1
Aşik, G; Ayçiçek, A; Cetinkaya, Z; Kenar, F; Kiraz, N; Kiyici, H1
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K1
Kida, M1
Inagaki, N; Mori, T; Yasuda, H1
Bosselmann, S; McConville, JT; Nelson, NA; Peters, JI; Son, YJ; Tolman, JA; Wiederhold, NP; Williams, RO1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S1
Ben-Ami, R; Chamilos, G; Kontoyiannis, DP; Lamaris, GA; Lewis, RE; Samonis, G1
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R1
Bourcier, T; Fabre, M; Labetoulle, M; Offret, H; Proença-Pina, J; Ssi Yan Kai, I1
Bluemel, A; Ghebremedhin, B; Koenig, B; Koenig, W; Neumann, KH1
Maschmeyer, G1
Heinz, WJ; Helle, A; Kahle, K; Keller, D; Klinker, H; Langmann, P; Lenker, U; Schirmer, D1
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P1
Costa-de-Oliveira, S; Pina-Vaz, C; Pinto e Silva, AT; Rodrigues, AG; Silva-Dias, A1
Aguirre, JM; Carrillo-Muñoz, AJ; Eraso, E; Gaitán-Cepeda, LA; Quindós, G; Sánchez Vargas, LO1
Baggen, L; Chisholm, J; Sharland, M; Thomas, L1
De Carolis, E; Fadda, G; Fiori, B; Florio, AR; La Sorda, M; Martucci, R; Posteraro, B; Sanglard, D; Sanguinetti, M1
Segal, BH1
Pérez, P; Piñar, D; Quiles, JA; Reus, S1
Schots, R; Vande Broek, I1
Han, FC; Jureen, R; Tew, CW; Tey, BH1
Castel, V; Gonzalez-Esteban, J; Madero, L; Sanchez de Toledo, J; Sanz-Rodriguez, C; Sevilla, J1
Kampik, A; Kernt, M1
Hasegawa, A; Imaji, M; Kano, R; Maruyama, H; Murakami, Y; Okabayashi, K; Osumi, T; Watanabe, T1
Al-Badriyeh, D; Daniell, M; Davies, GE; Fullinfaw, R; Kong, DC; Leung, L; Roydhouse, T; Stewart, K1
Al-Badriyeh, D; Davies, GE; Kong, D; Leung, L; Stewart, K2
Ayats, J; Cabellos, C; Fernandez-Viladrich, P; Ferran, E; Font, F; Garcia-Vidal, C1
Bhavna, B; Kumar, K; Narayan, SK; Roopeshkumar, VR; Swaminathan, RP1
Bulut, Y; Günday, E; Güven, M; Yenişehirli, G1
de La Blanchardière, A; de La Gastine, B; Fromager, G; Gendrot, A; Massias, L; Verdon, R1
Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S1
Guarro, J; Mariné, M; Pastor, FJ; Serena, C1
Beck, O; Björkhem, I; Björkhem-Bergman, L; Heo, GY; Lütjohann, D; Mast, N; Nayef, R; Pikuleva, IA; Shafaati, M1
Joshi, A; Khattry, N; Shah, MS; Singh, R; Umesh, S1
Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I1
Almony, A; Apte, RS; Kraus, CL1
Angerer, K; Bonatti, H; Geltner, C; Lass-Floerl, C; Lechner, M; Schmid, T; Singh, N; Singh, R; Stelzmueller, I1
Abboud, I; Antoine, C; Benammar, M; Berge, M; Billaud, EM; Glotz, D; Lefeuvre, S1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM1
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL1
Bosselmann, S; Coalson, JJ; Nelson, NA; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO1
Dinc, BM; Kalkanci, A; Kekilli, M; Kurt, M; Odemis, B; Oztas, E; Parlak, E; Sasmaz, N1
Batoz, H; Breilh, D; Dromer, C; Janvier, G; Joannes-Boyau, O; Lafargue, M; Rozé, H1
Aguado, JM; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F1
Li, R; Liu, W; Wan, Z; Wang, X; Yang, J1
Clemons, KV; Kass, PH; Kline, Y; Martinez, M; Stevens, DA; Tell, LA; Woods, L1
Aoyagi, I; Hidaka, H; Katori, Y; Kobayashi, T; Kudo, T; Nakaya, K; Oda, K; Oshima, T; Ota, J1
Hawkins, MG; Nguyen, KQ; Taylor, IT; Tell, LA; Wiebe, VJ1
Andrade, SE; Elizondo, M; González, GM; Portillo, OJ; Robledo, M; Rodríguez, C; Uscanga, GI1
Canton, E; Espinel-Ingroff, A; Fothergill, AW; Peman, J; Rinaldi, MG1
Baert, K; Beernaert, LA; Chiers, K; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L1
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S1
Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F1
Fung, CP; Lee, N; Lee, SC; Lo, HJ; See, LC1
Hiraga, A; Kamitsukasa, I; Numata, T; Shibuya, M; Sunami, S; Uzawa, A1
Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S1
Autthateinchai, R; Ikeda, R; Mekha, N; Nishikawa, A; Poonwan, N; Sawanpanyalert, P; Sugita, T1
Eberhardt, R; Ebinger, D; Eckerle, I; Eisenbach, C; Gotthardt, D; Junghanss, T; Schnabel, PA; Stremmel, W1
Alp, S; Arikan, S; Hasçelik, G; Sancak, B1
Laporta, R; Lázaro, MT; Ramos, A; Sánchez-Romero, I; Ussetti, P1
Albarrag, A; Anderson, MJ; Arendrup, MC; Cerar, D; Denning, DW; Fisher, MC; Howard, SJ; Laverdiere, M; Pasqualotto, AC; Perlin, DS1
Aggermann, T; Binder, S; Haas, P; Hochwarter, A; Krepler, K1
Alex, A; Harvey, S; Parsons, T; Pullen, FS; Riley, JA; Wright, P1
Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY1
Angel, LF; Brady, R; Cadena, J; Levine, DJ; Levine, SM; Maxwell, PR; Michalek, JE; Restrepo, MI; Sanchez, JF1
Chan, HM; Duran, SH; Ravis, WR; Walz, PH1
Feder, RS; Gupta, G; Lyon, AT1
Acharya, NR; Hong, K; Lee, S; Loh, AR; Mannis, M1
Lass-Flörl, C; Perkhofer, S1
Balajee, SA; Brandt, ME; Gade, L; McCloskey, CB1
Chang, CM; Chang, HH; Ko, WC; Lee, HC; Lee, NY; Wu, CJ; Yang, YH1
Al-Badriyeh, D; Davies, GE; Fullinfaw, R; Kong, DC; Leung, L; Li, J; Stewart, K1
Denning, DW; Howard, SJ; Pasqualotto, AC1
Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S2
Lapthorn, C; Pullen, F1
Atienzar, M; Blanch, JJ; Escribano, E; Rodríguez, M1
Delaere, L; Lagrou, K; Maertens, J; Peetermans, WE; Spriet, I; Willems, L1
Anasetti, C; Field, T; Gergis, U; Greene, J; Huang, Y; Kharfan-Dabaja, M; Markey, K; Perkins, J; Schell, MJ; Wetzstein, G1
Ader, F; Bienvenu, AL; Nseir, S; Rammaert, B1
Costa, CR; de Aquino Lemos, J; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Hasimoto e Souza, LK; Jesuíno, RS; Passos, XS1
Carter, JE; Culpepper, M; Goel, S; Kahn, AG1
Akova, M; Beyazit, Y; Purnak, T; Sahin, GO; Shorbagi, A1
Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K1
Genzen, JR; Kenney, B1
Allen, PJ; Davies, GE; Ferdinands, M; Fullinfaw, RO; Kong, DC; Lau, D; Leung, L1
Flowers, SA; Rogers, PD; Ta, M1
Frueh, BE; Goldblum, D; Muehlethaler, K; Theoulakis, P; Zimmerli, S1
Hirano, T; Imai, K; Kagawa, K; Kasai, M; Kiyama, Y; Kobayashi, K; Kobayashi, N; Miyazono, T; Ogasawara, M; Tanimoto, M1
Alffenaar, JW; Daenen, SM; Kosterink, JG; Uges, DR; van der Elst, KC1
Cao, Y; Che, X; Ji, H; Miao, Z; Sheng, C; Wang, W; Yao, J; Zhang, W1
Alastruey-Izquierdo, A; Castelli, MV; Cuesta, I; Mellado, E; Monzón, A; Rodríguez-Tudela, JL; Zaragoza, O1
Kontoyiannis, DP; Lewis, RE; Pongas, GN; Samonis, G1
Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Ohno, H1
Abderrahim, E; Ben Abdallah, T; Ben Hamida, F; Ben Maïz, H; Bezzine, H; Hedri, H; Khaled, S; Kheder, A; Ounissi, M; Trabelsi, S1
Bahador, A; Dehghani, M; Gholami, S; Hashemi, SB; Janghorban, P; Kakaei, F; Kazemi, K; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Shishegar, M1
Banevicius, MA; Crandon, JL; Crownover, PH; Fang, AF; Knauft, RF; Kuti, JL; Nicolau, DP; Pope, JS; Russomanno, JH; Shore, E1
Colby, KA; Mandell, KJ1
Gu, P; Li, Y1
George, E; Shinohara, MM1
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A1
Damon, L; Guglielmo, BJ; Hwang, J; Kaplan, L; Linker, C; Martin, T; O'Malley, R; Sharma, M; Working, M1
Ali, R; Altundal, Y; Ener, B; Hakyemez, B; Kocaeli, H; Ozçelik, T; Ozkalemkaş, F; Ozkocaman, V; Tunali, A1
Constantinou, M; Jhanji, V; Sheorey, H; Vajpayee, RB; Yohendran, J1
Fujii, A; Hamano, T; Itoh, H; Kuriyama, M; Matsunaga, A; Naganuma, S; Ueno, A; Yoneda, M1
Hogan, BK; Lewis, JS; Nierenberg, NE; Patterson, TF; Thompson, GR1
Annaert, PP; Augustijns, P; Benjamin, DK; Ibrahim, JG; Thakker, DR; Yanni, SB1
Boikov, D; Nagappan, V; Vazquez, JA1
Altman, R; Belperio, JA; Eshaghian, P; Gregson, A; Kubak, B; Lynch, JP; Ross, DJ; Saggar, R; Wang, T; Wang, TF; Weigt, SS1
Marriott, D; Miyakis, S; Ray, J; van Hal, SJ1
Aloisi, T; Aversa, F; Bonini, A; Caira, M; Candoni, A; Caramatti, C; Cattaneo, C; Chierichini, A; de Waure, C; Fadda, RM; Fanci, R; Ferrara, F; Fianchi, L; Invernizzi, R; Leone, G; Luppi, M; Martino, B; Melillo, L; Mitra, ME; Nosari, A; Offidani, M; Pagano, L; Pastore, D; Picardi, M; Potenza, L; Riva, M; Rossini, F; Specchia, G; Stanzani, M; Vacca, A1
Azeredo, J; Henriques, M; Martins, M; Negri, M; Oliveira, R; Svidzinski, TI1
Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B1
Gómez-Bueno, M; Lázaro, MT; Pulpón, L; Ramos, A; Salas, C; Sanchez, I; Segovia, J1
Bang, S; Edell, E; Eghrari, AO; Gottsch, JD1
Badenoch, PR; Chang, JH; Coster, DJ; Klebe, S; Mills, RA; Sadlon, TA1
Capote, M; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rojas, R; Sánchez-García, J; Serrano, J; Tabares, S; Torres, A1
Olson, EL; Tonelli, AR1
Al-Abdely, HM; Al-Tawfiq, JA1
Böhme, A; Cornely, OA; Drzisga, I; Frommolt, P; Hallek, M; Harnischmacher, U; Mousset, S; Müller, C; Rüping, MJ; Vehreschild, JJ; Wassmer, G1
Bertout, S; Bourgeois, N; Bousquet, PJ; Dehandschoewercker, L; Lachaud, L; Rispail, P1
Arron, ST; Cowen, EW; Fox, LP; McShane, D; Miller, DD; Nguyen, JC; Prose, NS; Turner, ML1
Higuchi, T; Kako, S; Kanda, Y; Kimura, S; Nakasone, H; Nishida, J; Okuda, S; Oshima, K; Sato, K; Sato, M; Tanaka, Y; Tanihara, A; Terasako, K; Yamazaki, R1
Allenet, B; Auzéric, M; Bedouch, P; Bellemère, J; Charpiat, B; Conort, O; Juste, M; Rose, FX; Roubille, R1
In, KH; Kang, EH; Kim, MJ; Yoon, YK1
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D1
Blanch-Iribarne, P; Garcia-Ramirez, M; Martin-Carballido, S; Martinez-Ferriz, MC; Martinez-Pajares, JD; Moreno-Perez, D1
Grün, B; Krautter, S; Mikus, G; Riedel, KD1
Rappersberger, K; Saxa-Enenkel, M; Stos, S; Stur-Hofmann, K1
Beani, JC; Charles, J; Epaulard, O; Leccia, MT; Roch, N; Saint-Raymond, C; Villier, C1
Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Franke, B; Troke, PF1
Blisard, D; Capitano, B; Han, K; Husain, S; Johnson, HJ; Kwak, EJ; Linden, PK; Marcos, A; Paterson, DL; Potoski, B; Romkes, M; Venkataramanan, R1
Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S1
Lewis, JS; Thompson, GR1
Jiménez Caballero, PE; Mollejo Villanueva, M1
Hoffman, J; Jelliffe, R; Kovacs, A; Neely, M; Rushing, T1
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L1
Alagöz, N; Bozkurt, E; Cakir, M; Cekiç, O; Imamoğlu, S; Oksüz, L; Yilmaz, OF1
Fukazawa, H; Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Murakami, Y; Ohno, H1
Mehta, J; Pi, J; Scheetz, MH; Trifilio, SM1
Meletiadis, J; Pournaras, S; Roilides, E; Walsh, TJ1
Arendrup, MC; Krarup, E; Larsen, CG; Larsen, FG; Pedersen, M; Thybo, S1
Ethier, MC; Maloney, AM; Mitchell, D; Sung, L; Zaoutis, T1
Burhenne, J; Haefeli, WE; Mikus, G; Oberwittler, H; Riedel, KD; Scholz, I; Weiss, J1
Guarro, J; Madrid, H; Pastor, J; Ruíz-Cendoya, M1
Alvarez, M; Attal, M; Cassaing, S; Chabrol, A; Cuzin, L; Giron, J; Huguet, F; Linas, MD; Récher, C; Tetu, L; Verdeil, X1
Kumar, P; Matsumoto, C; Pien, E; Rosen, J; Shanmugam, VK; Steen, V; Whelton, S1
Andreolla, HF; Linden, R; Pasqualotto, AC; Xavier, MO1
Nehls, S; Ogawa, GS; Pariseau, B; Romanelli, AM; Sutton, DA; Wickes, BL1
Hara, Y; Mitani, A; Miyamoto, H; Ohashi, Y; Shiraishi, A; Uno, T; Yamaguchi, M1
Barlow, G; Lillie, P; Moss, PJ; Parsonage, MJ; Stafford, ND; Thaker, H1
Ikeda, R; Miyamoto, M; Nishikawa, A; Sugita, T; Takatori, K; Tsuboi, R1
Buil, JA; Díaz-Cascajosa, J; Roselló, N; Sanchez, F; Vela, JI1
Amigues, I; Barker, J; Chung, D; Cohen, N; Jakubowski, A; Papanicolaou, GA; Plescia, C; Seo, SK1
Bakker-Woudenberg, IA; Tavakol, M; van de Sande, WW; van Vianen, W1
Bellete, B; Flori, P; Hafid, J; Manhsung, RT; Morel, J; Raberin, H1
Blundell, CM; Greig, JM; Oddy, MJ; Suvarna, SK1
Cowen, EW; Fox, LP; McCalmont, TH; Miller, DD; Nguyen, JC1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ1
Cornely, OA1
Celik, U; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Nguyen, ML; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A; Yousem, SA1
Hsiao, CH; Lai, CH; Ma, DH; Tan, HY; Wu, PC1
Georgiadou, E; Roilides, E; Simitsopoulou, M; Walsh, TJ1
Klompas, M; Koo, S; Marty, FM1
Duval, A; Hickman, G; Petit, A; Picard, C1
Chang, SC; Chang, YL; Lin, KP; Sheng, WH; Wang, CP1
Guarro, J; Pastor, FJ; Rodríguez, MM; Serena, C1
Adiri, Y; Karatela, S; Lyon, GM; Sunay, S1
Miharu, M; Osumi, T; Shima, H; Shimada, H; Takahashi, T1
Wingard, J1
Choi, JH; Choi, SM; Kwon, EY; Lee, DG; Park, CM; Shin, WS; Stevens, DA; Yoo, JH1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J1
Diekema, DJ; Ellis, D; Fu, W; Gibbs, DL; Ling, TA; Newell, VA; Pfaller, MA; Rodloff, A; Tullio, V1
Chew, HF; Cohen, EJ; Jungkind, DL; Mah, DY; Raber, IM; Tokarczyk, MJ; Toll, AD1
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A1
Basile, V; Capone, D; Ciotola, A; D'Alessandro, V; Federico, S; Gentile, A; Nappi, R; Polichetti, G; Renda, A; Sabbatini, M; Santangelo, M; Tarantino, G1
Borse, N; Jain, V; Natarajan, S; Shome, D1
Baltopoulos, G; Despotelis, S; Evaggelopoulou, P; Evodia, E; Markantonis, SL; Myrianthefs, P; Panidis, D1
Dag, I; Kasifoglu, N; Kiraz, N; Kiremitci, A; Oz, Y; Yamac, M1
Grau, S; Rubio-Terrés, C1
Li, H; Lu, Q; Wan, Z; Zhang, J1
Damle, B; Luke, DR; Schlamm, HT; Tomaszewski, K1
Basara, N; Bierbach, U; Frenzel, K; Lange, T; Mauz-Körholz, C; Michael, C; Niederwieser, D; Preiss, R2
Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M1
Beral, L; Desbois, N; Donnio, A; Guyomarch, J; Merle, H; Olive, C; Theodose, R; van Nuoï, DN1
Besse, B; Hennequin, C; Le Pape, P; Loge, C; Morio, F1
Buzina, W; Horré, R; Lackner, M; Tintelnot, K1
Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G1
Al-Badriyeh, D; Bajel, A; Downey, M; Grigg, A; Kong, DC; Liew, D; Slavin, M; Stewart, K; Thursky, K1
Jensen, SG; Nielsen, TL1
Chudgar, SM; Norton, BL; Person, AK; Stout, JE; Tong, BC1
Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J1
Ailani, H; Cohen, EJ; Eagle, RC; Hammersmith, KM; Rapuano, CJ; Yildiz, EH1
Barton, R; Bijie, H; Bille, J; Chang, SC; da Luz Martins, M; Diekema, DJ; Duse, A; Dzierzanowska, D; Ellis, D; Finquelievich, J; Gibbs, DL; Gould, I; Gur, D; Hoosen, A; Lee, K; Mallatova, N; Mallie, M; Newell, VA; Peng, NG; Petrikos, G; Pfaller, MA; Santiago, A; Trupl, J; VanDen Abeele, AM; Wadula, J; Zaidi, M1
Bouchara, JP; Chabasse, D; Hitoto, H; Pihet, M; Rachieru-Sourisseau, P; Weil, B1
Vera-Cabrera, L; Welsh, E; Welsh, O1
King, AL; Massey, HD; Stolk, MJ1
Applegate, J; Flammer, K; Grooters, AM; Papich, MG; Sanchez-Migallon Guzman, D; Shaw, S; Tully, TN1
Bommer, J; Burhenne, J; Czock, D; Haefeli, WE; Hafner, V; Machleidt, C; Mikus, G; Riedel, KD; Weinreich, T1
Arendrup, MC; Cuenca-Estrella, M; Donnelly, JP; Lass-Flörl, C; Rodríguez-Tudela, JL1
Baert, K; Beernaert, L; de Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; van Rooij, P; Van Waeyenberghe, L1
Segal, BH; Sherif, R1
Li, R; Liu, W; Qiao, J1
Gabrielian, A; Hariprasad, SM1
Burhenne, J; Burkhardt, O; Kielstein, JT; Thon, S; Welte, T1
Alffenaar, JW; de Monchy, JG; Kosterink, JG; Uges, DR; van Assen, S; van der Werf, TS1
Hariga, D; Khaled, S; Trabelsi, S1
Chatzimoschou, A; Cotten, CJ; Diza-Mataftsi, E; Katragkou, A; Kruhlak, MJ; Paliogianni, F; Roilides, E; Simitsopoulou, M; Taparkou, A; Tsantali, C; Walsh, TJ1
Fuqua, TH; Knoll, M; Said-Al-Naief, N; Sittitavornwong, S1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G1
Corey, M1
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL1
Frick, MA; Guarner, ME; Martín Nalda, A; Nadal, CF; Soler-Palacín, P1
Lee, HN; Shen, YC; Tsai, HY; Wang, CY1
Ito, E; Kamio, T; Kudo, K; Sasaki, S; Sato, T; Terui, K1
Chan, HM; Duran, SH; Lin, HC; Passler, NH; Ravis, WR; Stewart, AJ; Welles, EG1
Arteaga, MA; Gómez, Cde B; Marín, AG; Moreno, AR; Parra, HH; Restrepo, CA; Rodríguez, AZ1
Dirr, F; Ebel, F; Echtenacher, B; Heesemann, J; Hoffmann, P; Wagener, J1
Kato, J; Mori, T; Okamoto, S; Ono, Y; Shimizu, T; Yamane, A1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA1
Patterson, K; Strek, ME1
Bernardin, G; Burel-Vandenbos, F; Dunais, B; Gari-Toussaint, M; Guidicelli, S; Hyvernat, H1
Anyfantakis, V; Camus, M; Dammak, A; Delouane, H; Guillet, G; Riche, A; Roblot, F1
Askari, SK; Beaty, SR; Burkemper, CN; Frisch, S1
Elston, DM1
Chen, HT; Cheng, WT; Leaw, SN; Lo, HJ; Wang, AH; Yang, YL1
Baert, K; Beernaert, L; Chiers, K; De Backer, P; Haesebrouck, F; Hellebuyck, T; Martel, A; Pasmans, F; Van Waeyenberghe, L1
Hoffman, SB; Smith, LN1
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE1
Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Sciandra, M; Siccardi, M; Simiele, M; Ventimiglia, G1
Arron, ST; Ibrahim, SF; Singer, JP1
Joslin, CE; Shoff, ME; Tu, EY1
Theurillat, R; Thormann, W; Zimmerli, S1
Castanheira, M; Jones, RN; Pfaller, MA1
Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Rodríguez, MM; Salas, V1
Acharya, NR; Hong, KC; Krishnan, T; Lee, SM; Lietman, TM; Mascarenhas, J; McLeod, SD; Porco, TC; Prajna, L; Prajna, NV; Reddy, PR; Srinivasan, M; Vaitilingam, CM; Zegans, ME1
Kondori, N; Mattsby-Baltzer, I; Svensson, E1
Kim, A; Kuti, JL; Nicolau, DP1
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T1
Azofra, MM; Carrillo, LH; Pérez, RD; Porras, MC; Somovilla, JL1
Boel, A; Cartuyvels, R; Magerman, K; Naesens, R; Nys, S; Vijgen, S1
Murayama, N; Nakamoto, M; Niwa, T; Shimizu, M; Yamazaki, H1
de Hoon, J; Meersseman, P; Meersseman, W; Spriet, I; Willems, L1
Bouza, E; Escribano, P; Gama, B; Guinea, J; Peláez, T; Recio, S1
Inoue, T; Kakita, T; Matsuda, H; Mori, T; Nagatoya, K; Teranishi, J; Yamauchi, Y1
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS1
Meersseman, W1
Bermudez, C; Clancy, CJ; Crespo, M; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, J; Silveira, FP; Toyoda, Y; Vadnerkar, A2
Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Johnson, E; Pelaez, T; Pfaller, MA; Rinaldi, MG; Turnidge, J1
Shen, YC; Tsai, HY; Tsai, TC; Wang, CY; Wei, LC1
Chen, JM; Kuo, CH; Lin, SC; Lin, SW1
Andreesen, R; Beier, F; Hildebrandt, GC; Holler, E; Holzmann, T; Kittan, N; Schardt, K1
McCormack, J; Pollard, J1
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F1
Hou, Z; Li, C; Liu, G; Liu, Z; Lu, M; Sha, X; Tan, D; Xie, J; Xie, Y1
Cisneros-Lanuza, A; Díaz-Llopis, M; Duch-Samper, A; Hurtado-Sarrió, M; Peman-Garcíia, J; Vazquez-Polo, A1
Calvo, E; Guarro, J; Pastor, FJ; Pujol, I; Rodríguez, MM1
Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG1
Bienvenu, AL; Biswas, P; Caillot, D; Chachaty, E; Cornet, M; Greene, J; Grenouillet, F; Herbrecht, R; Lacroix, C; Lortholary, O; Obenga, G; Raad, I; Sitbon, K; Troke, P1
Dalpke, A; Müller, FM; Salvenmoser, S; Seidler, MJ1
Biassoni, C; Borghi, E; Cuna, T; Iatta, R; Montagna, MT; Morace, G; Sciota, R1
Abecasis, M; Bilger, K; Bofarull, RM; Cordonnier, C; Cornely, OA; de la Cámara, R; Einsele, H; Faucher, C; Heussel, CP; Liakopoulou, E; Ljungman, P; Maertens, J; Olavarria, E; Pigneux, A; Pineau, M; Rovira, M; Ullmann, AJ; Weisser, M1
Aznar, J; de Toro, M; Maite, R; Torres, MJ1
Aversa, F; Caira, M; Candoni, A; Leone, G; Luppi, M; Martino, B; Nosari, A; Offidani, M; Pagano, L; Specchia, G; Tosti, ME; Valentini, CG1
Ceballos, P; Cociglio, M; Eiden, C; Eymard-Duvernay, S; Fegueux, N; Hillaire-Buys, D; Peyrière, H1
Chen, L; Mulligan, ME1
Barkmeier, A; Carvounis, PE; Kadikoy, H; Peck, B1
Heeres, J; Lewi, P; Meerpoel, L1
Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG1
Arrieta, AC; Driscoll, T; Groll, AH; Jafri, H; Klein, NJ; Lutsar, I; Milligan, PA; Schlamm, H; Walsh, TJ; Wood, ND1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A1
Belda, W; Careta, MF; Criado, PR; Martins, JE; Rivitti, EA; Spina, R; Valente, NY1
Buer, J; Huelsewede, J; Rath, PM; Steinmann, J1
Charvet, C; Mast, N; Pikuleva, IA; Stout, CD1
Chen, XP; Ouyang, DS; Shi, HY; Tan, ZR; Wu, WH; Yan, J; Yang, GP; Zhou, G; Zhu, WH1
Bies, R; Capitano, B; Gilbert, S; Han, K; Husain, S; McCurry, K; Paterson, DL; Potoski, BA; Venkataramanan, R1
Chavda, M; Clawson, JS; Edwards, AJ; Pham, TN; Strohmeier, M; Vogt, FG; Watson, SA1
Dag, I; Kiraz, N; Oz, Y3
Belda, S; Cremades, R; Lopez, P; Rodriguez, JC; Royo, G; Ruiz-Garcia, M; Soler, L1
Cleveland, KO; Mazumder, SA; Norwood, J1
Kim, SY; Lee, YC; Yang, J1
Costa, TD; Farias da Silva, C; Verlindo de Araujo, B1
Baert, K; Debacker, P; Ducatelle, R; Garner, TW; Haesebrouck, F; Martel, A; Pasmans, F; Van Rooij, P; Van Waeyenberghe, L; Vercauteren, G; Woeltjes, T1
Marriott, D; Miyakis, S; Ray, J; Solvag, CJ; van Hal, SJ1
Ahmad, S; Burhamah, MHA; Khan, ZU; Mokaddas, E1
Fisher, C; Jones, RL; Judson, IR; Ratnayake, G; Scurr, M; Thway, K1
Bowyer, P; Bueid, A; Denning, DW; Harrison, E; Howard, SJ; Moore, CB; Richardson, MD1
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M1
Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG1
Bruggemann, RJ; Mavridou, E; Melchers, WJ; Mouton, JW; Verweij, PE1
Magrath, GN; Mason, C; Montero, J; Pulido, JS; Wilson, J1
Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E1
Ehlert, K; Fegeler, W; Groll, AH; Kerl, K; Koch, B; Rossig, C1
Atalay, H; Erekul, S; Nar, A; Ozbek, O; Solak, Y; Turk, S; Turkmen, K1
Díaz-Llopis, M; Garcia-Delpech, S; Salom, D; Udaondo, P1
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N1
Cai, B; Chen, H; Li, G; Li, H; Liu, W; You, C1
Cutlan, JE; Geddes, ER; Hymes, SR; Polder, K; Torres-Cabala, CA1
Guarro, J; Mayayo, E; Pastor, FJ; Pujol, I; Ruíz-Cendoya, M; Sutton, DA1
Arendrup, MC; Johansen, HK; Lass-Flörl, C; Mellado, E; Mortensen, KL; Rodriguez-Tudela, JL1
Abe, M; Fujii, S; Harada, T; Jinno, T; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Ozaki, S; Takeuchi, K; Yata, K1
Kim, M; Kim, MN; Lee, K; Lee, MK; Yong, D1
Aydin, F; Bayramoglu, G; Guler, NC; Kaklikkaya, N; Tosun, I1
Fernandes, M; Lakshmipathy, M; Shah, SG; Sharma, S1
Bleyzac, N; Goutelle, S; Larcher, R; Mialou, V; Padoin, C1
Anandbabu, K; Basu, G; Devasia, A; Sundaram, M; Tamilarasi, V1
Chen, J; Chen, RZ; Huang, HQ; Lai, W; Xi, LY; Xue, RZ; Zhang, J; Zhang, XH1
Judson, MA; Kravitz, JN; Steed, LL1
Grundon, RA; Hardman, C; Muhlnickel, C; O'Reilly, A; Stanley, RG1
Bello, I; Golmia, R; Hamerschlak, N; Marra, A; Osawa, A; Scheinberg, M1
Guarro, J; Pastor, J; Ruíz-Cendoya, M1
Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D1
Bille, J; Calandra, T; Decosterd, LA; Marchetti, O; Mercier, T; Pesse, B; Rochat, B; Tissot, F; Widmer, N; Zanolari, B1
Mulliez, P1
Croxo, C; Mulliez, P; Saint-Georges, FR1
Huang, Y; Li, HY; Liu, L; Wang, GY; Xia, ZF; Zhang, JR; Zhu, SH1
Jiang, HR; Wu, XG; Xin, M; Yang, LN1
Duan, J; Lan, X; Wang, L; Xiong, X; Zhai, S1
Accoceberry, I; Gabriel, F; Noel, T1
Gupta, P; Haripriya, A; Lalitha, P; Nirmal, J; Prajna, NV; Senthilkumari, S; Velpandian, T1
Chong, PP; Jamal, F; Madhavan, P; Ng, KP1
Cosaert, K; de Hoon, J; Meyfroidt, G; Meyts, I; Proesmans, M; Renard, M; Spriet, I; Uyttebroeck, A; Verbesselt, R; Willems, L1
Heijink, A; Patel, R; Rouse, MS; Steckelberg, JM1
Chang, MR; Dias, AL; Gambale, V; Paula, CR; Prates, RA; Ribeiro, MS; Ruiz, Lda S; Silva, EG1
Esterly, JS; Fotis, M; Gorski, E; Postelnick, M; Scheetz, MH; Trifilio, S1
Hagihara, M; Hasegawa, T; Kawasumi, N; Kimura, M; Mikamo, H; Yamagishi, Y1
Kloft, C; Simmel, F1
Chen, DM; Guo, LN; Liu, Y; Lü, HX; Shi, JY; Shi, Y; Wang, H; Xi, LY; Xu, YC; Zhao, WS; Zhou, X1
Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA1
Auffarth, GU; Dithmar, S; Thomas, BC; Völcker, HE; Zimmermann, S1
Höger, PH; Ott, H; Schrum, J; Vöhringer, S1
Bulloch, MN1
Borghi, E; Iatta, R; Manca, A; Montagna, MT; Morace, G1
Bellmann, R; Bellmann-Weiler, R; Dunzendorfer, S; Fiegl, D; Joannidis, M; MacFarland, R; Stienecke, E; Weiler, S1
Cecil, JA; Wenzel, RP1
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR1
Fujiya, M; Hosoki, T; Ikuta, K; Kohgo, Y; Okamura, N; Sato, K; Torimoto, Y; Yamamoto, M1
Fernandes, M; Goyal, J; Shah, SG1
Higaki, T; Itokawa, T; Kami, M; Komatsu, T; Miura, Y; Murashige, N; Murata, K; Takei, N; Tsubokura, M1
Balestrazzi, A; Ciompi, L; Franceschini, R; Martone, G; Moramarco, A; Pichierri, P; Tosi, GM1
Coorevits, L; Jeurissen, A; Lagrou, K; Schuermans, C; Surmont, I; van Bergen, M; Verhaegen, J1
Arora, R; Goyal, J; Gupta, D; Kaur, R1
Balasingham, A; Balasingham, S; Chalkias, S; Saul, Z; Sutton, DA; Wickes, BL1
Falcone, M; Massetti, AP; Russo, A; Venditti, M; Vullo, V1
Brüggemann, RJ; Burger, DM; van der Linden, JW; Verweij, PE; Warris, A1
Bierings, MB; Melchers, WJ; Thors, VS; Verweij, PE; Wolfs, TF1
Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E1
Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H1
Fujishima, K; Fukae, J; Furuya, T; Hattori, N; Hirayama, T; Noda, K; Ogaki, K; Okuma, Y1
Dolton, MJ; McLachlan, AJ2
Al-Badriyeh, D; Heng, SC; Kong, DC; Neoh, CF; Slavin, M; Stewart, K1
Böhme, A; Heinz, WJ; Silling, G1
Durrani, OM; Joganathan, V; Mehta, P; Oppenheim, B1
Chen, KJ; Hsiao, CH; Sun, CC; Tan, HY; Yeh, LK1
Ko, KS; Lee, JY; Peck, KR; Song, JH1
Ayub, A; Kenney, CV; McKiernan, FE1
Charles, JF; Daikh, DI; Eberle, C; Rooney, T1
Abbes, S; Ayadi, A; Ben Jemaa, M; Bouaziz, M; Cheikhrouhou, F; Chelly, H; Hammami, B; Khaled, S; Makni, F; Néji, S; Sellami, A; Sellami, H1
Clemons, KV; Kline, Y; Stevens, DA; Tell, LA; Woods, L1
Ciecko, SC; Scher, R1
Bedouch, P; Belaiche, S; Pison, C; Quetant, S; Roustit, M; Saint-Raymond, C1
Azevedo, AC; Bizerra, FC; Colombo, AL; da Matta, DA; de Almeida, LP; Rosas, R1
Askari, E; Cáceres Agra, JJ; Jarque, I; Nicolás Franco, S1
Burhenne, J; Czock, D; Haefeli, WE; Hassan, A; Mikus, G; Riedel, KD; Weiss, J1
Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S1
Bloomer, MM; Fintelmann, RE; Gilmer, W; Jeng, BH1
Chiba, S; Hara, A; Homma, M; Kohda, Y; Momo, K; Okoshi, Y; Wada, T; Watanabe, M1
Boyken, L; Diekema, DJ; Espinel-Ingroff, A; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S1
Deeren, D1
Cooper, K; Deziel, PJ; Kremers, WK; Moyer, TP; Razonable, RR; Wermers, RA; Whitford, GM1
Chai, LY; Hsu, LY1
Kuithan, F; Scheer, F; Wiggermann, P1
Alvarez Tundidor, S; González Rozas, M; Pineda Alonso, M1
Cornely, OA; Farowski, F; Hussaini, T; Rüping, MJ; Vehreschild, JJ1
Cuenca-Estrella, M; Cuesta, I; Gomez-Lopez, A; Mellado, E; Rodriguez-Tudela, JL; Zaragoza, O1
Cars, O; Lignell, A; Löwdin, E; Sanglard, D; Sjölin, J1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR1
Cordonnier, C; Cornely, OA; Einsele, H; Ljungman, P; Maertens, J; Rovira, M1
Wilson, MA; Wise, SM1
Boyken, LB; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS1
Giguère, P; Kravcik, S; la Porte, CJ; Toy, J1
Bies, R; Capitano, B; Han, K; Johnson, H; Venkataramanan, R1
De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M1
de Queiroz-Telles, F; Fraunfelder, FT; Goodrich, J; Laties, AM; Moreira, AT; Sato, MT; Tomaszewski, K1
Jones, B; Lang, S; Lappin, DF; Majithiya, JB; McCulloch, E; Mowat, E; Rajendran, R; Ramage, G; Warn, P; Williams, C1
Bouza, E; Escribano, P; Guinea, J; Peláez, T; Recio, S1
Deuel, T; Folkerth, R; Jiang, JX; Kesari, S; Lechpammer, M; Marty, FM; Milner, DA; Rosow, L; Zamani, AA1
Bigorra, L; Garduño, E; Hidalgo, R; Torres, JP1
Pena, TA; Samavati, L; Soubani, AO1
Gurgle, HE; Oinonen, MJ; Pakyz, AL1
Antachopoulos, C; Chatzimoschou, A; Georgiadou, E; Katragkou, A; Roilides, E; Simitsopoulou, M; Walsh, TJ1
Davis, JL; Goldstein, SC; Lombardi, LR; Miano, TA; Mitra, N; Morgan, SC; Vardhanabhuti, S; Vozniak, JM1
Ananda-Rajah, MR; Cheng, A; Dooley, M; Morrissey, CO; Neville, AM; Slavin, M; Spelman, T1
Bajwa, RP; Fung, B; Garee, A; Gross, TG; Pietryga, D; Rawlinson, NJ; Skeens, M; Soni, S; Termuhlen, AM1
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H1
Hao-Ran, J; Li-Na, Y; Meng, X; Xiang-Gen, W1
Azim, S; Fadoo, Z; Manzoor, NF1
Bourgeois, N; Crouzet, J; Lachaud, L; Picard, E; Sotto, A1
Cohen, PR; Riahi, RR1
Actis Dato, GM; Bardi, G; Casabona, R; Del Ponte, S; Flocco, R; Forsennati, P; Parisi, F; Punta, G; Sansone, F; Zingarelli, E1
Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V1
Yong, L1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC1
Flynn, HW; Liggett, PE; Scartozzi, R; Tom, D1
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y1
Lodise, TP; Pai, MP1
Huang, CY; Sun, PL; Tseng, HK1
Durand, CM; Durand, DJ; Lee, R; Neofytos, D; Ray, SC1
Cheng, Y; Li, WJ; Tian, Y; Wei, W; Zhang, ZJ1
Hatta, Y; Inoue, Y; Kato, M; Miura, I; Ogawa, K; Saito, T; Shibuya, Y; Suzuki, Y; Takahashi, M; Takeuchi, J; Takimoto, M1
Bency, R; Blyth, CC; Chapman, J; Chen, SC; Gilroy, N; Harun, A; Meyer, W; Ong, A; Shingde, M; Vicaretti, M1
Iwata, N; Kimotsuki, T; Kinoshita, J; Ohba, M; Yasuda, M1
Hoshika, Y; Kato, M; Katsura, Y; Kikuchi, K; Misawa, S; Nagaoka, T; Ohashi, R; Seyama, K; Sugawara, T; Takahashi, K; Takekawa, H; Togo, S; Tsuchiya, K; Yoshimi, K1
Daneshgar, F; Khodabande, A; Siatiri, H; Siatiri, N1
Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M1
Agarwal, P; Sharma, N; Sinha, R; Titiyal, JS; Vajpayee, RB; Velpandian, T1
Katragkou, A; Roilides, E1
Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A1
Cormican, M; Hanahoe, B; Lyons, M; O'Connell, K1
Caira, M; Fianchi, L; Pagano, L; Valentini, CG1
Kurokawa, M; Masamoto, Y; Nannya, Y1
Brizio, A; Cantoni, S; Lombardi, G; Morra, E; Nosari, A; Riva, M1
Grossniklaus, HE; Hall, T; Khandelwal, SS; Stulting, RD; Woodward, MA1
Maschmeyer, G; Sandherr, M1
Barnes, A; Barr, FJ; Hotston-Moore, A; Malik, R; Murphy, KF; Pearson, GR1
Funakoshi, Y; Matsuoka, H; Minami, H; Yakushijin, K1
Booth, DR; Liddle, C; O'Connor, K; Stewart, GJ; Suan, D1
Reisman, A; Schwartz, S; Troke, PF1
Geller, L; Mercer, SE; Phelps, RG; Raciti, PM1
Amorim, A; Butler, G; Guida, A; Miranda, IM; Pina-Vaz, C; Rocha, R; Rodrigues, AG; Silva, AP; Silva, R; Synnott, J1
Kong, DC; Leung, L; Neoh, CF; Stewart, K; Vajpayee, RB1
Nweze, EI; Ogbonnaya, UL1
Angoulvant, A; Epaud, R; Le Pointe, HD; Levine, E; Petit, A1
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Zhang, D; Zhang, J; Zou, Y1
Clemons, KV; Schwartz, JA; Stevens, DA2
Arendrup, MC; Fuursted, K; Gahrn-Hansen, B; Howard, SJ; Jensen, RH; Johansen, HK; Knudsen, JD; Mortensen, KL1
He, L; Ji, WB; Liang, YR; Lu, F; Lü, SC; Luo, Y; Shi, XJ; Zhao, ZM1
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M1
Alexander, BD; Andes, D; Arendrup, MC; Brown, SD; Chaturvedi, V; Diekema, DJ; Espinel-Ingroff, A; Fowler, CL; Ghannoum, MA; Johnson, EM; Knapp, CC; Motyl, MR; Ostrosky-Zeichner, L; Pfaller, MA; Walsh, TJ1
Spriet, I; Wauters, J; Willems, L1
Borman, A; Cartwright, KE; Clark, TW; Hussain, AM; Johnson, EM; Wiselka, M1
Caggiano, G; Cuna, T; Iatta, R; Montagna, MT1
Alvarez, MA; Gómez, P; Martín, C; Martín, V; Martínez, F; Molina, JR; Rodríguez, G; Rodríguez-Villa, A; Rojas, R; Sánchez-García, J; Serrano, J; Tallón, D; Torres, A1
Calvo, E; Guarro, J; Hernández, P; Mayayo, E; Pastor, FJ1
Chugh, TD; Duggal, S; Jain, H; Sharma, A; Tyagi, A1
Ilkit, M; Kiraz, N; Oz, Y; Ozdemir, HG1
Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P1
Dong, X; Min, X; Wu, X; Xie, L; Yang, L1
Malfertheiner, MV; Schreiber, J; Waldburg, N1
Badali, H; de Hoog, GS; Meis, JF; Sudhadham, M1
Falade-Nwulia, O; Henning, SA; Huang, X; JJingo, C; Leung, J; Moriyama, B; Penzak, SR; Walsh, TJ; Wilson, WH1
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L1
Aki, ŞZ; Akyürek, N; Şenol, E; Sucak, G; Tunçcan, ÖG1
Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S1
Chvojka, J; Karvunidis, T; Krouzecky, A; Matejovic, M; Novak, I; Radej, J; Stehlik, P; Sykora, R1
Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA1
Ko, WC; Lee, HC; Lo, HJ; Wu, CJ1
Bajaj, MS; Kashyap, S; Meel, R; Pushker, N; Sen, S1
Avery, S; Chang, CC; Grigoriadis, G; Morrissey, O; Patil, S; Spencer, A; Walker, P1
George, J; Reboli, AC1
Das, M; Dikshit, S; Murthy, SI; Rathi, V1
Jang, IJ; Kim, KH; Kim, NJ; Lee, S; Oh, MD; Park, WB; Yu, KS; Yun, NR1
Fujiwara, Y; Ota, Y; Takeuchi, M; Yoshida, C1
Dan, M; Edelman, A; Gottesman-Yekutieli, T; Hendel, D; Shwartz, O1
Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M1
Hagiwara, E; Kamei, K; Ogata, R; Ogura, T; Shiihara, J; Takahashi, H1
Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ1
Biancalana, FS; Lyra, L; Schreiber, AZ1
Mikus, G; Scholz, IM; Weiss, J1
El-Hadidy, GN; El-Milligi, MF; Ibrahim, HK; Mohamed, MI1
Castanheira, M; Hata, K; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA1
Chavala, SH; Ehlers, JP; Postel, EA; Woodward, JA1
Agarwal, P; Gogia, V; Gupta, S; Satpathy, G; Shrivastava, RM; Tandon, R1
Williams, D1
Salameire, D1
Blanche, S; Bougnoux, ME; Elie, C; Gerin, M; Jullien, V; Lanternier, F; Lortholary, O; Mahlaoui, N1
de Hoog, S; Debourgogne, A; Lozniewski, A; Machouart, M1
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY1
Bignell, EM; Cairns, T; Doyle, S; Kavanagh, K; Larsen, TO; Miggin, SM; O'Hanlon, KA; O'Keeffe, G; Schrettl, M; Stack, D1
Osmond, GW; Puri, PK; Walters, RW1
Miller, CJ; Seykora, JT; Shinohara, MM1
Brown, M; O'Reilly Zwald, F1
Kullberg, BJ; Oborska, IT; Oude Lashof, AM; Pappas, PG; Rex, JH; Rothova, A; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, W; Smith, RP1
Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V1
Hockey, HP; Hope, WW; Troke, PF1
Han, SB; Hyon, JY; Shin, YJ; Wee, WR1
Stirbu, O; Suriano, MM; Vila Arteaga, J1
Lingegowda, PB; Tan, AL; Tan, BH; Tan, CK1
Björkholm, M; Celsing, F; Grane, P; Kalin, M1
Mitrokhin, SD; Sokolov, AA1
Asslaber, M; Buzina, W; Haas, D; Heiling, B; Hoenigl, M; Koidl, C; Krause, R; Neumeister, P; Pichler, M; Rohn, A; Salzer, HJ; Valentin, T; Zollner-Schwetz, I1
Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS1
Chang, SE; Choi, JH; Kim, MS; Lee, HM; Lee, MW; Moon, KC; Sung, HS; Won, CH1
Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P1
Banerjee, R; Dhiman, N; Henry, NK; Huskins, WC; Joshi, AY; Santillan Salas, CF; Wengenack, NL1
Fujieda, A; Iwamoto, T; Katayama, N; Monma, F; Nakatani, K; Okuda, M1
Doroftei, B; Mareş, M; Năstasă, V; Ramona, FM; Stefanache, A1
Fothergill, AW; Grimsrud, C; Kim, HT; Raven, R1
Akalin, H; Dizdar, OS; Ener, B; Ersoy, A; Koc, AO1
Beiras-Fernandez, A; Bigdeli, AK; Kaczmarek, I; Michel, S; Nickel, T; Reichart, B; Ueberfuhr, P1
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K1
Berbel, RF; Casella, AM; de Freitas, D; Höfling-Lima, AL1
Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH1
Bentley, RT; Faissler, D; Sutherland-Smith, J1
Alves, SH; Azevedo, MI; Rossato, L; Santurio, JM; Spader, TB; Tronco-Alves, GR; Venturini, TP; Weiler, CB1
Carrillo-Muñoz, AJ; Eraso, E; Madariaga, L; Marcos-Arias, C; Quindós, G1
Castanheira, M; Duncanson, F; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA1
Dickmeyer, NJ; Kiel, PJ1
Afshari, NA; Goldhagen, BE; Majka, CP; Perfect, JR; Rebong, RA; Santaella, RM; Steinbach, WJ1
Agrawal, S; Bali, R; Bhagol, A; Sen, R; Sharma, B; Singh, V1
Damle, B; Luke, DR; Tomaszewski, KE; Wood, ND1
Alcazar-Fuoli, L; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Rodriguez-Tudela, JL; Sanglard, D1
Damle, B; Varma, MV; Wood, N1
Cook, G; Glasmacher, A; Heussel, CP; Kantecki, M; Kibbler, CC; Marks, DI; Miller, PJ; Pagliuca, A; Ribaud, P; Schlamm, HT; Solano, C1
Kamei, K; Nishimura, K; Sugaya, K; Sugiyama, Y; Suzuki, Y; Tokura, Y; Yaguchi, T1
Aubry-Rozier, B; Boubaker, A; Dunet, V; Marchetti, O; Rossier, C; Tissot, F1
Al-Nawas, B; Karbach, J; Walter, C1
Baruch, A; Blumer, J; Driscoll, TA; Frangoul, H; Krance, RA; Liu, P; Murphey, DK; Nemecek, ER; Yu, LC1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA1
Binder, DR; Herring, IP; Sugrue, JE1
Beguin, H; Detandt, M; Hendrickx, M1
Katkov, AI; Katkova, VO; Nesterov, AP; Novikova, NA; Ovchinnikov, RS; Sedov, VP; Syrkin, AL; Vakhliaev, AV1
Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C1
Arda, B; Ceylan, N; Erdem, A; Işıkgöz Taşbakan, M; Metin, DY; Midilli, R; Pullukçu, H; Sipahi, OR; Taşbakan, MS; Ulusoy, S; Yamazhan, T1
Burhenne, J; Haefeli, WE; Katzenmaier, S; Markert, C; Mikus, G; Riedel, KD1
Haagsma, CJ; Hendrix, R; Ruinemans, GM1
Atalay, S; Aypar, E; Çiftçi, E; Ileri, T; Ince, E; Kendirli, T; Tutar, E1
Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D1
Arrieta, A; Baruch, A; Blumer, J; Bradfield, SM; Driscoll, TA; Frangoul, H; Graham, ML; Krance, RA; Liu, P; Nemecek, E; Yu, LC1
Bell, JE; Christenson, JC; Hulbert, ML; Imel, EA; Skiles, JL1
Aoun, M; Gadisseur, A; Jacobs, F; Selleslag, D; Sonet, A1
Acharya, NR; Gronert, K; Keenan, JD; Krishnan, T; Lietman, TM; Oldenburg, CE; Prajna, NV; Ray, KJ1
Prasad, PA; Vaughan, AM; Zaoutis, TE1
Hamoud, S; Hayek, T; Keidar, Z1
de Hoog, GS; Hell, M; Lackner, M; Neureiter, J; Presterl, E; Willinger, B; Wojna, A1
Fulco, PP; Gibson, JN1
Chang, TC; Hsiue, HC; Hsiue, YC; Hsueh, PR; Huang, YT; Lee, PI; Wu, TH1
Cornish, NE; Hoffman, MA; Simonsen, KA1
Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH1
Falcone, M; Mancini, C; Morelli, A; Russo, A; Vena, A; Venditti, C; Venditti, M1
Bays, D; Cohen, SH; Pappagianis, D; Thompson, GR1
Bouza, E; Escribano, P; González-Rivera, M; Guinea, J; Peláez, T; Recio, S1
Blosser, SJ; Cramer, RA1
Cui, Y; Jin, C; Li, X; Wu, N1
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A1
Chu, J; Meehan, S; Patel, R; Patel, U1
Bakhshi, S; Kabra, SK; Mandhaniya, S; Swaroop, C; Thulkar, S; Vishnubhatla, S; Xess, I1
Blair, JE; Kim, MM; Kusne, S; Seville, MT; Vikram, HR1
Granata, JD; Lustenberger, DP; Scharschmidt, TJ1
Blanche, S; Chosidow, O; Epaulard, O; Leccia, MT; Lortholary, O; Mamzer-Bruneel, MF; Ravaud, P; Thiebaut, A; Villier, C2
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M1
Bahlaoui, A; Bakhatar, A; Chakib, A; El Fane, M; El Filali, KM; Ouladlahsen, A; Sodqi, M1
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J1
Hope, WW1
Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L1
Cendejas-Bueno, E; Cuenca-Estrella, M; Cuesta, I; García Rodríguez, J; Gómez-López, A; Gutiérrez-Altés, A; Rodríguez-Tudela, JL1
de Assis Baroni, F; Gambale, W; Paula, CR; Silva, EG1
Schmutz, JL; Trechot, P1
Bedini, A; Cavrini, F; Cocchi, S; Codeluppi, M; De Ruvo, N; Di Benedetto, F; Gennari, W; Gerunda, GE; Grottola, A; Guaraldi, G; Rumpianesi, F; Venturelli, C1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA1
Hayashi, T; Hosokawa, K; Ishiyama, K; Kondo, Y; Mochizuki, K; Nakao, S; Ohata, K; Okumura, H; Sugimori, N; Takami, A; Yamazaki, H1
Alcazar-Fuoli, L; Bignell, E; Blatzer, M; Cairns, T; Grimalt, JO; Gründlinger, M; Haas, H; Lopez, JF; Puempel, T; Yasmin, S1
Mada, SR; Pillai, VC; Strom, S; Venkataramanan, R; Zhang, S1
Herbrecht, R; Kemmel, V; Levêque, D; Nivoix, Y; Scholler, J1
Godschalk, PC; Klein, SK; Malingré, MM1
Gray, C; Labois, A; Lepretre, S1
Rocha, L; Saleiro, S1
Wintenberger, C1
Kawakami, J; Mino, Y; Naito, T; Yagi, T; Yamada, T1
Calvo, E; Guarro, J; Mayayo, E; Pastor, FJ; Salas, V1
Lass-Flörl, C1
Chiche, L; Dicostanzo, MP; Durand, JM; Eldin, C; Harle, JR; Ranque, S; Thomas, G1
Gyotoku, H; Ikeda, H; Imamura, Y; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, T; Kohno, S; Miyazaki, T; Miyzaki, Y; Morinaga, Y; Nakamura, S; Nishino, T; Ohno, H; Takazono, T; Yaguchi, T; Yamamoto, Y; Yanagihara, K; Yasuoka, A1
Chang, YC; Dolan, MA; Garraffo, HM; Ghannoum, MA; Kwon-Chung, KJ; Sionov, E1
Briegel, J; Chouker, A; Frey, L; Kaufmann, I; Mayr, D; Spiekermann, K; Thiel, M; van der Heide, V1
de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P1
Koshy, R; Malhotra, P1
Balakrishnan, P; Chong, S; Chung, SJ; Kim, DD; Shim, CK; Song, CK1
de Hoog, GS; Mahgoub, el-S; van de Sande, WW; van Diepeningen, AD1
Chan, C; Chen, J; Colantonio, D; Seto, W1
Feng, AM; Wei, JY; Yu, WJ1
Capilla, J; Gazzoni, AF; Guarro, J; Mayayo, E1
Hamada, Y; Kuroyama, M; Seto, Y; Yago, K1
Desta, Z; Guo, Y; Ogburn, ET; Xu, C1
Allizond, V; Banche, G; Cuffini, AM; Fucale, G; Mandras, N; Roana, J; Scalas, D; Tullio, V1
Bocanegra, R; Kirkpatrick, WR; Kugler, AR; Najvar, LK; Patterson, TF; Perkins, K; Pfeiffer, J; Sweeney, TD; Vallor, AC; Wiederhold, NP1
Bouza, E; Giannella, M; Guinea, J; Klaassen, CH; Muñoz, P; Peláez, T; Valerio, M1
Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ1
Ibrahim, A; Kontoyiannis, DP; Lewis, RE; Lortholary, O; Lotholary, O; Petrikkos, G; Roilides, E; Roillides, E; Spellberg, B; Walsh, TJ1
Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L1
Desmet, K; Pauwels, S; Van Eldere, J; Vermeersch, P1
Doudounakis, S; Katelari, A; Markantonis, SL; Pappa, E1
Ahmad, Z; Chung, JH; Kadir, AA; Somchit, N; Yaacob, A; Zakaria, ZA1
Curfs-Breuker, I; de Hoog, GS; Klaassen, CH; Lackner, M; Meis, JF; Najafzadeh, MJ; Verweij, PE1
Campos-Herrero, MI; Horcajada, I; Medina-Rivero, F; Tandón, L1
Benjamin, DK; Blaschke, AJ; Cohen-Wolkowiez, M; Doby, EH; Driscoll, TA; Martin, PL; Moran, C; Pavia, AT; Ward, RM1
Hu, Y; Li, X; Liang, Y; Lu, C; Xi, L; Yang, Y; Zhang, J1
Dukhan, A; Paderu, P; Park, S; Perlin, DS; Senter, M; Zhao, Y1
Bu, D; Chen, W; Li, R; Liu, W; Sun, Y; Wan, Z1
Catania, MR; De Domenico, G; Panellis, D; Pulcrano, G; Rossano, F1
De Smet, J; Frueh, BE; Stary, J; Tappeiner, C; Thormann, W; Tschopp, M; Van Bocxlaer, J1
Niki, Y; Ohbayashi, H; Shoji, H; Takuma, T; Yamamoto, T; Yoshida, K1
Cheng, MF; Hsieh, LY; Liou, CH; Lo, HJ; Lu, DC; Shi, ZY; Tsai, MS; Wang, AH; Wang, LS; Wu, CJ; Yang, YL1
Ahmad, S; Al-Ghimlas, F; Al-Mutairi, S; Chandy, R; Guarro, J; Joseph, L; Khan, Z; Sutton, DA1
Mavridou, E; Melchers, WJ; Meletiadis, J; Mouton, JW; Verweij, PE1
Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y1
Acharya, NR; Krishnan, T; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Vaitilingam, CM; Zegans, ME1
Shen, YF; Sun, HL; Zhou, X1
Cil, H; Elbey, MA; Islamoglu, Y; Onturk, E1
Bowman, CJ; Chmielewski, G; Cross, DM; Lewis, EM; Liu, L; Modesitt, MS; Ripp, SL; Sawaryn, CM1
Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V1
Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S1
Beom, SH; Chin, HJ; Kim, S; Kim, YC; Lee, H; Ryu, HH; Yang, Y1
Chishimba, L; Cooley, J; Denning, DW; Niven, RM1
Han, SB; Hyon, JY; Shin, YJ; Wee, WR; Yang, HK1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G1
Daajani, NA; Farouq, MF; Ghanem, AT; Kamal, JS; Saadah, OI1
Cook, G; Cordonnier, C; Hicheri, Y1
Mittal, R; Mittal, V1
Buresova, L; Cetkovsky, P; Kocmanova, I; Kouba, M; Lengerova, M; Malaskova, L; Mayer, J; Racil, Z; Rolencova, M; Timilsina, S; Toskova, M; Weinbergerova, B; Winterova, J; Zak, P1
Friberg, LE; Karlsson, MO; Liu, P; Ravva, P1
Newton, EJ1
Beinborn, NA; Lirola, HL; Williams, RO1
Deering, KM; Dunn, JL; Field, CL; Frasca, S; Gilbert-Marcheterre, K; Meegan, J; Nyaoke, A; Risatti, G; Romano, TA; Sidor, IF; Spoon, T; Tuttle, AD1
Kullberg, BJ; Oude Lashof, AM; Pappas, PG; Rex, JH; Ruhnke, M; Schlamm, HT; Sobel, JD; Viscoli, C1
Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR1
Kato, J; Kikuchi, T; Kohashi, S; Mori, T; Okamoto, S; Ono, Y; Sakurai, M; Yamane, A1
Barreiro, GC; Leite, PF; Samano, MN; Siciliano, RF; Strabelli, TM; Tuma Júnior, P; Waisberg, DR1
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M1
Biswas, J; Gopal, L; Selvakumar, P; Sofia, O1
Arron, ST; Binstock, M; Boettger, R; Boker, A; Glidden, DV; Golden, JA; Metchnikoff, C; Singer, JP1
Campbell, WN; Fothergill, AW; Keshtkar-Jahromi, M; McTighe, AH; Segalman, KA1
Azad, S; Boutros, PC; Chaparro, C; Hosseini-Moghaddam, SM; Husain, S; Keshavjee, S; Lazar, N; Luong, ML; Rotstein, C; Singer, LG1
Alou, L; Cafini, F; Corcuera, MT; Gómez-Aguado, F; González, N; Guinea, J; Prieto, J; Sevillano, D1
Eberhard, R; Fleischhauer, J; Kocher, C; Trachsler, S1
Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC1
Allbaugh, RA; Pucket, JD; Rankin, AJ1
Aebi, C; Ammann, RA; Bernhard, S; Diepold, M; Kernland Lang, K; Leibundgut, K; Lüer, S1
Egerer, G1
Chakrabarti, A; Jatana, M; Rudramurthy, SM; Singh, R1
Corso, V; Drudi, F; Fantini, M; Imola, M; Mianulli, AM; Pasini, G; Ravaioli, A; Santelmo, C; Veneroni, L1
Carroll, KC; Illei, PB; Lederman, HM; Marr, KA; Meriden, Z; Riedel, S; Villa, K; Zhang, SX1
Chen, SC; Lawrence, C; Lemos, BD; Marshall Lyon, G; Spratt, M; Veledar, E; Zwald, FO1
Chakrabarty, A; Gupta, A; Gupta, N; Parchand, S; Ram, J1
Kim, HR; Lee, MK; Yu, N1
Beinborn, NA; Du, J; Smyth, HD; Wiederhold, NP; Williams, RO1
Bouza, E; Bunsow, E; Cuenca-Estrella, M; Gama, B; Gijón, P; Mellado, E; Pelaez, T; Sánchez-Yebra, W; Valerio, M1
Constantinou, M; Jhanji, V; Ramakrishnan, T; Vajpayee, RB1
Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E1
Andersen, N; Baltch, AL; Bopp, LH; Carlyn, CJ; Lawrence, D; Michelsen, PB; Ritz, WJ; Smith, RP1
Chandrasekar, PH; Krishnan-Natesan, S; Wu, W1
Cheng, ML; Ha, E; Leibowitz, M1
Andes, D; Lepak, A1
Bille, J; Bolay, S; Buclin, T; Calandra, T; Csajka, C; Marchetti, O; Pascual, A1
Bai, C; Chen, B; Huang, HD; Huang, Y; Li, Q; Wang, Q; Wu, N; Yao, XP1
Bader, O; Gross, U; Hull, CM; Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG; Weig, M2
Alanio, A; Bougnoux, ME; Dannaoui, E; Ducroz, S; Lortholary, O; Planche, V1
Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P1
Chen, TC; Chen, YC; Chen, YH; Lu, PL1
Chen, Z; Wei, J; Yang, Q1
Mukherjee, B; Pattnaik, G; Sinha, B1
Al-Nakeeb, Z; Arendrup, MC; Cuenca-Estrella, M; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Lass-Flörl, C; Majithiya, JB; Warn, PA1
Kuroki, K; Murakami, T1
Bartolesi, AM; Fanci, R; Pecile, P; Pini, G1
Abdi, RF; Al-Tawfiq, JA; Tarazi, AE1
Chandra, J; Ghannoum, MA; Mukherjee, PK; Pearlman, E; Sun, Y; Yu, C1
Lacroix, C; Le Pape, P; Miegeville, M; Morio, F; Pagniez, F1
Bua, J; Marchetti, F; Ventura, A; Zennaro, F1
Andes, DR; Baddley, JW; Boeckh, M; Brizendine, KD; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lyon, GM; Marr, KA; Oster, RA; Pappas, PG; Patterson, TF; Schuster, MG1
Ieda, M; Kobayashi, D; Ohshima, S; Yamamoto, M1
Gárate, C; García, P; Guzmán, AM; Labarca, J; León, P; Porte, L1
Goel, RS; Gupta, A; Jain, A; Kataria, R; Singh, S; Sinha, VD1
Brilhante, RS; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DS; Cordeiro, RA; Fechine, MA; Lima, RA; Mesquita, JR; Monteiro, AJ; Pereira, JF; Rocha, MF; Sidrim, JJ1
Ito, M; Kato, K; Kawashima, N; Matsumoto, K; Matsushita, N; Yoshida, N1
Alanio, A; Bretagne, S; Brisse, S; Cabaret, O; Cordonnier, C; Costa, JM; Sitterlé, E1
Behrens-Baumann, W; Haeberle, H; Hofmüller, W; Seibold, M; Tammer, I; Tintelnot, K; Walter, S; Wecke, T1
Ackerman, BH; Guilday, RE; Haith, LR; Hornbeek, H; Patton, ML; Reigart, CL; Stair-Buchmann, M1
Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH1
Ganesan, P; Philip, A; Sagar, TG; Sivaprakasam, P1
Fukushima, K; Goto, H; Miharu, M; Mori, M; Shoji, S; Yoshida, M1
Bienvenu, AL; Borderie, V; Chaumeil, C; Cornet, M; Gaujoux, T; Goldschmidt, P; Grenouillet, F; Lortholary, O; Obenga, G; Pons, D; Ranque, S; Sitbon, K; Troke, P1
Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W1
Kikuti, K1
Cantón, E; Martínez, JP; Pemán, J; Valentín, A1
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, NV; Srinivasan, M; Sy, A; Toutain-Kidd, CM; Zegans, ME1
Dag, I; Kiraz, N; Kiremitci, A; Metintas, S; Oz, Y1
Kema, GH; Melchers, WJ; van de Sande-Bruisma, N; Verweij, PE1
Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE1
Andersen, CU; Bendstrup, E; Henning, O; Hilberg, O; Lundby, T; Mortensen, J1
Choe, PG; Jang, IJ; Kim, KH; Kim, NH; Kim, NJ; Lee, SH; Nam, WS; Oh, MD; Park, WB; Song, KH; Yoon, SH; Yu, KS1
Cendejas-Bueno, E; Cuenca-Estrella, M; Gómez-López, A; Rodríguez-Tudela, JL1
Deniz, K; Karakukcu, M; Ozdemir, MA; Patiroglu, T; Tucer, B; Unal, E; Yikilmaz, A1
Becce, F; Lecouvet, FE; Malghem, J; Omoumi, P; Vande Berg, BC1
Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M1
Clarke, HD; McLaren, AC; McLemore, R; Miller, RB; Pauken, C1
Das, S; Gupta, N; Jain, S; Malik, JN1
Goletz, G; Groll, AH; Gumbinger, HG; Kolve, H; Pieper, S; Würthwein, G1
Andersen, CB; Carlsen, J; Iversen, M; Jensen, C; Tofte, N; Tvede, M1
Egli, A; Fuller, J; Humar, A; Kapasi, A; Kumar, D; Lien, D; Nador, R; Weinkauf, J1
Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA1
Hockey, H; Holford, N; Senn, S1
Grimault, A; Lyoen, M; Minello, A; Rostain, F; Sgro, C1
Feist, A; Lane, J; Lee, R; Osborne, S; Yung, G1
Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F1
Adachi, Y; Araki, K; Ikeda, T; Ishikawa, S; Kadowaki, T; Kimura, M; Kobayashi, K; Nagaoka, S; Wakabayashi, K; Yano, S1
Beltran, C; Bourge, RC; Bourke, P; Castro, P; Rabagliati, R; Verdejo, H; Winter, JL1
Clark, LP; Folio, L; Henderson, CM; Holland, SM; Kwon-Chung, KJ; Nardone, G; Peterson, SW; Riedlinger, G; Shea, Y; Sugui, JA; Zelazny, AM; Zerbe, CS1
Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA1
Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G1
Denning, DW; Felton, S; Haylett, AK; Rhodes, LE1
Al-Saigh, R; Elefanti, A; Meletiadis, J; Velegraki, A; Zerva, L1
Bilbao, J; Duplisea, K; Guiot, MC; Kolyvas, G; Qvarnstrom, Y; Umar, I; Visvesvara, GS; Webster, D1
Chen, Y; Groothuis, GM; Hadi, M; Merema, MT; Starokozhko, V1
Debaveye, Y; Grootaert, V; Meyfroidt, G; Spriet, I; Willems, L1
Baez, AA; Bonfietti, LX; Castro e Silva, DM; Martins, MA; Melhem, MS; Pukinskas, SR; Purisco, SU; Szeszs, MW1
Cid Lama, A; Crespo Erchiga, V; Fernández Ballesteros, MD; Gomez-Moyano, E; Lova Navarro, M; Vera Casaño, A1
Choi, SH; Hwang, JY; Kim, YJ; Koo, HH; Lee, SH; Lee, SY; Sung, KW; Yoo, KH1
Bhavan, KP; Boyd, NK; Swancutt, MA; Zoellner, CL1
Chandrasekar, PH; Cutright, JL; Krishnan Natesan, S; Wu, W1
Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ1
Cowen, EW; Elbaum, DJ1
Acharya, NR; Keenan, JD; Krishnan, T; Lalitha, PS; Lietman, TM; Mascarenhas, J; Oldenburg, CE; Porco, TC; Prajna, VN; Srinivasan, M; Sy, A; Vaitilingam, CM1
Koselke, E; Kraft, S; Nagel, J; Smith, J1
Harada, H; Inoue, A; Iwata, S; Kumon, Y; Ohnishi, T; Teraoka, M; Yamashita, D1
Hayashi, Y; Kobayashi, T; Mito, T; Ohashi, Y; Shiraishi, A; Suzuki, T; Zheng, X1
Atkinson, G; Lee, GA; McLintock, CA1
Baker, SD; Chaudhry, AS; Finkelstein, D; Gibson, A; Inaba, H; Li, L; Roberts, JL; Rubnitz, JE; Schuetz, EG; Zimmerman, EI1
Arnalich-Montiel, F; Irigoyen, C; López-Vélez, R; Lorenzo-Morales, J; Morcillo-Laiz, R; Muñoz-Negrete, F; Piñero, JE; Valladares, B1
Maack, KH; Tarp, B1
Costa, CR; de Fátima Lisboa Fernandes, O; de Paula, JA; de Souza Lino Junior, R; do Rosário Rodrigues Silva, M; Hasimoto E Souza, LK; Vinaud, MC1
Logan, BR; Zhang, MJ1
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L1
Aller, AI; Canton, E; Castañón-Olivares, LR; Chowdhary, A; Cordoba, S; Cuenca-Estrella, M; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Govender, N; Hagen, F; Illnait-Zaragozi, MT; Johnson, E; Kidd, S; Lass-Flörl, C; Lockhart, SR; Martins, MA; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Schell, WA; St-Germain, G; Trilles, L; Turnidge, J1
Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y1
Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW1
Su, J; Sun, W; Xu, S; Yan, D1
Curtis, LT1
Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K1
Bos, B; Buchheidt, D; Cornely, OA; Halbsguth, TV; Hallek, M; Hamprecht, A; Kahl, P; Kutsch, N; Persigehl, T; Plum, G; Spiess, B; Steinbach, A; Stippel, D; Vehreschild, JJ; Vehreschild, MJ1
Gamaletsou, MN; Kontos, AN; Kontoyiannis, DP; Kordossis, T; Sipsas, NV; Stefanou, I; Tsiakalos, A1
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K1
de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS1
Hide, M; Kamegashira, A; Kan, T; Ooiwa, H; Takahagi, S; Yaguchi, T1
Almendral, A; Arnalich, F; Arnalich-Montiel, F; Lorenzo-Morales, J; Valladares, B1
Campo, S; De Santis, R; Lo Giudice, P; Salvatori, G1
Strohmeier, M; Vogt, FG1
Chakrabarti, A; Darji, P; Patel, AK; Patel, KK; Shivaprakash, MR; Singh, R1
Chen, W; Li, L; Li, R; Liu, W; Sun, Y; Wan, Z1
Cherian, T; Giakoustidis, A; Heaton, DN; Heneghan, M; O'Grady, J; Rela, M; Verma, A; Wendon, J; Yokoyama, S1
Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL1
Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB1
Matsumoto, K1
Auzinger, G; Bernal, W; Heneghan, MA; López, JC; Solís-Muñoz, P; Verma, A; Wendon, J; Willars, C1
Denes, E; Dupon, M; Fiorenza, F; Megherbi, M; Saint-Marcoux, F; Weinbreck, P1
Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A1
Fiehler, J; Gerloff, C; Kruetzelmann, A; Rosenkranz, M; Sobottka, I; Tolosa, E1
Erdogan, Z; Kirbs, C; Kloft, C; Lackner, E; Simmel, F; Zeitlinger, M1
Lu, HZ; Shen, YZ; Wang, ZY1
Higgins, HW; Telang, GH; Vaidya, DC1
Basse, G; Berry, A; Cassaing, S; Cointault, O; Fillaux, J; Iriart, X; Kamar, N; Lamant, L; Lavayssière, L; Lavergne, RA; Linas, MD; Magnaval, JF; Nocera, T; Paul, C; Pauwels, C; Valentin, A1
Berzins, IK; Naples, LM; Poll, CP1
Kauffman, CA; Pappas, PG; Patterson, TF1
Choi, YL; Joo, H; Kang, SW; Kim, E; Kim, TH; Kim, YH; Park, SJ; Shin, JG; Son, JH; Song, IS; Yoon, YC1
Bojtarova, E; Cetkovsky, P; Drgona, L; Foralova, R; Forsterova, K; Guman, T; Haber, J; Kandrnal, V; Kocmanova, I; Kouba, M; Mallatova, N; Masarova, L; Mayer, J; Mudry, P; Muzik, J; Racil, Z; Sejnova, D; Tothova, E; Vydra, J; Weinbergerova, B; Ziakova, B1
Duan, J; Xiong, X; Zhai, S1
Balfour-Lynn, IM; Bentley, S; Gupta, A1
Chen, J; Liang, L; Liu, D1
Bartelink, IH; Bierings, M; Boelens, JJ; de Waal, M; Egberts, TC; Jonker, M; Ververs, TT; Wolfs, T1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Seyedmousavi, S; Verweij, PE2
Chang, YF; Lee, FL; Lee, SM; Yang, CS1
Brüggemann, RJ; Melchers, WJ; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE1
Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH1
Alió, JL; Arnalich-Montiel, F; López-Vélez, R; Lorenzo-Morales, J; Martín-Navarro, CM; Martínez-Carretero, E; Piñero, JE; Valladares, B1
Brokalaki, EI; Hillen, U; Sommerwerck, U; von Heinegg, EH1
Chen, L; Li, G; Lin, D1
Marr, KA; Shoham, S1
Barclay, ML; Begg, EJ; Moore, GA; Zhang, M1
Fan, YM; Huang, WM; Li, W; Yang, YP; Zhou, Y1
Allisy, C; Bougnoux, ME; Charlier, C; Hermine, O; Lecuit, M; Lortholary, O; Roth, P; Shoai Tehrani, M; Sicre de Fontbrune, F1
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J1
Boehme, A; Egerer, G; Greiner, J; Heinz, WJ; Lellek, H1
Traynor, K1
Aversa, F; Cesaro, S; de Rosa, FG; Girmenia, C; Micozzi, A; Mikulska, M; Novelli, A; Sanguinetti, M; Viscoli, C1
Melchers, WJ; Meletiadis, J; Mouton, JW; Rijs, AJ; Seyedmousavi, S; Verweij, PE1
Aldoghaither, RA; Baffoe-Bonnie, AW; Bansal, E; Demicco, DD; Garner, DC; Grifasi, ML; Kerkering, TM; Savaliya, VA; Schleupner, CJ; Smith, JA1
Atalay, MA; Koç, N; Sav, H; Unal, E1
Brilhante, RS; Caetano, EP; Camargo, ZP; Castelo Branco, DS; Cordeiro, RA; Fechine, MA; Lima, DT; Lima, RA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Rocha, MF; Sidrim, JJ1
Li, L; Ling, Z; Shao, F; Sheng, J; Wu, Z1
Dua, V; Oberoi, J; Sachdeva, A; Yadav, SP1
Altcheh, J; Bournissen, FG; Cutrullis, RA; Eagleson, MA; Freilij, H; Gulin, JE; Petray, PB; Postan, M1
Autmizguine, J; Krajinovic, M; Litalien, C; Marquis, C; Ovetchkine, P; Rousseau, J; Tapiéro, B; Théorêt, Y1
Plummer, CE; Tsujita, H1
Bennett, JE; Myers, TG; Noble, JA; Su, Q; Suffis, SD; Tsai, HF1
Estes, LL; Wilson, JW; Zeuli, JD1
Abdulaziz, S; Al Jahdali, H; Baharoon, S1
Chacko, J; Satpathy, G; Sharma, N; Sinha, R; Tandon, R; Titiyal, JS; Vajpayee, RB; Velpandian, T1
Nishiyama, Y1
Arabia, FA; Blair, JE; Kusne, S; Scott, RL; Steidley, DE; Vikram, HR; Webb, BJ1
Cornely, OA; Heinz, WJ; Hertenstein, B; Horst, HA; Löffler, J; Maschmeyer, G; Requadt, C; Ruhnke, M; Wagner, T1
Inoue, A; Kaneko, H; Kawamura, A; Matsumoto, S; Ohbuchi, M; Usui, T; Yamazoe, Y; Yoshinari, K1
Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG1
Cools, HJ; Fraaije, BA; Griffiths, WJ; Kelly, DE; Kelly, SL; Lucas, JA; Parker, JE; Rigdova, K; Warrilow, AG1
Hoenigl, M; Krause, R1
Ahmed, R; Akdal, G; Ananda, A; Chan, R; Chiu, AL; Crompton, JL; Francis, I; Ghabrial, R; Gibson, J; Goold, LA; Halmagyi, GM; Madge, SN; McCluskey, PJ; Rodriguez, M; Selva, D; Thompson, EO; Thurtell, MJ1
Cavaleiro, I; Félix, S; Proença, L; Salema-Oom, M1
Blondonnet, R; Cayot-Constantin, S; Constantin, JM; Guérin, R; Perbet, S1
Calvo, E; Fothergill, AW; Guarro, J; Pastor, FJ; Salas, V; Sutton, DA1
Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA1
Annaert, P; Brüggemann, RJ; Lagrou, K; Meersseman, P; Spriet, I; Van Wijngaerden, E; Willems, L1
Dadwal, SS; Davies-Vorbrodt, S; Ito, JI; Kriengkauykiat, J; Tegtmeier, BR1
Husain, S; Luong, ML; Rotstein, C1
Heng, SC; Kong, DC; Levvey, B; Nation, RL; Slavin, MA; Snell, GI1
Bennett, D; Endo, J; Kleker, B; Snow, S1
Al-Saigh, R; Elefanti, A; Krompa, K; Meletiadis, J; Mouton, JW; Verweij, PE; Zerva, L1
Allen, PB; Baer, MR; Kleinberg, ME; Koka, R1
Lilly, CM; Luke, DR; Mayer, T; Meisner, J; Ranauro, P; Welch, VL1
Carter, Y; Christie, J; Rimawi, RH; Siraj, D; Ware, T1
Fujioka, S; Hoffmann, T; Husar, S; Idlhammer, M; Kalaivanan, F; Khan, M; Lange, T; Poppenberger, B; Rozhon, W; Schwab, W; Shumilina, D1
Yoshida, M1
Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW1
Gärtner, P; Knoth, H; Petry, T1
Barkai, G; Jacoby, E; Keller, N1
Askew, DS; Bick, G; Feng, X; Krishnan, K; Powers-Fletcher, MV; Richie, DL; Woollett, LA1
Li, R; Mu, X; Yu, J1
Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC1
Borowiec-Chłopek, Z; Czepita, D; Giedrys-Kalemba, S; Karczewicz, D; Kot, J; Lachowicz, E1
Ayed, S; Bouguila, H; Malek, I; Nacef, L1
Shi, Y; Sun, HM; Xu, XY; Zhao, BL1
Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L1
Blijlevens, NM; Brüggemann, RJ; Donnelly, JP; Hope, WW; Jelliffe, RW; Neely, MN; Vanguilder, M1
Del Rosario, RC; Halloush, RA; Khasawneh, FA1
Furuya, N; Mano, Y; Morishige, H; Oguri, T1
Stevens, DA1
Banerjee, D; Khetan, A; Mandal, SM; Saha, S; Sengupta, J1
Golden, JA; Kukreja, J; Leard, LE; Sayah, DM; Schwartz, BS; Singer, JP1
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C1
Gude, T; Kulkarni, MM; McGwire, BS; Reddy, N1
Abe, K; Arakawa, H; Ishida, T; Notani, H; Ookubo, Y; Suto, C1
Aharchi, F; Hoetelmans, RM; Kakuda, TN; Nijs, S; Smedt, GD; Van Solingen-Ristea, R; Vyncke, V; Witek, J1
Danner, RL; Figg, WD; Henning, SA; Jarosinski, PF; Moriyama, B; Penzak, SR; Walsh, TJ; Wayne, AS1
Hu, LF; Lin, GY; Liu, YJ; Pan, XF; Shi, DW; Xu, RA; Ye, XL; Zhang, CH; Zhang, XH1
Dinesh, K; Karim, PM; Khan, S; Pillai, GS; Vivek, V1
Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C1
Jones, B; Jose, A; Lappin, DF; Ramage, G; Sherry, L; Williams, C1
Bouchara, JP; Diquet, B; Franconi, F; Godon, C; Legras, P; Lelièvre, B; Saint-André, JP1
Arora, R; Chaudhary, SC; Kumar, V; Sawlani, KK1
McLaren, A; McLemore, R; Pauken, C; Schmidt, K1
Hamill, R; Kamili, Q; Lai, S; Lin, D; Musher, DM; Qurat-Ul-Ain, K1
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H1
Bhatt, YM; Nair, B; Pahade, N1
Deuse, T; Kluge, S; Loderstaedt, U; Sobottka, I; Soeffker, G; Wichmann, D1
Barreto, JN; Beach, CL; Hogan, WJ; Litzow, MR; Merten, JA; Tosh, PK; Wilson, JW; Wolf, RC1
Levy, ER; McCarty, JM; Shane, AL; Weintrub, PS1
Galgiani, JN1
Aguirre, HD; Cataño, JC1
Hamada, Y; Hirayama, T; Ichibe, Y; Katori, Y; Kuroyama, M; Okuma, R; Takahashi, S1
Celkan, T; Eroğlu, AG; Ozdemir, N; Tüysüz, G; Uludağ, D1
Abdi, R; Basiri, A; Hedayati, MT; Najafi, N; Parvin, M; Shokohi, T; Taghavi, F; Yadegarinia, D1
Al-Badriyeh, D; Bajel, A; Grigg, A; Heng, SC; Kirsa, S; Kong, DC; Nation, RL; Seymour, JF; Slavin, MA; Thursky, K1
Aram, JA; Barbers, RG; Equils, O; Mardekian, J; McLaughlin, JM; Schlamm, HT; Somerville, KT; Welch, VL1
Ahmad, S; Al-Wathiqi, F; Khan, Z1
Huang, L; Miao, X; Wu, Y1
Chen, H; Hu, J; Hu, L; Jiang, M; Li, B; Li, Y; Lou, X; Ning, H; Wang, J; Xu, C; Yu, Z1
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK1
Charles, JI; Jeanbourquin, D; Mostofi, K1
Campoli, C; Capone, A; Chiappetta, D; Chinello, P; Di Bella, S; Petrosillo, N1
Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K1
Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S1
Barbaz, M; Bellissant, E; Lemaitre, F; Scailteux, LM; Tadié, JM; Uhel, F; Verdier, MC1
Akture, E; Baskaya, MK; Salamat, S1
Cuenca-Estrella, M; de Lucas, MP; Fusco-Almeida, AM; Lozano, E; Mendes-Giannini, MJ; Mesa-Arango, AC; Scorzoni, L; Zaragoza, O1
Cano, J; Crous, PW; da Cunha, KC; Fothergill, AW; Gené, J; Guarro, J; Hoog, Sd; Madrid, H; Sutton, DA1
Barrett, DM; Gerber, JS; Larru, B1
Arima, N; Iida, J; Inano, S; Kimura, M1
Bush, JW; Del Bigio, MR; Embil, JM; Krawitz, S; McDonald, PJ; Wuerz, T1
Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG1
Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L1
Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL1
Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A1
Doisaki, S; Furukawa-Hibi, Y; Hama, A; Kato, K; Kojima, S; Kudo, K; Matsumoto, K; Muramatsu, H; Narita, A; Sakaguchi, H; Shimada, A; Takahashi, Y; Tanaka, M; Yamada, K; Yoshida, N1
Chayakulkeeree, M; Sangsiriwut, K1
Berry, A; Cardeau-Desangles, I; Cassaing, S; Cointault, O; Esposito, L; Fabre, A; Guitard, J; Iriart, X; Kamar, N; Valentin, A1
Mast, N; Pikuleva, IA; Stout, CD; Zheng, W1
Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS; Uras, N1
da Trindade, MC; de Menezes, AI; de Souza, DW; Dos Santos, VM; Nascimento, AL; Oguma, PM1
Huang, JT; Margossian, SP; Nambudiri, VE; Rork, JF1
Arıkan Akdağlı, S; Aydeniz Ozansoy, F; Dursunoğlu, N; Ergin, C; Kutlu, M; Sarı, I; Sarıbaş, Z1
Bonhomme, J; de la Blanchardière, A; Hamon, M; Hitier, M; Leclercq, R; Nicolle, A1
Hatipoglu, H; Hatipoglu, N1
Amsden, JR; Anaissie, E; Gubbins, PO; McConnell, S1
Coste, A; Eddouzi, J; Ischer, F; Kelly, S; Manai, M; Parker, JE; Sanglard, D; Vale-Silva, LA1
Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I1
Hubschman, JP; Reed, DC; Shah, KH1
Cendejas-Bueno, E; Cuenca-Estrella, M; Gomez-Lopez, A1
Frechen, S; Fuhr, U; Junge, L; Neuvonen, PJ; Olkkola, KT; Rokitta, D; Saari, TI; Suleiman, AA1
El-Sherief, A; Gordon, S; Olbrych, T; Tedja, R1
Azzam, R; Katirji, B; Serra, A; Shaikh, AG1
Arends, JP; Camps, SM; Debets-Ossenkopp, YJ; Haas, PJ; Kampinga, GA; Karawajczyk, A; Kuijper, EJ; Melchers, WJ; Rijnders, BJ; van der Linden, JW; van Tiel, FH; Varga, J; Verweij, PE; Zoll, J1
Bowyer, P; Denning, DW1
Chang, CL; Jang, HC; Jang, MJ; Kim, MN; Kim, SH; Lee, HS; Lee, K; Lee, MK; Lee, WG; Ryang, DW; Shin, JH; Shin, MG; Song, ES; Suh, SP1
Bader, O; Buchheidt, D; Christner, M; Groß, U; Held, J; Kuhns, M; Lugert, R; Peter, S; Reichard, U; Schumacher, U; Tintelnot, K; Weig, M1
Hamada, Y; Igarashi, M; Kasahara, K; Kimura, M; Kimura, T; Kobayashi, M; Matsumoto, K; Mikamo, H; Mochizuki, T; Nishi, Y; Ohmagari, N; Okada, K; Seki, M; Takahashi, Y; Takakura, S; Takesue, Y; Tanigawara, Y; Tokimatsu, I1
Co, VM; Hsueh, PR; Mootsikapun, P; Ong, ML; Rajadhyaksha, V; Talwar, D1
Arnalich-Montiel, F; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Valladares, B1
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Porco, TC; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Sun, CQ1
Acharya, NR; Krishnan, T; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Porco, TC; Prajna, L; Prajna, NV; Raghavan, A; Rajaraman, R; Ray, KJ; Srinivasan, M; Zegans, ME1
Abreu, P; Colombo, AL; Magana, M; Nucci, M; Petti, M; Sanchez, SP; Schlamm, HT1
Chowdhary, A; Espinel-Ingroff, A; Gonzalez, GM; Lass-Flörl, C; Martin-Mazuelos, E; Meis, J; Peláez, T; Pfaller, MA; Turnidge, J1
Chaudry, MN; Park, BJ; Schaefer, MK; Smith, RM; Tipple, M1
Krishnan, T; Rishi, P1
Gao, X; Ji, X; Marks, DI; Schlamm, HT; Stephens, JM; Tarallo, M1
Goto, T; Hashinaga, K; Hiramatsu, K; Itoh, H; Kadota, J; Kawasaki, K; Sato, Y; Suzuki, Y; Tokimatsu, I1
Kashyap, H; Malhotra, S; Pawar, P; Sindhu, R1
Azari, AA; Ghoghawala, SY; Kanavi, MR; Lee, V; Nehls, S; Potter, HD1
Burhenne, J; Egerer, G; Geist, MJ; Mikus, G; Riedel, KD; Weiss, J1
Bobek-Billewicz, B; Foroncewicz, B; Jarząb, B; Krawczyk, M; Mucha, K; Orłowski, T; Pączek, L; Raczyńska, J; Religioni, J1
Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H1
Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T1
Benjamin, DK; Ericson, J; Manzoni, P1
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M1
Behera, A; Bhansali, A; Chakrabarti, A; De, D; Dutta, P; Premkumar, A; Rudramurthy, SM; Shah, VN1
Heng, SC; Keating, D; Kong, DC; Levvey, B; Morrissey, O; Nation, RL; Slavin, MA; Snell, GI; Westall, GP; Whitford, H; Williams, TJ1
Bhaskaran, A; Hosseini-Moghaddam, SM; Husain, S; Rotstein, C1
Johnston, RB; Shenefelt, PD; Thareja, S1
Elefanti, A; Meletiadis, J; Mouton, JW; Tsakris, A; Verweij, PE; Zerva, L1
Biswas, C; Chen, SC; Djordjevic, JT; Jolliffe, KA; Sorrell, TC; Zuo, X1
Burgos Teruel, A; Domínguez-Márquez, V; Martinez-Macias, O; Navalpotro Rodríguez, D1
Arikan-Akdagli, S; Canton, E; Hazirolan, G; Sahin, S1
Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E1
Geffroy, L; Gras-Le Guen, C; Launay, E; Lortholary, O; Moreau, A; Thomas, C1
Lamichchane, AK; Natesan, SK; Swaminathan, S; Wu, W1
Cicora, F; Mos, F; Paz, M; Roberti, J1
Gnanalingham, K; Nadig, A; Pal, P; Singh, N; Subudhi, CP1
Sebestyén, Z; Szabó, B; Szepesi, K1
Furustrand Tafin, U; Meis, JF; Trampuz, A1
Andrews, E; Bolo, NR; Cayetano, K; Churchill, JH; Damle, BD; Glue, P; Henry, ME; Lauriat, TL; Rana, NS; Renshaw, PF; Villafuerte, RA; Zuo, CS1
Baden, LR; Bolaños-Meade, J; Brown, JM; Chirila, C; Gersten, ID; Graham, J; Horowitz, MH; Kurtzberg, J; Leather, H; Marr, KA; Mauskopf, J; Maziarz, RT; Walsh, TJ; Wingard, JR1
Calzada, JI; Diaz, RI; Randolph, JC; Sigler, EJ1
Blitz, A; Burger, P; Gallia, G; Ishii, M; Leyngold, I; Olivi, A; Subramanian, PS1
Arnalich-Montiel, F; Jaumandreu, L; Leal, M; Lorenzo-Morales, J; Valladares, B1
Graovac, A; Ibric, S; Kyriakos, K; Miletic, T1
Aline-Fardin, A; Buot, G; Dannaoui, E; Degulys, A; Guitard, J; Hennequin, C; Lapusan, S; Marie, JP; Rio, B1
Borkar, V; Joshi, M; Kalamkar, V; Kanyalkar, M; Srivastava, S1
Doyle, S; Jöchl, C; Kavanagh, K; O'Keeffe, G1
Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A1
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C1
Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Johnson, A; McEntee, L; Moore, CB; Richardson, M1
Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C1
Brüggemann, RJ; Mouton, JW; Seyedmousavi, S; Verweij, PE1
Chen, SC; Meyer, W; Middleton, PG1
Abdel Aziz, S; Kowalski, RP; Nau, AC; Raju, LV; Romanowski, EG; Shanks, RM1
Berger, JR; Lahoti, S1
Cai, J; Chen, S; Cheng, X; Dong, H; Dong, W; Dong, Y; Sun, J; Wang, T; Wang, X; Xing, J; Yao, H1
Pea, F2
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA1
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA1
Furutachi, M; Kumagai, N; Shibasaki, M; Tamura, K1
Dupont, L; Lagrou, K; Maertens, J; Meersseman, P; Saegeman, V; Vermeulen, E1
Dony, A; Ducastelle, S; Ferry, T; Perpoint, T1
Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J1
Leroux, S; Ullmann, AJ1
Bierings, MB; Boelens, JJ; Gerhardt, CE; Hol, JA; Lindemans, CA; Versluys, AB; Wildt de, A; Wolfs, TF1
Adamski, Z; Gil, L; Komarnicki, M; Kubisiak-Michalska, A; Kubisiak-Rzepczyk, H; Mol, A; Reich, A; Zawirska, A1
Fernandez Miralbell, A; Garcia Mellado, V; Martin Castro, A; Martinez Peinado, C; Nogueras Morillas, P; Soto Diaz, A; Tercedor Sanchez, J; Valenzuela Salas, I1
Al Asmi, MM; Al-Hussaini, AA; Alshahrani, DA; Faqeehi, HY1
Chen, J; Huang, J; Li, L; Yang, Q1
Dominelli, GS; Shaipanich, T1
Mikamo, H; Nishiyama, Y; Ohki, E; Satoh, K; Terada, M; Uchida, K; Yamagishi, Y; Yamaguchi, H1
Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T1
Benatti, C; Cavallini, GM; Ducange, P; Volante, V1
Dorsey, SA; Fothergill, AW; Furmaga, W; Lewis, JS; Patterson, TF; Pennick, GJ; Sutton, DA; Wiederhold, NP1
Goletz, G; Groll, AH; Jürgens, H; Kolve, H; Pieper, S; Yunus, S1
Açıkgöz, ZC; Cağıl, N; Can, ME; Celikbilek, N; Dereli Can, G; Kalkan Akçay, E1
Atalay, MA; Copur Çiçek, A; Kasap Tekinşen, FF; Kaynar, L; Koç, AN; Sav, H1
Endo, S; Fujimura, I; Kamei, K; Kato, K; Miyamoto, S; Murata, O; Nagashima, H; Nakadate, T; Nakajima, Y; Nakamura, Y; Ogino, Y; Saito, H; Sasaki, N; Shibuya, K; Suzuki, N; Terayama, Y; Utsumi, Y; Yamauchi, K; Yarita, K1
Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D1
Clements, RM; Estrada, L; Jon, CK; Mosquera, RA1
Balci, I; Eksi, F; Gayyurhan, ED1
Chang, K; Chang, TC; Chen, CY; Chen, YH; Lai, CC; Lee, KM; Lin, CY; Lin, WR; Lu, PL1
Fox, DA; Gladue, HS1
Cabello-Vílchez, AM; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Reyes-Batlle, M; Sifaoui, I; Valladares, B1
Dasararaju, R; Many, WJ; Samant, JS1
Gomes, MZ; Jiang, Y; Kontoyiannis, DP; Lewis, RE; Mulanovich, VE2
Al-Badriyeh, D; Dinleyici, EC; Kara, A; Kong, DC; Senol, E; Turner, SJ1
Dorazilova, Z; Maly, J; Netuka, I; Pirk, J; Szarszoi, O1
Kamei, K; Watanabe, A1
Akata, K; Aoki, T; Fujii, M; Hisaoka, M; Ishimoto, H; Kawanami, T; Kinoshita, S; Korogi, Y; Mukae, H; Yatera, K1
Chen, F; Shi, Y; Su, X; Sun, WK; Xu, XY; Zhang, M1
Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D1
Gamaletsou, MN; Walsh, TJ1
Badoual, C; Devars Du Mayne, M; El Naderi, S; Rodriguez, C1
Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó1
Bašková, L; Buchta, V; Feuermannová, A; Kubátová, A; Kutová, R; Váša, M; Vejsová, M1
Elenitsas, R; Massey, PR; Rosenbach, M; Wanat, KA1
Almeida Júnior, JN; Benard, G; Campos, SV; Del Negro, GM; Figueiredo, DS; Guitard, J; Hennequin, C; Motta, AL; Rossi, F; Song, AT; Strabelli, TM1
Bennett, JE; Childs, R; Murayama, N; Natarajan, V; Palmore, T; Skinner, J; Yamazaki, H; Zonios, D1
Barbosa, NS; Wetter, DA1
Chang, CY; Chen, KH; Hou, JY; Huang, TH; Liang, DC; Liu, HC; Yeh, TC1
Bonfietti, LX; Bustamante, B; Canton, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Martin-Mazuelos, E; Meis, JF; Melhem, MS; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; St-Germain, G; Szeszs, MW; Turnidge, J1
Bucknor, MD; Gross, AJ; Link, TM1
Kim, DY; Lee, YJ; Park, HJ1
Ascioglu, S; Chan, KA1
Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K1
Acharya, NR; Cevallos, V; Geetha, M; Karpagam, R; Lalitha, P; Lietman, TM; McLeod, SD; O'Brien, KS; Prajna, NV; Sun, CQ1
Acar, N; Bretillon, L; Bron, AM; Creuzot-Garcher, CP; Fourgeux, C; Martine, L1
Ahmad, S; Alkharashi, M; Jun, AS1
Halderman, A; Shrestha, R; Sindwani, R1
Luliński, P; Maciejewska, D; Sobiech, M; Żołek, T1
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK1
Brownell, I; Cowen, EW; De Ravin, SS; Lee, CC; Malech, HL; Turegano, MM1
Dalbøge, CS; Gøtzsche, PC; Johansen, HK; Jørgensen, KJ1
Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG1
Balasubramanian, S; Dhanakodi, N; Shashidhar, N; Tripathy, SK; Venkataramaiah, S1
Cogley, KM; Gehris, RP; Goyal, RK; Howrie, D; Venkataramanan, R; Windreich, RM1
Aslan, SO; Dizbay, M; Fidan, I; Kalkanci, A; Ogan, MC; Sahin, N; Yesilyurt, E1
Jackson, TL; Rodrigues, IA1
Procter, DG; Schmitt, TL1
Bandeira, TJPG; Brilhante, RSN; Cordeiro, RA; Macedo, RB; Marques, FJF; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Teixeira, CEC1
Chan, T; Ding, WY; McWilliams, R; Yadavilli, RK1
Cevallos, V; Hoover, C; Jeng, BH; Keenan, JD; Layer, N; Maxwell, AJ1
Duarte, M; Foppa, M; Goldani, L; Jeffman, M; Rohde, LE; Sprinz, E; Torres, FS1
Aguiar, A; Faria, M; Fernandes, C; Lago, M; Natário, A; Pinto, E1
Kauffman, CA; Kerr, L; Malani, AN; Obear, J; Singal, B1
Benedetti, E; Choudhury, N; Garcia-Roca, R; Jeon, H; Khan, AB; Oberholzer, J; Tzvetanov, I1
Fung, HC; Peksa, GD; Schultz, K1
Cooke, RP; Denning, DW; Ellenbogen, JR; Javadpour, M; Lesser, T; Skinner, DW; Waqar, M1
Capilla, J; Fothergill, AW; Guarro, J; Mayayo, E; Paredes, K; Sutton, DA1
Azie, NE; Franks, B; Freifeld, AG; Horn, DL; Kauffman, CA; Schuster, MG1
Chowdhary, A; Hagen, F; Meis, JF; Sharma, C1
Borghi, E; Falleni, M; Jones, B; Lappin, DF; Nile, CJ; Perdoni, F; Rajendran, R; Ramage, G; Sherry, L; Smith, K; Tosi, D; Williams, C1
Alfonso, EC; Iovieno, A; Ledee, DR; Miller, D1
Capilla, J; Fothergill, AW; Guarro, J; Pastor, FJ; Sanchis, M; Sutton, DA1
Alp Meşe, E; Atalay, MA; Koç, AN; Koyuncu, S; Kurtsoy, A; Ulu Kiliç, A1
Aquino, VR; Bergamasco, MD; Castro, PT; Colombo, AL; Gonçalves, SS; Negri, CE; Xafranski, H1
Akshita, K; Datry, A; Fekkar, A; Lescar, J; Mazier, D; Meyer, I; Palous, M; Srinivasaraghavan, K; Verma, C1
Kikuchi, T; Kikuchi, Y; Miki, H; Nishimaki, K; Saito, W; Sasamori, K; Shishikura, Y1
Boekhout, T; Doroftei, B; Flonta, MM; Kolecka, A; Lupse, M; Man, A; Marangoci, N; Mares, M; Marincu, I; Minea, B; Moraru, RF; Nastasa, V; Pinteala, M; Toma, F1
Amazzough, K; Arvieux, C; Barete, S; Bougnoux, ME; Crabol, Y; Lanternier, F; Lecuit, M; Lortholary, O; Maunoury, C; Pineau, S; Poiree, S; Zeller, V1
Alfaya Muñoz, L; Avendaño Cantos, EM; Celis Sánchez, J; Mesa Varona, D; Romero Moraleda, L1
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ1
Bosschaerts, T; Boulet, G; Cos, P; Fortin, A; Maes, L; Paulussen, C1
Kohn, R; Kotton, CN; Markmann, JF; Patel, MS; Vagefi, PA; Wright, AJ1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA1
Conant, MM; Proia, LA; Sha, BE1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R1
Marr, K; Ostrander, D; Shoham, S1
Goeman, E; Kidd, SE; Meis, JF; Slavin, MA; Verweij, PE1
Chang, SC; Ko, BS; Lee, SH; Sun, HY1
Chang, YC; Eckhaus, MA; Fedorova, N; Figat, A; Joardar, V; Kwon-Chung, KJ; Losada, L; Mounaud, S; Nierman, WC; Pakala, S; Pakala, SB; Sugui, JA; Venepally, P1
Carver, PL; Pettit, NN1
Kelly, DE; Kelly, SL; Lamb, DC; Nes, WD; Parker, JE; Rolley, NJ; Smith, SN; Warrilow, AG1
Ağca, H; Ak, S; Akalın, H; Cilo, BD; Ener, B; Özmerdiven, GE; Tunca, B1
Bulanda, M; Jagielski, T; Skóra, M1
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF1
Bernal-Martínez, L; Cendejas, E; Forastiero, A; Gomez-Lopez, A; Mellado, E1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF1
Bailly, S; Cornet, M; Gautier-Veyret, E; Maubon, D; Pelloux, H; Stanke-Labesque, F; Thiébaut-Bertrand, A; Tonini, J; Wambergue, C1
Barrs, VR; Beatty, JA; Kidd, SE; Martin, P; Talbot, JJ1
Albert, ND; Bellanger, AP; Kontoyiannis, DP; Lewis, RE; Walsh, TJ1
Maertens, J; Miceli, MH1
Gregg, KS; Kauffman, CA1
Patterson, TF; Wiederhold, NP1
Thompson, GR; Twarog, M1
Chowdhary, A; Hagen, F; Kathuria, S; Meis, JF; Singh, PK1
Capilla, J; Fothergill, AW; Guarro, J; Sanchis, M; Sutton, DA; Wiederhold, N1
Coste, AT; Sanglard, D1
Aftab, M; Almanfi, A; El-Sayed Ahmed, MM; Frazier, OH; Mallidi, HR; Singh, SK1
Chai, LY; Khoo, AL; Lim, BP; Ong, B; Tan, BH; Tan, G; Tee, C; Teng, M; Zhao, YJ1
Dehghan, P; Hashemi, SJ; Melchers, WJ; Mohammadi, F; Rafati, H; Rezaie, S; Seyedmousavi, S; Tamadon, Y; Tolooe, A; van der Lee, HA; Verweij, PE; Zoll, J1
Arendrup, MC; Cuenca-Estrella, M; Jensen, RH1
Cogliati, M; De Lorenzis, G; Esposto, MC; Lazzarini, C; Prigitano, A; Tortorano, AM1
Manavathu, EK; Vazquez, JA1
Fosso, MY; Garneau-Tsodikova, S; Shrestha, SK1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S1
Badali, H; Dolatabadi, S; Fakhim, H; Mirhendi, H; Nabili, M; Poorzad, N; Vaezi, A; Zarei, F1
Molinelli, AR; Rose, CH1
Aoun, M; Baddley, JW; Bow, EJ; Cornely, OA; Giladi, M; Heinz, WJ; Herbrecht, R; Hope, W; Karthaus, M; Kontoyiannis, DP; Lee, DG; Lee, M; Lortholary, O; Maertens, JA; Maher, RM; Marr, KA; Morrison, VA; Neofytos, D; Oren, I; Patterson, TF; Raad, II; Rahav, G; Schmitt-Hoffmann, AH; Selleslag, D; Shoham, S; Thompson, GR; Ullmann, AJ; Zeiher, B1
Slavin, MA; Thursky, KA1
Capilla, J; Guarro, J; Mayayo, E; Paredes, K1
Alencar, LP; Bandeira, SP; Bandeira, TJ; Brandine, GS; Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Guedes, GM; Melo, LM; Moreira, JL; Paiva, MA; Pereira-Neto, WA; Ponte, YB; Rocha, MF; Sales, JA; Sidrim, JJ1
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W1
Aala, F; Amirizad, K; Aslani, N; Badali, H; Hashemi, SJ; Khodavaisy, S; Nazeri, M; Nouripour-Sisakht, S; Rezaie, S; Sorkherizi, MS1
Azie, N; Franks, B; Goff, D; Horn, D; Khandelwal, N; Shi, F; Shorr, AF; Spalding, J1
Ding, X; Gao, L; Liu, Z; Sun, Y; Wu, Q; Zeng, T1
Lanternier, FL; Lortholary, O; Pilmis, B1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ1
Andes, D; Azie, N; Franks, B; Harrington, R; Kelley, C; Khandelwal, N; Kristy, R; Lee, E; Spalding, J; Tan, RD; Wu, EQ; Yang, H1
Jacobsen, AA; Papo, YB; Sarro, R; Strasswimmer, J; Weisse, K1
Alem, N; Karabıçak, N1
Eljaaly, K; Nix, DE1
Chakrabarti, A; Ghosh, A; Honnavar, P; Pamidi, U; Rastogi, V; Rudramurthy, SM1
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C1
Garneau-Tsodikova, S; Ngo, HX; Shrestha, SK1
Chung, SJ; Hwang, WY; Tan, AL; Tan, BH; Tan, TT; Thien, SY1
Alffenaar, JC; Ter Avest, M; Touw, DJ; Veringa, A1
Backman, JT; Fihlman, M; Hagelberg, NM; Hemmilä, T; Kuusniemi, K; Laine, K; Laitila, J; Neuvonen, PJ; Olkkola, KT; Saari, TI1
Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ1
Bader, O; Buname, G; Groß, U; Mshana, SE; Mushi, MF1
Akiti, T; Barreiros, G; Nouér, SA; Nucci, M; Trope, BM; Varon, AG1
Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B1
Al-Hatmi, AM; de Hoog, GS; Meis, JF; Meletiadis, J; Normand, AC; Piarroux, R; Ranque, S1
Basu, SS; Jarolim, P; Mason, DS; Petrides, A1
Ahmed, SA; Behrens-Baumann, W; de Hoog, GS; Harak, H; Hofmüller, W; Seibold, M; Tammer, I; van Diepeningen, AD1
Azie, N; Harrington, R; Lee, E; Messali, A; Spalding, J; Wei, J; Wu, EQ; Yang, H1
Guo, H; Jiang, L; Li, DM; Li, SX; Song, YJ; Zhang, H; Zhao, YJ; Zhu, KJ1
Annaert, P; Bouwsma, H; Hilbrands, L; Kuypers, DRJ; Spriet, I; Swen, JJ; Vanaudenaerde, B; Vanhove, T; Verleden, G; Vos, R1
Alkhazraji, S; Baldin, C; Gebremariam, T; Ibrahim, AS; Kovanda, L; Wiederhold, NP1
Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M1
Bateman, AC; Clarridge, J; Garvin, K; Greenbaum, A; Grim, J; Liu, AW1
Chen, F; Feng, CL; He, Q; Shi, Y; Su, X; Zhang, M1
Crusz, SA; Denning, D; Mitchell, S; Simmonds, L; White, B1
Birch, M; Law, D; Wiederhold, NP1
Liu, Q; Marks, DI; Slavin, M1
Hope, WW; Stott, KE1
Bassetti, M; Bouza, E1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K1
Ivulich, S; Jeong, W; Kong, DCM; Levvey, BJ; Morrissey, CO; Neoh, CF; Slavin, MA; Snell, GI; Westall, GP1
Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE1
D'Inzeo, T; De Carolis, E; Mello, E; Posteraro, B; Sanguinetti, M; Torelli, R; Vella, A; Verweij, PE1
Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L1
Hanretty, AM; Langelier, C; Trang, TP; Yang, K1
Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE1
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P1
Ashu, EE; Korfanty, GA; Xu, J1
Blaich, C; Gehlen, D; Liss, B; Müller, C; Prozeller, D; Streichert, T; Wiesen, MHJ1
Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F1
Hassan, FAM; Tartor, YH1
Gao, L; Lu, Q; Sun, Y; Tian, D; Xiang, S1
Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A1
Harris, C; Morales, MK; Shoham, S1
Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG1
Fish, DN; Jaeger, J; Kiser, TH; MacLaren, R; Mueller, SW; Schoeppler, KE; Yi, WM1
Gao, L; He, C; Li, M; Sun, Y; Zeng, T1
Box, H; Colombo, AL; Hope, WW; Johnson, A; Kolamunnage-Dona, R; Livermore, J; McEntee, L; Negri, CE; Ramos-Martín, V; Schwartz, JA; Whalley, S1
Byun, SA; Choi, MJ; Jung, JS; Kim, SH; Park, YJ; Shin, JH; Shin, MG; Suh, SP; Won, EJ1
Brüggemann, RJM; Buil, JB; Meis, JF; Melchers, WJG; Mouton, JW; Verweij, PE; Wasmann, RE; Zoll, J1
Benamu, E; Fernandez-Pol, S; Ho, DY; Liu, AY; Xie, L; Yu, AT1
Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A1
Foolad, F; Kontoyiannis, DP1
Badali, H; Badiee, P; Boekhout, T; Diba, K; Hossaini Nasab, A; Jafarian, H; Mirhendi, H; Moghadam, AG; Mohammadi, R; Najafzadeh, MJ; Shamsizadeh, A; Soltani, J1
Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Hope, W; Kontoyiannis, DP; Lademacher, C; Lortholary, O; Mullane, K; Patterson, TF; Selleslag, D1
Basak, GW; Brillowska-Dąbrowska, A; Kurzyk, E; Mroczyńska, M; Nawrot, U; Sulik-Tyszka, B; Wróblewska, M; Włodarczyk, K1
Alakel, N; Behre, G; Buchheidt, D; Christopeit, M; Cornely, OA; Hasenkamp, J; Kiehl, M; Koldehoff, M; Krause, SW; Lehners, N; Löhnert, AY; Maschmeyer, G; Mayer, K; Mellinghoff, SC; Ostermann, H; Panse, J; Penack, O; Ruhnke, M; Teschner, D; Ullmann, AJ; von Lilienfeld-Toal, M; Wolf, HH1
Bouchand, F; Bougnoux, ME; Coignard, H; Davido, B; Demay, O; Dinh, A; Duran, C; Gaudot, F; Nich, C; Rottman, M; Rouzaud, C1
Birkenbach, M; Faizer, R; Green, JS; Ustun, C; Wasko, JA1
Ahangarkani, F; Aslani, N; Badali, H; Boekhout, T; Hagen, F; Kolecka, A; Meis, JF; Meyabadi, MF; Shokohi, T1
Bader, O; Becker, K; Groß, U; Idelevich, EA1
Bailleux, C; Gari-Toussaint, M; Gastaud, L; Hasseine, L; Martiano, D; Simon, L1
Greene, M; Harris, B; Kuriakose, K; Nesbitt, WJ1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A1
Butterton, JR; Cho, CR; de Haes, JIU; Drexel, M; Hulskotte, EGJ; Hussaini, A; Iwamoto, M; Jordan, HR; Kantesaria, BS; Liu, F; Macha, S; Marshall, WL; McCrea, JB; Menzel, K; Tsai, C; van Schanke, A1
Bartoszewicz, M; Król, J; Nawrot, U1
Alcazar-Fuoli, L; Cuesta, I; Garcia-Rubio, R; Mellado, E; Monteiro, MC; Monzon, S; Pelaez, T1
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L1
Andes, D; Desai, A; Kitt, T; Kovanda, L; Walsh, TJ; Zhao, M1
Alcazar-Fuoli, L; Bernal-Martínez, L; Gomez-Lopez, A1
Lang, R; Minion, J; Skinner, S; Wong, A1
Landsberg, D; Leung, M; Poinen, K; Wright, AJ1
Bollmann, T; Ewert, R; Nowak, S; Rathmann, E; Ribback, S; Rosenstengel, C; Schroeder, HWS1
Escrig, C; Herbrecht, R; Kuessner, D; Pooley, N; Posthumus, J1
Bartizal, K; Daruwala, P; Locke, JB; Wiederhold, NP1
Aoun, M; Cornely, OA; Engelhardt, M; Giladi, M; Heinz, WJ; Herbrecht, R; Kaufhold, A; Kovanda, L; Maertens, J; Rahav, G; Saulay, M; Selleslag, D; Ullmann, AJ1
Dowis, J; French, D; Smith, A1
Keniya, MV; Monk, BC; Ruma, YN; Tyndall, JDA1
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR1
Folić, M; Janković, SM; Jović, Z; Kostić, M; Milovanović, D; Milovanović, J; Ružić Zečević, D; Stefanović, S1
French, B; Mandell, K; Martinez, R1
Ahuja, T; Cirrone, F; Papadopoulos, J; Phillips, K; Siegfried, J1
Shen, L; Tu, F; Wang, J; Wang, R; Xia, G; Xu, J; Ye, C; Yi, Y; Yu, C; Zheng, Z1
Andes, DR; Ghannoum, MA; Hope, WW; Jones, ME; Kovanda, LL; Lademacher, C; Lu, Q; Mukherjee, PK; Santerre Henriksen, A1
Lehrnbecher, T; Schmidt, S; Schubert, R; Tramsen, L1
Girmenia, C; Goffredo, BM; Marchesi, F; Mengarelli, A; Menna, P; Minotti, G; Romano, A; Salvatorelli, E1
Bandettini, R; Cavanna, C; Esposto, MC; Grancini, A; Lallitto, F; Lo Cascio, G; Mularoni, A; Ossi, C; Prigitano, A; Tejada, M; Tortorano, AM1
Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R1
Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H1
Chen, L; Li, M; Li, N; Qi, F; Wang, N; Zhu, L1
Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J1
Flowers, SA; Kelly, DE; Kelly, SL; Nishimoto, AT; Parker, JE; Price, CL; Rogers, PD; Warrilow, AG1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E1
Al-Hatmi, AM; Arastehfar, A; Bakhtiari, M; Boekhout, T; Daneshnia, F; Fang, W; Groenewald, M; Hagen, F; Liao, W; Pan, W; Sadati, SK; Sharifi-Mehr, H; Zomorodian, K1
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M1
Evans, SL; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Van Matre, ET1
Alflen, A; Aranda Lopez, P; Beckert, H; Radsak, MP; Ries, F; Schild, H; Teschner, D; Theobald, M1
Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X1
Belga, S; Cervera, C; Hussain, MW; Kabbani, D; MacDonald, C; Roelofs, K1
Floros, L; Georgallis, M; Pagliuca, A; Rita Capparella, M; Sung, AH; Taie, AA; Weidlich, D1
Colley, T; Daly, L; Ito, K; Kimura, G; Kizawa, Y; Nakaoki, T; Nishimoto, Y; Rapeport, G; Sehra, G; Strong, P1
Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Warrilow, AGS1
Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA1
Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R1
Braga, SS1
Li, R; Sun, L; Wan, Z; Yu, J1
Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH1
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K1
Bigot, J; Botterel, F; Bougnoux, ME; Dannaoui, E; Dellière, S; Fekkar, A; Guitard, J; Hennequin, C; Senghor, Y; Verdurme, L1
Moncada, D; Ramírez, I1
Elgierari, ETM; Kirkpatrick, LM; Manicke, NE; Ren, GJ; Shi, RZ; Skaggs, CL; Sturmer, LR1
Dobiáš, R; Hošková, L; Hubka, V; Jaworská, P; Kautznerová, D; Kubánek, M; Lysková, P; Mrázek, J; Němcová, D; Skružná, M; Sumerauerová, P; Vrbská, J; Žáčková, P1
Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş1
Kauffman, CA; Schwartz, IS1
Li, H; Tu, B; Yin, G1
Abou El-Alamin, MM; Aboul-Enein, HY; Atia, MA; Sultan, MA1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA1
Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M1
Agarwal, R; Dhooria, S; Muthu, V; Prasad, KT; Sehgal, IS1
Böll, B; Böttiger, BW; Cornely, OA; Dusse, F; Eichenauer, DA; Fuchs, F; Hallek, M; Jung, N; Klein, F; Kochanek, M; Koehler, P; Persigehl, T; Rybniker, J; Shimabukuro-Vornhagen, A1
Assaf, A; Chopin, MC; Dozier, A; Faure, E; Faure, K; Goeminne, C; Leroy, J; Loridant, S; Panaget, S; Sermet, K; Vuotto, F1
Arron, ST; Brownell, I; Cahoon, EK; Cowen, EW; D'Arcy, ME; Engels, EA; Hess, GP; Israni, AK; Pfeiffer, RM; Rivera, DR; Triplette, MA; Yanik, EL1
Clancy, CJ; Clarke, L; Falcione, BA; Kwak, EJ; Marini, RV; McCreary, EK; Morrell, M; Nguyen, MH; Rivosecchi, RM; Sacha, L; Samanta, P; Sanchez, PG; Shields, RK; Silveira, FP; Viehman, A1
Kaye, K; Majdick, K; Shorman, MA1
Arendrup, MC; Guinea, J; Hare, RK; Jørgensen, KM; Meletiadis, J1
Arendrup, MC; Friberg, N; Guinea, J; Kahlmeter, G; Mares, M; Meletiadis, J1
Dong, J; Li, D; Li, X; Liu, W; Mei, H; Song, N; Zheng, H1
Usayaporn, S; Vanichanan, J; Weeraphon, B1
Azanza, JR; Grau, S; López-Gómez, V; López-Ibáñez de Aldecoa, A; Peral, C; Rebollo, P; Vázquez, L1
Brito Devoto, T; Carmona, M; Cuestas, ML; Formento, N; Gordó, M; Hermida-Alava, K; Luque, A; Sautua, F; Scandiani, M1
Chen, B; Wan, Y; Wang, J; Xu, JY; Zhou, M; Zhou, RF1
Corallo, CE; Ivulich, SP; Kotecha, DS; Morrissey, O1
Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y1
Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A1
Clerkin, P; Kuzmic, B; Laningham, F; McCarty, J; Naeem, F1
Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP1
Agarwal, R; Chakrabarti, A; Choudhary, H; Ghosh, A; Kaur, H; Rudramurthy, SM; Singh, R; Singh, S1
Ben-Ami, R; Diego Vélez, J; Grandhi, A; Haider, S; Han, S; Karthaus, M; Klimko, N; Koh, LP; Lee, DG; Maertens, JA; Motyl, MR; Ponce-de-León, A; Raad, I; Rahav, G; Ramírez Sánchez, IC; Sonet, A; Waskin, H; Zhou, J1
Castanheira, M; Collingsworth, TD; Davis, AP; Deshpande, LM; Pfaller, MA1
Akbari, F; Deng, S; Houbraken, J; Najafzadeh, MJ; Naseri, A; Wang, X; Xu, X; Zhang, H; Zhao, R1
Aguirre, MA; Basquiera, AL; Buttazzoni, M; Degrave, AM; Diehl, M; Fernández Ávila, DC; Pereira, T; Scolnik, M1
Azmanis, P; Naidoo, V; Pappalardo, L; Sara, ZAJ; Silvanose, C1
Mammen, MD; Rupa, V; Sahni, RD; Varghese, GM1
Brüggemann, RJ; Bury, D; Muilwijk, EW; Tissing, WJE; Wolfs, TFW1
Bogler, Y; Lee, YJ; Neofytos, D; Papanicolaou, GA; Perales, MA; Seo, SK; Shaffer, B; Stern, A; Su, Y1
Eadie, K; Fahal, AH; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A1
Castanheira, M; Deshpande, LM; Messer, SA; Pfaller, MA; Rhomberg, PR; Utt, EA1
Carvalhaes, CG; Castanheira, M; Messer, SA; Pfaller, MA; Rhomberg, PR1
Bafghi, MH; Darroudi, M; Nazari, R; Zargar, M; Zarrinfar, H1
Dumoulin, A; Van Hoecke, F; Vangheluwe, T; Vogelaers, D1
Beauchemin, C; Claveau, D; Dufresne, SF; Guinan, K; Rotstein, C1
Athayde-Filho, PF; Barbosa-Filho, JM; Castro, RD; Cordeiro, LV; Ferreira, ES; Lima, EO; Scotti, L; Silva, DF; Souza, HDS1
Debaveye, Y; Lagrou, K; Spriet, I; Van Daele, R; Vandenbriele, C; Vos, R; Wauters, J1
Couraud, S; Dannaoui, E; Déméautis, T; Devouassoux, G; Dupont, D; Durieu, I; Garnier, H; Kramer, R; Lina, B; Menotti, J; Persat, F; Rabodonirina, M; Reix, P; Sénéchal, A; Simon, L; Wallon, M1
Hochstetler, LJ; Jones, SL; McKinzie, BP; Musick, KL; Norris, AM; Williams, FN1
Carlesse, F; Colombo, AL; Kontoyiannis, DP; Nobrega de Almeida, J; Rossato, L1
Bernards, S; de Boer, MGJ; Hendriks, BJC; Jolink, H; Koopmans, JG; van de Peppel, RJ; van der Beek, MT; van Grootveld, R; van Paassen, J; von dem Borne, PA1
Chen, L; Chen, W; Li, L1
Buil, JB; den Dekker, BM; Festen, B; Heusinkveld, M; Melchers, M; Mooren, ERM; Schellaars, R; van Binsbergen, AL; van Bree, SHW; van Zanten, ARH; Verweij, PE1
Gao, L; Sun, Y; Tan, L; Yang, J; Yao, Z; Zeng, T1
Atas, U; Aydin Ersoy, M; Iltar, U; Salim, O; Turkoglu, EB; Yucel, OK1
Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS1
Ito, H; Ogawa, R1
DiNardo, CD; DiPippo, AJ; Jiang, Y; Kadia, T; Kontoyiannis, DP; Maiti, A; Montalban-Bravo, G; Rausch, CR; Ravandi, F1
Belotti, T; Campoli, C; Cojutti, PG; Gatti, M; Masetti, R; Pea, F; Pession, A; Viale, P1
Chen, W; Goldman, GH; Li, R; Li, Y; Liang, T; Liu, W; Osherov, N; Verweij, PE; Wan, Z; Wang, Q; Zheng, B1
Chen, SC; Greenwood, M; Hill, JA; Joshi, A; Kong, DCM; Krantz, EM; Lindsay, J; Liu, C; Morris, J; Pergam, SA; Slavin, M; Sweet, A; Tverdek, F; Yeh, R1
Ito, K1
Abou Kandil, A; Handelman, M; Morogovsky, A; Osherov, N; Shadkchan, Y1
Chaphekar, N; Cheng, Y; Huang, H; Huang, W; Liu, M; Wu, X; Zheng, Y1
Dong, Y; Liu, Z; Wang, Y; Wang, YF; Xie, J; Yang, Q; Zhang, K1
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y1
Hakki, M; Lewis, JS; Thompson, GR; Wiederhold, NP1
Buchweitz, JP; Johnson, SD; Lehner, AF1
Cai, Y; Chen, A; He, J; Ju, C; Li, S; Lian, Q; Wei, L; Xie, H; Zhao, B; Zhou, S1
Cheng, H; Gao, SY; Hu, W; Jiang, QL; Li, WJ; Lu, Y; Wang, XX; Wu, DF; Yang, K1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M1
Abastabar, M; Aghili, SR; Akhtari, J; Al Hatmi, AMS; Al-Harrasi, A; Badali, H; Haghani, I; Hajheydari, Z; Hedayati, MT; Javidnia, J; Kermani, F; Khojasteh, S; Moazeni, M; Shokohi, T; Yahyazadeh, Z1
Colombo, AL; Dieleman, C; Francisco, EC; Hagen, F1
Chen, P; Chen, Y; Feng, Z; Gao, F; Jin, Y; Lin, W; Lu, C; Shang, Z; Wang, F; Yang, J1
Aram, JA; Engelhardt, M; Hamed, K; Huang, JJ; Kovanda, LL; Yan, J1
Meng, XX; Su, CZ; Su, F; Zhang, JL1
Bellomo, R; Costa-Pinto, R; Finlay, L; Klink, S; Perera, P; Rotherham, H; Trubiano, J; Urbancic, K; Vaz, K1
Asai, N; Hagihara, M; Hirai, J; Iwamoto, T; Kato, H; Mikamo, H; Mori, N; Umemura, T; Yamagishi, Y1
Andes, DR; Cattaneo, D; Christian, R; Davis, MR; Johnson, MD; Lewis, RE; McCreary, EK; Narayanan, N; Watt, KM; Wiederhold, NP1
Kakizaki, MIT; Melhem, MSC1
Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G1
Bamba, S; Denis, O; Lagrou, K; Montesinos, I; Nakanabo Diallo, S; Resendiz-Sharpe, A; Rodriguez-Villalobos, H; Rouamba, T; Yerbanga, IW1
Grandhi, A; Haider, S; Han, S; Klimko, N; Lee, DG; Maertens, JA; Ponce-de-León, A; Rahav, G; Ramirez-Sanchez, IC; Waskin, H; Winchell, GA; Wrishko, R1
Cha, JH; Cho, Y; Choi, H; Kim, J; Kim, KJ; Lee, CK; Nam, M; Nam, MH; Yim, J; Yun, SG1
Chu, J; Tu, S; Wang, N; Xie, Z; Yang, L; Zhang, K1
Bazydlo, L; Girton, M; Tomsig, J1

Reviews

272 review(s) available for triazoles and voriconazole

ArticleYear
The search for new triazole antifungal agents.
    Current opinion in chemical biology, 1997, Volume: 1, Issue:2

    Topics: Antifungal Agents; Drugs, Investigational; Humans; Pyrimidines; Triazoles; Voriconazole

1997
[Present problems and future trend of antifungals for deep seated mycosis. Azole antifungal agents].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 1999, Volume: 40, Issue:3

    Topics: Animals; Antifungal Agents; Azoles; Dosage Forms; Drug Interactions; Drug Resistance, Microbial; Fungi; Humans; Pyrimidines; Thiazoles; Triazoles; Voriconazole

1999
Role of newer azoles in surgical patients.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:6

    Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Humans; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole

1999
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer.
    The oncologist, 2000, Volume: 5, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2000
Antifungal activity of the new azole UK-109, 496 (voriconazole).
    Mycoses, 1999, Volume: 42 Suppl 2

    Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1999
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Central Nervous System; Drainage; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2000
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.
    Mycopathologia, 2001, Volume: 150, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole

2001
Update on antifungal agents.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:10

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Enzyme Inhibitors; Glucosyltransferases; Humans; Membrane Proteins; Mycoses; Pyrimidines; Schizosaccharomyces pombe Proteins; Treatment Outcome; Triazoles; Voriconazole

2001
Review of the safety and efficacy of voriconazole.
    Expert opinion on investigational drugs, 2002, Volume: 11, Issue:3

    Topics: Animals; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole

2002
Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:2

    Topics: Antifungal Agents; Aspergillus; Humans; Lung Diseases, Fungal; Pneumonia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole -- better chances for patients with invasive mycoses.
    European journal of medical research, 2002, May-31, Volume: 7, Issue:5

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Interactions; Drug Resistance, Fungal; Drug Tolerance; Humans; Mycoses; Pyrimidines; Safety; Triazoles; Voriconazole

2002
Successful treatment of Paecilomyces lilacinus endophthalmitis with voriconazole.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Endophthalmitis; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole: in the treatment of invasive aspergillosis.
    Drugs, 2002, Volume: 62, Issue:18

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Injections, Intravenous; Pyrimidines; Triazoles; Voriconazole

2002
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:12

    Topics: Antifungal Agents; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Trichosporon; Voriconazole

2002
Voriconazole: a new triazole antifungal agent.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Mar-01, Volume: 36, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Dermatitis; Drug Interactions; Exanthema; Humans; Liver; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
Pharmacological aspects of the new triazole voriconazole.
    Annals of hematology, 2002, Volume: 81 Suppl 2

    Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole: a new triazole antifungal agent.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:3

    Topics: Antifungal Agents; Drug Administration Schedule; Drug Interactions; Formularies as Topic; Humans; Length of Stay; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2003
[Present status and future prospects of azole antifungal agents in Japan].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6

    Topics: Antifungal Agents; Azoles; Cyclodextrins; Drug Design; Fluconazole; Forecasting; Itraconazole; Japan; Miconazole; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
[Clinical development of antimycotics. Medical challenges].
    Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Excipients; Fungi; Humans; Itraconazole; Lipopeptides; Liposomes; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Voriconazole

2003
[A silver lining on the horizon: new antimycotics].
    Pharmazie in unserer Zeit, 2003, Volume: 32, Issue:2

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[Voriconazole - applications and perspectives].
    Mycoses, 2002, Volume: 45 Suppl 3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Triazoles; Voriconazole

2002
[Aspergillosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole

2003
Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Humans; Immunocompetence; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pyrimidines; Risk Assessment; Severity of Illness Index; Spondylitis; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole

2003
Laboratory evaluation of new antifungal agents against rare and refractory mycoses.
    Current opinion in infectious diseases, 2002, Volume: 15, Issue:6

    Topics: Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Fungi; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Current medical research and opinion, 2003, Volume: 19, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Voriconazole.
    Clinical therapeutics, 2003, Volume: 25, Issue:5

    Topics: Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Candidiasis; Child; Child, Preschool; Female; Fungi; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Pyrimidines; Randomized Controlled Trials as Topic; Scedosporium; Tissue Distribution; Triazoles; Voriconazole; Yeasts

2003
New antifungal drugs and new clinical trials: interpreting results may be difficult.
    Current opinion in oncology, 2003, Volume: 15, Issue:4

    Topics: Animals; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Data Interpretation, Statistical; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:8

    Topics: Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Biguanides; Caspofungin; Child, Preschool; Disinfectants; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Mucormycosis; Osteomyelitis; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2003
[Drug of the month. Voriconazole (Vfend)].
    Revue medicale de Liege, 2003, Volume: 58, Issue:5

    Topics: Antifungal Agents; Drug Interactions; Humans; Molecular Structure; Pyrimidines; Triazoles; Voriconazole

2003
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Mycoses, 2003, Volume: 46 Suppl 1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungi; Glucosyltransferases; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
New antifungal agents.
    Dermatologic clinics, 2003, Volume: 21, Issue:3

    Topics: Administration, Oral; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Drug Approval; Echinocandins; Humans; Lipopeptides; Macrolides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
Antifungal pharmacotherapy for neonatal candidiasis.
    Seminars in perinatology, 2003, Volume: 27, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Humans; Immunocompromised Host; Lipopeptides; Male; Mitosporic Fungi; Mycoses; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2004
History of the development of azole derivatives.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10 Suppl 1

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10 Suppl 1

    Topics: Antifungal Agents; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole for serious fungal infections.
    International journal of clinical practice, 2004, Volume: 58, Issue:1

    Topics: Antifungal Agents; Aspergillus; Candida; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2004
[New antifungal agents: voriconazole and caspofungin].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10 Suppl 5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Interactions; Echinocandins; Humans; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[Experience with voriconazole in invasive aspergillosis].
    Mycoses, 2003, Volume: 46 Suppl 2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole

2003
CNS-aspergillosis: are there new treatment options?
    Mycoses, 2003, Volume: 46 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
    Mycoses, 2003, Volume: 46 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Fungi; Humans; Intensive Care Units; Lipopeptides; Lung Diseases, Fungal; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2003
Aspergillus fumigatus septic arthritis complicating intra-articular corticosteroid injection.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Debridement; Diagnosis, Differential; Humans; Injections, Intra-Articular; Magnetic Resonance Imaging; Male; Pain; Pyrimidines; Shoulder Injuries; Shoulder Joint; Triamcinolone Acetonide; Triazoles; Voriconazole

2004
New options for the treatment of invasive fungal infections.
    Seminars in oncology, 2004, Volume: 31, Issue:2 Suppl 4

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycetoma; Mycoses; Neoplasms; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
    Medicina clinica, 2004, May-01, Volume: 122, Issue:16

    Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fever; Humans; Liposomes; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2004
Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:4

    Topics: Absidia; Antibiotic Prophylaxis; Antifungal Agents; Bronchi; Fatal Outcome; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2004
[Voriconazole: a new weapon against invasive fungal infections].
    Revue medicale de Bruxelles, 2004, Volume: 25, Issue:3

    Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Safety; Tissue Distribution; Triazoles; Voriconazole

2004
[New antifungal agents and bronchopulmonary mycoses].
    Revue de pneumologie clinique, 2004, Volume: 60, Issue:3

    Topics: Antifungal Agents; Caspofungin; Drug Costs; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Successful treatment of Candida infections in peritoneal dialysis patients: case reports and review of the literature.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2004, Volume: 20

    Topics: Aged; Antifungal Agents; Candidiasis; Catheters, Indwelling; Cefazolin; Female; Humans; Middle Aged; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2004
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    Nederlands tijdschrift voor geneeskunde, 2004, Aug-21, Volume: 148, Issue:34

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Carriers; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole

2004
[Invasive aspergillosis: clinical manifestations and treatment].
    Revista iberoamericana de micologia, 2003, Volume: 20, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Dermatomycoses; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Immunologic Factors; Itraconazole; Lipopeptides; Neuroaspergillosis; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Respiratory Tract Infections; Triazoles; Voriconazole

2003
Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
    Respiratory medicine, 2004, Volume: 98, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Azoles; Evidence-Based Medicine; Forecasting; Humans; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole: therapeutic review of a new azole antifungal.
    Expert review of anti-infective therapy, 2004, Volume: 2, Issue:4

    Topics: Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Endocarditis; Female; Follow-Up Studies; Fungemia; Fusarium; Humans; Immunocompromised Host; Infant; Leukemia, Myeloid, Acute; Liposomes; Opportunistic Infections; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2004
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:11

    Topics: Adult; Antifungal Agents; Empyema, Subdural; Female; Humans; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2004
Aspergillus mediastinitis following orthotopic heart transplantation: case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Administration Schedule; Heart Transplantation; Humans; Male; Mediastinitis; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2004
Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004
Combination antifungal therapy: where are we now, and where are we going?
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2004
Antifungal resistance: the clinical front.
    Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:14 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Health Status; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Risk Factors; Thiazoles; Treatment Outcome; Triazoles; United States; Voriconazole

2004
Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Arm; Female; Hand; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole

2005
Emerging azole antifungals.
    Expert opinion on emerging drugs, 2005, Volume: 10, Issue:1

    Topics: Animals; Antifungal Agents; Azoles; Drugs, Investigational; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole.
    Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:1

    Topics: Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Humans; Infant; Male; Middle Aged; Pyrimidines; Saccharomyces; Sepsis; Treatment Outcome; Triazoles; Voriconazole

2005
Pharmacological management of paracoccidioidomycosis.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:3

    Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole

2005
Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature.
    Transplant international : official journal of the European Society for Organ Transplantation, 2005, Volume: 18, Issue:5

    Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fusarium; Humans; Kidney Transplantation; Middle Aged; Mycoses; Organ Transplantation; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2005
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
    Infection, 2005, Volume: 33, Issue:2

    Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole

2005
A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Female; Heart Transplantation; Humans; Lipopeptides; Mediastinitis; Middle Aged; Peptides, Cyclic; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole

2005
[Update on therapy of invasive mycoses in hematology and oncology].
    Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2005
Antifungal agents in children.
    Pediatric clinics of North America, 2005, Volume: 52, Issue:3

    Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole

2005
Chronic granulomatous disease presenting with disseminated intracranial aspergillosis.
    Pediatric blood & cancer, 2006, Volume: 47, Issue:1

    Topics: Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Child; Diagnosis, Differential; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole: review of a broad spectrum triazole antifungal agent.
    Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:7

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cryptococcosis; Cyclic N-Oxides; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Injections, Intravenous; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2005
Pseudoporphyria induced by voriconazole.
    Journal of the American Academy of Dermatology, 2005, Volume: 53, Issue:2

    Topics: Antifungal Agents; Humans; Male; Middle Aged; Porphyrias; Pyrimidines; Triazoles; Voriconazole

2005
Scedosporium apiospermum brain abscess treated with surgery and voriconazole. Case report.
    Journal of neurosurgery, 2005, Volume: 103, Issue:1 Suppl

    Topics: Antifungal Agents; Brain Abscess; Drainage; Humans; Immunocompetence; Infant; Magnetic Resonance Imaging; Male; Mycetoma; Near Drowning; Neurosurgical Procedures; Pyrimidines; Quadriplegia; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2005
Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:9

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Chemoprevention; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2005
Combination antifungal therapy for invasive aspergillosis: utilizing new targeting strategies.
    Current drug targets. Infectious disorders, 2005, Volume: 5, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
    Pharmacology, 2005, Volume: 75, Issue:4

    Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole

2005
[Drug-drug interaction of antifungal drugs].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:10

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
[Voriconazole-medicalneeds, evidence, potential for the future].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2005, Volume: 46, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Biological Availability; Candida; Candidiasis; Guinea Pigs; Humans; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2005
Voriconazole versus amphotericin B in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2006, Jan-25, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Fungal infections in bone marrow transplant recipients.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Administration Schedule; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Postoperative Complications; Premedication; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Invasive Acremonium strictum infection in a bone marrow transplant recipient.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:3

    Topics: Acremonium; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Mycoses; Opportunistic Infections; Osteomyelitis; Pyrimidines; Tibia; Triazoles; Urine; Voriconazole

2006
Zygomycoses in patients with acute leukaemia.
    Annals of hematology, 2006, Volume: 85, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Female; Humans; Immunocompromised Host; Leukemia; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2006
Clinical pharmacokinetics of voriconazole.
    International journal of antimicrobial agents, 2006, Volume: 27, Issue:4

    Topics: Absorption; Antifungal Agents; Drug Interactions; Humans; Metabolic Clearance Rate; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2006
Fungal prosthetic mitral valve endocarditis caused by Scopulariopsis species: case report and review of the literature.
    The Journal of thoracic and cardiovascular surgery, 2006, Volume: 131, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Device Removal; Endarterectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Leg; Mitosporic Fungi; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Triazoles; Voriconazole

2006
[In vitro activity of voriconazole against yeast and algae isolates according to new resistance pattern cut-off points].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Fungal; Fungi; Microbial Sensitivity Tests; Prototheca; Pyrimidines; Rhodotorula; Saccharomyces cerevisiae; Saccharomycetales; Species Specificity; Triazoles; Trichosporon; Voriconazole

2006
Treatment of invasive infections due to rare or emerging yeasts and moulds.
    Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Mucormycosis; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2006
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Thiazoles; Triazoles; Voriconazole

2006
Invasive aspergillosis with central nervous system dissemination in a presumably immunocompetent, non-neutropenic patient: case report and review.
    Southern medical journal, 2006, Volume: 99, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Immunocompetence; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2006
Pharmacokinetic/pharmacodynamic profile of voriconazole.
    Clinical pharmacokinetics, 2006, Volume: 45, Issue:7

    Topics: Animals; Antifungal Agents; Biotransformation; Drug Interactions; Fungi; Half-Life; Humans; Mycoses; Protein Binding; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2006
Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.
    Mycopathologia, 2006, Volume: 162, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Therapy, Combination; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2006
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2006
Lethal brain abscess due to the fungus Scedosporium apiospermum (teleomorph Pseudallescheria boydii) after a near-drowning incident: case report and review of the literature.
    Medical mycology, 2006, Volume: 44, Issue:5

    Topics: Accidents, Traffic; Adolescent; Adult; Antifungal Agents; Brain Abscess; Child; Child, Preschool; Fatal Outcome; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Mycetoma; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Telencephalon; Triazoles; Voriconazole

2006
[Efficacies and clinical roles of new antifungal agents].
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2006, Volume: 47, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2006
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
    Medizinische Klinik (Munich, Germany : 1983), 2006, Sep-15, Volume: 101, Issue:9

    Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis

2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Successful treatment of disseminated scedosporium infection in 2 lung transplant recipients: review of the literature and recommendations for management.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:10

    Topics: Antifungal Agents; Blindness; Diagnosis, Differential; Drug Administration Schedule; Endophthalmitis; Humans; Kidney Pelvis; Lung Transplantation; Male; Middle Aged; Mycetoma; Polymerase Chain Reaction; Postoperative Complications; Pyrimidines; Recurrence; Retreatment; Scedosporium; Therapeutic Irrigation; Triazoles; Urine; Vision, Monocular; Voriconazole

2006
Disseminated phaeohyphomycosis due to Ochroconis gallopavum in the setting of advanced HIV infection.
    Medical mycology, 2006, Volume: 44, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Ascomycota; Biopsy; Fatal Outcome; Histocytochemistry; Humans; Male; Marijuana Abuse; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
[Voriconazole safety: short review of clinical data].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:3-4

    Topics: Antifungal Agents; Drug Interactions; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole : a review of its use in the management of invasive fungal infections.
    Drugs, 2007, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Antifungal Agents; Child; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
[The future of antifungal agents].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2007
Aspergillus infection of implantable cardioverter-defibrillators and pacemakers: case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus flavus; Defibrillators, Implantable; Female; Humans; Mycoses; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole

2007
[Voriconazole as an effective therapy against pulmonary aspergillosis in a man with immunodeficiency virus-infection: a case report].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2007, Volume: 81, Issue:2

    Topics: Antifungal Agents; Aspergillosis; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2007
Use of voriconazole in the treatment of fungal keratitis.
    International ophthalmology clinics, 2007,Spring, Volume: 47, Issue:2

    Topics: Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2007
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Mycoses, 2007, Volume: 50, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Fusarium infections of the skin.
    Current opinion in infectious diseases, 2007, Volume: 20, Issue:2

    Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2007
[Native valve Aspergillus fumigatus endocarditis with blood culture positive and negative for galactomannan antigen. Case report and literature review].
    Revista iberoamericana de micologia, 2007, Volume: 24, Issue:2

    Topics: Amaurosis Fugax; Aneurysm, Infected; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Caspofungin; Combined Modality Therapy; Echinocandins; Endocarditis; False Negative Reactions; Fatal Outcome; Fungemia; Galactose; Heart Valve Prosthesis Implantation; Humans; Infarction; Kidney; Lipopeptides; Male; Mannans; Mesenteric Arteries; Mesenteric Vascular Occlusion; Middle Aged; Mitral Valve; Peptides, Cyclic; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Renal Artery; Triazoles; Voriconazole

2007
Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:2

    Topics: Antifungal Agents; Humans; International Cooperation; Liver Transplantation; Male; Middle Aged; Mycoses; Paecilomyces; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2008
Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.
    Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:8

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fever; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2007
Scedosporium apiospermum infection after near-drowning.
    Mycoses, 2007, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Antifungal Agents; Brain Abscess; Child; Child, Preschool; Fatal Outcome; Female; Humans; Lung Abscess; Lung Diseases; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Near Drowning; Pyrimidines; Radiography; Rare Diseases; Scedosporium; Triazoles; Voriconazole

2007
Changing epidemiology of rare mould infections: implications for therapy.
    Drugs, 2007, Volume: 67, Issue:13

    Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Fusarium; Humans; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Zygomycosis

2007
[In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillus; Biofilms; Candida; Cryptococcus; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
[Role of voriconazole in critically ill patients with invasive mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Comorbidity; Critical Care; Fungemia; Humans; Intensive Care Units; Kidney; Multicenter Studies as Topic; Mycoses; Prospective Studies; Pyrimidines; Spain; Triazoles; Voriconazole

2007
[Current indications for voriconazole in onco-hematological patients].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Drug Resistance, Fungal; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Salvage Therapy; Spain; Triazoles; Voriconazole; Zygomycosis

2007
[Voriconazole for the therapy of mycoses in recipients of solid organ transplants].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Mycoses; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2007
[The role of voriconazole in the treatment of emerging mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007
Antifungal agents.
    The Medical journal of Australia, 2007, Oct-01, Volume: 187, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2007
[New development in the treatment of deep-seated mycoses].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Sep-10, Volume: 96, Issue:9

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Candida endophthalmitis: focus on current and future antifungal treatment options.
    Pharmacotherapy, 2007, Volume: 27, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2007
Efficacy of voriconazole for Scedosporium apiospermum skull base osteomyelitis: case report and literature review.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Antifungal Agents; Humans; Male; Middle Aged; Osteomyelitis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2008
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
    AIDS patient care and STDs, 2008, Volume: 22, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole

2008
Invasive pulmonary aspergillosis after liver transplantation: rapid and complete response to combined and sequential antifungal therapy.
    Surgical infections, 2008, Volume: 9, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Immunosuppression Therapy; Lipopeptides; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography, Thoracic; Tomography, Emission-Computed; Triazoles; Voriconazole

2008
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:2

    Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Complexity of interactions between voriconazole and antiretroviral agents.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:5

    Topics: Anti-Retroviral Agents; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole

2008
Antifungal agents--clinical pharmacokinetics and drug interactions.
    Mycoses, 2008, Volume: 51 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Echinocandins; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:4

    Topics: Adult; Antibiotics, Antineoplastic; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage; Caspofungin; Cytarabine; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Monocytic, Acute; Lipopeptides; Lung Neoplasms; Male; Pyrimidines; Thailand; Triazoles; Voriconazole

2008
Voriconazole in the treatment of fungal eye infections: a review of current literature.
    The British journal of ophthalmology, 2008, Volume: 92, Issue:7

    Topics: Animals; Antifungal Agents; Eye Infections, Fungal; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Therapeutic drug monitoring of voriconazole.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:4

    Topics: Aging; Antifungal Agents; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Liver Failure; Male; Pyrimidines; Renal Insufficiency; Sex Characteristics; Triazoles; Voriconazole

2008
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
    Mycoses, 2008, Volume: 51 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2008
Treatment of invasive candidal infections: systematic review and meta-analysis.
    Mayo Clinic proceedings, 2008, Volume: 83, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Anidulafungin in the treatment of patients with invasive candidiasis.
    International journal of antimicrobial agents, 2008, Volume: 32 Suppl 2

    Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole

2008
Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Liver Function Tests; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole

2008
[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mutation; Pyrimidines; Saccharomyces cerevisiae Proteins; Sterols; Trans-Activators; Triazoles; Voriconazole

2008
[Oral antifungal agents].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2008
[Clinical efficacies of antifungal injections].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2008
Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Otitis Externa; Pyrimidines; Radiography; Temporal Bone; Treatment Outcome; Triazoles; Voriconazole

2009
Cerebral aspergillosis: tissue penetration is the key.
    Medical mycology, 2009, Volume: 47 Suppl 1

    Topics: Animals; Antifungal Agents; Fluconazole; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
New therapies for fungal pneumonia.
    Current opinion in infectious diseases, 2009, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole

2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1

    Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole

2009
Diagnosis and treatment of aspergillosis in children.
    Expert review of anti-infective therapy, 2009, Volume: 7, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2009
Aspergillosis.
    The New England journal of medicine, 2009, Apr-30, Volume: 360, Issue:18

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Echinocandins; Humans; Immunity, Cellular; Immunity, Innate; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole

2009
Fungal postoperative spondylodiscitis due to Scedosporium prolificans.
    The spine journal : official journal of the North American Spine Society, 2009, Volume: 9, Issue:9

    Topics: Anti-Bacterial Agents; Antifungal Agents; Arthrodesis; Debridement; Discitis; Female; Humans; Intervertebral Disc Displacement; Magnetic Resonance Imaging; Middle Aged; Mycoses; Orthopedic Procedures; Postoperative Complications; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2009
Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.
    Malaria journal, 2009, Jul-20, Volume: 8

    Topics: Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Malaria, Falciparum; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2009
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
    Expert opinion on investigational drugs, 2009, Volume: 18, Issue:9

    Topics: Anidulafungin; Animals; Antifungal Agents; Clinical Trials, Phase III as Topic; Drug Combinations; Drug Synergism; Echinocandins; Humans; Molecular Structure; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
    International journal of chronic obstructive pulmonary disease, 2009, Volume: 4

    Topics: Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
The role of voriconazole in the treatment of central nervous system blastomycosis.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:10

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Humans; Infant; Magnetic Resonance Imaging; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2009
In vitro activity of antifungals against Zygomycetes.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15 Suppl 5

    Topics: Amphotericin B; Antifungal Agents; Echinocandins; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15 Suppl 5

    Topics: Antifungal Agents; Chemoprevention; Drug Resistance, Fungal; Humans; Immunocompromised Host; Mucorales; Mucormycosis; Pyrimidines; Transplantation; Triazoles; Voriconazole

2009
Unilateral ureteral obstruction caused by Aspergillus, subgenus Nidulantes in a patient on steroid therapy: a case report and review of the literature.
    Medical mycology, 2010, Volume: 48, Issue:4

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Bezoars; Female; Humans; Immunocompromised Host; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Triazoles; Ureteral Obstruction; Voriconazole

2010
Pharmacology and clinical use of voriconazole.
    Expert opinion on drug metabolism & toxicology, 2010, Volume: 6, Issue:1

    Topics: Animals; Antifungal Agents; Drug Interactions; Drug Monitoring; Drug Resistance, Fungal; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole therapeutic drug monitoring: focus on safety.
    Expert opinion on drug safety, 2010, Volume: 9, Issue:1

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Clinical Laboratory Techniques; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Humans; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2010
Fonsecaea monophora cerebral phaeohyphomycosis: case report of successful surgical excision and voriconazole treatment and review.
    Medical mycology, 2010, Volume: 48, Issue:5

    Topics: Antifungal Agents; Ascomycota; beta-Glucans; Central Nervous System Fungal Infections; Female; Frontal Lobe; Histocytochemistry; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Magnetic Resonance Imaging; Microscopy; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2010
Pharmacoeconomics of voriconazole.
    Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:6

    Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Evidence-Based Medicine; Humans; Models, Economic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:8

    Topics: Animals; Antifungal Agents; beta-Cyclodextrins; Dogs; Excipients; Humans; Pyrimidines; Rats; Triazoles; Voriconazole

2010
Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
    Diagnostic microbiology and infectious disease, 2010, Volume: 66, Issue:4

    Topics: Amino Acid Substitution; Antifungal Agents; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Pyrimidines; Sequence Analysis, DNA; Sterol 14-Demethylase; Triazoles; Voriconazole

2010
Onychomycosis.
    Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole

2010
Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.
    Current opinion in pulmonary medicine, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillus; DNA, Fungal; Female; Fungemia; Humans; Immunocompromised Host; Incidence; Male; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Risk Assessment; Severity of Illness Index; Survival Rate; Triazoles; Voriconazole

2010
First case of Trichoderma longibrachiatum infection in a renal transplant recipient in Tunisia and review of the literature.
    La Tunisie medicale, 2010, Volume: 88, Issue:1

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Trichoderma; Tunisia; Voriconazole

2010
Primary invasive oral aspergillosis: an updated literature review.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010, Volume: 68, Issue:10

    Topics: Acyclovir; Aged; Amphotericin B; Antifungal Agents; Antiviral Agents; Aspergillosis; Fatal Outcome; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mouth Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole

2010
Modern antifungal therapy for neutropenic fever.
    Current hematologic malignancy reports, 2006, Volume: 1, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2006
Traditional and emerging antifungal therapies.
    Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2010
Allergic bronchopulmonary aspergillosis.
    Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3

    Topics: Antibodies, Monoclonal; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Disease Susceptibility; Glucocorticoids; Humans; Immunoglobulin E; Lymphocyte Activation; Pyrimidines; Respiratory Function Tests; T-Lymphocytes, Helper-Inducer; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2010
Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.
    Skeletal radiology, 2011, Volume: 40, Issue:2

    Topics: Aged; Antibiotic Prophylaxis; Antifungal Agents; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Periostitis; Pyrimidines; Radiography; Triazoles; Voriconazole

2011
Conazoles.
    Molecules (Basel, Switzerland), 2010, Jun-09, Volume: 15, Issue:6

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole

2010
Aspergillus fumigatus joint infection: a review.
    Seminars in arthritis and rheumatism, 2011, Volume: 40, Issue:6

    Topics: Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Caspofungin; Combined Modality Therapy; Drainage; Echinocandins; Female; Humans; Immunocompromised Host; Lipopeptides; Middle Aged; Pyrimidines; Sacroiliac Joint; Treatment Outcome; Triazoles; Voriconazole

2011
Severe phototoxicity associated with long-term voriconazole treatment.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2011, Volume: 9, Issue:4

    Topics: Antifungal Agents; Child; Dermatitis, Photoallergic; Diagnosis, Differential; Drug Eruptions; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.
    Expert review of hematology, 2009, Volume: 2, Issue:3

    Topics: Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature.
    Medical mycology, 2011, Volume: 49, Issue:4

    Topics: Aged; Antifungal Agents; Caspofungin; Child; Echinocandins; Fatal Outcome; Female; Geotrichosis; Geotrichum; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2011
Invasive aspergillosis in patients with liver disease.
    Medical mycology, 2011, Volume: 49, Issue:4

    Topics: Aged; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Liver Diseases; Lung; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2011
Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
    Expert review of pharmacoeconomics & outcomes research, 2010, Volume: 10, Issue:6

    Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Recent advances in invasive pulmonary aspergillosis.
    Current opinion in pulmonary medicine, 2011, Volume: 17, Issue:3

    Topics: Antifungal Agents; Biomarkers; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Genetic; Pyrimidines; Toll-Like Receptor 4; Triazoles; Voriconazole

2011
Therapeutic drug monitoring of voriconazole and posaconazole.
    Pharmacotherapy, 2011, Volume: 31, Issue:2

    Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole

2011
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3

    Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole

2010
Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
    Lung, 2011, Volume: 189, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Risk Factors; Sarcoidosis, Pulmonary; Treatment Outcome; Triazoles; Voriconazole

2011
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2011
Best practice in treating infants and children with proven, probable or suspected invasive fungal infections.
    Current opinion in infectious diseases, 2011, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Child; Echinocandins; Fever of Unknown Origin; Humans; Infant; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2011
Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
    European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4

    Topics: Antifungal Agents; Drug Interactions; Humans; Invasive Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2011
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
    European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2011
Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Rhodotorula fungemia: two cases and a brief review.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Female; Fungemia; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Pyrimidines; Rhodotorula; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2011
Anidulafungin: when and how? The clinician's view.
    Mycoses, 2012, Volume: 55, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Pharmacogenomics of the triazole antifungal agent voriconazole.
    Pharmacogenomics, 2011, Volume: 12, Issue:6

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Interactions; Humans; Pharmacogenetics; Pyrimidines; Triazoles; Voriconazole

2011
Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2

    Topics: Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Education, Medical, Continuing; Female; Humans; Immunocompromised Host; Incidence; Male; Melanoma; Organ Transplantation; Prognosis; Pyrimidines; Risk Assessment; Sarcoma, Kaposi; Sirolimus; Skin Neoplasms; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2011
Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Adult; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Monitoring; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Phototoxicity and photocarcinogenesis associated with voriconazole.
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:12

    Topics: Antifungal Agents; Biotransformation; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cocarcinogenesis; Comorbidity; Dermatitis, Phototoxic; Drug Interactions; Humans; Immunocompromised Host; Melanoma; Mycoses; Neoplasms, Radiation-Induced; Photochemistry; Postoperative Complications; Pyrimidines; Retinoids; Retrospective Studies; Skin Neoplasms; Sunlight; Transplantation; Triazoles; Voriconazole

2011
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2012
Triazole antifungal agents in invasive fungal infections: a comparative review.
    Drugs, 2011, Dec-24, Volume: 71, Issue:18

    Topics: Antifungal Agents; Fluconazole; Fungi; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Scedosporium apiospermum catheter-related soft-tissue infection: a case report and review of the literature.
    Medical mycology, 2012, Volume: 50, Issue:6

    Topics: Aged; Catheter-Related Infections; DNA, Fungal; Genes, Fungal; Humans; Male; Mycoses; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Scedosporium; Sequence Analysis, DNA; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole

2012
Treatment of primary aspergilloma of the central nervous system in a diabetic immunocompetent patient with surgical resection and voriconazole: a case report and review of the literature.
    Turkish neurosurgery, 2011, Volume: 21, Issue:4

    Topics: Aged; Antifungal Agents; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Immunocompetence; Neuroaspergillosis; Neurosurgical Procedures; Pyrimidines; Temporal Lobe; Treatment Outcome; Triazoles; Voriconazole

2011
Therapeutic drug monitoring of voriconazole in children.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:1

    Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Investigation and threshold of optimum blood concentration of voriconazole: a descriptive statistical meta-analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:4

    Topics: Age Factors; Antifungal Agents; Drug Monitoring; Female; Humans; Liver Diseases; Male; Mycoses; Odds Ratio; Pyrimidines; Triazoles; Voriconazole

2012
Endophthalmitis caused by Phialophora verrucosa: a case report and literature review of Phialophora ocular infections.
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:3

    Topics: Aged; Amphotericin B; Antifungal Agents; Caspofungin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Glaucoma; Humans; Hypertension; Intravitreal Injections; Lipopeptides; Male; Phialophora; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2012
Antifungal prophylaxis in haematology patients: the role of voriconazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18 Suppl 2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole

2012
Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
    Mycopathologia, 2012, Volume: 174, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Bursa, Synovial; Dermatomycoses; Female; Hand; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Synovitis; Treatment Outcome; Triazoles; Voriconazole

2012
Ochroconis gallopava infection in a patient with chronic granulomatous disease: case report and review of the literature.
    Medical mycology, 2012, Volume: 50, Issue:8

    Topics: Antifungal Agents; Ascomycota; Granulomatous Disease, Chronic; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
[Azole resistance in Aspergillus fumigatus in the Netherlands--increase due to environmental fungicides?].
    Nederlands tijdschrift voor geneeskunde, 2012, Volume: 156, Issue:25

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Triazoles; Voriconazole

2012
Exophiala dermatitidis endocarditis on native aortic valve in a postrenal transplant patient and review of literature on E. dermatitidis infections.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Antifungal Agents; Aortic Valve; Chest Pain; DNA, Fungal; Endocarditis; Exophiala; Female; Fever; Humans; Kidney Transplantation; Middle Aged; Phaeohyphomycosis; Pyrimidines; Triazoles; Voriconazole

2013
Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2012, Volume: 10, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Encephalitis; Humans; Liver Transplantation; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
[The development of appropriate dosage of anti-bacterial and anti-fungal agents based on pharmacokinetics and pharmacodynamics].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:10

    Topics: Anti-Bacterial Agents; Antifungal Agents; Female; HMGB1 Protein; Humans; Liposomes; Male; Pyrimidines; Teicoplanin; Triazoles; Voriconazole

2012
Fungal infections associated with contaminated methylprednisolone injections.
    The New England journal of medicine, 2013, Jun-27, Volume: 368, Issue:26

    Topics: Antifungal Agents; Aspergillus fumigatus; Cerebrospinal Fluid; Disease Outbreaks; Drug Compounding; Drug Contamination; Drug Monitoring; Humans; Injections, Spinal; Meningitis, Fungal; Methylprednisolone; Pyrimidines; Saccharomycetales; Tennessee; Triazoles; United States; Voriconazole

2013
Voriconazole in clinical practice.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:6

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Evidence-Based Medicine; Fungi; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.
    Current pharmaceutical design, 2013, Volume: 19, Issue:20

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Neuroaspergillosis; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2013
Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.
    Clinical & experimental ophthalmology, 2013, Volume: 41, Issue:6

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Cause of Death; Eye Infections, Fungal; Female; Fungi; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review.
    Pharmacotherapy, 2013, Volume: 33, Issue:1

    Topics: Body Mass Index; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Obesity; Overweight; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2013
Pharmacoeconomic assessment of therapy for invasive aspergillosis.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cost-Benefit Analysis; Empirical Research; Humans; Length of Stay; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Male; Middle Aged; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
    Journal de mycologie medicale, 2013, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult

2013
Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Aged; Aneurysm, Infected; Antifungal Agents; Aortic Aneurysm; Drug Resistance, Fungal; Female; Humans; Lung Transplantation; Mycoses; Pericarditis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Bibliographical investigation (domestic and overseas) on the treatment of endogenous Candida endophthalmitis over an 11-year period.
    Medical mycology journal, 2013, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Female; Fluconazole; Humans; Infant; Japan; Male; MEDLINE; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole; Young Adult

2013
Aspergillus terreus-related ureteral obstruction in a diabetic patient.
    Iranian journal of kidney diseases, 2013, Volume: 7, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diabetes Complications; Humans; Lithotripsy; Male; Middle Aged; Pyrimidines; Stents; Tomography, X-Ray Computed; Triazoles; Ureter; Ureteral Obstruction; Voriconazole

2013
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
    Journal de mycologie medicale, 2012, Volume: 22, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug Therapy, Combination; Fusariosis; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2013
Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature.
    Infection, 2013, Volume: 41, Issue:4

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Diabetes Complications; Humans; Male; Osteomyelitis; Pyrimidines; Spondylitis; Triazoles; Voriconazole

2013
Combination antifungal therapy for invasive fungal infections in children and adults.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:5

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Child; Cryptococcosis; Cryptococcus; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Pyrimidines; Triazoles; Voriconazole

2013
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Aged; Antifungal Agents; Chemoprevention; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Background changing patterns of neonatal fungal sepsis in a developing country.
    Journal of tropical pediatrics, 2013, Volume: 59, Issue:6

    Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Humans; Incidence; Infant, Newborn; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Factors; Socioeconomic Factors; South Africa; Treatment Outcome; Triazoles; Voriconazole

2013
Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
    Early human development, 2013, Volume: 89 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Echinocandins; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Neonatology; Pyrimidines; Triazoles; Voriconazole

2013
Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: a case report and review of the literature.
    Mycopathologia, 2013, Volume: 176, Issue:3-4

    Topics: Antifungal Agents; Biopsy, Fine-Needle; Diabetes Complications; Diabetes Mellitus, Type 2; Foot; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2013
Mold infections in lung transplant recipients.
    Seminars in respiratory and critical care medicine, 2013, Volume: 34, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bronchiolitis Obliterans; Fungi; Humans; Lung Diseases, Fungal; Lung Transplantation; Neoplasms, Squamous Cell; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2013
Disseminated histoplasmosis in a renal transplant patient.
    Cutis, 2013, Volume: 91, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow; Dermatomycoses; Histoplasmosis; Humans; Immunocompromised Host; Kidney Transplantation; Lung; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2013
[Pharmaceutical applications of sulfobuthylether-beta-cyclodextrin].
    Acta pharmaceutica Hungarica, 2013, Volume: 83, Issue:2

    Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antiemetics; Antifungal Agents; Antipsychotic Agents; Aripiprazole; beta-Cyclodextrins; Chemistry, Pharmaceutical; Dosage Forms; Drug Stability; Humans; Hungary; Multiple Myeloma; Oligopeptides; Piperazines; Pyrimidines; Quinolones; Quinuclidines; Solubility; Thiazoles; Triazoles; Voriconazole

2013
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Drug Resistance, Fungal; Humans; Pyrimidines; Triazoles; Voriconazole

2013
Fungal infections and treatment in cystic fibrosis.
    Current opinion in pulmonary medicine, 2013, Volume: 19, Issue:6

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole

2013
Iatrogenic fungal infections of central nervous system.
    Current neurology and neuroscience reports, 2013, Volume: 13, Issue:11

    Topics: Animals; Antifungal Agents; Central Nervous System Fungal Infections; Drug Contamination; Humans; Iatrogenic Disease; Pyrimidines; Triazoles; Voriconazole

2013
Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
    Expert review of anti-infective therapy, 2013, Volume: 11, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Critical Illness; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Echinocandins; Humans; Practice Guidelines as Topic; Pyrimidines; Sepsis; Triazoles; Voriconazole

2013
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
    Mycoses, 2014, Volume: 57, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole

2014
Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Evidence-Based Medicine; Humans; Mucormycosis; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole

2013
A case of pediatric gastrointestinal basidiobolomycosis mimicking Crohn`s disease. A review of pediatric literature.
    Saudi medical journal, 2013, Volume: 34, Issue:10

    Topics: Antifungal Agents; Child, Preschool; Crohn Disease; Diagnosis, Differential; Humans; Male; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2013
Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan.
    Respiratory investigation, 2013, Volume: 51, Issue:4

    Topics: Aged; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Delayed Diagnosis; Female; Humans; Japan; Lung Diseases, Fungal; Magnetic Resonance Imaging; Near Drowning; Pyrimidines; Scedosporium; Survivors; Tomography, X-Ray Computed; Triazoles; Tsunamis; Voriconazole

2013
Fungal infections associated with long-term mechanical circulatory support-diagnosis and management.
    Journal of cardiac surgery, 2014, Volume: 29, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Incidence; Mycoses; Pyrimidines; Risk Factors; Time Factors; Triazoles; Voriconazole

2014
Treatment of fungal disease in the setting of neutropenia.
    Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013

    Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
[Invasive fungal rhinosinusitis in an apparently immunocompetant patient].
    Annales de pathologie, 2013, Volume: 33, Issue:6

    Topics: Aged; Antifungal Agents; Aortic Valve Stenosis; Aspergillosis; Chronic Disease; Female; Humans; Immunocompetence; Incidental Findings; Maxillary Sinusitis; Preoperative Care; Pyrimidines; Recurrence; Rhinitis; Triazoles; Voriconazole

2013
Invasive Trichosporon infection in solid organ transplant patients: a report of two cases identified using IGS1 ribosomal DNA sequencing and a review of the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1

    Topics: Adult; Antifungal Agents; DNA, Fungal; DNA, Intergenic; DNA, Ribosomal; Drug Resistance, Fungal; Empyema; Graft Rejection; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Male; Mediastinitis; Microbial Sensitivity Tests; Pericarditis; Pleural Effusion; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult

2014
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
    Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole

2014
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
    The Cochrane database of systematic reviews, 2014, Feb-24, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Fluconazole; Humans; Liposomes; Mycoses; Neoplasms; Neutropenia; Opportunistic Infections; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2014
Exploring azole antifungal drug resistance in Aspergillus fumigatus with special reference to resistance mechanisms.
    Future microbiology, 2014, Volume: 9, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cholesterol; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2014
The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2014, Volume: 17, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Models, Biological; Mutation; Translational Research, Biomedical; Triazoles; Voriconazole

2014
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections.
    Current opinion in infectious diseases, 2014, Volume: 27, Issue:6

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Itraconazole; Mycoses; Population Surveillance; Precision Medicine; Triazoles; Voriconazole

2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.
    Internal medicine journal, 2014, Volume: 44, Issue:12b

    Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole

2014
Isavuconazole: A New Option for the Management of Invasive Fungal Infections.
    The Annals of pharmacotherapy, 2015, Volume: 49, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillosis; Candidemia; Candidiasis; Candidiasis, Invasive; Clinical Trials as Topic; Drug Resistance, Fungal; Humans; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Bronchoalveolar Lavage Fluid; Galactose; Humans; Mannans; Proteoglycans; Triazoles; Voriconazole

2015
Invasive Aspergillosis: Epidemiology, Clinical Aspects, and Treatment.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lung Transplantation; Magnetic Resonance Imaging; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2015
Emergence of Azole Resistance in Aspergillus.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2015
Coccidioidomycosis: Recent Updates.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Humans; Nitriles; Pneumonia; Pyridines; Risk Factors; Triazoles; Voriconazole

2015
Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillus; Candida; Cost-Benefit Analysis; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Mycoses; Singapore; Survival Analysis; Triazoles; Voriconazole

2016
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation.
    Expert review of anti-infective therapy, 2017, Volume: 15, Issue:5

    Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Practice Guidelines as Topic; Primary Prevention; Transplantation, Homologous; Triazoles; Voriconazole

2017
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole

2017
Invasive mould infections in the ICU setting: complexities and solutions.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole

2017
Graded isavuconazole introduction in a patient with voriconazole allergy.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:6

    Topics: Amphotericin B; Angioedema; Antifungal Agents; Aspergillus; Desensitization, Immunologic; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Liver Cirrhosis; Liver Transplantation; Lung; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2017
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
    Mycoses, 2018, Volume: 61, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2018
Scedosporium apiospermum infection of the urinary system with a review of treatment options and cases in the literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Adult; Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Immunocompromised Host; Itraconazole; Male; Mycoses; Pyrimidines; Scedosporium; Triazoles; Urinary Tract Infections; Voriconazole

2018
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    Annals of hematology, 2018, Volume: 97, Issue:2

    Topics: Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Medical Oncology; Myelodysplastic Syndromes; Primary Prevention; Societies, Medical; Triazoles; Voriconazole

2018
Case of femoral pseudarthrosis due to Scedosporium apiospermum in an immunocompetent patient with successful conservative treatment and review of literature.
    Mycoses, 2018, Volume: 61, Issue:6

    Topics: Antifungal Agents; Conservative Treatment; Disease Management; Femur; Humans; Immunocompetence; Male; Middle Aged; Pseudarthrosis; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2018
Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature.
    Clinical neurology and neurosurgery, 2018, Volume: 172

    Topics: Antifungal Agents; Aspergillosis; Biopsy; Humans; Immunocompetence; Male; Middle Aged; Triazoles; Voriconazole

2018
Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.
    Current medical research and opinion, 2018, Volume: 34, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Network Meta-Analysis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole

2018
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
    European journal of drug metabolism and pharmacokinetics, 2019, Volume: 44, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Triazoles; Voriconazole

2019
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
    European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

    Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole

2019
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
    Mycopathologia, 2020, Volume: 185, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2020
Blastomycosis.
    Seminars in respiratory and critical care medicine, 2020, Volume: 41, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Humans; Immunocompromised Host; Itraconazole; Triazoles; Voriconazole

2020
An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
    Expert review of respiratory medicine, 2020, Volume: 14, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Disease Management; Echinocandins; Humans; Itraconazole; Nitriles; Practice Guidelines as Topic; Pulmonary Aspergillosis; Pyridines; Triazoles; Voriconazole

2020
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
    Mycoses, 2020, Volume: 63, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole

2020
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Triazoles; Voriconazole

2020
Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Network Meta-analysis.
    JAMA network open, 2020, 10-01, Volume: 3, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pre-Exposure Prophylaxis; Triazoles; Voriconazole

2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
    The Lancet. Infectious diseases, 2021, Volume: 21, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole

2021
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:9

    Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Mycoses; Triazoles; Voriconazole

2021
How different is invasive fusariosis in pediatric patients than in adults? A systematic review.
    Current opinion in infectious diseases, 2021, 12-01, Volume: 34, Issue:6

    Topics: Adult; Antifungal Agents; Child; Fusariosis; Hematologic Neoplasms; Humans; Triazoles; Voriconazole

2021
Inhaled antifungal therapy: benefits, challenges, and clinical applications.
    Expert opinion on drug delivery, 2022, Volume: 19, Issue:7

    Topics: Antifungal Agents; Drug Interactions; Triazoles; Voriconazole

2022
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
    Future microbiology, 2022, Volume: 17

    Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2022
New Perspectives on Antimicrobial Agents: Isavuconazole.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Antifungal Agents; Candidiasis, Invasive; Caspofungin; Fungi; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles; Voriconazole

2022
A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections.
    Mycoses, 2023, Volume: 66, Issue:9

    Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Triazoles; Voriconazole

2023
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium.
    Pharmacotherapy, 2023, Volume: 43, Issue:10

    Topics: Antifungal Agents; Communicable Diseases; Drug Monitoring; Humans; Mycoses; Pharmacists; Triazoles; Voriconazole

2023
CRYPTOCOCCOSIS: A bibliographic narrative review on antifungal resistance.
    Anais da Academia Brasileira de Ciencias, 2023, Volume: 95, Issue:suppl 1

    Topics: Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole

2023
Performances of disk diffusion method for determining triazole susceptibility of Aspergillus species: Systematic review.
    Journal de mycologie medicale, 2023, Volume: 33, Issue:4

    Topics: Agar; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Reproducibility of Results; Triazoles; Voriconazole

2023

Trials

139 trial(s) available for triazoles and voriconazole

ArticleYear
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Nov-01, Volume: 33, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2001
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2002
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Mar-01, Volume: 34, Issue:5

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:4

    Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2002
Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
    Clinical pharmacology and therapeutics, 2002, Volume: 71, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Antifungal Agents; Area Under Curve; Confidence Intervals; Cross-Over Studies; Cyclosporine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Humans; Kidney Transplantation; Male; Middle Aged; Patients; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    The Pediatric infectious disease journal, 2002, Volume: 21, Issue:3

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2002
Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8

    Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Injections, Intravenous; Liver Function Tests; Male; Pyrimidines; Saliva; Triazoles; Voriconazole

2002
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    The New England journal of medicine, 2002, Aug-08, Volume: 347, Issue:6

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2002
Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; In Vitro Techniques; Kinetics; Liver Transplantation; Microsomes, Liver; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2002
Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies.
    Annals of hematology, 2002, Volume: 81 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
Voriconazole treatment for less-common, emerging, or refractory fungal infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-01, Volume: 36, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Humans; Infusions, Intravenous; Male; Middle Aged; Plasma; Pyrimidines; Saliva; Single-Blind Method; Triazoles; Voriconazole

2003
Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Plasma; Pyrimidines; Single-Blind Method; Triazoles; Voriconazole

2003
Effect of food on the pharmacokinetics of multiple-dose oral voriconazole.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Food; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Pyrimidines; Time Factors; Triazoles; Voriconazole

2003
Voriconazole potentiates warfarin-induced prothrombin time prolongation.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adult; Anticoagulants; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Drug Combinations; Drug Interactions; Drug Synergism; Humans; Male; Prothrombin Time; Pyrimidines; Triazoles; Voriconazole; Warfarin

2003
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Azithromycin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2003
Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Adult; Anticonvulsants; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Male; Phenytoin; Pyrimidines; Triazoles; Voriconazole

2003
Voriconazole does not affect the steady-state pharmacokinetics of digoxin.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Cardiotonic Agents; Digoxin; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Male; Plasma; Pyrimidines; Triazoles; Voriconazole

2003
Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adult; Antifungal Agents; Cimetidine; Cross-Over Studies; Drug Combinations; Drug Interactions; Histamine H2 Antagonists; Humans; Male; Pyrimidines; Ranitidine; Triazoles; Voriconazole

2003
Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Antifungal Agents; Cross-Over Studies; Drug Combinations; Drug Interactions; Humans; Male; Omeprazole; Pyrimidines; Triazoles; Voriconazole

2003
No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Administration, Oral; Adult; Antifungal Agents; Cross-Over Studies; Drug Combinations; Drug Interactions; HIV Protease Inhibitors; Humans; Indinavir; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2003
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Aging; Alleles; Antifungal Agents; Body Weight; Child; Child, Preschool; Cohort Studies; Female; Genotype; Humans; Immunocompromised Host; Injections, Intravenous; Liver Function Tests; Male; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40, Issue:8

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Child, Preschool; Humans; Middle Aged; Osteitis; Osteomyelitis; Pyrimidines; Salvage Therapy; Spondylitis; Triazoles; Voriconazole

2005
Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:5

    Topics: Aged; Antifungal Agents; Critical Illness; Female; Humans; Intubation, Gastrointestinal; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2005
Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics.
    Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:1

    Topics: Administration, Oral; Adult; Alleles; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Gas Chromatography-Mass Spectrometry; Genotype; Half-Life; Humans; Hypericum; Male; Metabolic Clearance Rate; Mixed Function Oxygenases; Patient Selection; Plant Extracts; Pyrimidines; Time Factors; Triazoles; Voriconazole

2005
Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients.
    Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Intensive Care Units; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Probability; Prospective Studies; Pyrimidines; Risk Assessment; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Triazoles; Voriconazole

2005
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Nov-15, Volume: 41, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Humans; Itraconazole; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2005
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin.
    Journal of clinical pharmacology, 2005, Volume: 45, Issue:12

    Topics: Adult; Anidulafungin; Antifungal Agents; Cross-Over Studies; Drug Therapy, Combination; Echinocandins; Humans; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
    American journal of veterinary research, 2006, Volume: 67, Issue:2

    Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Aqueous Humor; Dose-Response Relationship, Drug; Female; Horses; Male; Pyrimidines; Triazoles; Voriconazole

2006
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Transplantation, 2006, Feb-15, Volume: 81, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Voriconazole

2006
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Data Interpretation, Statistical; Drug Resistance, Fungal; Endpoint Determination; Fluconazole; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2006
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
    Clinical pharmacology and therapeutics, 2006, Volume: 79, Issue:4

    Topics: Administration, Oral; Adult; Anesthetics, Intravenous; Antifungal Agents; Area Under Curve; Cross-Over Studies; Humans; Infusions, Intravenous; Male; Midazolam; Pyrimidines; Triazoles; Voriconazole

2006
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Adult; Analgesics, Non-Narcotic; Antifungal Agents; Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluconazole; Half-Life; Humans; Ibuprofen; Male; Pyrimidines; Therapeutic Equivalency; Triazoles; Voriconazole

2006
Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    American journal of veterinary research, 2006, Volume: 67, Issue:6

    Topics: Administration, Oral; Animals; Antifungal Agents; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Stability; Female; Horses; Injections, Intravenous; Male; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    The American journal of medicine, 2006, Volume: 119, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole

2006
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects.
    British journal of clinical pharmacology, 2007, Volume: 63, Issue:1

    Topics: Adult; Antifungal Agents; Cross-Over Studies; Drug Interactions; Humans; Hypnotics and Sedatives; Male; Pyridines; Pyrimidines; Triazoles; Voriconazole; Zolpidem

2007
Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.
    Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:2

    Topics: Adult; Alleles; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Genotype; Humans; Male; Mixed Function Oxygenases; Pyrimidines; Ritonavir; Triazoles; Voriconazole

2006
Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aqueous Humor; Aspergillus fumigatus; Candida albicans; Humans; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Adult; Antifungal Agents; Area Under Curve; Back Pain; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Headache; Humans; Male; Metabolic Clearance Rate; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Pyrimidines; Sleep Initiation and Maintenance Disorders; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2007
Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1

    Topics: Adult; Antifungal Agents; Area Under Curve; Biological Assay; Candida albicans; Candidiasis; Chromatography, High Pressure Liquid; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Reproducibility of Results; Spectrophotometry, Ultraviolet; Treatment Outcome; Triazoles; Voriconazole

2007
Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:5

    Topics: Administration, Oral; Adult; Alfentanil; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Color Vision Defects; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Naphthalenes; Photophobia; Pyrimidines; Sex Factors; Terbinafine; Triazoles; Vomiting; Voriconazole

2006
Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Female; Humans; Male; Middle Aged; Pyrimidines; Tablets; Triazoles; Voriconazole

2007
Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.
    Chest, 2007, Volume: 131, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunocompetence; Lung; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Costs; Humans; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole

2007
Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Drug Interactions; Humans; Male; Middle Aged; Pyrimidines; Ritonavir; Sample Size; Triazoles; Voriconazole

2007
Voriconazole and fluconazole increase the exposure to oral diazepam.
    European journal of clinical pharmacology, 2007, Volume: 63, Issue:10

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cognition; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Enzyme Inhibitors; Female; Fluconazole; Genotype; Half-Life; Humans; Hypnotics and Sedatives; Male; Mixed Function Oxygenases; Nordazepam; Pyrimidines; Triazoles; Voriconazole; Wakefulness

2007
Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Area Under Curve; Biotransformation; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dealkylation; Desvenlafaxine Succinate; Drug Interactions; Enzyme Inhibitors; Genotype; Half-Life; Humans; Male; Naphthalenes; Phenotype; Polymorphism, Genetic; Pyrimidines; Reference Values; Terbinafine; Triazoles; Venlafaxine Hydrochloride; Voriconazole

2008
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    The Journal of infection, 2007, Volume: 55, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Incidence; Length of Stay; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Mycoses; Placebos; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2007
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.
    European journal of clinical pharmacology, 2008, Volume: 64, Issue:1

    Topics: Administration, Oral; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Female; Fentanyl; Fluconazole; Humans; Injections, Intravenous; Male; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2008
An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Dec-01, Volume: 45, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Paracoccidioidomycosis; Pilot Projects; Pyrimidines; Triazoles; Voriconazole

2007
Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Age Factors; Alkynes; Antifungal Agents; Area Under Curve; Benzoxazines; Body Weight; Capsules; Creatine Kinase; Cyclopropanes; Drug Interactions; Heart Block; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Reverse Transcriptase Inhibitors; Rhabdomyolysis; Tablets; Triazoles; Voriconazole

2008
Effect of voriconazole on the pharmacokinetics of diclofenac.
    Fundamental & clinical pharmacology, 2007, Volume: 21, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C9; Diclofenac; Drug Interactions; Half-Life; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2007
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2008
Pharmacokinetics of voriconazole after oral administration of single and multiple doses in African grey parrots (Psittacus erithacus timneh).
    American journal of veterinary research, 2008, Volume: 69, Issue:1

    Topics: Administration, Oral; Animals; Antifungal Agents; Drug Administration Schedule; Psittaciformes; Pyrimidines; Triazoles; Voriconazole

2008
Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3

    Topics: Amphotericin B; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Changes in causes of death over time after treatment for invasive aspergillosis.
    Cancer, 2008, May-15, Volume: 112, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cause of Death; Graft vs Host Disease; Humans; Neoplasms; Pyrimidines; Survival Rate; Time Factors; Triazoles; Voriconazole

2008
Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.
    Clinical drug investigation, 2008, Volume: 28, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Creatinine; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Renal Insufficiency; Severity of Illness Index; Solubility; Triazoles; Voriconazole

2008
Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Biotransformation; Cross-Over Studies; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Etoricoxib; Gels; Humans; Male; Miconazole; Pyridines; Pyrimidines; Sulfones; Thromboxane B2; Triazoles; Voriconazole; Young Adult

2009
Voriconazole drastically increases exposure to oral oxycodone.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:3

    Topics: Administration, Oral; Adult; Analgesics, Opioid; Antifungal Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole

2009
Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1

    Topics: Amphotericin B; Australia; Cost-Benefit Analysis; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Blood Coagulation; Cross-Over Studies; Cyclooxygenase 1; Cytochrome P-450 Enzyme System; Drug Interactions; Genotype; Half-Life; Humans; Itraconazole; Male; Meloxicam; Protein Binding; Pyrimidines; Thiazines; Thiazoles; Thromboxane B2; Triazoles; Voriconazole; Young Adult

2009
Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:4

    Topics: Adolescent; Alleles; Aryl Hydrocarbon Hydroxylases; Asian People; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Interactions; Enzyme Induction; Ginkgo biloba; Humans; Male; Phytotherapy; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:2

    Topics: Aged; Antifungal Agents; Biological Availability; Chromatography, High Pressure Liquid; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Triazoles; Vitreous Body; Voriconazole

2009
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Adult; Anidulafungin; Antifungal Agents; Bronchoalveolar Lavage Fluid; Drug Therapy, Combination; Echinocandins; Female; Humans; Injections, Intravenous; Male; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole; Young Adult

2010
Pharmacokinetics of CsA during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2010, Volume: 45, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Biological Availability; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:5

    Topics: Adult; Analgesics, Opioid; Analysis of Variance; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Pyrimidines; Tilidine; Triazoles; Voriconazole; Young Adult

2009
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Tacrolimus use in adult allogeneic stem cell transplant recipients receiving voriconazole: preemptive dose modification and therapeutic drug monitoring.
    Bone marrow transplantation, 2010, Volume: 45, Issue:8

    Topics: Adult; Antifungal Agents; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole

2010
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:6

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP2C19; Female; Genotype; Germany; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis).
    American journal of veterinary research, 2010, Volume: 71, Issue:4

    Topics: Administration, Oral; Amazona; Animals; Antifungal Agents; Area Under Curve; Drug Administration Schedule; Half-Life; Pyrimidines; Triazoles; Voriconazole

2010
Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Adult; Aged; Antifungal Agents; beta-Cyclodextrins; Cross-Over Studies; Female; Half-Life; Hemodiafiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Pyrimidines; Renal Dialysis; Solvents; Triazoles; Voriconazole

2010
Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.
    Journal of veterinary pharmacology and therapeutics, 2010, Volume: 33, Issue:1

    Topics: Animals; Antifungal Agents; Body Fluids; Drug Administration Schedule; Female; Horses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole pharmacokinetics and safety in immunocompromised children compared to adult patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Injections, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:6

    Topics: Administration, Topical; Anti-Infective Agents, Local; Antifungal Agents; Cornea; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2010
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
    Haematologica, 2010, Volume: 95, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia; Male; Middle Aged; Mycoses; Pyrimidines; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Antifungal Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:11

    Topics: Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; China; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP2C19; Erythromycin; Humans; Male; Polymorphism, Single Nucleotide; Protein Synthesis Inhibitors; Pyrimidines; Triazoles; Voriconazole; Young Adult

2010
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
    The Journal of infection, 2010, Volume: 61, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2010
Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans.
    Current eye research, 2010, Volume: 35, Issue:11

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Area Under Curve; Cataract Extraction; Chromatography, High Pressure Liquid; Corneal Ulcer; Drug Stability; Eye Infections, Fungal; Female; Half-Life; Humans; Male; Middle Aged; Preservatives, Pharmaceutical; Pyrimidines; Tandem Mass Spectrometry; Tissue Distribution; Triazoles; Voriconazole

2010
Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Clinical & experimental ophthalmology, 2011, Volume: 39, Issue:5

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Male; Microbiological Techniques; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2011
Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
    Current medical research and opinion, 2011, Volume: 27, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Injections, Intravenous; Male; Middle Aged; Mycoses; Professional Practice; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Long-term visual safety of voriconazole in adult patients with paracoccidioidomycosis.
    Clinical therapeutics, 2010, Volume: 32, Issue:13

    Topics: Antifungal Agents; Brazil; Drug Administration Schedule; Eye; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmoscopes; Paracoccidioidomycosis; Pyrimidines; Time Factors; Triazoles; Vision, Ocular; Visual Acuity; Visual Field Tests; Voriconazole

2010
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
Steady-state plasma pharmacokinetics of oral voriconazole in obese adults.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Cross-Over Studies; Female; Humans; Male; Middle Aged; Obesity; Pyrimidines; Triazoles; Voriconazole; Young Adult

2011
Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT.
    Bone marrow transplantation, 2012, Volume: 47, Issue:4

    Topics: Acute Disease; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Time Factors; Triazoles; Voriconazole

2012
Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Anti-Infective Agents; Area Under Curve; Critical Illness; Drug Monitoring; Half-Life; Hemofiltration; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Ocular manifestations of candidemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Aug-01, Volume: 53, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidemia; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Incidence; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult

2011
[Modern antifungals in therapy of nosocomial mycosis in oncologic patients].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:1-2

    Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Neoplasms; Pyrimidines; Triazoles; Voriconazole

2011
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.
    Mycoses, 2012, Volume: 55, Issue:3

    Topics: Antifungal Agents; Australia; Caspofungin; Echinocandins; Economics, Pharmaceutical; Fever; Humans; Lipopeptides; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2012
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:11

    Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult

2011
Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Adult; Body Mass Index; Cross-Over Studies; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Young Adult

2011
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
    British journal of haematology, 2011, Volume: 155, Issue:3

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2011
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Child; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Genotype; Humans; Immunocompromised Host; Injections, Intravenous; Liver Function Tests; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using A limited sampling strategy.
    Clinical pharmacology and therapeutics, 2011, Volume: 90, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Midazolam; Middle Aged; Pyrimidines; Ritonavir; Time Factors; Triazoles; Voriconazole; Young Adult

2011
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adults.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Immunocompromised Host; Infusions, Intravenous; Liver Function Tests; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Gender differences in re-epithelialisation time in fungal corneal ulcers.
    The British journal of ophthalmology, 2012, Volume: 96, Issue:1

    Topics: Antifungal Agents; Corneal Ulcer; Epithelium, Corneal; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Natamycin; Prospective Studies; Pyrimidines; Sex Characteristics; Triazoles; Voriconazole; Wound Healing

2012
Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mycoses; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2012, Volume: 11, Issue:3

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Pyrimidines; Sunlight; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.
    Cornea, 2012, Volume: 31, Issue:6

    Topics: Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2012
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Adolescent; Adult; Antifungal Agents; Female; Humans; Immunocompromised Host; Male; Models, Theoretical; Pyrimidines; Triazoles; Voriconazole

2012
Voriconazole for fungal corneal ulcers.
    Ophthalmology, 2012, Volume: 119, Issue:5

    Topics: Acremonium; Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Ascomycota; Aspergillus flavus; Aspergillus niger; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Itraconazole; Middle Aged; Mycoses; Natamycin; Prospective Studies; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2012
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:6

    Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Predictors of outcome in fungal keratitis.
    Eye (London, England), 2012, Volume: 26, Issue:9

    Topics: Administration, Topical; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Debridement; Double-Blind Method; Eye Infections, Fungal; Female; Humans; Male; Natamycin; Ophthalmic Solutions; Outcome and Process Assessment, Health Care; Prognosis; Prospective Studies; Pyrimidines; Re-Epithelialization; Risk Factors; Time Factors; Triazoles; Visual Acuity; Voriconazole

2012
The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:8

    Topics: Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Chi-Square Distribution; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Single-Blind Method; Treatment Outcome; Triazoles; Voriconazole

2012
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2012
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:5

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole

2012
Ontogeny and sorafenib metabolism.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Oct-15, Volume: 18, Issue:20

    Topics: Adolescent; Age Factors; Azoles; Child; Child, Preschool; Cytochrome P-450 CYP3A; Female; Humans; Infant; Infant, Newborn; Liver; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Sex Factors; Sorafenib; Triazoles; Voriconazole; Young Adult

2012
Determination of voriconazole in human plasma by HPLC-ESI-MS and application to pharmacokinetic study.
    Journal of chromatographic science, 2013, Volume: 51, Issue:6

    Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Least-Squares Analysis; Male; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole

2013
Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
    Ophthalmology, 2013, Volume: 120, Issue:4

    Topics: Adult; Antifungal Agents; Corneal Stroma; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections; Keratitis; Male; Middle Aged; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Neutropenia; Placebos; Pyrimidines; Triazoles; Voriconazole

2013
Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Anti-HIV Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Fluconazole; Genotype; HIV Infections; Humans; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole; Young Adult

2013
Steady-state pharmacokinetics of oral voriconazole and its primary metabolite, N-oxide voriconazole, pre- and post-autologous peripheral stem cell transplantation.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Aged; Antifungal Agents; Aspergillosis; Cyclic N-Oxides; Female; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Triazoles; Voriconazole

2013
A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole.
    Clinical pharmacokinetics, 2013, Volume: 52, Issue:9

    Topics: Antifungal Agents; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Liver; Male; Midazolam; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2013
Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial.
    BMC infectious diseases, 2013, May-15, Volume: 13

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Anidulafungin; Antifungal Agents; Candidemia; Echinocandins; Female; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
    Investigative ophthalmology & visual science, 2013, Jun-14, Volume: 54, Issue:6

    Topics: Antifungal Agents; Bayes Theorem; Corneal Ulcer; Expert Testimony; Eye Infections, Fungal; Fusariosis; Humans; Natamycin; Pyrimidines; Surveys and Questionnaires; Triazoles; Voriconazole

2013
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
    JAMA ophthalmology, 2013, Volume: 131, Issue:4

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Perforation; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole; Wound Healing

2013
An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America.
    Mycoses, 2014, Volume: 57, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Echinocandins; Female; Humans; Latin America; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2014
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult

2013
Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Blood-Brain Barrier; Brain; Drug Administration Schedule; Humans; Magnetic Resonance Spectroscopy; Male; Pyrimidines; Triazoles; Voriconazole

2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Sep-01, Volume: 70, Issue:17

    Topics: Antifungal Agents; Case-Control Studies; Cohort Studies; Cost-Benefit Analysis; Decision Support Techniques; Double-Blind Method; Fluconazole; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2013
Identification of factors influencing the pharmacokinetics of voriconazole and the optimization of dosage regimens based on Monte Carlo simulation in patients with invasive fungal infections.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monte Carlo Method; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2014
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
    American journal of ophthalmology, 2014, Volume: 157, Issue:2

    Topics: Adult; Antifungal Agents; Corneal Ulcer; Double-Blind Method; Eye Infections, Fungal; Female; Fungi; Humans; Inhibitory Concentration 50; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole

2014
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2014
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Lancet (London, England), 2016, Feb-20, Volume: 387, Issue:10020

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2016
Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.
    Journal of medical economics, 2016, Volume: 19, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Double-Blind Method; Female; Glomerular Filtration Rate; Hospital Charges; Humans; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult

2016
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.
    European journal of clinical pharmacology, 2016, Volume: 72, Issue:11

    Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Antifungal Agents; Buprenorphine; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Healthy Volunteers; Humans; Male; Pain; Single-Blind Method; Triazoles; Voriconazole; Young Adult

2016
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis.
    Advances in therapy, 2017, Volume: 34, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Fees, Pharmaceutical; Female; Hospitalization; Humans; Male; Models, Econometric; Nitriles; Pyridines; Triazoles; Voriconazole

2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Aspergillus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neutropenia; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2018
Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
    Journal of clinical pharmacology, 2018, Volume: 58, Issue:7

    Topics: Acetates; Administration, Oral; Adult; Antifungal Agents; Antiviral Agents; Area Under Curve; Drug Combinations; Drug Interactions; Female; Healthy Volunteers; Humans; Middle Aged; Quinazolines; Triazoles; Voriconazole

2018
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
    Mycoses, 2018, Volume: 61, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Female; Fungi; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2018
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2019
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
    Lancet (London, England), 2021, 02-06, Volume: 397, Issue:10273

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Triazoles; Voriconazole; Young Adult

2021
Single oral or intravenous administration of voriconazole achieved recommended therapeutic minimum inhibitory concentrations against Aspergillus in the common raven (Corvus corax).
    American journal of veterinary research, 2022, Aug-31, Volume: 83, Issue:10

    Topics: Administration, Intravenous; Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Aspergillus; Crows; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2022
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole

2023
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
    Clinical drug investigation, 2023, Volume: 43, Issue:9

    Topics: Aspergillosis; Double-Blind Method; Humans; Triazoles; Voriconazole

2023

Other Studies

2032 other study(ies) available for triazoles and voriconazole

ArticleYear
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:1

    Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole

1996
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:8

    Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1996
Comparison of voriconazole (UK-109,496) and itraconazole in prevention and treatment of Aspergillus fumigatus endocarditis in guinea pigs.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:1

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Dose-Response Relationship, Drug; Endocarditis; Guinea Pigs; Itraconazole; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1997
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth; Pyrimidines; Triazoles; Voriconazole

1997
Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Itraconazole; Lung; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole

1997
In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1997
Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column.
    Journal of chromatography. B, Biomedical sciences and applications, 1997, Apr-11, Volume: 691, Issue:2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

1997
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
    British journal of haematology, 1997, Volume: 97, Issue:3

    Topics: Acute Disease; Adolescent; Antifungal Agents; Aspergillosis; Brain Diseases; Humans; Leukemia; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

1997
In vitro evaluation of voriconazole against some clinically important fungi.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:8

    Topics: Antifungal Agents; Evaluation Studies as Topic; Fungi; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1997
Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:8

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Microscopy, Electron; Pyrimidines; Time Factors; Triazoles; Voriconazole

1997
A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:11

    Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sterols; Triazoles; Voriconazole

1997
In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.
    Arzneimittel-Forschung, 1997, Volume: 47, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Culture Media; Fluconazole; Fungi; Griseofulvin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

1997
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:1

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

1998
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.
    Journal of chemotherapy (Florence, Italy), 1998, Volume: 10, Issue:1

    Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Activity of voriconazole, a new triazole, combined with neutrophils or monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Antifungal Agents; Candida albicans; Fluconazole; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; In Vitro Techniques; Monocytes; Neutrophils; Pyrimidines; Recombinant Proteins; T-Lymphocytes, Regulatory; Triazoles; Voriconazole

1998
Microgranulomatous aspergillosis in a patient with chronic granulomatous disease: cure with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

1998
Use of voriconazole in treatment of Scedosporium apiospermum infection: case report.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:5

    Topics: Acute Disease; Adult; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Leukemia, Myeloid; Male; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

1998
In vitro activity of voriconazole against Candida species.
    Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:1

    Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease.
    American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:5 Pt 1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

1998
In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole

1998
In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Antifungal Agents; Aspergillus fumigatus; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Monocytes; Neutrophils; Pyrimidines; Triazoles; Voriconazole

1998
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:10

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole

1998
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:2

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study.
    Medical mycology, 1998, Volume: 36, Issue:4

    Topics: Antifungal Agents; Coloring Agents; Cryptococcus neoformans; Fluconazole; Humans; Pyrimidines; Time Factors; Triazoles; Voriconazole

1998
In vitro activity of voriconazole against selected fungi.
    Medical mycology, 1998, Volume: 36, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Basidiomycota; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Environmental Microbiology; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

1998
[Antifungal drugs: the new frontier].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:3

    Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole

1998
In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:8

    Topics: Antifungal Agents; Aspergillus; Drug Evaluation, Preclinical; Fusarium; Pyrimidines; Triazoles; Voriconazole

1998
Organism-dependent fungicidal activities of azoles.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Dose-Response Relationship, Drug; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
A rapid HPLC assay for voriconazole in human plasma.
    Journal of pharmaceutical and biomedical analysis, 1998, Volume: 17, Issue:8

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

1998
Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
    AIDS (London, England), 1998, Nov-12, Volume: 12, Issue:16

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:12

    Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole

1998
Anticryptococcal activity of voriconazole against Cryptococcus neoformans var. gatti vs var. neoformans: comparison with fluconazole and effect of human serum.
    Mycopathologia, 1998, Volume: 142, Issue:1

    Topics: Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1998
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Africa; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole

1999
[Rare pulmonary mycoses in patients with hematologic diseases].
    Revue de pneumologie clinique, 1998, Volume: 54, Issue:5

    Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole

1998
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Itraconazole; Kinetics; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

1999
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

1999
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

1999
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:4

    Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole

1999
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Drug Resistance, Microbial; Fluconazole; Guinea Pigs; Male; Neutropenia; Pyrimidines; Random Allocation; Triazoles; Voriconazole

1999
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Medical mycology, 1998, Volume: 36, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1998
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6

    Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole

1999
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

1999
Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Spain; Triazoles; Voriconazole

1999
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; Hydrogen-Ion Concentration; Itraconazole; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Osmolar Concentration; Phenotype; Pyrimidines; Staining and Labeling; Temperature; Triazoles; Voriconazole

1999
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:6

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

1999
Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Glucose; Microbial Sensitivity Tests; Pyrimidines; Spectrophotometry; Time Factors; Triazoles; Voriconazole

1999
Effects of voriconazole on Candida glabrata in vitro.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:1

    Topics: Antifungal Agents; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Phospholipids; Pyrimidines; Sterols; Triazoles; Voriconazole

1999
Separation of the voriconazole stereoisomers by capillary electrophoresis and liquid chromatography.
    Enantiomer, 1999, Volume: 4, Issue:2

    Topics: Antifungal Agents; Chromatography, Liquid; Electrophoresis, Capillary; Pyrimidines; Stereoisomerism; Triazoles; Voriconazole

1999
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

1999
Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
Voriconazole. UK 109496.
    Drugs in R&D, 1999, Volume: 1, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Drugs, Investigational; Fungi; Guinea Pigs; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

1999
Activity of voriconazole: post-antifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes.
    Scandinavian journal of infectious diseases, 1999, Volume: 31, Issue:5

    Topics: Antifungal Agents; Blood; Candida albicans; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Leukocytes; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

1999
Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species.
    Mycoses, 1999, Volume: 42, Issue:9-10

    Topics: Antifungal Agents; Candida; Colorimetry; Coloring Agents; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Oxazines; Pyrimidines; Triazoles; Voriconazole; Xanthenes

1999
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:5

    Topics: Antifungal Agents; Biological Assay; Candida; Chromatography, High Pressure Liquid; Evaluation Studies as Topic; Humans; In Vitro Techniques; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2000
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2000
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Blastomyces; Coccidioides; Histoplasma; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2000
In vitro susceptibility of environmental Cryptococcus neoformans variety neoformans isolates from Turkey to six antifungal agents, including SCH56592 and voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2000, Volume: 19, Issue:4

    Topics: Animals; Antifungal Agents; Columbidae; Cryptococcus neoformans; Environmental Microbiology; Feces; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole

2000
Evaluation of voriconazole pharmacodynamics using time-kill methodology.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7

    Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2000
Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole.
    Scandinavian journal of infectious diseases, 2000, Volume: 32, Issue:3

    Topics: Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2000
Meningitis caused by Pseudallescheria boydii treated with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:6

    Topics: Adult; Antifungal Agents; Humans; Immunocompetence; Male; Meningitis, Fungal; Mycetoma; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2000
Effect of grapefruit juice on serum voriconazole concentrations in the mouse.
    Medical mycology, 2000, Volume: 38, Issue:3

    Topics: Administration, Oral; Animals; Antifungal Agents; Beverages; Citrus; Drug Administration Schedule; Food-Drug Interactions; Male; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole

2000
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole

2000
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole

2000
Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole.
    The British journal of ophthalmology, 2000, Volume: 84, Issue:8

    Topics: Adolescent; Antifungal Agents; Eye Infections, Fungal; Female; Fusarium; Humans; Pyrimidines; Triazoles; Voriconazole

2000
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2000
Voriconazole: a new triazole antifungal.
    The Annals of pharmacotherapy, 2000, Volume: 34, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Controlled Clinical Trials as Topic; Drug Interactions; Drug Resistance, Microbial; Humans; Pyrimidines; Retrospective Studies; Tissue Distribution; Triazoles; Voriconazole

2000
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Fluocinolone Acetonide; Glucocorticoids; Guinea Pigs; Immunocompromised Host; Immunosuppressive Agents; Male; Organ Culture Techniques; Pyrimidines; Triazoles; Voriconazole

2000
Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:10

    Topics: Agar; Antifungal Agents; Candida; Candida albicans; Candidiasis; Culture Media; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2000
Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biopsy, Needle; Child, Preschool; Diagnostic Errors; DNA, Fungal; Galactose; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung Abscess; Lung Diseases, Fungal; Male; Mannans; Pyrimidines; Triazoles; Voriconazole

2000
Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reference Standards; Time Factors; Triazoles; Trichosporon; Turkey; Voriconazole

2000
Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984.
    International journal of antimicrobial agents, 2000, Volume: 16, Issue:3

    Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2000
Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:6

    Topics: Adrenal Cortex Hormones; Aged; Antifungal Agents; Asthma; Dermatomycoses; Female; Humans; Lung Diseases, Fungal; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2000
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2000, Volume: 26, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole

2000
Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1

    Topics: Antifungal Agents; Aspergillus; Coloring Agents; Dye Dilution Technique; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:1

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2

    Topics: Animals; Antifungal Agents; Blastomycosis; Colony Count, Microbial; Lung; Male; Mice; Mice, Inbred BALB C; Pyrimidines; Survival Analysis; Time Factors; Triazoles; Voriconazole

2001
Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Synergism; HIV Infections; Humans; Microbial Sensitivity Tests; Naphthalenes; Pharyngitis; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2001
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2001
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
    Medical mycology, 2001, Volume: 39, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2001
Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:4

    Topics: Antifungal Agents; Calibration; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
[Invasive aspergillosis on a surgical intensive care unit].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2000
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Mycoses, 2000, Volume: 43 Suppl 2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole

2000
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Clinical activity of the new triazole drug voriconazole (UK 109, 496) against disseminated hepatosplenic aspergillosis in a patient with relapsed leukemia.
    Haematologia, 2001, Volume: 31, Issue:1

    Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Humans; Immunosuppression Therapy; Leukemia, Myeloid; Liver Diseases; Male; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole

2001
In vitro activities of four novel triazoles against Scedosporium spp.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:7

    Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Scedosporium; Thiazoles; Triazoles; Voriconazole

2001
Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2000, Volume: 2, Issue:3

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Drug Therapy, Combination; Humans; Male; Maxillary Sinus; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2000
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
    Electrophoresis, 2001, Volume: 22, Issue:12

    Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole

2001
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
    Journal of clinical microbiology, 2001, Volume: 39, Issue:9

    Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North America; Pyrimidines; Sentinel Surveillance; Thiazoles; Triazoles; Voriconazole

2001
Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.
    Medical mycology, 2001, Volume: 39, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2001
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    AIDS (London, England), 2001, Nov-23, Volume: 15, Issue:17

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole

2001
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.
    Clinical and experimental dermatology, 2001, Volume: 26, Issue:8

    Topics: Adult; Antifungal Agents; Aspergillosis; Cheilitis; Erythema; Female; Humans; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Middle Aged; Pyrimidines; Retinoids; Sinusitis; Triazoles; Voriconazole

2001
Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:10

    Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Pyrimidines; Sputum; Triazoles; Voriconazole

2001
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2001
Antifungal activity of the new azole UK-109 496 (voriconazole): addition and clarification.
    Mycoses, 2001, Volume: 44, Issue:9-10

    Topics: Antifungal Agents; Cyclodextrins; Pyrimidines; Triazoles; Voriconazole

2001
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
    Diagnostic microbiology and infectious disease, 2001, Volume: 41, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2001
Azole cross-resistance in Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Microbial; Drug Resistance, Multiple; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2002
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2002
Empirical antifungal therapy--new options, new tradeoffs.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    The New England journal of medicine, 2002, Jan-24, Volume: 346, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Treatment Outcome; Triazoles; Voriconazole

2002
Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2000, Volume: 6, Issue:2

    Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Microbial; Humans; Pyrimidines; Triazoles; Voriconazole

2000
The 2001 Garrod lecture. The treatment of cytomegalovirus infection.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:2

    Topics: Antifungal Agents; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunity, Cellular; Pyrimidines; Triazoles; Voriconazole

2002
Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans.
    Medical mycology, 2002, Volume: 40, Issue:1

    Topics: Antifungal Agents; Cryptococcus neoformans; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophages; Monocytes; Neutrophils; Pyrimidines; Triazoles; Voriconazole

2002
[Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
    Deutsche medizinische Wochenschrift (1946), 2002, Mar-08, Volume: 127, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Male; Middle Aged; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2002
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Canada; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Quality Control; Thiazoles; Triazoles; United States; Voriconazole

2002
A multidrug, including voriconazole, resistant oral Candida infection in an AIDS patient effectively treated with echinocandin.
    The Journal of infection, 2002, Volume: 44, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Male; Peptides; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:5

    Topics: Antifungal Agents; Candida; Freezing; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:5

    Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole

2002
Decisions about voriconazole versus liposomal amphotericin B.
    The New England journal of medicine, 2002, May-09, Volume: 346, Issue:19

    Topics: Amphotericin B; Antifungal Agents; Clinical Protocols; Data Interpretation, Statistical; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Research Design; Triazoles; Voriconazole

2002
Voriconazole and fluconazole susceptibility of Candida isolates.
    Journal of medical microbiology, 2002, Volume: 51, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:6

    Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Fever; Humans; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    The New England journal of medicine, 2002, May-30, Volume: 346, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fever; Humans; Neutropenia; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2002
Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:7

    Topics: Adult; Antifungal Agents; Humans; Hyphae; Itraconazole; Neutrophils; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2002
Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:5

    Topics: Antifungal Agents; Candida; Culture Media; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole

2002
Influence of voriconazole and fluconazole on Candida albicans in long-time continuous flow culture.
    Mycoses, 2002, Volume: 45 Suppl 1

    Topics: Aerobiosis; Antifungal Agents; Biofilms; Candida albicans; Fluconazole; Kinetics; Microbial Sensitivity Tests; Mycology; Pyrimidines; Triazoles; Voriconazole

2002
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.
    Journal of clinical microbiology, 2002, Volume: 40, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Netherlands; Pyrimidines; Time Factors; Triazoles; Voriconazole

2002
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1

    Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2002
Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Culture Media; France; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Naphthalenes; Observer Variation; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2002
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Guinea Pigs; Lipopeptides; Male; Organ Culture Techniques; Peptides; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2002
Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Sep-05, Volume: 776, Issue:2

    Topics: Animals; Antifungal Agents; Aqueous Humor; Chromatography, High Pressure Liquid; Pyrimidines; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole

2002
Voriconazole.
    The Medical letter on drugs and therapeutics, 2002, Jul-22, Volume: 44, Issue:1135

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fusarium; Humans; Injections, Intravenous; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2002
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole treatment of disseminated paecilomyces infection in a patient with acquired immunodeficiency syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Oct-01, Volume: 35, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Antifungal Agents; Colony Count, Microbial; Culture Media; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2002
Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility test
    Journal of clinical microbiology, 2002, Volume: 40, Issue:10

    Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Quality Control; Saccharomyces cerevisiae; Triazoles; Voriconazole

2002
New drugs, old drugs - dear drugs, cheap drugs.
    Swiss medical weekly, 2002, Jun-15, Volume: 132, Issue:23-24

    Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bone Marrow Transplantation; Caspofungin; Cyclosporine; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole

2002
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Area Under Curve; Candidiasis; Catheterization; Fluconazole; Half-Life; Microbial Sensitivity Tests; Microscopy, Electron; Pyrimidines; Triazoles; Voriconazole

2002
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Nov-01, Volume: 35, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
The safety of voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Nov-15, Volume: 35, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Liver Function Tests; Pyrimidines; Triazoles; Voriconazole

2002
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592).
    Mycoses, 2002, Volume: 45, Issue:9-10

    Topics: Antifungal Agents; Cerebrospinal Fluid; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 30, Issue:12

    Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxycholic Acid; Drug Combinations; Drug Resistance, Fungal; Etoposide; Fatal Outcome; Humans; Immunocompromised Host; Itraconazole; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelomonocytic, Acute; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2002
Successful treatment of Candida glabrata myocarditis with voriconazole.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:10

    Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Follow-Up Studies; Fungemia; Humans; Male; Myocarditis; Pyrimidines; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2002
Voriconazole versus amphotericin B for invasive aspergillosis.
    The New England journal of medicine, 2002, Dec-19, Volume: 347, Issue:25

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Patient Dropouts; Pyrimidines; Triazoles; Voriconazole

2002
Voriconazole versus amphotericin B for invasive aspergillosis.
    The New England journal of medicine, 2002, Dec-19, Volume: 347, Issue:25

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Liposomes; Pyrimidines; Triazoles; Voriconazole

2002
In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1

    Topics: Antifungal Agents; Drug Interactions; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole

2003
Activity of voriconazole against corneal isolates of Scedosporium apiospermum.
    Cornea, 2003, Volume: 22, Issue:1

    Topics: Antifungal Agents; Cornea; Eye Infections, Fungal; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2003
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:1

    Topics: Antifungal Agents; Blood; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole

2003
Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2002, Volume: 8, Issue:4

    Topics: Antifungal Agents; Aspergillus; Colorimetry; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2002
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:2

    Topics: Antifungal Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii.
    American journal of respiratory cell and molecular biology, 2003, Volume: 29, Issue:2

    Topics: Amino Acid Sequence; Animals; Antifungal Agents; Base Sequence; Blotting, Northern; Candida; Chromosome Mapping; Cloning, Molecular; Cytochrome P-450 Enzyme System; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fluconazole; Gene Deletion; Immunoblotting; Itraconazole; Lung; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidoreductases; Pneumocystis; Polymerase Chain Reaction; Protein Biosynthesis; Pyrimidines; Rats; Recombinant Proteins; RNA, Messenger; RNA, Ribosomal; Saccharomyces cerevisiae; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Triazoles; Voriconazole

2003
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2

    Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole

2003
Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:3

    Topics: Antifungal Agents; Blood; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:3

    Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Triazoles; Voriconazole

2003
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:2

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycetoma; Naphthalenes; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2003
Successful treatment of disseminated fusariosis.
    Bone marrow transplantation, 2003, Volume: 31, Issue:5

    Topics: Amphotericin B; Child, Preschool; Female; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2003
Effect of increasing inoculum sizes of Aspergillus hyphae on MICs and MFCs of antifungal agents by broth microdilution method.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; In Vitro Techniques; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2003
Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.
    Haematologica, 2003, Volume: 88, Issue:3

    Topics: Antifungal Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Neuroaspergillosis; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:4

    Topics: Amino Acid Sequence; Antifungal Agents; Candida; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Enzyme Inhibitors; Fluconazole; Models, Molecular; Molecular Sequence Data; Oxidoreductases; Protein Structure, Secondary; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2003
Comment: caspofungin acetate for treatment of invasive fungal infections.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:4

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Guinea Pigs; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2003
Safety of voriconazole and dose individualization.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Apr-15, Volume: 36, Issue:8

    Topics: Antifungal Agents; Humans; Immunocompromised Host; Liver Function Tests; Pyrimidines; Triazoles; Voriconazole

2003
Voriconazole inhibition of tacrolimus metabolism.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Apr-15, Volume: 36, Issue:8

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2003
Lack of cross-hepatotoxicity between fluconazole and voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Apr-15, Volume: 36, Issue:8

    Topics: Antifungal Agents; Candidiasis; Fluconazole; Humans; Liver; Liver Function Tests; Male; Pyrimidines; Transaminases; Triazoles; Voriconazole

2003
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.
    Drug metabolism and disposition: the biological fate of chemicals, 2003, Volume: 31, Issue:5

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; In Vitro Techniques; Ketoconazole; Microsomes, Liver; Oxidation-Reduction; Pyrimidines; Quinidine; Sulfaphenazole; Theophylline; Triazoles; Voriconazole

2003
Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5

    Topics: Antifungal Agents; Candida; Diffusion; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:5

    Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole

2003
Keratitis caused by Scedosporium apiospermum successfully treated with a cornea transplant and voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:5

    Topics: Antifungal Agents; Ascomycota; Corneal Transplantation; Corneal Ulcer; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2003
Two cases of cerebral aspergillosis successfully treated with voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:5

    Topics: Administration, Oral; Antifungal Agents; Brain Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:5

    Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Eye Infections, Fungal; Female; Humans; Orbital Diseases; Pyrimidines; Scleral Buckling; Scleritis; Surgical Wound Infection; Triazoles; Voriconazole

2003
Improving the mouse model for studying the efficacy of voriconazole.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:6

    Topics: Animals; Beverages; Citrus paradisi; Disease Models, Animal; Fusarium; Kidney; Mice; Mice, Inbred ICR; Mycoses; Pyrimidines; Spleen; Triazoles; Voriconazole

2003
An unusual dematiaceous fungal infection of the skin caused by Fonsecaea pedrosoi: a case report and review of the literature.
    Journal of cutaneous pathology, 2003, Volume: 30, Issue:5

    Topics: Adult; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Male; Pyrimidines; Skin; Triazoles; Voriconazole

2003
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human.
    Drug metabolism and disposition: the biological fate of chemicals, 2003, Volume: 31, Issue:6

    Topics: Adult; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Cyclic N-Oxides; Dogs; Dose-Response Relationship, Drug; Feces; Female; Glucuronic Acid; Guinea Pigs; Humans; Male; Mice; Oxides; Protein Binding; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Scintillation Counting; Sex Characteristics; Species Specificity; Triazoles; Ultraviolet Rays; Voriconazole

2003
Voriconazole inhibits fungal growth without impairing antigen presentation or T-cell activation.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antigen Presentation; Aspergillosis; Aspergillus fumigatus; Caspofungin; Dendritic Cells; Echinocandins; Lipopeptides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Peptides, Cyclic; Pyrimidines; Specific Pathogen-Free Organisms; T-Lymphocytes; Triazoles; Voriconazole

2003
Use of voriconazole in Scedosporium apiospermum keratitis.
    Cornea, 2003, Volume: 22, Issue:4

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Humans; Keratitis; Male; Mycetoma; Pyrimidines; Scedosporium; Treatment Failure; Triazoles; Voriconazole

2003
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery.
    Mycoses, 2003, Volume: 46, Issue:5-6

    Topics: Aged; Ankle Injuries; Antifungal Agents; Debridement; Drug Synergism; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole

2003
Successful treatment of coccidioidal meningitis with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jun-15, Volume: 36, Issue:12

    Topics: Antifungal Agents; Coccidioidomycosis; Humans; Magnetic Resonance Imaging; Male; Meningitis, Fungal; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2003
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole

2003
Development and validation of a high-performance liquid chromatography assay for voriconazole.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:7

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2003
Voriconazole in the treatment of invasive mold infections in transplant recipients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Organ Transplantation; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2003
Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Jul-15, Volume: 37, Issue:2

    Topics: Aged; Amphotericin B; Antifungal Agents; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Three drug reviews: one reformulated and one new antifungal agent and optimal dosing of the anticonvulsant gabapentin.
    Clinical therapeutics, 2003, Volume: 25, Issue:5

    Topics: Acetates; Amines; Amphotericin B; Anticonvulsants; Antifungal Agents; Chemistry, Pharmaceutical; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Gabapentin; gamma-Aminobutyric Acid; Humans; Pyrimidines; Triazoles; Voriconazole

2003
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:8

    Topics: Amphotericin B; Anti-Bacterial Agents; Aspergillus; Caspofungin; Echinocandins; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Penicillium; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2003
Two cases of subcutaneous Scedosporium apiospermum infection treated with voriconazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:7

    Topics: Aged; Aged, 80 and over; Antifungal Agents; DNA Fingerprinting; Humans; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2003
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-01, Volume: 37, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Animals; Antifungal Agents; Brain; Brain Chemistry; Child; Child, Preschool; Drug Administration Schedule; Female; Guinea Pigs; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2003
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
    Diagnostic microbiology and infectious disease, 2003, Volume: 46, Issue:4

    Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Fungemia; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Spain; Triazoles; Voriconazole

2003
Liver failure in a child receiving highly active antiretroviral therapy and voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Sep-15, Volume: 37, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Child; Fatal Outcome; Female; Humans; Infectious Disease Transmission, Vertical; Liver Failure; Pyrimidines; Triazoles; Voriconazole

2003
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
    Medical mycology, 2003, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Brain Abscess; Brain Diseases; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Immunologic Deficiency Syndromes; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2003
[Update on voriconazole].
    Deutsche medizinische Wochenschrift (1946), 2003, Aug-15, Volume: 128, Issue:33

    Topics: Adult; Age Factors; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Child; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2003
Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9

    Topics: Acute Disease; Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Lung Diseases, Fungal; Opportunistic Infections; Osteomyelitis; Pyrimidines; Remission Induction; Sacroiliac Joint; Splenic Diseases; Triazoles; Voriconazole

2003
[In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2003, Volume: 16, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2003
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11

    Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2003
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Spain; Triazoles; Voriconazole

2003
In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Antifungal Agents; Chaetomium; Colony Count, Microbial; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Pyrimidines; Reference Standards; Thiazoles; Triazoles; Voriconazole

2003
In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Female; Fluconazole; Kidney; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2003
Serum voriconazole levels following administration via percutaneous jejunostomy tube.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:10

    Topics: Aged; Candida glabrata; Candidiasis; Drug Administration Routes; Humans; Jejunostomy; Male; Pyrimidines; Triazoles; Voriconazole

2003
Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Mycetoma; Opportunistic Infections; Pyrimidines; Risk Assessment; Scedosporium; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2003
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
    Annals of hematology, 2004, Volume: 83, Issue:2

    Topics: Adult; Antifungal Agents; Aspergillosis; Female; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Myeloablative Agonists; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation Conditioning; Triazoles; Voriconazole

2004
Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:10

    Topics: Adult; Amphotericin B; Antifungal Agents; Burkitt Lymphoma; Dermatomycoses; Drug Therapy, Combination; Female; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Successful treatment of pulmonary invasive aspergillosis with voriconazole in patients who failed conventional therapy.
    Infection, 2003, Volume: 31, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Follow-Up Studies; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Sampling Studies; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2003
Voriconazole--superior in antimycotic treatment.
    Infection, 2003, Volume: 31, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Female; Humans; Male; Pyrimidines; Sensitivity and Specificity; Treatment Outcome; Triazoles; Voriconazole

2003
Voriconazole salvage treatment of invasive candidiasis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fungemia; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Assessment; Salvage Therapy; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2003
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:11

    Topics: Adult; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fungemia; Granulomatous Disease, Chronic; Humans; Lung Diseases, Fungal; Male; Polymerase Chain Reaction; Pyrimidines; Sensitivity and Specificity; Serologic Tests; Treatment Outcome; Triazoles; Voriconazole

2003
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
    Enfermedades infecciosas y microbiologia clinica, 2003, Volume: 21, Issue:9

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole

2003
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Colorimetry; Fluconazole; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole

2003
Flow cytometry antifungal susceptibility testing of Aspergillus fumigatus and comparison of mode of action of voriconazole vis-à-vis amphotericin B and itraconazole.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Flow Cytometry; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
The pharmacokinetics of voriconazole.
    British journal of clinical pharmacology, 2003, Volume: 56 Suppl 1

    Topics: Antifungal Agents; Humans; Intestinal Absorption; Pyrimidines; Triazoles; Voriconazole

2003
Changes in Candida albicans colonization and morphology under influence of voriconazole.
    Mycoses, 2003, Volume: 46, Issue:9-10

    Topics: Antifungal Agents; Biofilms; Candida albicans; Fluorescent Dyes; In Vitro Techniques; Microscopy, Fluorescence; Mycelium; Nucleic Acids; Pyrimidines; Triazoles; Vacuoles; Voriconazole

2003
Voriconazole serum concentrations in an infant treated for Trichosporon beigelii infection.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:11

    Topics: Antifungal Agents; Fatal Outcome; Humans; Infant; Mycoses; Neutropenia; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2003
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:12

    Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Scedosporium; Spleen; Survival Analysis; Triazoles; Voriconazole

2003
Successful treatment of Acremonium fungemia with voriconazole.
    Mycoses, 2003, Volume: 46, Issue:11-12

    Topics: Acremonium; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Female; Fungemia; Humans; Lymphoma, Mantle-Cell; Middle Aged; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2003
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2003, Nov-15, Volume: 60, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2003
Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:1

    Topics: Adolescent; Antifungal Agents; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:12

    Topics: Antifungal Agents; Candida; Candidiasis; Diffusion; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2003
Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
    Annals of hematology, 2004, Volume: 83, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Leukemia, Myelomonocytic, Acute; Lipopeptides; Male; Middle Aged; Peptides; Peptides, Cyclic; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2004
In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Fungi; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Thiazoles; Triazoles; Voriconazole

2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:12

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2003
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
    Transplantation, 2003, Dec-15, Volume: 76, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole

2003
Invasive aspergillosis: current and future challenges in diagnosis and therapy.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2004
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Biological Availability; Biological Transport; Chromatography, High Pressure Liquid; Female; Fungi; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2004
Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana.
    Scandinavian journal of infectious diseases, 2003, Volume: 35, Issue:11-12

    Topics: Aged; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatal Outcome; Fungemia; Humans; Male; Pyrimidines; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole

2003
Novel effect of voriconazole on conidiation of Aspergillus species.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole

2004
Voriconazole in fungal keratitis caused by Scedosporium apiospermum.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:3

    Topics: Adult; Antifungal Agents; Eye Injuries; Humans; Keratitis; Male; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole

2004
Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Microbial Sensitivity Tests; Mycology; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2004
Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:2

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Humans; Infusions, Intravenous; Liposomes; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2004
[symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug and therapeutics bulletin, 2004, Volume: 42, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2004
Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Transactions of the American Ophthalmological Society, 2003, Volume: 101

    Topics: Animals; Antifungal Agents; Dose-Response Relationship, Drug; Electroretinography; Injections; Necrosis; Osmolar Concentration; Pyrimidines; Rats; Rats, Sprague-Dawley; Retina; Triazoles; Vitreous Body; Voriconazole

2003
Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:3

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diffusion; Empyema, Pleural; Humans; Male; Pleura; Pyrimidines; Triazoles; Voriconazole

2004
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
    The New England journal of medicine, 2004, Feb-26, Volume: 350, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2004
Stability of Mueller-Hinton agar supplemented with glucose and methylene blue for disk diffusion testing of fluconazole and voriconazole.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:3

    Topics: Agar; Candida; Candida albicans; Culture Media; Fluconazole; Glucose; Methylene Blue; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole

2004
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:3

    Topics: Adolescent; Amphotericin B; Bone Marrow Transplantation; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Humans; Leukemia; Lipopeptides; Liposomes; Male; Peptides; Peptides, Cyclic; Pneumonia; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2004
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:3

    Topics: Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multicenter Studies as Topic; Probability; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2004
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.
    Bone marrow transplantation, 2004, Volume: 33, Issue:9

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Female; Graft vs Host Disease; Humans; Leukemia; Male; Middle Aged; Prognosis; Prospective Studies; Pyrimidines; Recurrence; Risk; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2004
Fever and eosinophilia associated with voriconazole.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:5

    Topics: Adult; Antifungal Agents; Eosinophilia; Fever; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
    The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dermatomycoses; Female; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole

2004
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
    Bone marrow transplantation, 2004, Volume: 33, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2004
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2004, Volume: 242, Issue:10

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2004
A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:5

    Topics: Antifungal Agents; Aspergillus; Culture Media; Diffusion; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole

2004
Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:4

    Topics: Agar; Antifungal Agents; Candida; Candida albicans; Culture Media; Europe; Glucose; International Cooperation; Laboratories; Methylene Blue; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole

2004
Endogenous endophthalmitis caused by Scedosporium apiospermum treated with voriconazole.
    Retina (Philadelphia, Pa.), 2004, Volume: 24, Issue:2

    Topics: Adult; Antifungal Agents; Endophthalmitis; Fundus Oculi; Humans; Male; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2004
Cutaneous infection by Fusarium: successful treatment with oral voriconazole.
    The British journal of dermatology, 2004, Volume: 150, Issue:4

    Topics: Administration, Oral; Aged; Antifungal Agents; Dermatomycoses; Female; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2004
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Spain; Terbinafine; Triazoles; Voriconazole

2004
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Drug Interactions; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2004
In vitro activity of anidulafungin against selected clinically important mold isolates.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Use of voriconazole in candida retinitis.
    Eye (London, England), 2005, Volume: 19, Issue:4

    Topics: Adult; Antifungal Agents; Candidiasis; Eye Infections, Fungal; Fatal Outcome; Female; Humans; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Blindness; Brain Diseases; Child, Preschool; Cytokines; Drug Therapy, Combination; Female; Humans; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2004
Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2004, Volume: 45, Issue:2

    Topics: Antifungal Agents; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Antifungal Agents; Cornea; Databases, Factual; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Fungi; Humans; In Vitro Techniques; Keratitis; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:5

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Female; Humans; Meningitis, Fungal; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
Pseudoallescheria boydii pneumonia and empyema: a rare complication of heart transplantation cured with voriconazole.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2004, Volume: 23, Issue:5

    Topics: Antifungal Agents; Empyema; Heart Transplantation; Humans; Immunosuppression Therapy; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Pneumonia; Postoperative Complications; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2004
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:6

    Topics: Africa; Amphotericin B; Antifungal Agents; Cambodia; Cryptococcosis; Cryptococcus neoformans; Developing Countries; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Risk Assessment; Sampling Studies; Triazoles; Voriconazole

2004
Effects of voriconazole on Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Amphotericin B; Animals; Antibodies, Monoclonal; Antifungal Agents; Cell Line; Cryptococcus neoformans; Levodopa; Melanins; Mice; Microbial Sensitivity Tests; Microscopy, Electron; Phagocytosis; Polysaccharides; Pyrimidines; Triazoles; Voriconazole

2004
Successful use of voriconazole for treatment of Coccidioides meningitis.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Adult; Antifungal Agents; Coccidioidomycosis; Humans; Male; Meningitis, Fungal; Pyrimidines; Triazoles; Voriconazole

2004
Images in cardiovascular medicine. Left ventricular mass after treatment with chemotherapic drugs.
    Circulation, 2004, Jun-01, Volume: 109, Issue:21

    Topics: Acute Disease; Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Echocardiography; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Pyrimidines; Triazoles; Ventricular Outflow Obstruction; Voriconazole

2004
Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:1

    Topics: Aged; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Fatal Outcome; Female; Half-Life; Hemofiltration; Humans; Kidney Failure, Chronic; Pneumonia, Pneumocystis; Pyrimidines; Respiratory Distress Syndrome; Triazoles; Voriconazole

2004
Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status.
    Clinical pharmacology and therapeutics, 2004, Volume: 75, Issue:6

    Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Humans; Mixed Function Oxygenases; Pyrimidines; Triazoles; Voriconazole

2004
Adverse effects of voriconazole.
    Orthopedics, 2004, Volume: 27, Issue:5

    Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole

2004
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    European journal of haematology, 2004, Volume: 73, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Child; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Liposomes; Male; Mycoses; Myelodysplastic Syndromes; Peptides; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole

2004
In vitro activities of voriconazole (UK-109, 496), fluconazole, itraconazole and amphotericin B against 132 non-albicans bloodstream yeast isolates (CANARI study).
    Mycoses, 2004, Volume: 47, Issue:5-6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Voriconazole

2004
Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
    The Pediatric infectious disease journal, 2004, Volume: 23, Issue:6

    Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus nidulans; Caspofungin; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Opportunistic Infections; Peptides; Peptides, Cyclic; Pyrimidines; Risk Assessment; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2004
Alternatives to amphotericin B for Candida rugosa infection.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Fluconazole; Kidney; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Organ Size; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole

2004
Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Japanese journal of infectious diseases, 2004, Volume: 57, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Serotyping; Taiwan; Triazoles; Voriconazole

2004
Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair.
    Cornea, 2004, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Foreign-Body Migration; Hair; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2004
Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2004, Volume: 6, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Liver Transplantation; Peptides; Peptides, Cyclic; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole

2004
Pfizer's Vfend as effective in treating candidemia as two-drug standard of care according to study.
    Infection, 2004, Volume: 32, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Pyrimidines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Voriconazole

2004
Two cases of severe phototoxic reactions related to long-term outpatient treatment with voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:8

    Topics: Adult; Ambulatory Care; Aspergillosis; Dermatitis, Phototoxic; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Leg Dermatoses; Long-Term Care; Male; Middle Aged; Outpatients; Pyrimidines; Risk Assessment; Severity of Illness Index; Triazoles; Voriconazole

2004
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:8

    Topics: Antifungal Agents; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Humans; In Vitro Techniques; Italy; Microbial Sensitivity Tests; Pyrimidines; Sampling Studies; Sensitivity and Specificity; Triazoles; Voriconazole

2004
Fatal peripheral neuropathy following FLA chemotherapy.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:4

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vidarabine; Voriconazole

2004
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-15, Volume: 39, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Cohort Studies; Female; Graft vs Host Disease; Humans; Logistic Models; Male; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2004
Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
    Mycoses, 2004, Volume: 47, Issue:7

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Cell Line, Tumor; Epithelial Cells; Esophagitis; Esophagus; Fluconazole; Humans; Microbial Sensitivity Tests; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2004
In vitro activity of voriconazole against Candida species isolated in Taiwan.
    International journal of antimicrobial agents, 2004, Volume: 24, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole

2004
Penetration of Candida biofilms by antifungal agents.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole

2004
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2004
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-01, Volume: 39, Issue:5

    Topics: Adult; Aspergillosis; Aspergillus; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Female; Fungemia; Fungi; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis

2004
Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4

    Topics: Adult; Antifungal Agents; Female; Fungi; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Rhizopus; Triazoles; Voriconazole; Zygomycosis

2004
Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Aug-15, Volume: 39, Issue:4

    Topics: Aspergillosis; Aspergillus fumigatus; Brain Abscess; Cerebrospinal Fluid; Female; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2004
Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole.
    Bone marrow transplantation, 2004, Volume: 34, Issue:9

    Topics: Adult; Anemia, Aplastic; Antifungal Agents; Female; Fusarium; Humans; Mycoses; Pyrimidines; Radiography, Thoracic; Stem Cell Transplantation; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2004
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:9

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Base Sequence; Bronchoalveolar Lavage Fluid; DNA Primers; DNA, Fungal; Humans; Leukemia; Middle Aged; Neoplasms; Polymerase Chain Reaction; Pyrimidines; Transplantation; Triazoles; Voriconazole

2004
Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:9

    Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus niger; Colorimetry; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2004
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2004
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2004
Successful treatment of brain aspergillosis with voriconazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Brain Diseases; Critical Care; Female; Humans; Immunocompromised Host; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2004
Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis.
    British journal of clinical pharmacology, 2004, Volume: 58, Issue:4

    Topics: Gentamicins; Humans; Models, Chemical; Pefloxacin; Pharmacokinetics; Pharmacology; Pyrimidines; Regression Analysis; Time Factors; Triazoles; Voriconazole

2004
Direct injection HPLC micro method for the determination of voriconazole in plasma using an internal surface reversed-phase column.
    Biomedical chromatography : BMC, 2004, Volume: 18, Issue:9

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Pyrimidines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole

2004
Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:10

    Topics: Animals; Antifungal Agents; Brain; Colony Count, Microbial; Culture Media; Guinea Pigs; Kidney; Microbial Sensitivity Tests; Mycetoma; Organ Culture Techniques; Pyrimidines; Scedosporium; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2004
[Successful treatment with voriconazol of a Pseudallescheria boydii fungus ball in a HIV positive patient and previous tuberculosis].
    Revista iberoamericana de micologia, 2003, Volume: 20, Issue:2

    Topics: Adult; Antifungal Agents; Female; HIV Infections; Humans; Lung Diseases, Fungal; Pseudallescheria; Pyrimidines; Remission Induction; Triazoles; Tuberculosis, Pulmonary; Voriconazole

2003
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    The New England journal of medicine, 2004, Sep-30, Volume: 351, Issue:14

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Liposomes; Mycoses; Neoplasms; Neutropenia; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Post-antifungal effect of amphotericin B and voriconazole against Aspergillus fumigatus analysed by an automated method based on fungal CO2 production: dependence on exposure time and drug concentration.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Carbon Dioxide; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2004
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:10

    Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Thiazoles; Triazoles; Voriconazole

2004
Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:10

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Humans; Lung Diseases, Fungal; Male; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2004
Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Antifungal Agents; Bradycardia; Female; Fusarium; Humans; Mycoses; Opportunistic Infections; Pyrimidines; Tachycardia, Ventricular; Torsades de Pointes; Triazoles; Voriconazole

2004
Combination antifungal therapy for invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2004
Combination therapy for invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-01, Volume: 39, Issue:7

    Topics: Adult; Antifungal Agents; Coccidioidomycosis; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2004
Pseudoporphyria as a result of voriconazole use: a case report.
    International journal of dermatology, 2004, Volume: 43, Issue:10

    Topics: Aged; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Humans; Lung Diseases, Fungal; Male; Mycetoma; Porphyria, Acute Intermittent; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2004
Adverse reactions to voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-15, Volume: 39, Issue:8

    Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2004
How does a patient maximally benefit from anti-infective chemotherapy?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-15, Volume: 39, Issue:8

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Humans; Pyrimidines; Triazoles; Voriconazole

2004
Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Oral microbiology and immunology, 2004, Volume: 19, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Azoles; Candida; Candidiasis, Oral; Carcinoma, Squamous Cell; Cranial Irradiation; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Pyrimidines; Stomatitis; Triazoles; Voriconazole

2004
Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11

    Topics: Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Hydrogen-Ion Concentration; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2004
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2004
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
    Mycopathologia, 2004, Volume: 158, Issue:2

    Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole

2004
Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis.
    Haematologica, 2004, Volume: 89, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Drug Resistance, Fungal; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2004
Intravitreal voriconazole: an electroretinographic and histopathologic study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:11

    Topics: Animals; Antifungal Agents; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Injections; Ophthalmic Solutions; Pyrimidines; Rats; Rats, Sprague-Dawley; Retina; Triazoles; Vitreous Body; Voriconazole

2004
Design issues in a prospective randomized double-blinded trial of prophylaxis with fluconazole versus voriconazole after allogeneic hematopoietic cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-15, Volume: 39 Suppl 4

    Topics: Antifungal Agents; Double-Blind Method; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Research Design; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2004
Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fluoresceins; Fluorescence; Fluorescent Dyes; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
[Some new drugs: valdecoxib (Betra), voriconazole (Vfend), ezetimide (Ezetrol), teriparatide (Forsteo)].
    Journal de pharmacie de Belgique, 2004, Volume: 59, Issue:3

    Topics: Antifungal Agents; Azetidines; Cyclooxygenase Inhibitors; Ezetimibe; Female; Humans; Hypolipidemic Agents; Isoxazoles; Osteoporosis, Postmenopausal; Pyrimidines; Sulfonamides; Teriparatide; Triazoles; Voriconazole

2004
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Calcineurin Inhibitors; Caspofungin; Cyclosporine; Echinocandins; Humans; Immunosuppressive Agents; Lipopeptides; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2004
In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2004
Validation of an assay for voriconazole in serum samples using liquid chromatography-tandem mass spectrometry.
    Therapeutic drug monitoring, 2004, Volume: 26, Issue:6

    Topics: Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole

2004
[Efficiency of voriconazole in fungal keratitis caused by candida albicans].
    Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:11

    Topics: Aged; Antifungal Agents; Candidiasis; Female; Humans; Keratitis; Pyrimidines; Triazoles; Voriconazole

2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:12

    Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2004
Toxic epidermal necrolysis as a complication of treatment with voriconazole.
    Southern medical journal, 2004, Volume: 97, Issue:11

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Immunoglobulins, Intravenous; Pyrimidines; Stevens-Johnson Syndrome; Triazoles; Voriconazole

2004
Effect of voriconazole on a corneal abscess caused by fusarium.
    Acta ophthalmologica Scandinavica, 2004, Volume: 82, Issue:6

    Topics: Abscess; Antifungal Agents; Corneal Diseases; Eye Infections, Fungal; Fusarium; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jan-01, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Transplantation; Treatment Outcome; Triazoles; Voriconazole

2005
Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
    Transplantation proceedings, 2004, Volume: 36, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications; Pyrimidines; Sirolimus; Triazoles; Voriconazole

2004
Voriconazole-induced musical hallucinations.
    Infection, 2004, Volume: 32, Issue:5

    Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2004
Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child.
    European journal of pediatrics, 2005, Volume: 164, Issue:4

    Topics: Absidia; Antifungal Agents; Child; Drug Resistance, Fungal; Female; Humans; Neutropenia; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2005
Candida infection of the subacromial bursa. A case report.
    The Journal of bone and joint surgery. American volume, 2005, Volume: 87, Issue:1

    Topics: Acromion; Aged; Anti-Inflammatory Agents; Antifungal Agents; Bupivacaine; Bursa, Synovial; Bursitis; Candidiasis; Decompression, Surgical; Humans; Injections, Intra-Articular; Lidocaine; Male; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Shoulder Impingement Syndrome; Triazoles; Voriconazole

2005
Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:1

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Reference Standards; Triazoles; Voriconazole

2005
Fast, fully automated analysis of voriconazole from serum by LC-LC-ESI-MS-MS with parallel column-switching technique.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Jan-25, Volume: 814, Issue:2

    Topics: Antifungal Agents; Automation; Calibration; Chromatography, Liquid; Pyrimidines; Reference Standards; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole

2005
Painful peripheral neuropathy associated with voriconazole use.
    Archives of neurology, 2005, Volume: 62, Issue:1

    Topics: Adult; Antifungal Agents; Female; Humans; Liver Transplantation; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Voriconazole

2005
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
    American journal of ophthalmology, 2005, Volume: 139, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Female; Fungemia; Humans; Infusions, Intravenous; Injections; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Pyrimidines; Retrospective Studies; Triazoles; Vitreous Body; Voriconazole

2005
Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Lung Diseases, Fungal; Middle Aged; Myocardial Ischemia; Postoperative Complications; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2005
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
    Bone marrow transplantation, 2005, Volume: 35, Issue:5

    Topics: Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Premedication; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole

2005
Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.
    HIV medicine, 2005, Volume: 6, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2005
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Cell Membrane; Cholesterol; Culture Media, Conditioned; Ergosterol; Humans; Itraconazole; Magnetic Resonance Spectroscopy; Oxygen Consumption; Pyrimidines; Spores, Fungal; Sterols; Triazoles; Voriconazole

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Infusions, Intravenous; Lipopeptides; Liposomes; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Caspofungin versus liposomal amphotericin B for empirical therapy.
    The New England journal of medicine, 2005, Jan-27, Volume: 352, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fever; Humans; Lipopeptides; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2005
[Voriconazol and liposomal amphotericin B: true evidence of their differences with regard to effectiveness and safety].
    Medicina clinica, 2005, Jan-15, Volume: 124, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Humans; Liposomes; Meta-Analysis as Topic; Pyrimidines; Triazoles; Voriconazole

2005
[Drugs used in prophylaxis and treatment of fungal infections in immunosuppressed children].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Drug Resistance, Fungal; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Neoplasms; Peptides, Cyclic; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2004
Clinical relevance of sirolimus drug interactions in transplant patients.
    Transplantation proceedings, 2004, Volume: 36, Issue:10

    Topics: Aged; Antifungal Agents; Area Under Curve; Biotransformation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole

2004
Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:1

    Topics: Administration, Oral; Adult; Antifungal Agents; Dialysis Solutions; Drug Administration Schedule; Drug Evaluation; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Pyrimidines; Triazoles; Voriconazole

2005
Successful antifungal combination therapy with voriconazole and caspofungin.
    Pediatric blood & cancer, 2005, Jun-15, Volume: 44, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Child, Preschool; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2005
[Stability of voriconazole in infusion bags].
    Die Pharmazie, 2005, Volume: 60, Issue:1

    Topics: Antifungal Agents; Drug Packaging; Drug Stability; Drug Storage; Infusions, Parenteral; Pharmaceutical Solutions; Pyrimidines; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole

2005
[In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
    Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2005
Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Feb-15, Volume: 40, Issue:4

    Topics: Absidia; Adult; Antifungal Agents; Child, Preschool; Female; Hematologic Diseases; Humans; Immunocompromised Host; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizomucor; Rhizopus; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2005
Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Mar-01, Volume: 40, Issue:5

    Topics: Aged; Antifungal Agents; Fever; Humans; Mucormycosis; Neutropenia; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost Savings; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Health Care Costs; Humans; Immunocompromised Host; Pyrimidines; Triazoles; Voriconazole

2005
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colorimetry; Fluorescence; Fusarium; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole

2005
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Interaction between voriconazole and tacrolimus in a kidney-transplanted patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:3

    Topics: Antifungal Agents; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2005
Potential fungicidal effect of voriconazole against Candida spp.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:3

    Topics: Antifungal Agents; Candida; Candida albicans; Candida tropicalis; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2005
Mycotic brain abscess caused by opportunistic reptile pathogen.
    Emerging infectious diseases, 2005, Volume: 11, Issue:2

    Topics: Adult; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Chrysosporium; HIV Seropositivity; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole

2005
Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
    Intensive care medicine, 2005, Volume: 31, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2005
In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    International journal of antimicrobial agents, 2005, Volume: 25, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-15, Volume: 40, Issue:8

    Topics: Adult; Antifungal Agents; Fusarium; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
Infection of a total knee prosthesis by Candida glabrata: a case report.
    Acta orthopaedica Belgica, 2005, Volume: 71, Issue:1

    Topics: Aged; Antifungal Agents; Arthroplasty, Replacement, Knee; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2005
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:4

    Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2005
Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
    British journal of haematology, 2005, Volume: 129, Issue:1

    Topics: Antifungal Agents; Bone Marrow Transplantation; Female; Humans; Leukemia, Myeloid; Maxillary Sinusitis; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis

2005
In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida glabrata; Candida tropicalis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Saccharomyces cerevisiae; Species Specificity; Triazoles; Voriconazole

2005
Successful treatment of disseminated aspergillosis with the combination of voriconazole, caspofungin, granulocyte transfusions, and surgery followed by allogeneic blood stem cell transplantation in a patient with primary failure of an autologous stem cell
    European journal of haematology, 2005, Volume: 74, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Granulocytes; Humans; Leukocyte Transfusion; Lipopeptides; Magnetic Resonance Imaging; Male; Melphalan; Middle Aged; Multiple Myeloma; Necrosis; Peptides, Cyclic; Pyrimidines; Radiography; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Voriconazole

2005
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:4

    Topics: Antifungal Agents; Child; Female; Fungemia; Humans; Immunocompromised Host; Mycetoma; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2005
A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Dose-Response Relationship, Drug; Hyphae; Pyrimidines; Triazoles; Voriconazole

2005
Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:5

    Topics: Antifungal Agents; Candida; Cell Survival; Humans; Kinetics; Neutrophils; Pyrimidines; Triazoles; Voriconazole

2005
Combination antifungal therapy for invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Apr-01, Volume: 40, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Successful treatment of cerebral blastomycosis with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40, Issue:9

    Topics: Antifungal Agents; Blastomycosis; Brain Diseases; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2005
[Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
    Mycoses, 2005, Volume: 48 Suppl 1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Chemoprevention; Humans; Itraconazole; Lung Transplantation; Pyrimidines; Triazoles; Voriconazole

2005
Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.
    Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:5 Suppl 1

    Topics: Adolescent; Antifungal Agents; Blister; Cheilitis; Erythema; Female; Humans; Pyrimidines; Sinusitis; Skin Aging; Triazoles; Voriconazole

2005
In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:5

    Topics: Antifungal Agents; Microbial Sensitivity Tests; Prototheca; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2005
Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against zygomycetes.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Absidia; Antifungal Agents; Caspofungin; Culture Media; Cunninghamella; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Mucor; Mucorales; Peptides, Cyclic; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2005
Madurella mycetomatis mycetoma treated successfully with oral voriconazole.
    The British journal of dermatology, 2005, Volume: 152, Issue:5

    Topics: Administration, Oral; Adult; Antifungal Agents; Foot Dermatoses; Humans; Magnetic Resonance Imaging; Male; Mycetoma; Pyrimidines; Triazoles; Voriconazole

2005
Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Paecilomyces; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2005
Economic effects of aspergillosis management in high-risk patients.
    Managed care interface, 2005, Volume: 18, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Hospitalization; Humans; Insurance, Health, Reimbursement; Pyrimidines; Triazoles; United States; Voriconazole

2005
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:5

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Fungemia; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2005
Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages.
    Diagnostic microbiology and infectious disease, 2005, Volume: 52, Issue:4

    Topics: Antifungal Agents; Candida; Candida glabrata; Colony Count, Microbial; Drug Resistance, Fungal; Fluconazole; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Macrophages; Monocytes; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2005
Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
    Bone marrow transplantation, 2005, Volume: 36, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Male; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2005
Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-15, Volume: 40, Issue:12

    Topics: Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; Fusarium; Humans; Itraconazole; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2005
In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Humans; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:3

    Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2005
[Subcutaneous phaeohyphomycosis due to Exophiala spinifera in a renal transplant recipient].
    Annales de dermatologie et de venereologie, 2005, Volume: 132, Issue:3

    Topics: Antifungal Agents; Cyclosporine; Exophiala; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leg; Middle Aged; Mycoses; Prednisone; Pyrimidines; Triazoles; Voriconazole

2005
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
    Pharmacotherapy, 2005, Volume: 25, Issue:6

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Deoxycholic Acid; Drug Combinations; Economics, Pharmaceutical; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2005
Intravenous voriconazole therapy in a preterm infant.
    Pharmacotherapy, 2005, Volume: 25, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Pyrimidines; Triazoles; Voriconazole

2005
Treatment of candida chorioretinitis with voriconazole.
    Korean journal of ophthalmology : KJO, 2005, Volume: 19, Issue:1

    Topics: Antifungal Agents; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fungemia; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2005
[Disseminated fusarium infection in two neutropenic children].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Child; Drug Combinations; Fatal Outcome; Female; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole in the treatment of invasive fungal infections.
    Intensive & critical care nursing, 2005, Volume: 21, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Critical Care; Drug Interactions; Drug Monitoring; Humans; Immunocompromised Host; Infusions, Intravenous; Mycoses; Patient Selection; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2005
Improved outcome in central nervous system aspergillosis, using voriconazole treatment.
    Blood, 2005, Oct-15, Volume: 106, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Triazoles; Voriconazole

2005
In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
    Medical mycology, 2005, Volume: 43, Issue:3

    Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Species Specificity; Thiazoles; Triazoles; Voriconazole

2005
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C.
    Clinical & experimental ophthalmology, 2005, Volume: 33, Issue:4

    Topics: Amphotericin B; Antibiotics, Antineoplastic; Antifungal Agents; Chemotherapy, Adjuvant; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Keratitis; Male; Middle Aged; Mitomycin; Mycetoma; Naphthalenes; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Terbinafine; Triazoles; Voriconazole

2005
Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia.
    Pediatric blood & cancer, 2005, Volume: 45, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Child, Preschool; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2005
Isocratic high-performance liquid chromatographic method with ultraviolet detection for simultaneous determination of levels of voriconazole and itraconazole and its hydroxy metabolite in human serum.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Ultraviolet Rays; Voriconazole

2005
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:3

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Fungal; Fungi; Geotrichum; Humans; Inpatients; Italy; Microbial Sensitivity Tests; Mycoses; Outpatients; Pyrimidines; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole

2005
Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
    Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole; Weil Disease

2005
Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Sep-01, Volume: 41, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Endocarditis; Heart Valve Prosthesis; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2005
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:8

    Topics: Antifungal Agents; Candida; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2005
Lung infection due to opportunistic fungus, Phialemonium obovatum, in a bone marrow transplant recipient: an emerging infection with fungemia and Crohn disease-like involvement of the gastrointestinal tract.
    Annals of diagnostic pathology, 2005, Volume: 9, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Bone Marrow Transplantation; Drug Resistance, Fungal; Fungemia; Gastrointestinal Diseases; Graft vs Host Disease; Granuloma; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2005
In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2005, Volume: 46, Issue:3

    Topics: Antifungal Agents; Candida albicans; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Phenotype; Pyrimidines; Triazoles; Voriconazole

2005
Endogeneous endophthalmitis caused by Sporobolomyces salmonicolor.
    Eye (London, England), 2006, Volume: 20, Issue:8

    Topics: Adult; Antifungal Agents; Basidiomycota; Endophthalmitis; Female; Humans; Pyrimidines; Triazoles; Voriconazole

2006
[In vitro susceptibility of fungal and yeast clinical isolates to itraconazole and voriconazole].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Scedosporium; Sporothrix; Triazoles; Voriconazole; Yeasts

2005
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
    Revista iberoamericana de micologia, 2005, Volume: 22, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Dermatomycoses; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2005
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Drug Synergism; Flow Cytometry; Fluconazole; Fungal Proteins; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole

2005
Zygomycete infection following voriconazole prophylaxis.
    The Lancet. Infectious diseases, 2005, Volume: 5, Issue:9

    Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Drug Resistance, Fungal; Fatal Outcome; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Male; Microbial Sensitivity Tests; Pyrimidines; Rhizopus; Triazoles; Voriconazole; Zygomycosis

2005
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:9

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Echinocandins; Guinea Pigs; Kidney; Lipopeptides; Male; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2005
[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Spain; Treatment Outcome; Triazoles; Voriconazole

2005
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin.
    American journal of ophthalmology, 2005, Volume: 140, Issue:3

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cataract Extraction; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Lens Implantation, Intraocular; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:9

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry; Triazoles; Voriconazole

2005
Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:9

    Topics: Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Flow Cytometry; Fluorescent Dyes; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Propidium; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer.
    Journal of medical microbiology, 2005, Volume: 54, Issue:Pt 10

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth Diseases; Mycoses; Neoplasms; Palliative Care; Pyrimidines; Triazoles; Voriconazole; Yeasts

2005
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
    Mycopathologia, 2005, Volume: 160, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole

2005
Breakthrough zygomycosis and voriconazole.
    The Journal of infectious diseases, 2005, Oct-15, Volume: 192, Issue:8

    Topics: Antifungal Agents; Humans; Immunocompromised Host; Immunosuppressive Agents; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2005
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:9

    Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Israel; Itraconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2005
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5

    Topics: Antifungal Agents; Aspergillus; Drug Combinations; Echinocandins; Fluorescence; Fungal Proteins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Fluorescence; Peptides, Cyclic; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole

2005
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
    British journal of haematology, 2005, Volume: 131, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2005
Successful treatment with voriconazole of fungal cerebral abscess due to Cladophialophora bantiana.
    Clinical neurology and neurosurgery, 2005, Volume: 107, Issue:6

    Topics: Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Cladosporium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2005
Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry.
    Clinical chemistry and laboratory medicine, 2005, Volume: 43, Issue:7

    Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, Liquid; Humans; Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Triazoles; Voriconazole

2005
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:10

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Humans; Laboratories; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Quality Control; Triazoles; Voriconazole

2005
Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Pyrimidines; Quality Control; Triazoles; Voriconazole

2005
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.
    Transplantation, 2005, Sep-27, Volume: 80, Issue:6

    Topics: Adolescent; Adult; Candida glabrata; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbial Sensitivity Tests; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2005
Fatal Trichosporon asahii septicemia in a Guatemalan farmer with acute lymphoblastic leukemia.
    Southern medical journal, 2005, Volume: 98, Issue:9

    Topics: Adult; Agriculture; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Catheterization, Peripheral; Emigration and Immigration; Fatal Outcome; Fever; Guatemala; Humans; Male; Mycoses; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Trichosporon; United States; Urease; Voriconazole; Yeasts

2005
Advances in antifungal therapy.
    The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole

2005
Endogenous Phialemonium curvatum endophthalmitis.
    American journal of ophthalmology, 2005, Volume: 140, Issue:4

    Topics: Aged; Antifungal Agents; Ascomycota; Cataract Extraction; Drug Contamination; Endocarditis; Endophthalmitis; Erectile Dysfunction; Eye Infections, Fungal; Fungemia; Humans; Male; Muscle, Smooth; Mycoses; Parasympatholytics; Pyrimidines; Triazoles; Ultrasonography; Vitrectomy; Vitreous Body; Voriconazole

2005
[Economic evaluation of the treatment of systemic fungal infections in immunocompromised patients: the role of itraconazole].
    Recenti progressi in medicina, 2005, Volume: 96, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Mycoses; Neutropenia; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Emergence of Candida albicans fungemia during voriconazole therapy.
    The Journal of infection, 2005, Volume: 51, Issue:3

    Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fatal Outcome; Female; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
In vitro susceptibility of oral Candida to seven antifungal agents.
    Oral microbiology and immunology, 2005, Volume: 20, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole

2005
Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.
    Current medical research and opinion, 2005, Volume: 21, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Markov Chains; Netherlands; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole therapy in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2005, Volume: 4, Issue:4

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole

2005
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits.
    Documenta ophthalmologica. Advances in ophthalmology, 2005, Volume: 110, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole

2005
Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
    Pediatric hematology and oncology, 2005, Volume: 22, Issue:8

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Brain Abscess; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Remission Induction; Triazoles; Voriconazole

2005
To treat or not to treat with antifungal agents?
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2005, Volume: 4, Issue:4

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole

2005
Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.
    Infection, 2005, Volume: 33, Issue:5-6

    Topics: Aged; Amphotericin B; Anemia, Aplastic; Ascomycota; Aspergillosis; Body Fluids; Caspofungin; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Mycoses; Peptides, Cyclic; Pyrimidines; Saccharomycetales; Shock, Septic; Triazoles; Voriconazole

2005
Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:12

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Female; Humans; Hypercalcemia; Leukemia, Promyelocytic, Acute; Pyrimidines; Treatment Outcome; Tretinoin; Triazoles; Voriconazole

2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole

2005
[Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].
    Revue des maladies respiratoires, 2005, Volume: 22, Issue:5 Pt 1

    Topics: Antifungal Agents; Aspergillosis; Bronchitis; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2005
Severe pustular eruption associated with imatinib and voriconazole in a patient with chronic myeloid leukemia.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:4

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Benzamides; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Eruptions; Drug Interactions; Enzyme Inhibitors; Exanthema; Humans; Imatinib Mesylate; Irritants; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Fungal; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Triazoles; Voriconazole

2005
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fungemia; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Neutropenia; Paecilomyces; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2005
Disseminated Pseudallescheria boydii infection successfully treated with voriconazole.
    Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:12

    Topics: Antifungal Agents; Cerebral Infarction; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mycetoma; Pseudallescheria; Pyrimidines; Subarachnoid Hemorrhage; Treatment Outcome; Triazoles; Voriconazole

2005
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:11

    Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole

2005
Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2007, Volume: 48, Issue:3

    Topics: AC133 Antigen; Amphotericin B; Antifungal Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Caspofungin; Child; Combined Modality Therapy; Contraindications; Dexamethasone; Drug Therapy, Combination; Echinocandins; Glycoproteins; Humans; Immunomagnetic Separation; Lipopeptides; Male; Mercaptopurine; Methotrexate; Peptides; Peptides, Cyclic; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Triazoles; Vincristine; Voriconazole; Zygomycosis

2007
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2005
Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Antifungal Agents; Aspergillus; Candida; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fusarium; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2005
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
    Medical mycology, 2005, Volume: 43, Issue:6

    Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole

2005
Comparison between Aspergillus fumigatus conidia and hyphae susceptibilities to amphotericin B, itraconazole, and voriconazole by use of the mold rapid susceptibility assay.
    Medical mycology, 2005, Volume: 43, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2005
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:12

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole; Yeasts

2005
Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Brain Abscess; Carboplatin; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Diagnostic Errors; Etoposide; Humans; Immunocompromised Host; Infusions, Intravenous; Lomustine; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuroaspergillosis; Pyrimidines; Surgical Wound Infection; Triazoles; Vincristine; Voriconazole

2007
Voriconazole in the treatment of fungal osteomyelitis of the orbit in the immunocompromised host.
    Orbit (Amsterdam, Netherlands), 2005, Volume: 24, Issue:4

    Topics: Adult; Antifungal Agents; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Mycetoma; Orbital Diseases; Osteomyelitis; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole

2005
Voriconazole in the management of Alternaria keratitis.
    Cornea, 2006, Volume: 25, Issue:2

    Topics: Administration, Oral; Aged; Alternaria; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole

2006
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:1

    Topics: Animals; Antifungal Agents; Drug Synergism; Fungi; Lovastatin; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Topical voriconazole as a novel treatment for fungal keratitis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:1

    Topics: Administration, Topical; Animals; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Humans; Keratitis; Paecilomyces; Pilot Projects; Pyrimidines; Rabbits; Triazoles; Voriconazole

2006
A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Disseminated histoplasmosis.
    Archives of pathology & laboratory medicine, 2006, Volume: 130, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Bone Marrow; Female; Fever of Unknown Origin; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Pyrimidines; Silver Staining; Treatment Outcome; Triazoles; Voriconazole

2006
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
    Medical mycology, 2005, Volume: 43, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Treatment Outcome; Triazoles; Voriconazole

2005
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:7

    Topics: Adult; Anticonvulsants; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Breast Neoplasms; Drug Interactions; Humans; Lung Diseases, Fungal; Male; Phenytoin; Pyrimidines; Stevens-Johnson Syndrome; Triazoles; Voriconazole

2006
Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus.
    Medical mycology, 2005, Volume: 43, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Drug Resistance, Fungal; Growth Substances; Hyphae; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Serum Albumin; Triazoles; Voriconazole

2005
Septic Candida krusei thrombophlebitis of inferior vena cava with persistent fungemia successfully treated by new antifungal agents.
    Medical mycology, 2005, Volume: 43, Issue:8

    Topics: Adult; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Female; Fungemia; Humans; Intensive Care Units; Lipopeptides; Peptides, Cyclic; Pyrimidines; Thrombophlebitis; Triazoles; Vena Cava, Inferior; Voriconazole

2005
Voriconazole.
    Indian pediatrics, 2005, Volume: 42, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Drug Interactions; Humans; Pyrimidines; Triazoles; Voriconazole

2005
The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
    The Journal of infection, 2006, Volume: 52, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:2

    Topics: Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver Function Tests; Male; Pyrimidines; Regression Analysis; Retrospective Studies; Risk Assessment; ROC Curve; Triazoles; Vision Disorders; Voriconazole

2006
[Activity of voriconazole against yeasts isolated from blood culture determined by two methods].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005, Volume: 18, Issue:4

    Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

2005
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
    Haematologica, 2006, Volume: 91, Issue:2

    Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
[Invasive multisystemic aspergillosis in an immunocompetent child: case report].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2006, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole

2006
Cyclomyces tabacinus as a cause of deep tissue infection: the first case report.
    Mycoses, 2006, Volume: 49, Issue:2

    Topics: Aged; Antifungal Agents; Arthritis, Infectious; Basidiomycota; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2006
Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4

    Topics: Antifungal Agents; Female; Fusarium; Humans; Immunocompromised Host; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Fast and reliable determination of the antifungal drug voriconazole in plasma using monolithic silica rod liquid chromatography.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006, Mar-07, Volume: 832, Issue:2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Silicon Dioxide; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole

2006
[Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 1

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Mycoses; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2006
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts

2006
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Caspofungin; Cryptococcus neoformans; Dose-Response Relationship, Drug; Echinocandins; Enzyme-Linked Immunosorbent Assay; Fluconazole; Formazans; Lipopeptides; Melanins; Microbial Sensitivity Tests; Microscopy, Confocal; Peptides, Cyclic; Plankton; Pyrimidines; Triazoles; Voriconazole

2006
Coccidioidomycosis in HIV-infected persons.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-01, Volume: 42, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coccidioidomycosis; HIV-1; Humans; Pyrimidines; Triazoles; Voriconazole

2006
Candidaemia secondary to intravascular catheter colonisation?
    Lancet (London, England), 2006, Mar-04, Volume: 367, Issue:9512

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Equipment Contamination; Humans; Pyrimidines; Triazoles; Voriconazole

2006
Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries.
    Medical mycology, 2006, Volume: 44, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Clarithromycin; Dermatomycoses; Disasters; Female; Humans; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pyrimidines; Soft Tissue Infections; Soft Tissue Injuries; Triazoles; Voriconazole; Wounds and Injuries

2006
Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
    Plastic and reconstructive surgery, 2006, Volume: 117, Issue:3

    Topics: Aged; Antifungal Agents; Cellulitis; Comorbidity; Debridement; Disease Progression; Hepatitis C, Chronic; Humans; Immunocompromised Host; Leg Ulcer; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
[Hallucinosis as side effect of voriconazole].
    Revista clinica espanola, 2005, Volume: 205, Issue:12

    Topics: Aged; Antifungal Agents; Hallucinations; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2005
Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.
    Intensive care medicine, 2006, Volume: 32, Issue:6

    Topics: Antifungal Agents; Aspergillosis; France; Humans; Immunocompromised Host; Male; Middle Aged; Outcome Assessment, Health Care; Pericardium; Pleura; Pyrimidines; Triazoles; Ultrasonography; Voriconazole

2006
Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Hematologic Diseases; Humans; Injections, Intravenous; Liver; Liver Function Tests; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
    The Pediatric infectious disease journal, 2006, Volume: 25, Issue:4

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Drug Administration Schedule; Humans; Immunocompetence; Male; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole

2006
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Disease Models, Animal; Drug Therapy, Combination; Guinea Pigs; Liposomes; Male; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Disease Progression; Drug Monitoring; Female; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2006
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.
    The Journal of infection, 2006, Volume: 53, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 5

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Heart Valve Diseases; Humans; Male; Pulmonary Embolism; Pyrimidines; Sepsis; Triazoles; Tricuspid Valve; Voriconazole

2006
Improved outcome in central nervous system aspergillosis.
    Blood, 2006, Apr-15, Volume: 107, Issue:8

    Topics: Antifungal Agents; Bone Marrow Transplantation; Disease-Free Survival; Female; Humans; Immunosuppression Therapy; Male; Neuroaspergillosis; Organ Transplantation; Pyrimidines; Triazoles; Voriconazole

2006
[Allergic broncho-pulmonary aspergillosis treated with voriconazole].
    Revue des maladies respiratoires, 2006, Volume: 23, Issue:1 Pt 1

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2006
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole.
    BMC infectious diseases, 2006, Apr-11, Volume: 6

    Topics: Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
[A case of resistant pulmonary and cerebral aspergillosis successfully treated with voriconazole].
    Tuberkuloz ve toraks, 2006, Volume: 54, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Telencephalon; Triazoles; Voriconazole

2006
Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole.
    Current genetics, 2006, Volume: 50, Issue:1

    Topics: Antifungal Agents; Aspergillus fumigatus; Gene Expression Profiling; Gene Expression Regulation, Fungal; Genes, Fungal; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Triazoles; Voriconazole

2006
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Diagnostic microbiology and infectious disease, 2006, Volume: 55, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Middle Aged; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole

2006
Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole.
    Clinical and laboratory haematology, 2006, Volume: 28, Issue:2

    Topics: Adult; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Central Nervous System Fungal Infections; Humans; Leukemia, Erythroblastic, Acute; Male; Pyrimidines; Telencephalon; Triazoles; Voriconazole

2006
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:5

    Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Creatinine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leukemia; Lipids; Male; Middle Aged; Mycoses; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Pyrimidines; Retrospective Studies; Sirolimus; Transplantation, Homologous; Triazoles; Voriconazole

2006
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Clinical Protocols; Epithelial Cells; Female; Humans; Lung; Lung Diseases, Fungal; Male; Middle Aged; Pilot Projects; Pleura; Prospective Studies; Pyrimidines; Reference Standards; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Urea; Voriconazole

2006
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2006
Black fluid from a traumatic wound.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jun-01, Volume: 42, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Fractures, Open; Humans; Male; Meropenem; Mycoses; Pyrimidines; Soft Tissue Infections; Thienamycins; Triazoles; Voriconazole; Wound Infection

2006
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:5

    Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2006
Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Discitis; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2006
Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:5

    Topics: Adult; Antifungal Agents; Bronchi; Chorioretinitis; Cystic Fibrosis; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Transplantation; Meningitis, Fungal; Mycetoma; Pyrimidines; Scedosporium; Sputum; Triazoles; Voriconazole

2006
Nodular erythema as early sign of systemic aspergillosis.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Erythema Nodosum; Humans; Immunocompromised Host; Male; Pyrimidines; Triazoles; Voriconazole

2006
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis

2006
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
    Ophthalmology, 2006, Volume: 113, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Immunosuppressive Agents; Injections; Lung Transplantation; Opportunistic Infections; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole

2006
Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, Volume: 100, Issue:9

    Topics: Antifungal Agents; Bone Diseases, Infectious; Female; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Tarsal Bones; Tibia; Treatment Outcome; Triazoles; Voriconazole

2006
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Guinea Pigs; Humans; Kidney; Liver; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2006
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Peptides, Cyclic; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2006
[Voriconazole photosensitivity: 7 cases].
    Annales de dermatologie et de venereologie, 2006, Volume: 133, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2006
Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:8

    Topics: Abscess; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy, Fine-Needle; Caspofungin; Contraindications; Cyclosporine; Delayed Graft Function; Drug Interactions; Echinocandins; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipopeptides; Male; Middle Aged; Mycophenolic Acid; Peptides, Cyclic; Postoperative Complications; Prednisone; Pyrimidines; Radionuclide Imaging; Stenotrophomonas maltophilia; Surgical Wound Infection; Thyroiditis; Triazoles; Ultrasonography; Voriconazole

2006
Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
    Annals of hematology, 2006, Volume: 85, Issue:9

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Galactose; Graft vs Host Disease; Humans; Liver Diseases; Lymphoproliferative Disorders; Mannans; Middle Aged; Pyrimidines; Rituximab; Splenic Diseases; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2006
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Infections; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Kidney; Mice; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2006
Antifungal effect of voriconazole on intracellular Candida glabrata, Candida krusei and Candida parapsilosis in human monocyte-derived macrophages.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 7

    Topics: Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Humans; Macrophages; Pyrimidines; Triazoles; Voriconazole

2006
Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.
    Journal of the National Medical Association, 2006, Volume: 98, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; Meningitis, Fungal; Pyrimidines; Triazoles; Voriconazole

2006
Candida peritonitis in a patient with necrotising cholecystitis and pancreatitis.
    Mycoses, 2006, Volume: 49, Issue:4

    Topics: Aged; Aged, 80 and over; Candida albicans; Cholecystitis; Humans; Male; Pancreatitis; Peritonitis; Pyrimidines; Triazoles; Voriconazole

2006
Amphotericin B is still the drug of choice for invasive aspergillosis.
    American journal of respiratory and critical care medicine, 2006, Jul-01, Volume: 174, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Pyrimidines; Research Design; Triazoles; Voriconazole

2006
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.
    Transplantation, 2006, Jun-27, Volume: 81, Issue:12

    Topics: Aged; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole

2006
Scedosporium apiospermum soft-tissue infection: a case report and review of kidney transplant literature.
    Transplantation proceedings, 2006, Volume: 38, Issue:5

    Topics: Antifungal Agents; Drainage; Environmental Pollution; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2006
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis

2006
Fusarium oxysporum pneumonia in an immunocompetent host.
    Southern medical journal, 2006, Volume: 99, Issue:6

    Topics: Aged; Antifungal Agents; Bronchoscopy; Female; Fusarium; Humans; Immunocompetence; Mycoses; Pneumonia; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2006
Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
    Pediatrics, 2006, Volume: 118, Issue:2

    Topics: Administration, Cutaneous; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bone Marrow Transplantation; Combined Modality Therapy; Debridement; Dermatomycoses; Disease Susceptibility; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Injections, Subcutaneous; Nystatin; Postoperative Complications; Pyrimidines; Skin; Transplantation, Homologous; Triazoles; Voriconazole

2006
Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:7

    Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Fluconazole; Griseofulvin; Humans; Microbial Sensitivity Tests; Pyrimidines; Tinea Capitis; Triazoles; Voriconazole

2006
Management of paecilomyces keratitis.
    Eye (London, England), 2007, Volume: 21, Issue:2

    Topics: Adult; Antifungal Agents; Corneal Transplantation; Eye Infections, Fungal; Female; Humans; Keratitis; Paecilomyces; Pyrimidines; Recurrence; Sclera; Treatment Outcome; Triazoles; Voriconazole

2007
Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
    Transplant international : official journal of the European Society for Organ Transplantation, 2006, Volume: 19, Issue:8

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2006
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2006
Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Aug-01, Volume: 63, Issue:15

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Excipients; Glucose; Hydrogen-Ion Concentration; Injections; Pyrimidines; Sodium Chloride; Solutions; Temperature; Time Factors; Triazoles; Voriconazole

2006
A case of pulmonary aspergillosis with lack of response to caspofungin.
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Acute Disease; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Diseases; Candidiasis; Caspofungin; Combined Modality Therapy; Contraindications; Echinocandins; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid; Lipopeptides; Lung Diseases, Fungal; Middle Aged; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Splenic Diseases; Triazoles; Voriconazole

2006
[Clinical cases in medical mycology. Case no. 21].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Endophthalmitis; Exophiala; Female; Fungemia; Humans; Itraconazole; Middle Aged; Mycoses; Opportunistic Infections; Osteolysis; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Th2 Cells; Triazoles; Voriconazole

2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    European journal of haematology, 2006, Volume: 77, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2006
Combination antifungal therapy in solid organ transplant recipients.
    Transplantation, 2006, Jul-27, Volume: 82, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Humans; Kidney Transplantation; Liver Transplantation; Organ Transplantation; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2006
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight.
    Journal of perinatology : official journal of the California Perinatal Association, 2006, Volume: 26, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Drug Resistance, Fungal; Female; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pyrimidines; Triazoles; Voriconazole

2006
Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:9

    Topics: Antifungal Agents; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2006
Application of fluorescent probes to study structural changes in Aspergillus fumigatus exposed to amphotericin B, itraconazole, and voriconazole.
    Mycopathologia, 2006, Volume: 162, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Benzenesulfonates; Fluorescent Dyes; Itraconazole; Microbial Sensitivity Tests; Microscopy, Fluorescence; Propidium; Pyrimidines; Triazoles; Voriconazole

2006
Efficacy of voriconazole in experimental Cryptococcus neoformans infection.
    Mycopathologia, 2006, Volume: 162, Issue:2

    Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Female; Lung Diseases, Fungal; Mice; Mice, Inbred C57BL; Polysaccharides; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis; Aspergillus fumigatus; Brain; Brain Abscess; Caspofungin; Chromatography, Liquid; Echinocandins; Female; Humans; Lipopeptides; Magnetic Resonance Imaging; Mass Spectrometry; Neuroaspergillosis; Paranasal Sinus Diseases; Peptides, Cyclic; Pyrimidines; Staphylococcus aureus; Triazoles; Voriconazole

2006
Aspergillus infection limited to renal allograft: case report and review of literature.
    Transplant infectious disease : an official journal of the Transplantation Society, 2006, Volume: 8, Issue:3

    Topics: Adult; Aspergillosis; Aspergillus; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole

2006
Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Acute Kidney Injury; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bacteremia; Caspofungin; Chlamydophila Infections; Chlamydophila pneumoniae; Doxorubicin; Drug Resistance, Multiple, Fungal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Liposomes; Lung Diseases, Fungal; Medical Futility; Methotrexate; Middle Aged; Neuroaspergillosis; Peptides, Cyclic; Pneumonia, Bacterial; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Streptococcal Infections; Triazoles; Vincristine; Voriconazole

2006
AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Adult; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Combined Modality Therapy; Cytarabine; Cytomegalovirus Infections; Enterococcus faecalis; Fatal Outcome; Humans; Idarubicin; Immunocompromised Host; Immunoglobulins, Intravenous; Liposomes; Male; Mycoses; Peripheral Blood Stem Cell Transplantation; Pneumonia; Postoperative Complications; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pseudomonas putida; Pulmonary Edema; Pyrimidines; Sinusitis; Staphylococcus epidermidis; Transplantation, Autologous; Triazoles; Voriconazole

2006
A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
    Acta bio-medica : Atenei Parmensis, 2006, Volume: 77 Suppl 2

    Topics: Abscess; Amphotericin B; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Cytarabine; Foot Dermatoses; Fusarium; Humans; Imatinib Mesylate; Immunocompromised Host; Liposomes; Male; Middle Aged; Muscular Diseases; Onychomycosis; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Recurrence; Remission Induction; Reoperation; Rituximab; Teniposide; Triazoles; Voriconazole

2006
Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Genotype; Humans; Mixed Function Oxygenases; Pyrimidines; Triazoles; Voriconazole

2006
Aspergillus meningitis following spinal anaesthesia for caesarean section in Colombo, Sri Lanka.
    International journal of obstetric anesthesia, 2007, Volume: 16, Issue:3

    Topics: Abducens Nerve Diseases; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Brain; Cesarean Section; Diabetes, Gestational; Fatal Outcome; Female; Fluconazole; Glasgow Coma Scale; Humans; Meningitis, Fungal; Pregnancy; Pyrimidines; Respiration, Artificial; Sri Lanka; Tomography, X-Ray Computed; Triazoles; Voriconazole

2007
Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    The Veterinary record, 2006, Aug-26, Volume: 159, Issue:9

    Topics: Air Sacs; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Treatment Outcome; Triazoles; Voriconazole

2006
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infections; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Polysorbates; Pyrimidines; Triazoles; Urea; Voriconazole

2006
Use of the BIOMIC Video System to evaluate the susceptibility of clinical yeast isolates to fluconazole and voriconazole by a disk diffusion method.
    Acta microbiologica et immunologica Hungarica, 2006, Volume: 53, Issue:2

    Topics: Candida; Candidiasis; Fluconazole; Humans; Image Processing, Computer-Assisted; Microbial Sensitivity Tests; Microscopy, Video; Pyrimidines; Triazoles; Voriconazole

2006
Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.
    Annals of clinical microbiology and antimicrobials, 2006, Sep-08, Volume: 5

    Topics: Child, Preschool; Humans; Knee Injuries; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole

2006
[Candida albicans induced spondylodiscitis of the cervical spine of a polytraumatized patient].
    Der Unfallchirurg, 2006, Volume: 109, Issue:11

    Topics: Adult; Antifungal Agents; Candidiasis; Cervical Vertebrae; Combined Modality Therapy; Discitis; Epidural Abscess; Fluconazole; Follow-Up Studies; Head Movements; Humans; Lung Diseases, Fungal; Male; Multiple Trauma; Pyrimidines; Radiography; Triazoles; Voriconazole

2006
Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
    BMC clinical pharmacology, 2006, Sep-18, Volume: 6

    Topics: Aged; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Solvents; Triazoles; Voriconazole

2006
Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Indicator Dilution Techniques; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2006
[Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8

    Topics: Antifungal Agents; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole

2006
Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 10

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Humans; Hydroxycorticosteroids; Itraconazole; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Pyrimidines; Sarcoidosis; Treatment Outcome; Triazoles; Voriconazole

2006
Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
    Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Male; Middle Aged; Panophthalmitis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:10

    Topics: Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Global Health; Humans; Lipopeptides; Peptides, Cyclic; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2006
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Journal of clinical microbiology, 2006, Volume: 44, Issue:10

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2006
[Keratomycosis due to Cylindrocarpon lichenicola].
    Mycoses, 2006, Volume: 49 Suppl 2

    Topics: Aged; Amphotericin B; Antifungal Agents; Clematis; Eye Infections, Fungal; Fusarium; Humans; Hypocreales; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2006
Successful treatment of an Aspergillus fumigatus Infection with voriconazole via a nasogastric tube.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:4

    Topics: Administration, Intranasal; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Intubation, Gastrointestinal; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole

2006
Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
    Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Humans; Injections; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Vitreous Body; Voriconazole

2006
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura.
    Annals of hematology, 2007, Volume: 86, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antifungal Agents; Aspergillosis; Aspergillus niger; Humans; Immunologic Factors; Male; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rituximab; Treatment Outcome; Triazoles; Voriconazole

2007
Multi-azole resistance in Aspergillus fumigatus.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2006
Treatment of protothecosis with voriconazole.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Suppl

    Topics: Aged; Antifungal Agents; Humans; Infections; Male; Prototheca; Pyrimidines; Triazoles; Voriconazole

2006
Voriconazole prophylaxis in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Female; Humans; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Probability; Pyrimidines; Retrospective Studies; Survival Analysis; Time Factors; Triazoles; Voriconazole

2006
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen.
    Medical mycology, 2006, Volume: 44, Issue:7

    Topics: Adult; Antifungal Agents; Blastomycosis; Brain Diseases; Central Nervous System Fungal Infections; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2006
Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Drug Antagonism; Drug Combinations; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Brain; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Echinocandins; Fluorescence Resonance Energy Transfer; Immunocompromised Host; Immunosuppression Therapy; Itraconazole; Kidney; Lipopeptides; Liver; Lung; Male; Mice; Neutropenia; Nitriles; Peptides, Cyclic; Polymerase Chain Reaction; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2006
Successful early voriconazole treatment of Aspergillus infection in two non immunocompromised patients in Intensive Care Unit.
    Minerva anestesiologica, 2007, Volume: 73, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Critical Care; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2007
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:1

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Laboratories; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Reference Standards; Triazoles; Voriconazole

2007
Invasive aspergillosis: is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?
    Swiss medical weekly, 2006, Sep-30, Volume: 136, Issue:39-40

    Topics: Acute Kidney Injury; Amphotericin B; Antifungal Agents; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Models, Economic; Pyrimidines; Triazoles; Voriconazole

2006
[Successful treatment by voliconazole for pulmonary and adductor magnus muscle aspergillosis induced by immunosuppressive therapy for hypersensitivity pneumonia].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:10

    Topics: Aged; Alveolitis, Extrinsic Allergic; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclosporine; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Myositis; Opportunistic Infections; Prednisolone; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
Treatment of cutaneous infection by Alternaria alternata with voriconazole in a liver transplant patient.
    Transplantation proceedings, 2006, Volume: 38, Issue:8

    Topics: Alternaria; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Liver Transplantation; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Skin; Triazoles; Voriconazole

2006
Successful topical therapy with voriconazole: pseudallescheriasis after injury.
    The Journal of trauma, 2007, Volume: 62, Issue:5

    Topics: Administration, Topical; Adolescent; Antifungal Agents; Fibula; Fracture Fixation; Humans; Male; Mycetoma; Pseudallescheria; Pyrimidines; Surgical Wound Infection; Tibial Fractures; Triazoles; Voriconazole

2007
Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2007
Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.
    Medical mycology, 2006, Volume: 44, Issue:8

    Topics: Antifungal Agents; Biopsy, Fine-Needle; Blood Sedimentation; Child; DNA, Fungal; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Male; Microscopy; Molecular Sequence Data; Mycoses; Osteomyelitis; Penicillium; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Triazoles; Voriconazole

2006
[Susceptibility of fungi isolated from clinical materials to voriconazole].
    Medycyna doswiadczalna i mikrobiologia, 2006, Volume: 58, Issue:2

    Topics: Antifungal Agents; Aspergillus; Candida albicans; Fungi; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Trichophyton; Voriconazole; Yeasts

2006
Effect of antifungal treatment in a murine model of blastoschizomycosis.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2007
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
    Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:3

    Topics: Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2007
Change of the blood concentration of tacrolimus after the switch from fluconazole to voriconazole in patients receiving allogeneic hematopoietic stem cell transplantation.
    Biological & pharmaceutical bulletin, 2006, Volume: 29, Issue:12

    Topics: Fluconazole; Humans; Immunosuppressive Agents; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Tacrolimus; Triazoles; Voriconazole

2006
Invasive sphenoidal aspergillosis: successful treatment with sphenoidotomy and voriconazole.
    ORL; journal for oto-rhino-laryngology and its related specialties, 2007, Volume: 69, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Endoscopy; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Otorhinolaryngologic Surgical Procedures; Pyrimidines; Severity of Illness Index; Sphenoid Sinus; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2007
Successful treatment of black-grain mycetoma with voriconazole.
    The American journal of tropical medicine and hygiene, 2006, Volume: 75, Issue:6

    Topics: Antifungal Agents; Humans; Madurella; Male; Middle Aged; Mycetoma; Pyrimidines; Recurrence; Triazoles; Voriconazole

2006
[Therapy with voriconazol for a case of chronic mucocutaneous candidiasis].
    Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:10

    Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Multiple, Fungal; Female; Humans; Onychomycosis; Pyrimidines; Triazoles; Voriconazole

2006
Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Cells, Cultured; Chemokine CCL2; Chemokine CCL3; Chemokine CCL4; DNA, Complementary; Gene Expression Regulation; Humans; Hyphae; Immunity, Innate; Interleukin-10; Interleukin-12; Interleukin-1beta; Macrophage Inflammatory Proteins; Monocytes; Oligonucleotide Array Sequence Analysis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole

2007
Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
    Swiss medical weekly, 2006, Nov-11, Volume: 136, Issue:45-46

    Topics: Adult; Antifungal Agents; Asthenia; Cognition Disorders; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hallucinations; Humans; Irritable Mood; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Triazoles; Vision Disorders; Voriconazole

2006
Pseudoporphyria.
    International journal of dermatology, 2006, Volume: 45, Issue:12

    Topics: Antifungal Agents; Diagnosis, Differential; Humans; Porphyrias; Pyrimidines; Triazoles; Voriconazole

2006
Topical and oral voriconazole in the treatment of fungal keratitis.
    American journal of ophthalmology, 2007, Volume: 143, Issue:1

    Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Female; Fungi; Humans; Keratitis; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology

2007
Echinocandins for candidemia.
    The New England journal of medicine, 2006, Dec-28, Volume: 355, Issue:26

    Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole

2006
Unexplained increase in Paecilomyces variotii blood culture isolates in the UK.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2006, Nov-16, Volume: 11, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Blood; Caspofungin; Diagnosis, Differential; Echinocandins; Equipment Contamination; False Positive Reactions; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Mycoses; Paecilomyces; Peptides, Cyclic; Pyrimidines; Species Specificity; Triazoles; United Kingdom; Voriconazole

2006
Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, cas
    Journal of clinical microbiology, 2007, Volume: 45, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; Triazoles; Voriconazole

2007
Antifungal activities of azole agents against the Malassezia species.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:3

    Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole

2007
In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27-A2, Sensititre YeastOne, disk diffusion, and Etest methods.
    Microbial drug resistance (Larchmont, N.Y.), 2006,Winter, Volume: 12, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Colorimetry; Indicator Dilution Techniques; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Reference Standards; Triazoles; Voriconazole; Yeasts

2006
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole

2006
Voriconazole and fungal keratitis: a report of two treatment failures.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:6

    Topics: Administration, Topical; Aged, 80 and over; Antifungal Agents; Colletotrichum; Fusarium; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2006
Voriconazole-induced pseudoporphyria.
    Photodermatology, photoimmunology & photomedicine, 2007, Volume: 23, Issue:1

    Topics: Antifungal Agents; Candidiasis; Drug Eruptions; Female; Humans; Middle Aged; Porphyria, Acute Intermittent; Pyrimidines; Triazoles; Voriconazole

2007
[Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
    Archivos de bronconeumologia, 2007, Volume: 43, Issue:1

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2007
Caspofungin for the treatment of azole resistant candidemia in a premature infant.
    Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:2

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Hypercalcemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Male; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:6

    Topics: Aged; Antifungal Agents; Device Removal; Endocarditis; Humans; Lung; Male; Mycetoma; Pacemaker, Artificial; Postoperative Complications; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2006
Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Mar-01, Volume: 44, Issue:5

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Female; Granulomatous Disease, Chronic; Humans; Photosensitivity Disorders; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2007
Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain.
    Clinical drug investigation, 2007, Volume: 27, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Body Weight; Caspofungin; Cost-Benefit Analysis; Echinocandins; Health Care Costs; Humans; Injections, Intravenous; Lipopeptides; Multivariate Analysis; Peptides, Cyclic; Pyrimidines; Severity of Illness Index; Spain; Treatment Outcome; Triazoles; Voriconazole

2007
Voriconazole and multidrug resistance in Candida albicans.
    Mycoses, 2007, Volume: 50, Issue:2

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Candida albicans; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Genes, MDR; Membrane Transport Proteins; Microbial Sensitivity Tests; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole

2007
Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Jun-01, Volume: 852, Issue:1-2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole

2007
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
    Bone marrow transplantation, 2007, Volume: 39, Issue:7

    Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2007
Torsades de pointes associated with voriconazole use.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1

    Topics: Administration, Oral; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cardiomyopathies; Dermatomycoses; Drug Synergism; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Voriconazole

2007
A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1

    Topics: Acanthamoeba; Acute Disease; Amebiasis; Amphotericin B; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Female; Humans; Injections, Intravenous; Lipids; Lung Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Skin Diseases, Parasitic; Treatment Outcome; Triazoles; Voriconazole

2007
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole

2007
Invasive cutaneous infection with Geotrichum candidum: sequential treatment with amphotericin B and voriconazole.
    Medical mycology, 2007, Volume: 45, Issue:1

    Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Diabetes Mellitus; Geotrichosis; Geotrichum; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2007
Voriconazole concentrations in synovial fluid and bone tissues.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:4

    Topics: Aged, 80 and over; Antifungal Agents; Arthritis, Infectious; Aspergillosis; Aspergillus fumigatus; Bone and Bones; Chromatography, High Pressure Liquid; Female; Humans; Microbial Sensitivity Tests; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole

2007
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    Archives of dermatological research, 2007, Volume: 299, Issue:2

    Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole

2007
Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital.
    Mycopathologia, 2007, Volume: 163, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Hospitals; Humans; Intensive Care Units; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients.
    Cancer, 2007, Apr-15, Volume: 109, Issue:8

    Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.
    Clinical drug investigation, 2007, Volume: 27, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Decision Support Techniques; Economics, Pharmaceutical; Fever; Health Care Costs; Humans; Liposomes; Neutropenia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2007
The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
    Current eye research, 2007, Volume: 32, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Cornea; Disease Models, Animal; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Itraconazole; Lipopeptides; Peptides, Cyclic; Pyrimidines; Rabbits; Triazoles; Voriconazole

2007
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine.
    Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:1

    Topics: Adult; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Drug Resistance, Fungal; Granulomatous Disease, Chronic; Humans; Male; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole

2007
Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
    Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cambodia; Candida; Candidiasis, Oral; Child; Drug Resistance, Multiple, Fungal; Humans; Oropharynx; Pharyngeal Diseases; Pyrimidines; Saccharomyces; Triazoles; Voriconazole

2007
Successful treatment of aspergillus granuloma involving the cavernous sinus and the middle fossa by using surgery and voriconazole. Case illustration.
    Journal of neurosurgery, 2007, Volume: 106, Issue:3

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Cavernous Sinus; Combined Modality Therapy; Cranial Fossa, Middle; Granuloma; Humans; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole

2007
A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2007, Volume: 13, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Colony Count, Microbial; Half-Life; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2007
Invasive Aspergillus fumigatus associated with liver and bone involvement in a patient with AIDS.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2007, Volume: 11, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bone Diseases; Humans; Liver Diseases; Male; Pyrimidines; Triazoles; Voriconazole

2007
Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
    Revista iberoamericana de micologia, 2006, Volume: 23, Issue:4

    Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole

2006
[Acanthamoeba keratitis: about the first two Tunisian cases].
    Bulletin de la Societe de pathologie exotique (1990), 2007, Volume: 100, Issue:1

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Amebicides; Animals; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Ketoconazole; Pyrimidines; Triazoles; Tunisia; Voriconazole

2007
Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report.
    Dento maxillo facial radiology, 2007, Volume: 36, Issue:2

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Endoscopy; Humans; Immunocompetence; Male; Paranasal Sinus Diseases; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2007
Multiple-triazole-resistant aspergillosis.
    The New England journal of medicine, 2007, Apr-05, Volume: 356, Issue:14

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Multiple, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole

2007
Efficacy and safety of voriconazole as an additive in Optisol GS: a preservation medium for corneal donor tissue.
    Cornea, 2007, Volume: 26, Issue:3

    Topics: Antifungal Agents; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Endothelium, Corneal; Fungi; Gentamicins; Humans; Middle Aged; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole

2007
Nasofacial phycomycosis: persistence pays.
    The Journal of craniofacial surgery, 2007, Volume: 18, Issue:2

    Topics: Adult; Antifungal Agents; Conidiobolus; Drug Resistance, Fungal; Facial Dermatoses; Female; Humans; Itraconazole; Pyrimidines; Timor-Leste; Triazoles; Voriconazole; Zygomycosis

2007
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Disseminated fusariosis presenting with pulmonary nodules following a line infection.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2006, Volume: 10, Issue:6

    Topics: Antifungal Agents; Catheterization, Central Venous; Fusarium; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Solitary Pulmonary Nodule; Triazoles; Voriconazole

2006
Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:1

    Topics: Aged; Antifungal Agents; Arthritis, Infectious; Debridement; Drug Therapy, Combination; Humans; Kidney Transplantation; Male; Mycetoma; Naphthalenes; Osteomyelitis; Pyrimidines; Scedosporium; Terbinafine; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Culture Media; Disk Diffusion Antimicrobial Tests; Echinocandins; Fungi; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2007
Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia.
    Annals of hematology, 2007, Volume: 86, Issue:9

    Topics: Acute Disease; Adult; Aspergillosis; Aspergillus; Humans; Leukemia, Myeloid; Male; Meningitis, Fungal; Pyrimidines; Sarcoma, Myeloid; Thyroid Neoplasms; Treatment Outcome; Triazoles; Voriconazole

2007
Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.
    Biochemical pharmacology, 2007, Jun-15, Volume: 73, Issue:12

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Escherichia coli; Humans; Hydroxylation; Isoenzymes; Kinetics; Magnetic Resonance Spectroscopy; Microsomes, Liver; Mixed Function Oxygenases; Models, Chemical; Molecular Structure; Oxidation-Reduction; Pyrimidines; Recombinant Proteins; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry; Triazoles; Voriconazole

2007
Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:2

    Topics: Antifungal Agents; Candida; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; In Vitro Techniques; Linear Models; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Saccharomyces; Triazoles; Voriconazole

2007
Relationship of blood level and susceptibility in voriconazole treatment of histoplasmosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Antifungal Agents; Cohort Studies; Histoplasma; Histoplasmosis; Humans; Microbial Sensitivity Tests; Pyrimidines; Secondary Prevention; Triazoles; Voriconazole

2007
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole

2007
Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.
    Bone marrow transplantation, 2007, Volume: 39, Issue:12

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Transplantation, Homologous; Triazoles; Voriconazole

2007
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:6

    Topics: Antifungal Agents; Candida; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Global Health; Humans; Population Surveillance; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Combined therapies in a murine model of blastoschizomycosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole

2007
Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Drug Interactions; Female; France; Humans; Liver Function Tests; Male; Middle Aged; Pyrimidines; Skin Diseases; Triazoles; Vision Disorders; Voriconazole

2007
Clearance of intravitreal voriconazole.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:5

    Topics: Animals; Antifungal Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Half-Life; Injections; Metabolic Clearance Rate; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole

2007
Successful management of Aspergillus liver abscess in a patient with necrotizing fasciitis.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:6

    Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Fasciitis, Necrotizing; Female; Humans; Lipopeptides; Liver Abscess; Peptides, Cyclic; Pregnancy; Pyrimidines; Triazoles; Voriconazole

2007
Management of tunnel fungal infection with voriconazole.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:5

    Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Female; Fusarium; Humans; Microsurgery; Mycoses; Pyrimidines; Surgical Wound Infection; Triazoles; Visual Acuity; Voriconazole

2007
Acquired resistance to echinocandins in Candida albicans: case report and review.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6

    Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2007
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
    Hawaii medical journal, 2007, Volume: 66, Issue:3

    Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole

2007
Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1

    Topics: Animals; Antifungal Agents; Brain; Central Nervous System Fungal Infections; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Humans; Lung; Male; Mice; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Inherited long QT syndrome revealed by antifungals drug-drug interaction.
    Journal of clinical pharmacy and therapeutics, 2007, Volume: 32, Issue:3

    Topics: Acute Disease; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Injections, Intravenous; Leukemia, Myeloid; Long QT Syndrome; Mixed Function Oxygenases; Mucormycosis; Pyrimidines; Torsades de Pointes; Triazoles; Voriconazole

2007
Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
    BMC infectious diseases, 2007, May-10, Volume: 7

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Fusarium; Humans; Lipopeptides; Mycoses; Peptides, Cyclic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994-1996 and 1997-2005.
    Chemotherapy, 2007, Volume: 53, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Cryptococcus neoformans; Drug Resistance, Viral; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Triazoles; Voriconazole

2007
[Correlations among itraconazole, voriconazole and posaconazole MICs in Aspergillus fumigatus].
    Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:5

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2007
Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chromatography, High Pressure Liquid; Culture Media; Dose-Response Relationship, Drug; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2007
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
    Journal of pharmaceutical sciences, 2007, Volume: 96, Issue:12

    Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole

2007
[Perspectives on allergic bronchopulmonary aspergillosis].
    Revue des maladies respiratoires, 2007, Volume: 24, Issue:5

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
    Cornea, 2007, Volume: 26, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Peptides, Cyclic; Pyrimidines; Scleritis; Substance Abuse, Intravenous; Triazoles; Voriconazole

2007
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Humans; Mucositis; Mycoses; Opportunistic Infections; Oxidoreductases; Point Mutation; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2007
Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:6

    Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Caspofungin; Cohort Studies; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Linezolid; Lipopeptides; Male; Middle Aged; Oxazolidinones; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Renal Insufficiency; Renal Replacement Therapy; Retrospective Studies; Triazoles; Voriconazole

2007
Validation of rapid and simple LC-MS/MS method for determination of voriconazole in rat plasma.
    Journal of pharmaceutical and biomedical analysis, 2007, Aug-15, Volume: 44, Issue:4

    Topics: Animals; Antifungal Agents; Chromatography, Liquid; Injections, Intravenous; Male; Mass Spectrometry; Pyrimidines; Quality Control; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Solvents; Triazoles; Voriconazole

2007
Does one voriconazole breakpoint suit all Candida species?
    Journal of clinical microbiology, 2007, Volume: 45, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2007
Acremonium vertebral osteomyelitis: molecular diagnosis and response to voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-01, Volume: 45, Issue:1

    Topics: Acremonium; Aged; Antifungal Agents; Drug Resistance, Fungal; Humans; Male; Osteomyelitis; Pyrimidines; Triazoles; Voriconazole

2007
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Triazoles; Voriconazole

2007
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Decision Trees; Drug Combinations; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Models, Economic; Models, Statistical; Netherlands; Pyrimidines; Reproducibility of Results; Survival Analysis; Triazoles; Voriconazole

2007
New guinea pig model of Cryptococcal meningitis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Fluconazole; Guinea Pigs; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2007
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Corneal Ulcer; Echinocandins; Eye Infections, Fungal; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Natamycin; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2007
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:1

    Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole

2008
[Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Infant; Leukemia; Male; Metabolic Clearance Rate; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2007
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole

2007
In vivo efficacy and pharmacokinetics of voriconazole in an animal model of dermatophytosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Colony Count, Microbial; Dermatomycoses; Extracellular Fluid; Female; Guinea Pigs; Microbial Sensitivity Tests; Microdialysis; Microsporum; Pyrimidines; Skin; Triazoles; Voriconazole

2007
Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Colony Count, Microbial; Colorimetry; Culture Media; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Regression Analysis; Reproducibility of Results; Species Specificity; Spores, Fungal; Tetrazolium Salts; Triazoles; Vitamin K 3; Voriconazole

2007
In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Antifungal Agents; Fluconazole; France; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2007
[A case of orbital apex syndrome caused by localized invasive aspergillosis successfully treated with voriconazole].
    Rinsho shinkeigaku = Clinical neurology, 2007, Volume: 47, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Pyrimidines; Triazoles; Voriconazole

2007
Pulmonary mucormycosis in a nondiabetic renal allograft recipient successfully managed by medical therapy alone.
    Transplantation, 2007, Jun-27, Volume: 83, Issue:12

    Topics: Antifungal Agents; Humans; Kidney Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Mucorales; Mucormycosis; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Bone marrow transplantation, 2007, Volume: 40, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Data Collection; Drug Evaluation; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Premedication; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis

2007
Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Pharmacotherapy, 2007, Volume: 27, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Female; Fever; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
In vitro activity of fluconazole, voriconazole and caspofungin against clinical yeast isolates.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3

    Topics: Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

2007
Antifungal susceptibility of Candida species using the Clinical and Laboratory Standards Institute disk diffusion and broth microdilution methods.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3

    Topics: Antifungal Agents; Candida; Disk Diffusion Antimicrobial Tests; Fluconazole; Humans; Microbial Sensitivity Tests; Microbiological Techniques; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2007
Basidiomycetous fungal Inonotus tropicalis sacral osteomyelitis in X-linked chronic granulomatous disease.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:7

    Topics: Adult; Antifungal Agents; Basidiomycota; Caspofungin; Echinocandins; Granulomatous Disease, Chronic; HMGB1 Protein; Humans; Lipopeptides; Male; Mycoses; Osteomyelitis; Peptides, Cyclic; Pyrimidines; Sacrum; Triazoles; Voriconazole

2007
Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2008
Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:3

    Topics: Antifungal Agents; Drug Synergism; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Male; Middle Aged; Mycetoma; Naphthalenes; Pyrimidines; Scedosporium; Stem Cell Transplantation; Terbinafine; Triazoles; Voriconazole

2007
Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    BMC infectious diseases, 2007, Jul-02, Volume: 7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Induction of voriconazole metabolism by rifampin in a patient with acute myeloid leukemia: importance of interdisciplinary communication to prevent treatment errors with complex medications.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Antibiotics, Antitubercular; Antifungal Agents; Area Under Curve; Communication; Drug Interactions; Humans; Leukemia, Myeloid; Medication Errors; Pyrimidines; Rifampin; Staphylococcal Infections; Triazoles; Voriconazole

2007
Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9

    Topics: Antifungal Agents; Fatty Liver; Humans; Liver Cirrhosis; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2007
The fusarium keratitis outbreak: not done yet?
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Child; Combined Modality Therapy; Corneal Ulcer; Disease Outbreaks; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoplasty, Penetrating; Microbial Sensitivity Tests; Mycoses; Natamycin; Pyrimidines; Triazoles; Voriconazole

2007
Scedosporium apiospermum lung infection with fatal subsequent postoperative outcome in an immunocompetent host.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Aug-15, Volume: 45, Issue:4

    Topics: Aged; Antifungal Agents; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Humans; Immunocompetence; Lung Diseases, Fungal; Male; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007
The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.
    The British journal of ophthalmology, 2007, Volume: 91, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Third-time lung transplant using extended criteria lungs.
    The Annals of thoracic surgery, 2007, Volume: 84, Issue:2

    Topics: Adult; Antifungal Agents; Brain Death; Humans; Lung Transplantation; Male; Mycoses; Patient Selection; Postoperative Complications; Pyrimidines; Reoperation; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole

2007
[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:6

    Topics: Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cytochrome P-450 Enzyme System; Humans; Lung Diseases, Fungal; Male; Pituitary ACTH Hypersecretion; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2007
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
    Medical mycology, 2007, Volume: 45, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2007
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
    Future microbiology, 2006, Volume: 1, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Candidiasis; Drug Evaluation; Drug Resistance, Fungal; Fluconazole; Humans; Injections, Intravenous; Molecular Structure; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2006
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole

2007
Images in HIV/AIDS. Invasive aspergillosis presenting as a neck mass in a person with HIV/AIDS.
    The AIDS reader, 2007, Volume: 17, Issue:7

    Topics: Adult; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Fatal Outcome; HIV Infections; Humans; Male; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2007
Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy.
    BMC infectious diseases, 2007, Jul-31, Volume: 7

    Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus flavus; Caspofungin; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole

2007
Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
    The American journal of tropical medicine and hygiene, 2007, Volume: 77, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Male; Mycoses; Penicillium; Pyrimidines; Triazoles; Voriconazole

2007
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2007
Lack of cross-hepatotoxicity between voriconazole and posaconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Sep-15, Volume: 45, Issue:6

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chemical and Drug Induced Liver Injury; Humans; Pyrimidines; Triazoles; Voriconazole

2007
Plasma concentrations of voriconazole in falcons.
    The Veterinary record, 2007, Aug-25, Volume: 161, Issue:8

    Topics: Animals; Antifungal Agents; Aspergillosis; Biological Availability; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil).
    Cornea, 2007, Volume: 26, Issue:8

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Beauveria; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole

2007
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
    Infection, 2007, Volume: 35, Issue:5

    Topics: Adult; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Encephalitis; Humans; Lipopeptides; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole

2007
Development and validation of a simple and rapid HPLC method for the quantitative determination of voriconazole in rat and beagle dog plasma.
    Journal of chromatographic science, 2007, Volume: 45, Issue:7

    Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Dogs; Female; Male; Pyrimidines; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2007
Random plasma concentrations of voriconazole decline over time.
    The Journal of infection, 2007, Volume: 55, Issue:5

    Topics: Antifungal Agents; Female; Humans; Male; Middle Aged; Neoplasms; Plasma; Pyrimidines; Retrospective Studies; Time Factors; Triazoles; Voriconazole

2007
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Oct-01, Volume: 45, Issue:7

    Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole

2007
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Female; Genetic Predisposition to Disease; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2007
Endogenous Scedosporium apiospermum endophthalmitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:9

    Topics: Adult; Antifungal Agents; Aqueous Humor; Biological Availability; Endophthalmitis; Eye Infections, Fungal; Fatal Outcome; Female; Fungemia; Humans; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole

2007
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:5

    Topics: Acute Kidney Injury; Adult; Aged; Antifungal Agents; Area Under Curve; Critical Illness; Female; Half-Life; Hemodiafiltration; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
[Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Comparison of 2 studies of treatment of invasive aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Oct-15, Volume: 45, Issue:8

    Topics: Amphotericin B; Aspergillosis; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
In vitro activities of voriconazole as a triazole derivative and caspofungin as an echinocandin were compared with those of some antifungal agents against Candida species isolated from clinical specimens.
    Japanese journal of infectious diseases, 2007, Volume: 60, Issue:5

    Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Sputum; Triazoles; Voriconazole

2007
Aspergillus fumigatus keratitis following laser in situ keratomileusis.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:10

    Topics: Adult; Amputation, Surgical; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Corneal Ulcer; Debridement; Eye Infections, Fungal; Female; Humans; Keratomileusis, Laser In Situ; Microbial Sensitivity Tests; Pyrimidines; Surgical Flaps; Triazoles; Voriconazole

2007
Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
    The Pediatric infectious disease journal, 2007, Volume: 26, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Female; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole

2007
Scedosporium apiospermum traumatic endophthalmitis successfully treated with voriconazole.
    International ophthalmology, 2007, Volume: 27, Issue:6

    Topics: Antifungal Agents; Child; Endophthalmitis; Eye Infections, Fungal; Eye Injuries, Penetrating; Female; Humans; Injections; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Vitreous Body; Voriconazole

2007
Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2

    Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Corneal Ulcer; Disease Models, Animal; Eye Infections, Fungal; Fusarium; Itraconazole; Mycoses; Pyrimidines; Rabbits; Treatment Outcome; Triazoles; Voriconazole

2008
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
    Journal of clinical microbiology, 2007, Volume: 45, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole

2007
Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
    American journal of veterinary research, 2007, Volume: 68, Issue:10

    Topics: Administration, Oral; Animals; Antifungal Agents; Biological Availability; Body Fluids; Cross-Over Studies; Half-Life; Horses; Pyrimidines; Reference Values; Triazoles; Voriconazole

2007
Voriconazole inhibits melanization in Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Animals; Antifungal Agents; Cell Line; Cryptococcus neoformans; Fluconazole; Gene Expression Regulation, Fungal; Laccase; Macrophages; Melanins; Mice; Microbial Sensitivity Tests; Phagocytosis; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole

2007
Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei.
    Diagnostic cytopathology, 2007, Volume: 35, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Biopsy, Needle; Brain Abscess; Central Nervous System Fungal Infections; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Pyrimidines; Triazoles; Voriconazole

2007
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.
    Infection, 2008, Volume: 36, Issue:1

    Topics: Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Leukemia, Plasma Cell; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Triazoles; Voriconazole

2008
Measurement of voriconazole in serum and plasma.
    Clinical biochemistry, 2007, Volume: 40, Issue:18

    Topics: Anticoagulants; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Interactions; Drug Monitoring; Drug Stability; Humans; Models, Biological; Pyrimidines; Serum; Triazoles; Voriconazole

2007
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
    European journal of medical research, 2007, Aug-16, Volume: 12, Issue:8

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole

2007
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Mycoses, 2007, Volume: 50, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear Diseases; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2007
Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report.
    Mycoses, 2007, Volume: 50, Issue:6

    Topics: Adult; Antifungal Agents; Brain Abscess; Humans; Male; Mycetoma; Near Drowning; Pyrimidines; Scedosporium; Thailand; Treatment Outcome; Triazoles; Voriconazole

2007
Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole.
    Transplantation proceedings, 2007, Volume: 39, Issue:8

    Topics: Adolescent; Antifungal Agents; Antilymphocyte Serum; Aspergillosis; Aspergillus fumigatus; Discitis; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.
    Yonsei medical journal, 2007, Oct-31, Volume: 48, Issue:5

    Topics: Antifungal Agents; Azoles; Bacteremia; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2007
Pseudoporphyria associated with voriconazole.
    Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:10

    Topics: Antifungal Agents; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Lung Transplantation; Middle Aged; Photosensitivity Disorders; Porphyrias; Pyrimidines; Skin; Skin Diseases, Vesiculobullous; Triazoles; Voriconazole

2007
[Case of invasive sino-orbital aspergillosis developing orbital apex syndrome].
    No shinkei geka. Neurological surgery, 2007, Volume: 35, Issue:10

    Topics: Aged; Antifungal Agents; Aspergillosis; Cavernous Sinus; Cranial Nerve Diseases; Female; Headache; Humans; Orbit; Orbital Diseases; Otorhinolaryngologic Surgical Procedures; Paranasal Sinus Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole

2007
Invasive tracheal aspergillosis treated successfully with voriconazole: clinical report and review of the literature.
    The Annals of otology, rhinology, and laryngology, 2007, Volume: 116, Issue:10

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus flavus; Fatal Outcome; Female; Humans; Laryngoscopy; Leukemia, Myeloid, Acute; Opportunistic Infections; Pyrimidines; Tracheitis; Triazoles; Voriconazole

2007
[Case of pulmonary pseudallescheriasis responding successfully to treatment with voriconazole].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:10

    Topics: Adult; Antifungal Agents; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Male; Mycetoma; Pneumonectomy; Pseudallescheria; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
    British journal of haematology, 2008, Volume: 140, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Combined Modality Therapy; Female; Fusarium; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin.
    International journal of antimicrobial agents, 2007, Volume: 30, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2007
Adjuvant endobronchial amphotericin B for refractory invasive pulmonary aspergillosis: evidence is scarce but promise does exist.
    Respiration; international review of thoracic diseases, 2007, Volume: 74, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chemotherapy, Adjuvant; Drug Evaluation; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Subgingival distribution of yeast and their antifungal susceptibility in immunocompetent subjects with and without dental devices.
    Acta odontologica latinoamericana : AOL, 2007, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Dental Plaque; Drug Resistance, Fungal; Female; Fluconazole; Gingivitis; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Middle Aged; Orthodontic Appliances; Periodontitis; Pyrimidines; Triazoles; Voriconazole

2007
Voriconazole into PLGA nanoparticles: improving agglomeration and antifungal efficacy.
    International journal of pharmaceutics, 2008, Mar-20, Volume: 352, Issue:1-2

    Topics: Animals; Antifungal Agents; Candida albicans; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Ethanol; Feasibility Studies; Kidney; Kinetics; Mice; Nanoparticles; Particle Size; Phosphates; Polyglactin 910; Pyrimidines; Solubility; Solvents; Surface Properties; Technology, Pharmaceutical; Triazoles; Voriconazole

2008
In vitro efficacy of voriconazole against clinical isolates of Scytalidium spp. from clinical lesions.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Antifungal Agents; Humans; Mitosporic Fungi; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2008
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2008
In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Drug Synergism; Horse Diseases; Horses; Infections; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Sheep; Sheep Diseases; Terbinafine; Triazoles; Voriconazole

2008
Comparative cost-effectiveness of voriconazole and amphotericin B in treatment of invasive pulmonary aspergillosis.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, Dec-15, Volume: 64, Issue:24

    Topics: Amphotericin B; Aspergillosis; Cost-Benefit Analysis; Decision Trees; Humans; Lung Diseases, Fungal; Models, Economic; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2007
Managing Candida endophthalmitis (Recurrent Candida albicans endophthalmitis in an immunocompromised host. Vol. 42[1]).
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Immunocompromised Host; Postoperative Complications; Pyrimidines; Recurrence; Triazoles; Voriconazole

2007
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Canadian journal of microbiology, 2007, Volume: 53, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole

2007
High-performance liquid chromatographic evaluation of a coated cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phase having a small-pore silica support.
    Journal of chromatography. A, 2008, Jan-18, Volume: 1178, Issue:1-2

    Topics: Cellulose; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Phenylcarbamates; Pyrimidines; Silicon Dioxide; Triazoles; Voriconazole

2008
In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fungi; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2007
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
    Chemotherapy, 2008, Volume: 54, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole

2008
Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
    Mycoses, 2008, Volume: 51, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Drug Combinations; Drug Therapy, Combination; Female; Humans; Middle Aged; Neuroaspergillosis; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Triazoles; Voriconazole

2008
Solitary cutaneous nodule in an immunocompromised patient.
    Archives of dermatology, 2007, Volume: 143, Issue:12

    Topics: Alternaria; Ankle; Dermatomycoses; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Middle Aged; Pyrimidines; Retreatment; Tacrolimus; Triazoles; Voriconazole

2007
A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation.
    Transplantation proceedings, 2007, Volume: 39, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Liver Transplantation; Living Donors; Lung Diseases, Fungal; Middle Aged; Postoperative Complications; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2007
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.
    Journal of clinical microbiology, 2008, Volume: 46, Issue:2

    Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Regression Analysis; Triazoles; Voriconazole

2008
Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2007, Volume: 44, Issue:10

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Hypersensitivity; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Sinusitis; Triazoles; Voriconazole

2007
Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Pharmacotherapy, 2008, Volume: 28, Issue:1

    Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Bilirubin; Creatinine; Exanthema; Female; Fever; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report.
    Haematologica, 2008, Volume: 93, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Child; Child, Preschool; Humans; Leukemia; Male; Middle Aged; Mycetoma; Pyrimidines; Retrospective Studies; Scedosporium; Triazoles; Voriconazole

2008
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole.
    Haematologica, 2008, Volume: 93, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2008
What is the "therapeutic range" for voriconazole?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46, Issue:2

    Topics: Antifungal Agents; Dose-Response Relationship, Drug; Humans; Pyrimidines; Triazoles; Voriconazole

2008
High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:2

    Topics: Antifungal Agents; Candidiasis; Child, Preschool; Critical Illness; Humans; Lung Diseases; Male; Neuroblastoma; Pyrimidines; Triazoles; Voriconazole

2008
[Successful treatment by voriconazole for pulmonary aspergilloma of elderly patient].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2007, Volume: 45, Issue:12

    Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2007
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
    The Journal of infectious diseases, 2007, Dec-15, Volume: 196, Issue:12

    Topics: Animals; Drosophila melanogaster; Drosophila Proteins; Female; Fusarium; Humans; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Spores, Fungal; Toll-Like Receptors; Triazoles; Virulence; Voriconazole

2007
Simultaneous mold infections in an orthotopic heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Aspergillus fumigatus; Basiliximab; Cardiomyopathy, Dilated; Debridement; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Mucormycosis; Prosthesis-Related Infections; Pulmonary Aspergillosis; Pyrimidines; Recombinant Fusion Proteins; Rhizopus; Triazoles; Voriconazole

2008
Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:1

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Aqueous Humor; Biological Availability; Candida; Chromatography, High Pressure Liquid; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2008
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
    Journal of clinical microbiology, 2008, Volume: 46, Issue:3

    Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europe; Fluconazole; Fungemia; Global Health; Humans; Latin America; Microbial Sensitivity Tests; Middle East; North America; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2008
Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:1

    Topics: Adult; Alternaria; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin Diseases; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2008
In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Antifungal Agents; Aspergillus; Candida; Fluconazole; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2008
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Clinical Trials as Topic; Female; Health Surveys; Humans; Infant; Male; Middle Aged; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2008
A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:4

    Topics: Algorithms; Antifungal Agents; Area Under Curve; Biological Availability; Candida; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Models, Statistical; Pyrimidines; Triazoles; Voriconazole

2008
The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:1

    Topics: Acute Kidney Injury; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Critical Illness; Fatal Outcome; Half-Life; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole

2008
Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Laboratories; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Triazoles; Voriconazole

2008
Cervical spondylodiscitis caused by Blastoschizomyces capitatus.
    Infection, 2009, Volume: 37, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Cervical Vertebrae; Dipodascus; Discitis; Female; Humans; Leukemia, Myeloid, Acute; Mycoses; Neck; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Ultrasonography; Voriconazole

2009
Use of voriconazole in fungal keratitis.
    Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:2

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Aspergillosis; Chloramphenicol; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Middle Aged; Pyrimidines; Staphylococcal Infections; Triazoles; Visual Acuity; Voriconazole

2008
Voriconazole plasma monitoring.
    Archives of disease in childhood, 2008, Volume: 93, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Drug Monitoring; Humans; Leukemia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2008
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.
    Mycoses, 2008, Volume: 51, Issue:2

    Topics: Absidia; Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Interactions; Humans; Hyphae; Liposomes; Microbial Sensitivity Tests; Neutrophils; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2008
Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2008, Volume: 8, Issue:4

    Topics: Aged; Antifungal Agents; Aspergillosis; Carcinoma, Squamous Cell; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Postoperative Complications; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2008
Invasive Aspergillus terreus sinusitis with orbitocranial extension: case report.
    Surgical neurology, 2008, Volume: 69, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Humans; Male; Middle Aged; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole

2008
Aspergillus "fungus ball" of the bladder after hematopoietic transplantation in a pediatric patient: successful treatment with intravesical voriconazole and surgery.
    Pediatric transplantation, 2008, Volume: 12, Issue:2

    Topics: Administration, Intravesical; Adolescent; Anemia, Sickle Cell; Antifungal Agents; Aspergillosis; Cystitis; Hematopoietic Stem Cell Transplantation; Humans; Male; Pyrimidines; Triazoles; Urinary Bladder Diseases; Voriconazole

2008
Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2008, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aspergillosis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Lung Transplantation; Male; Middle Aged; Neuromuscular Diseases; Pain; Postoperative Complications; Pyrimidines; Retrospective Studies; Risk Assessment; Severity of Illness Index; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole

2008
Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
    Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:3

    Topics: Adult; Antifungal Agents; Blister; Bone Marrow Transplantation; Extremities; Female; Fusarium; Graft vs Host Disease; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
[Clinical case of the month. Pulmonary aspergillosis: chimic necrotizing aspergillosis].
    Revue medicale de Liege, 2007, Volume: 62, Issue:12

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Chronic Disease; Glucocorticoids; Humans; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Necrosis; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Sputum; Triazoles; Voriconazole

2007
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
    International journal of hematology, 2008, Volume: 87, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.
    British journal of clinical pharmacology, 2008, Volume: 65, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Epidemiologic Methods; Female; Humans; Isoenzymes; Mass Spectrometry; Mixed Function Oxygenases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers.
    British journal of clinical pharmacology, 2008, Volume: 65, Issue:4

    Topics: Adult; Alkynes; Antifungal Agents; Benzoxazines; Body Weight; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Epidemiologic Methods; Humans; Male; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Outcome; Triazoles; Voriconazole

2008
Voriconazole in an infant with cryptococcal meningitis.
    Chinese medical journal, 2008, Feb-05, Volume: 121, Issue:3

    Topics: Antifungal Agents; Humans; Infant; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2008
Determination of the antifungal agent voriconazole in human plasma using a simple column-switching high-performance liquid chromatography and its application to a pharmacokinetic study.
    Chemical & pharmaceutical bulletin, 2008, Volume: 56, Issue:3

    Topics: Antifungal Agents; Area Under Curve; Calibration; Chromatography, High Pressure Liquid; Half-Life; Humans; Pyrimidines; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole

2008
Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:2

    Topics: Aged; Anterior Chamber; Antifungal Agents; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Injections; Male; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2008
Comparison of E-Test, disk diffusion and a modified CLSI broth microdilution (M 38-A) method for in vitro testing of itraconazole, fluconazole and voriconazole against dermatophytes.
    Medical mycology, 2008, Volume: 46, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Bile aspiration for diagnosis of Candida glabrata cholecystitis.
    Infection, 2008, Volume: 36, Issue:2

    Topics: Acalculous Cholecystitis; Aged; Animals; Antifungal Agents; Bile; Biopsy, Needle; Candida glabrata; Candidiasis; Female; Humans; Pyrimidines; Triazoles; Voriconazole

2008
Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:3

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Biological Availability; Humans; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2008
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity.
    International journal of laboratory hematology, 2008, Volume: 30, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Itraconazole; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2008
Recurrent Trichosporon asahii glossitis: a case report.
    The journal of contemporary dental practice, 2008, Mar-01, Volume: 9, Issue:3

    Topics: Administration, Inhalation; Adult; Antifungal Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Resistance, Fungal; Glossitis; Humans; Immunocompromised Host; Male; Mycoses; Pyrimidines; Recurrence; Triazoles; Trichosporon; Voriconazole

2008
Successful treatment of subcutaneous Scytalidium hyalinum infection with voriconazole and topical terbinafine in a cardiac transplant patient.
    Transplantation, 2008, Mar-15, Volume: 85, Issue:5

    Topics: Administration, Topical; Antifungal Agents; Ascomycota; Erythema; Heart Transplantation; Humans; Male; Middle Aged; Mycoses; Naphthalenes; Postoperative Complications; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2008
Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Apr-01, Volume: 865, Issue:1-2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reference Standards; Reproducibility of Results; Saliva; Sensitivity and Specificity; Spectrometry, Fluorescence; Triazoles; Voriconazole

2008
Comparison of disk diffusion, E-test and broth microdilution test in determination of susceptibility of Aspergillus species to amphotericin B, itraconazole and voriconazole.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Disk Diffusion Antimicrobial Tests; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1

    Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Critical Illness; Female; Humans; Infusions, Intravenous; Kidney; Liver; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole

2008
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Anaerobiosis; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Echinocandins; Hyphae; Microbial Sensitivity Tests; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole

2008
The use of voriconazole for the treatment of aspergillosis in falcons (Falco species).
    Journal of avian medicine and surgery, 2007, Volume: 21, Issue:4

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Dose-Response Relationship, Drug; Falconiformes; Female; Male; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2007
Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
    Ear, nose, & throat journal, 2008, Volume: 87, Issue:1

    Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole

2008
Role of flavin-containing monooxygenase in oxidative metabolism of voriconazole by human liver microsomes.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:6

    Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Humans; Microsomes, Liver; Oxidation-Reduction; Oxygenases; Pyrimidines; Recombinant Proteins; Triazoles; Voriconazole

2008
Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Carbon Dioxide; Dose-Response Relationship, Drug; Microbial Viability; Pyrimidines; Spores, Fungal; Time Factors; Triazoles; Voriconazole

2008
Voriconazole in newborns.
    Indian pediatrics, 2008, Volume: 45, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Critical Illness; Humans; Infant, Newborn; Pyrimidines; Triazoles; Voriconazole

2008
Unusual pharmacokinetics of intravitreal and systemic voriconazole in a patient with Scedosporium apiospermum endophthalmitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1

    Topics: Adult; Antifungal Agents; Endophthalmitis; Eye Injuries; Humans; Light Coagulation; Male; Ophthalmologic Surgical Procedures; Pyrimidines; Retina; Scedosporium; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2008
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole

2008
MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:1

    Topics: Animals; Antifungal Agents; Bird Diseases; Columbidae; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole

2008
Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
    The Journal of hospital infection, 2008, Volume: 69, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Cross Infection; Disease Outbreaks; Environmental Exposure; Hematology; Hospital Design and Construction; Hospital Units; Humans; Infection Control; Pyrimidines; Triazoles; Voriconazole

2008
Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug.
    Journal of pharmaceutical and biomedical analysis, 2008, Aug-05, Volume: 47, Issue:4-5

    Topics: Animals; Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Feasibility Studies; Kidney; Lipids; Male; Microdialysis; Models, Theoretical; Pyrimidines; Rats; Rats, Wistar; Reference Standards; Reproducibility of Results; Technology, Pharmaceutical; Triazoles; Voriconazole

2008
Successful treatment of disseminated Geotrichum capitatum infection with a combination of caspofungin and voriconazole in an immunocompromised patient.
    Mycoses, 2008, Volume: 51, Issue:3

    Topics: Antifungal Agents; Caspofungin; Drug Combinations; Echinocandins; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2008
[Usefulness of voriconazole in treatment of Phoma glomerata after penetrating injury].
    Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:1

    Topics: Aged; Antifungal Agents; Ascomycota; Eye Injuries, Penetrating; Humans; Male; Mycoses; Pyrimidines; Retinal Detachment; Triazoles; Voriconazole

2008
Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
    Annals of hematology, 2008, Volume: 87, Issue:8

    Topics: Absidia; Aged; Antifungal Agents; Diabetes Complications; Foot Injuries; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2008
Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Antagonism; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
[Case of Scedosporium apiospermum cutaneous soft tissue infection treated with voriconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2008, Volume: 82, Issue:2

    Topics: Administration, Oral; Aged; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole

2008
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2008
Disseminated infection by Bipolaris spicifera in an immunocompetent subject.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Ascomycota; DNA, Fungal; DNA, Ribosomal; Humans; Immunocompetence; Itraconazole; Lymph Nodes; Male; Mycoses; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10

    Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole

2008
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2008
Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
    AIDS (London, England), 2008, Apr-23, Volume: 22, Issue:7

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; HIV; HIV Infections; Humans; Male; Middle Aged; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2008
Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis.
    American journal of ophthalmology, 2008, Volume: 146, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intralesional; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
[Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Mikrobiyoloji bulteni, 2008, Volume: 42, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Interactions; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2008
[Diagnosis and treatment of pulmonary aspergillosis. Role of voriconazole (discussion)].
    The Japanese journal of antibiotics, 2007, Volume: 60, Issue:6

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Biomarkers; Clinical Trials as Topic; Galactose; Humans; Immunoglobulin E; Lung Diseases, Fungal; Lung Diseases, Interstitial; Mannans; Practice Guidelines as Topic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole

2007
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
    Bioorganic & medicinal chemistry letters, 2008, Jun-01, Volume: 18, Issue:11

    Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts

2008
[New systemic antifungal drugs].
    La Revue de medecine interne, 2008, Volume: 29 Suppl 1

    Topics: Antifungal Agents; Humans; Pyrimidines; Triazoles; Voriconazole

2008
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2008
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Base Sequence; Colony Count, Microbial; Disease Models, Animal; DNA Primers; DNA, Fungal; Galactose; Guinea Pigs; Humans; Immunoenzyme Techniques; Lung; Lung Diseases, Fungal; Male; Mannans; Mycology; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole

2008
Successful treatment of histoplasmosis brain abscess with voriconazole.
    Archives of neurology, 2008, Volume: 65, Issue:5

    Topics: Adult; Antifungal Agents; Arm; Bone Marrow Diseases; Brain Abscess; Cerebellar Ataxia; Cerebellum; Frontal Lobe; Histoplasmosis; Humans; Itraconazole; Liver Abscess; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Disseminated aspergillosis in an adolescent with acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2008, Volume: 51, Issue:3

    Topics: Adolescent; Aspergillosis; Aspergillus fumigatus; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Thyroid Diseases; Tomography, X-Ray Computed; Triazoles; Voriconazole

2008
Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Aminoglycosides; Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Aqueous humor concentration of voriconazole after topical administration in rabbits.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:8

    Topics: Administration, Topical; Animals; Antifungal Agents; Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Cornea; Male; Microbial Sensitivity Tests; Ophthalmic Solutions; Pyrimidines; Rabbits; Triazoles; Voriconazole

2008
Hallucinations during voriconazole therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jul-01, Volume: 47, Issue:1

    Topics: Adolescent; Adult; Aged; Female; Hallucinations; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2008
Combined therapy in treatment of murine infection by Fusarium solani.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole

2008
Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report.
    Mycoses, 2009, Volume: 52, Issue:1

    Topics: Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Central Nervous System Diseases; Drug Resistance, Fungal; Fatal Outcome; Humans; Male; Methylprednisolone; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Rhinitis; Rhizopus; Triazoles; Voriconazole; Zygomycosis

2009
Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.
    Pharmacotherapy, 2008, Volume: 28, Issue:6

    Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Humans; Immunosuppressive Agents; Pilot Projects; Pyrimidines; Retrospective Studies; Sirolimus; Triazoles; Voriconazole

2008
Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis.
    Mycopathologia, 2008, Volume: 166, Issue:2

    Topics: Administration, Oral; Antifungal Agents; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Recurrence; Scedosporium; Triazoles; Voriconazole

2008
[A suspected case of voriconazole-induced lung injury].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:4

    Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Lung Diseases; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2008
Osteomyelitis of the rib caused by Aspergillus flavus following cardiac surgery.
    Mycoses, 2009, Volume: 52, Issue:1

    Topics: Abscess; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Humans; Male; Osteomyelitis; Pyrimidines; Ribs; Surgical Wound Infection; Thoracic Surgery; Triazoles; Voriconazole

2009
Endogenous mycotic endophthalmitis in an immunocompetent patient.
    International ophthalmology, 2009, Volume: 29, Issue:4

    Topics: Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Fluorescein Angiography; Fundus Oculi; Humans; Immunocompetence; Injections; Male; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Vitrectomy; Vitreous Body; Voriconazole; Zygomycosis

2009
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drosophila melanogaster; Drosophila Proteins; Pyrimidines; Survival Analysis; Toll-Like Receptors; Triazoles; Virulence; Voriconazole

2008
Voriconazole-induced neuropathy.
    Chemotherapy, 2008, Volume: 54, Issue:3

    Topics: Adolescent; Adult; Female; Humans; Leukemia; Male; Nervous System Diseases; Pyrimidines; Triazoles; Voriconazole

2008
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole

2008
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.
    International journal of hematology, 2008, Volume: 88, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hallucinations; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2008
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results.
    Clinical drug investigation, 2008, Volume: 28, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Belgium; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Immunocompromised Host; Male; Middle Aged; Models, Economic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2008
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pyrimidines; Spain; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Effective management of pulmonary aspergillosis invading the thoracic spine in a child with high risk ALL requiring allogeneic bone marrow transplantation.
    Medical mycology, 2008, Volume: 46, Issue:5

    Topics: Adoptive Transfer; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Caspofungin; Child; Echinocandins; Female; Graft vs Host Disease; Granulocytes; Humans; Lipopeptides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Spine; Triazoles; Voriconazole

2008
Immunomodulatory effects of voriconazole on monocytes challenged with Aspergillus fumigatus: differential role of Toll-like receptors.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Antifungal Agents; Aspergillus fumigatus; Cell Line; Cells, Cultured; Gene Expression Regulation; Humans; Hyphae; Monocytes; NF-kappa B; Pyrimidines; RNA, Messenger; Toll-Like Receptor 2; Toll-Like Receptors; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole

2008
Angio-oedema as an unusual tolerable side effect of voriconazole therapy.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 8

    Topics: Adult; Angioedema; Antifungal Agents; Aspergillosis; Female; Histamine H1 Antagonists; Humans; Infusions, Intravenous; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
    Journal of clinical microbiology, 2008, Volume: 46, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Lipopeptides; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Thiazoles; Triazoles; Voriconazole; Young Adult

2008
Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Medical mycology, 2009, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Pyrimidines; Triazoles; Venezuela; Voriconazole; Young Adult

2009
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
    Medical mycology, 2009, Volume: 47, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
    Pharmacotherapy, 2008, Volume: 28, Issue:8

    Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole

2008
[Use of topical voriconazole in Alternaria keratitis].
    Archivos de la Sociedad Espanola de Oftalmologia, 2008, Volume: 83, Issue:8

    Topics: Administration, Oral; Adult; Alternaria; Antifungal Agents; Eye Infections, Fungal; Eye Injuries; Humans; Keratitis; Keratoplasty, Penetrating; Male; Mycoses; Ophthalmic Solutions; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2008
Post-traumatic osteomyelitis due to Aspergillus flavus successfully treated with voriconazole: a case report.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Diabetes Complications; Humans; Male; Osteomyelitis; Pyrimidines; Superinfection; Tibia; Triazoles; Voriconazole

2008
Development and validation of an efficient HPLC method for quantification of voriconazole in plasma and microdialysate reflecting an important target site.
    Analytical and bioanalytical chemistry, 2008, Volume: 392, Issue:3

    Topics: Calibration; Chromatography, High Pressure Liquid; Humans; Microdialysis; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2008
Designing voriconazole treatment for racing pigeons: balancing between hepatic enzyme auto induction and toxicity.
    Medical mycology, 2009, Volume: 47, Issue:3

    Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Chromatography, High Pressure Liquid; Columbidae; Female; Injections, Intravenous; Liver; Lung; Male; Plasma; Pyrimidines; Triazoles; Voriconazole

2009
First case of breakthrough pulmonary Aspergillus niveus infection in a patient after allogeneic hematopoietic stem cell transplantation.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Bronchoalveolar Lavage Fluid; Drug Resistance, Fungal; Fanconi Anemia; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases, Fungal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2008
Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Drug Resistance, Fungal; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:6

    Topics: Acanthamoeba; Amebiasis; Animals; Antifungal Agents; Antiprotozoal Agents; Drug Therapy, Combination; Encephalitis; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Phosphorylcholine; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Skin; Triazoles; Voriconazole

2008
In vitro synergy of caspofungin with licensed and novel antifungal drugs against clinical isolates of Fusarium spp.
    Medical mycology, 2009, Volume: 47, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Fusarium; Humans; Hyphae; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Tacrolimus; Terbinafine; Triazoles; Voriconazole

2009
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Acta ophthalmologica, 2008, Volume: 86, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2008
Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6

    Topics: Antifungal Agents; Candida glabrata; Caspofungin; Cells, Cultured; Drug Interactions; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Monocytes; Pyrimidines; Triazoles; Voriconazole

2008
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Amino Acid Sequence; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pyrimidines; Triazoles; Voriconazole

2008
[What distinctions do Candida biofilms have to offer?].
    Mycoses, 2008, Volume: 51 Suppl 3

    Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Culture Media; Drug Resistance, Fungal; Echinocandins; Glucose; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials, Phase III as Topic; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole; Yeasts

2008
Inhibition of voriconazole metabolism by chloramphenicol in an adolescent with central nervous system aspergillosis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Chloramphenicol; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Humans; Liver; Male; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole

2008
Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation.
    Intensive care medicine, 2009, Volume: 35, Issue:1

    Topics: Adult; Antifungal Agents; Caspofungin; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Myocarditis; Pyrimidines; Shock, Cardiogenic; Triazoles; Voriconazole

2009
Voriconazole-induced photosensitivity.
    Clinical medicine & research, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Candidiasis; Endocarditis; Humans; Male; Middle Aged; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2008
Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:11

    Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Everolimus; Fatal Outcome; Fluconazole; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Pyrimidines; Sirolimus; Triazoles; Voriconazole

2008
Successful medical treatment of a case of Paecilomyces lilacinus keratitis.
    Cornea, 2008, Volume: 27, Issue:9

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Middle Aged; Naphthalenes; Paecilomyces; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2008
Alternaria infectoria brain abscess in a child with chronic granulomatous disease.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2009, Volume: 28, Issue:4

    Topics: Alternaria; Antifungal Agents; Brain; Brain Abscess; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Granulomatous Disease, Chronic; Humans; Lipopeptides; Male; Mycoses; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 5.8S; Seizures; Triazoles; Voriconazole

2009
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
    Medical mycology, 2009, Volume: 47, Issue:5

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole

2009
Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biofilms; Caspofungin; Echinocandins; Formazans; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Mycelium; Oxidation-Reduction; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole

2008
EUCAST Technical Note on voriconazole.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:10

    Topics: Antifungal Agents; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycology; Pyrimidines; Triazoles; Voriconazole

2008
Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
    Journal of clinical microbiology, 2008, Volume: 46, Issue:11

    Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Microbial Viability; Mycology; Naphthalenes; Pyridones; Pyrimidines; Sensitivity and Specificity; Spectrophotometry; Terbinafine; Tetrazolium Salts; Triazoles; Vitamin K 3; Voriconazole

2008
Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Folia microbiologica, 2008, Volume: 53, Issue:2

    Topics: Antifungal Agents; Culture Media; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2008
Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:2

    Topics: Charcot-Marie-Tooth Disease; Child, Preschool; Drug Synergism; Female; Humans; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vincristine; Voriconazole

2009
[Chronic necrotizing aspergillosis].
    La Revue du praticien, 2008, Sep-30, Volume: 58, Issue:14

    Topics: Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Chronic Disease; Cough; Female; Fever; Humans; Lung Diseases, Fungal; Middle Aged; Necrosis; Pyrimidines; Triazoles; Voriconazole

2008
Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Debridement; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Pyrimidines; Soft Tissue Infections; Terbinafine; Triazoles; Voriconazole

2008
[Ocular penetration and pharmacokinetics of topical voriconazole in rabbit eyes].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2008, Volume: 44, Issue:4

    Topics: Administration, Topical; Animals; Chromatography, High Pressure Liquid; Ophthalmic Solutions; Pyrimidines; Rabbits; Triazoles; Voriconazole

2008
Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:11

    Topics: Adolescent; Antifungal Agents; Antigens, Fungal; Bone Marrow Transplantation; DNA, Fungal; Graft vs Host Disease; Humans; Immunocompromised Host; Latex Fixation Tests; Male; Microbial Sensitivity Tests; Mycoses; Polymerase Chain Reaction; Polysaccharides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
    Chemical biology & drug design, 2008, Volume: 72, Issue:3

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole

2008
[Case of an HTLV-1 carrier complicated with chronic pulmonary histoplasmosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:9

    Topics: Antibodies, Fungal; Antibodies, Viral; Antifungal Agents; Carrier State; Chronic Disease; Histoplasma; Histoplasmosis; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunodiffusion; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Serologic Tests; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2008
Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Oral microbiology and immunology, 2008, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Aged; Argentina; Candida; Candidiasis, Oral; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Periodontal Pocket; Phenotype; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole; Young Adult

2008
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Serotyping; Triazoles; Voriconazole

2009
Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2008, Volume: 14, Issue:11

    Topics: Adrenal Cortex Hormones; Anti-Retroviral Agents; Antifungal Agents; Female; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Immune System; Inflammation; Liver Transplantation; Magnetic Resonance Imaging; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole

2008
Pulmonary aspergillosis in hematologic malignancies: lights and shadows.
    Haematologica, 2008, Volume: 93, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2008
In vitro susceptibility of Pythium insidiosum and a Lagenidium sp to itraconazole, posaconazole, voriconazole, terbinafine, caspofungin, and mefenoxam.
    American journal of veterinary research, 2008, Volume: 69, Issue:11

    Topics: Alanine; Anti-Infective Agents; Caspofungin; Echinocandins; In Vitro Techniques; Itraconazole; Lagenidium; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Pythium; Terbinafine; Triazoles; Voriconazole

2008
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:3

    Topics: Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; China; Cytochrome P-450 CYP2C19; Genotype; Humans; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Dec-15, Volume: 47, Issue:12

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Drug Therapy; Female; Health Care Costs; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis.
    Retina (Philadelphia, Pa.), 2009, Volume: 29, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Cell Proliferation; Cells, Cultured; Colorimetry; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Middle Aged; Oxidative Stress; Pyrimidines; Retinal Pigment Epithelium; Treatment Outcome; Triazoles; Vitreous Body; Voriconazole

2009
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
    PLoS medicine, 2008, Nov-11, Volume: 5, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2008
Preparation and stability of voriconazole eye drop solution.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Antifungal Agents; Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Excipients; Hydrogen-Ion Concentration; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole

2009
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Africa; Antifungal Agents; Asia, Southeastern; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Latin America; Microbial Sensitivity Tests; Middle East; Mycoses; North America; Pyrimidines; Triazoles; Voriconazole; Yeasts

2009
Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Child; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2009
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:1

    Topics: Animals; Antifungal Agents; Brain; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluconazole; Kidney; Male; Mice; Neutropenia; Nitriles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:2

    Topics: Animals; Antifungal Agents; Area Under Curve; Candidiasis; Kidney; Male; Microdialysis; Models, Animal; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Serum; Triazoles; Voriconazole

2009
Pharmacokinetics, tissue concentrations, and safety of the antifungal agent voriconazole in chickens.
    Journal of avian medicine and surgery, 2008, Volume: 22, Issue:3

    Topics: Animals; Antifungal Agents; Biological Availability; Brain; Chickens; Kidney; Liver; Lung; Muscle, Skeletal; Pyrimidines; Skin; Specific Pathogen-Free Organisms; Tissue Distribution; Triazoles; Voriconazole

2008
International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Antifungal Agents; Azoles; Biological Assay; Fluconazole; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2009
A multi-centre comparison of nursing staff time required for the preparation and administration of liposomal amphotericin B and amphotericin B deoxycholate vs. voriconazole.
    Journal of clinical nursing, 2009, Volume: 18, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Costs and Cost Analysis; Deoxycholic Acid; Drug Combinations; Humans; Pyrimidines; Time Management; Triazoles; United Kingdom; Voriconazole

2009
Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 12

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Drug Therapy, Combination; Humans; Male; Mycoses; Naphthalenes; Paecilomyces; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2008
Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2

    Topics: Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Data Interpretation, Statistical; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Kinetics; Microsomes, Liver; Pilot Projects; Pyrimidines; Spectrophotometry, Ultraviolet; Triazoles; Voriconazole

2009
Hypotension due to the drug interaction of voriconazole with eplerenone and nifedipine.
    European journal of clinical pharmacology, 2009, Volume: 65, Issue:3

    Topics: Antifungal Agents; Antihypertensive Agents; Drug Interactions; Drug Therapy, Combination; Eplerenone; Humans; Hypotension; Male; Middle Aged; Nifedipine; Pyrimidines; Spironolactone; Triazoles; Voriconazole

2009
Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2008, Volume: 23, Issue:10

    Topics: Aged; Antifungal Agents; Aspergillosis; Drug Interactions; Follow-Up Studies; Hallucinations; Heart Failure; Humans; Itraconazole; Liver Function Tests; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2008
CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:2

    Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Controlled Clinical Trials as Topic; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Female; Genotype; Heterozygote; Homozygote; Humans; Male; Polymorphism, Genetic; Pyrimidines; Regression Analysis; Triazoles; Voriconazole; Young Adult

2009
Retrospective serological tests for determining the optimal blood concentration of voriconazole for treating fungal infection.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2008, Volume: 128, Issue:12

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillus; beta-Glucans; Biomarkers; Drug Monitoring; Female; Humans; Male; Pyrimidines; Retrospective Studies; Serologic Tests; Triazoles; Voriconazole

2008
Aspergillus mastoiditis, presenting with unexplained progressive otalgia, in an immunocompetent (older) patient.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2009, Volume: 266, Issue:10

    Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drug Therapy, Combination; Earache; Humans; Immunocompetence; Male; Mastoid; Mastoiditis; Miconazole; Postoperative Care; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Tympanic Membrane Perforation; Voriconazole

2009
Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Drug Monitoring; Extracorporeal Membrane Oxygenation; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2008
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2008, Volume: 46, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Respiratory Tract Diseases; Treatment Outcome; Triazoles; Voriconazole

2008
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Global Health; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Triazoles; Voriconazole

2009
Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
    Revista iberoamericana de micologia, 2008, Dec-31, Volume: 25, Issue:4

    Topics: Agar; Amphotericin B; Antifungal Agents; Cryptococcus; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2008
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Administration, Oral; Adult; Antifungal Agents; Area Under Curve; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Models, Biological; Pyrimidines; Triazoles; Voriconazole

2009
Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:1

    Topics: Antifungal Agents; Drug Monitoring; Hallucinations; Humans; Neurotoxicity Syndromes; Pyrimidines; Risk Assessment; Triazoles; Voriconazole

2009
[Case of orbital apex syndrome caused by invasive aspergillosis successfully treated during the diagnostic procedure by the use of voriconazole].
    Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:10

    Topics: Aged; Antifungal Agents; Aspergillosis; Female; Humans; Ocular Motility Disorders; Orbital Diseases; Pyrimidines; Syndrome; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole

2008
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
    Cornea, 2009, Volume: 28, Issue:1

    Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extraction; Contact Lenses; Corneal Stroma; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Eye Injuries; Female; Fluconazole; Humans; Injections; Keratitis; Lipopeptides; Male; Medical Records; Middle Aged; Pyrimidines; Steroids; Treatment Outcome; Triazoles; Voriconazole

2009
High voriconazole trough levels in relation to hepatic function: how to adjust the dosage?
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:2

    Topics: Antifungal Agents; Humans; Liver Diseases; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole and posaconazole resistant Candida pelliculosa fungemia after cardiac surgery.
    The Pediatric infectious disease journal, 2009, Volume: 28, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Cardiac Surgical Procedures; Child; Drug Resistance, Multiple, Fungal; Fungemia; Humans; Infant; Postoperative Complications; Pyrimidines; Triazoles; Voriconazole

2009
Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.
    Medical mycology, 2009, Volume: 47, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Feb-01, Volume: 48, Issue:3

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Deoxycholic Acid; Drug Combinations; Female; Fungi; Hematopoietic Stem Cell Transplantation; Humans; Logistic Models; Male; Middle Aged; Mucorales; Mycoses; North America; Prevalence; Prospective Studies; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Voriconazole

2009
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2008
Early detection of breakthrough trichosporonosis by serum PCR in a cord blood transplant recipient being prophylactically treated with voriconazole.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:12

    Topics: Adolescent; Antifungal Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; DNA, Fungal; Fungemia; Humans; Male; Mycoses; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2008
Voriconazole use for endemic fungal infections.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Female; Histoplasmosis; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2009
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].
    Medizinische Klinik (Munich, Germany : 1983), 2009, Jan-15, Volume: 104, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; HIV Seropositivity; Humans; Male; Meningitis, Cryptococcal; Pyrimidines; Recurrence; Triazoles; Voriconazole

2009
Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model.
    Chemotherapy, 2009, Volume: 55, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Lung; Male; Mice; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Ciprofloxacin; Fatal Outcome; Humans; Itraconazole; Male; Mucormycosis; Prednisolone; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2009
[Saccharomyces cerevisiae fungemia associated with multifocal pneumonia in a patient with alcohol-related hepatic cirrhosis].
    Le infezioni in medicina, 2008, Volume: 16, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Liver Cirrhosis, Alcoholic; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Radiography; Saccharomyces cerevisiae; Treatment Outcome; Triazoles; Voriconazole

2008
The use of voriconazole in the treatment of cylindrocarpon keratomycosis.
    Cornea, 2009, Volume: 28, Issue:2

    Topics: Antifungal Agents; Ascomycota; Cornea; Corneal Ulcer; Drug Resistance, Fungal; Female; Humans; Keratitis; Microscopy, Confocal; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Lack of allergic cross-reactivity between fluconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Aged; Antifungal Agents; Cross Reactions; Drug Hypersensitivity; Fluconazole; Humans; Liver; Male; Pyrimidines; Triazoles; Voriconazole

2009
Accelerated metabolism of voriconazole and its partial reversal by cimetidine.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Antifungal Agents; Cimetidine; Cytochrome P-450 CYP3A; Drug Interactions; Hemofiltration; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2009
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2009, Volume: 22, Issue:5

    Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole

2009
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Medical mycology, 2008, Volume: 46, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Drug Synergism; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2008
In vitro activities of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin, Italy.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Antifungal Agents; Candida; Diffusion; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Scedosporium apiospermum skeletal infection in an immunocompetent child.
    Medical mycology, 2009, Volume: 47, Issue:4

    Topics: Antifungal Agents; Child; Female; Humans; Knee; Mycoses; Osteomyelitis; Pyrimidines; Radiography; Scedosporium; Triazoles; Voriconazole

2009
Cerebral aspergillosis.
    European journal of haematology, 2009, Volume: 82, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Brain; Brain Abscess; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mood Disorders; Myelodysplastic Syndromes; Personality; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2009
Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:6

    Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Wood

2009
Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatitis, Phototoxic; Diagnosis, Differential; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2009
Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach.
    Mycoses, 2010, Mar-01, Volume: 53, Issue:2

    Topics: Antifungal Agents; Child; Debridement; Dermatomycoses; Fusarium; Humans; Leukemia, Myeloid; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Mycoses; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2010
Prolonged survival of a patient with AIDS and central nervous system aspergillosis.
    Medical mycology, 2009, Volume: 47, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Aspergillus fumigatus; Brain; Head; Humans; Male; Neuroaspergillosis; Pyrimidines; Radiography; Survival; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2009
Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Humans; Lipopeptides; Male; Plasma; Pyrimidines; Triazoles; Voriconazole

2009
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Packaging; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Infusions, Parenteral; Mycoses; Polyenes; Polyvinyl Chloride; Pyrimidines; Time Factors; Triazoles; Voriconazole

2008
Blastomycosis.
    Headache, 2009, Volume: 49, Issue:3

    Topics: Adult; Antifungal Agents; Blastomycosis; Contrast Media; Headache; Humans; Magnetic Resonance Imaging; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole

2009
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2009
Candida parapsilosis endocarditis in aged patient.
    European journal of internal medicine, 2009, Volume: 20, Issue:1

    Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis; Female; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole

2009
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole

2009
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
    Der Anaesthesist, 2009, Volume: 58, Issue:3

    Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole

2009
Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.
    Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Female; Humans; Male; Middle Aged; Osteomyelitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Amphotericin B; Animals; Animals, Domestic; Animals, Wild; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Pharmacokinetics of intracameral voriconazole injection.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Animals; Antifungal Agents; Aqueous Humor; Half-Life; Injections; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole

2009
[Usefulness of monitoring plasma voriconazole concentration in patients with chronic necrotizing pulmonary aspergillosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:1

    Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Liver; Male; Middle Aged; Plasma; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2009
Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Bone marrow transplantation, 2009, Volume: 44, Issue:6

    Topics: Adult; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Statistics, Nonparametric; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole

2009
Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient.
    Clinical nephrology, 2009, Volume: 71, Issue:3

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheters, Indwelling; Female; Fungemia; Humans; Paecilomyces; Pyrimidines; Renal Dialysis; Triazoles; Voriconazole

2009
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2009, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents, Phytogenic; Drug Interactions; Female; Fluconazole; Humans; Male; Middle Aged; Peristalsis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Vincristine; Voriconazole

2009
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Irish medical journal, 2009, Volume: 102, Issue:1

    Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Confidence Intervals; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2009
The use of voriconazole in the management of post-penetrating keratoplasty Paecilomyces keratitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:2

    Topics: Antifungal Agents; Combined Modality Therapy; Drug Administration Routes; Endophthalmitis; Eye Infections, Fungal; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2009
Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole.
    The Journal of dermatology, 2009, Volume: 36, Issue:2

    Topics: Antifungal Agents; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Mycetoma; Nephrotic Syndrome; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2009
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Invasive Pulmonary Aspergillosis; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole

2009
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Transplantation, 2009, Mar-15, Volume: 87, Issue:5

    Topics: Adult; Antifungal Agents; Antiviral Agents; Bronchiolitis Obliterans; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Graft Rejection; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Syndrome; Triazoles; Valganciclovir; Voriconazole

2009
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1

    Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:1

    Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Male; Meningitis, Cryptococcal; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole

2009
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult

2009
[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain Abscess; Caspofungin; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Leukoencephalopathy, Progressive Multifocal; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Galactose; Humans; Mannans; Pulmonary Aspergillosis; Pyrimidines; Rabbits; Triazoles; Voriconazole

2009
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, May-01, Volume: 48, Issue:9

    Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2009
Concentrations of voriconazole in healthy and inflamed lung in rats.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Animals; Antifungal Agents; Lung; Male; Muscle, Skeletal; Pneumonia; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Triazoles; Voriconazole

2009
Topical and oral voriconazole in the treatment of fungal keratitis.
    Korean journal of ophthalmology : KJO, 2009, Volume: 23, Issue:1

    Topics: Administration, Oral; Antifungal Agents; Candidiasis; Cornea; Diagnosis, Differential; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Triazoles; Voriconazole

2009
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:3

    Topics: Administration, Oral; Algorithms; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Theoretical; Pyrimidines; Time Factors; Triazoles; Voriconazole

2009
The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2009, Volume: 266, Issue:11

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cyclophosphamide; Disease Models, Animal; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Lipopeptides; Otitis Media; Pyrimidines; Rabbits; Triamcinolone Acetonide; Triazoles; Voriconazole

2009
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders.
    International journal of hematology, 2009, Volume: 89, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
[Two cases of mycoses associated with hematologic disease].
    The Japanese journal of antibiotics, 2008, Volume: 61, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cunninghamella; Fatal Outcome; Humans; Liposomes; Male; Mucormycosis; Myelodysplastic Syndromes; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2008
[Case of pulmonary mycoses associated with malignant lymphoma during chemotherapy].
    The Japanese journal of antibiotics, 2008, Volume: 61, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lymphoma; Male; Middle Aged; Muscle Neoplasms; Prednisolone; Psoas Muscles; Pyrimidines; Treatment Outcome; Triazoles; Vincristine; Voriconazole

2008
Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2009, Volume: 72, Issue:1

    Topics: Aerosols; Animals; Area Under Curve; beta-Cyclodextrins; Chemistry, Pharmaceutical; Drug Delivery Systems; Lipopeptides; Lung; Male; Mice; Particle Size; Pharmaceutical Solutions; Plasma; Pyrimidines; Solutions; Triazoles; Voriconazole

2009
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2009
Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    The Journal of infectious diseases, 2009, May-01, Volume: 199, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Drosophila; Fungi; Humans; Itraconazole; Mice; Mucor; Pyrimidines; Rhizopus; Triazoles; Virulence; Voriconazole; Zygomycosis

2009
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
    Le infezioni in medicina, 2009, Volume: 17, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2009
Fusarium keratitis and endophthalmitis associated with lens contact wear.
    International ophthalmology, 2010, Volume: 30, Issue:1

    Topics: Adult; Antifungal Agents; Contact Lens Solutions; Contact Lenses; Cornea; Corneal Transplantation; Disease Progression; Drug Resistance, Fungal; Endophthalmitis; Fusarium; Humans; Keratitis; Male; Patient Compliance; Pyrimidines; Time Factors; Triazoles; Visual Acuity; Voriconazole

2010
Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 5

    Topics: Antifungal Agents; Female; Humans; Kidney Failure, Chronic; Middle Aged; Mycoses; Neosartorya; Peritoneal Dialysis; Peritonitis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Simultaneous determination of voriconazole and posaconazole concentrations in human plasma by high-performance liquid chromatography.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2009
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2009
Dynamics of in vitro acquisition of resistance by Candida parapsilosis to different azoles.
    FEMS yeast research, 2009, Volume: 9, Issue:4

    Topics: Antifungal Agents; Biosynthetic Pathways; Candida; Drug Resistance, Fungal; Ergosterol; Fluconazole; Humans; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole

2009
In vitro activity of voriconazole against Mexican oral yeast isolates.
    Mycoses, 2010, Volume: 53, Issue:3

    Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Mexico; Microbial Sensitivity Tests; Mouth; Pharynx; Pyrimidines; Triazoles; Voriconazole

2010
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:6

    Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole

2009
[Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Bioprosthesis; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Endocarditis; Heart Valve Prosthesis; Humans; Lipopeptides; Liposomes; Male; Middle Aged; Photosensitivity Disorders; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole

2010
Fatal cerebral zygomycosis breakthrough in a patient with acute lymphoblastic leukemia on voriconazole prophylaxis after cord blood SCT.
    Bone marrow transplantation, 2009, Volume: 44, Issue:11

    Topics: Adult; Antifungal Agents; Central Nervous System Fungal Infections; Cord Blood Stem Cell Transplantation; Fatal Outcome; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2009
Aspergillus vertebral osteomyelitis and epidural abscess.
    Singapore medical journal, 2009, Volume: 50, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Epidural Abscess; Fatal Outcome; Humans; Infusions, Intravenous; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pneumonectomy; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Spinal Cord Compression; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole

2009
Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Lipopeptides; Male; Mycoses; Neutropenia; Pyrimidines; Retrospective Studies; Salvage Therapy; Triazoles; Voriconazole

2009
Intracameral voriconazole: in vitro safety for human ocular cells.
    Toxicology, 2009, Apr-28, Volume: 258, Issue:2-3

    Topics: Antifungal Agents; Cell Count; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Corneal; Eye; Formazans; Humans; Hydrogen Peroxide; Interleukin-6; Lipopolysaccharides; Molecular Structure; Organ Culture Techniques; Pigment Epithelium of Eye; Pyrimidines; Tetrazolium Salts; Time Factors; Trabecular Meshwork; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole

2009
Antifungal activity of itraconazole and voriconazole against clinical isolates obtained from animals with mycoses.
    Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2009, Volume: 50, Issue:2

    Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Prospective open-label study of the administration of two-percent voriconazole eye drops.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aqueous Humor; Female; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2009
Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Eye Infections, Fungal; Female; Humans; Keratitis; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Recurrence; Salvage Therapy; Scedosporium; Triazoles; Visual Acuity; Voriconazole

2009
Isolated cerebral aspergilloma in a young immunocompetent patient.
    Practical neurology, 2009, Volume: 9, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Brain Edema; Female; Humans; Muscle Weakness; Pyrimidines; Seizures; Treatment Outcome; Triazoles; Voriconazole

2009
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.
    The Journal of laryngology and otology, 2009, Volume: 123, Issue:9

    Topics: Antifungal Agents; Aspergillus; Candida albicans; Candidiasis; Colony Count, Microbial; Ear Diseases; Fluconazole; Humans; Itraconazole; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
[Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    La Revue de medecine interne, 2010, Volume: 31, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Male; Pain; Peripheral Nervous System Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole

2009
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Kidney; Male; Mice; Pyrimidines; Random Allocation; Triazoles; Voriconazole

2009
The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.
    Journal of lipid research, 2010, Volume: 51, Issue:2

    Topics: Animals; Antifungal Agents; Brain; Cattle; Cholesterol; Cholesterol 24-Hydroxylase; Enzyme Inhibitors; Gene Expression Regulation; Homeostasis; Humans; Hydroxycholesterols; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Pyrimidines; RNA, Messenger; Steroid Hydroxylases; Triazoles; Voriconazole

2010
Subcutaneous mycosis and fungemia by Aureobasidium pullulans: a rare pathogenic fungus in a post allogeneic BM transplant patient.
    Bone marrow transplantation, 2010, Volume: 45, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Fungemia; Humans; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2010
Infections caused by Candida krusei in five transplant and two surgical patients.
    Surgical infections, 2009, Volume: 10, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole

2009
Successful treatment of choroidal blastomycosis with oral administration of voriconazole.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Blastomycosis; Choroid Diseases; Dose-Response Relationship, Drug; Eye Infections, Fungal; Follow-Up Studies; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2009
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
    Mycoses, 2010, Volume: 53, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Caspofungin; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Female; Humans; Lipopeptides; Male; Middle Aged; Pneumonectomy; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Management of metabolic cytochrome P450 3A4 drug-drug interaction between everolimus and azole antifungals in a renal transplant patient.
    Clinical drug investigation, 2009, Volume: 29, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Everolimus; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pyrimidines; Sirolimus; Triazoles; Voriconazole

2009
Anidulafungin treatment of candidal central nervous system infection in a murine model.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole

2009
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole

2009
Dose tolerability of chronically inhaled voriconazole solution in rodents.
    International journal of pharmaceutics, 2009, Sep-08, Volume: 379, Issue:1

    Topics: Administration, Inhalation; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Invasive Pulmonary Aspergillosis; Lung; Macrophages, Alveolar; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles; Voriconazole

2009
Systemic phaeohyphomycosis resembling primary sclerosing cholangitis caused by Exophiala dermatitidis.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 9

    Topics: Amphotericin B; Antifungal Agents; Cholangitis, Sclerosing; Diagnosis, Differential; Exophiala; Female; Humans; Lymph Nodes; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
Toxicokinetics of voriconazole during massive intentional poisoning.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3

    Topics: Antifungal Agents; Humans; Male; Middle Aged; Poisoning; Pyrimidines; Serum; Triazoles; Voriconazole

2009
[Complex visual hallucinations induced by voriconazole].
    Medicina clinica, 2009, Jun-27, Volume: 133, Issue:4

    Topics: Aged; Antifungal Agents; Female; Hallucinations; Humans; Pyrimidines; Triazoles; Voriconazole

2009
In vitro interactions between antifungals and methotrexate against Aspergillus spp.
    Mycopathologia, 2009, Volume: 168, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Itraconazole; Methotrexate; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2009
Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus.
    Medical mycology, 2010, Volume: 48, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coturnix; Disease Models, Animal; Female; Histocytochemistry; Lung; Male; Microbial Sensitivity Tests; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole

2010
New treatment for invasive fungal sinusitis: three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole.
    Auris, nasus, larynx, 2010, Volume: 37, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    American journal of veterinary research, 2009, Volume: 70, Issue:7

    Topics: Antifungal Agents; Drug Compounding; Drug Stability; Pharmaceutical Vehicles; Pyrimidines; Suspensions; Tablets; Temperature; Time Factors; Triazoles; Voriconazole

2009
Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:3

    Topics: Administration, Intravaginal; Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Drug Resistance, Fungal; Female; Fluconazole; Mice; Mice, Inbred BALB C; Pyrimidines; Treatment Outcome; Triazoles; Vagina; Voriconazole

2009
Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) in three laboratories: results obtained with 2,162 clinical isolates of Candida spp. and othe
    Journal of clinical microbiology, 2009, Volume: 47, Issue:9

    Topics: Antifungal Agents; Candida; Diagnostic Errors; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2009
Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
    Veterinary microbiology, 2009, Nov-18, Volume: 139, Issue:3-4

    Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Columbidae; Invasive Pulmonary Aspergillosis; Liver; Pyrimidines; Triazoles; Voriconazole

2009
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
    The new microbiologica, 2009, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole

2009
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
    The new microbiologica, 2009, Volume: 32, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Italy; Microbial Sensitivity Tests; Outpatient Clinics, Hospital; Prevalence; Pyrimidines; Recurrence; Triazoles; Vagina; Voriconazole

2009
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2009, Volume: 42, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole

2009
Neuroaspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:14

    Topics: Aged; Antifungal Agents; Brain Diseases; Humans; Immunocompetence; Male; Neuroaspergillosis; Pyrimidines; Remission Induction; Triazoles; Voriconazole

2009
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
    Journal of pharmaceutical and biomedical analysis, 2009, Dec-05, Volume: 50, Issue:5

    Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole

2009
Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
    Mycopathologia, 2010, Volume: 169, Issue:1

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resistance, Multiple, Fungal; Genetic Variation; Genome, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Sequence Analysis, DNA; Thailand; Triazoles; Trichosporon; Voriconazole

2010
[Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of Blastoschizomyces capitatus (Geotrichum capitatum) by two different methods].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:2

    Topics: Antifungal Agents; Dipodascus; Fluconazole; Geotrichosis; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Cutaneous aspergillosis in a lung transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Female; Humans; Lung Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2009
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
    Emerging infectious diseases, 2009, Volume: 15, Issue:7

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Disease Progression; Drug Resistance, Fungal; Evolution, Molecular; Fungal Proteins; Humans; Itraconazole; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2009
Fusarium endophthalmitis following refractive lens exchange for correction of high myopia.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:8

    Topics: Anterior Chamber; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Mycoses; Myopia, Degenerative; Pyrimidines; Reoperation; Triazoles; Visual Acuity; Voriconazole

2009
Can density functional theory (DFT) be used as an aid to a deeper understanding of tandem mass spectrometric fragmentation pathways?
    Rapid communications in mass spectrometry : RCM, 2009, Volume: 23, Issue:17

    Topics: Antifungal Agents; Fluconazole; Molecular Structure; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole

2009
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
    Thorax, 2009, Volume: 64, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole

2009
Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:9

    Topics: Aged; Antifungal Agents; Cohort Studies; Female; Humans; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2009
Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
    Journal of veterinary pharmacology and therapeutics, 2009, Volume: 32, Issue:3

    Topics: Administration, Oral; Animals; Antifungal Agents; Camelids, New World; Chromatography, High Pressure Liquid; Female; Injections, Intravenous; Linear Models; Male; Pyrimidines; Triazoles; Voriconazole

2009
Fungal keratitis with intracameral extension following penetrating keratoplasty.
    Cornea, 2009, Volume: 28, Issue:8

    Topics: Administration, Oral; Administration, Topical; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Debridement; Drug Administration Schedule; Graft Rejection; Humans; Injections; Keratitis; Keratoconus; Keratoplasty, Penetrating; Male; Middle Aged; Postoperative Care; Prednisolone; Pyrimidines; Triazoles; Visual Acuity; Voriconazole

2009
Practice patterns in the management of fungal corneal ulcers.
    Cornea, 2009, Volume: 28, Issue:8

    Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Corneal Ulcer; Debridement; Drug Costs; Drug Therapy, Combination; Humans; Mycoses; Natamycin; Ophthalmology; Patients; Practice Patterns, Physicians'; Pyrimidines; Surveys and Questionnaires; Treatment Outcome; Triazoles; Voriconazole

2009
Atypical Aspergillus flavus isolates associated with chronic azole therapy.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Azoles; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2009
Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14, Issue:4

    Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Drug Interactions; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Meningitis, Cryptococcal; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2010
Stability of extemporaneously prepared voriconazole ophthalmic solution.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009, Aug-15, Volume: 66, Issue:16

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Compounding; Drug Packaging; Drug Stability; Drug Storage; Humans; Ophthalmic Solutions; Pyrimidines; Temperature; Triazoles; Voriconazole

2009
Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:6

    Topics: Adult; Amino Acid Substitution; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Azoles; Bronchitis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Middle Aged; Mutation, Missense; Plasma; Pyrimidines; Triazoles; Voriconazole

2010
Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
    Diagnostic microbiology and infectious disease, 2009, Volume: 65, Issue:1

    Topics: Antifungal Agents; Candida; Diagnostic Errors; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quality Assurance, Health Care; Sensitivity and Specificity; Triazoles; Voriconazole

2009
"Soft"or "hard" ionisation? Investigation of metastable gas temperature effect on direct analysis in real-time analysis of Voriconazole.
    European journal of mass spectrometry (Chichester, England), 2009, Volume: 15, Issue:5

    Topics: Pyrimidines; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Voriconazole

2009
[Cryptococcal meningitis with a fatal outcome in an immunocompetent adult].
    Enfermedades infecciosas y microbiologia clinica, 2010, Volume: 28, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Fatal Outcome; Fluconazole; Headache; Hearing Loss, Bilateral; Humans; Immunocompetence; Intracranial Hypertension; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Spinal Puncture; Triazoles; Voriconazole

2010
Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fusarium; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
    Bone marrow transplantation, 2010, Volume: 45, Issue:4

    Topics: Adult; Antifungal Agents; Chemoprevention; Female; Fluconazole; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2010
Effects of antifungal agents in sap activity of Candida albicans isolates.
    Mycopathologia, 2010, Volume: 169, Issue:2

    Topics: Antifungal Agents; Aspartic Acid Proteases; Candida albicans; Candidiasis; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole

2010
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient.
    The American journal of the medical sciences, 2009, Volume: 338, Issue:4

    Topics: Adrenalectomy; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Immunocompetence; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis

2009
A novel fungal pathogen under the spotlight--Acremonium spp. associated fungaemia in an immunocompetent host.
    Mycoses, 2011, Volume: 54, Issue:1

    Topics: Acremonium; Antifungal Agents; Female; Fungemia; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2011
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2009, Volume: 7, Issue:3

    Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2009
Central nervous system Aspergillus infection after epidural analgesia: diagnosis, therapeutic challenges, and literature review.
    Diagnostic microbiology and infectious disease, 2009, Volume: 65, Issue:3

    Topics: Adult; Analgesia, Epidural; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Infections; Female; Humans; Pyrimidines; Triazoles; Voriconazole

2009
Keratitis resulting from Thielavia subthermophila Mouchacca.
    Cornea, 2009, Volume: 28, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Child; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Retrospective Studies; Sordariales; Triazoles; Voriconazole

2009
Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
    Acta medica Okayama, 2009, Volume: 63, Issue:4

    Topics: Adult; Antifungal Agents; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Biphenotypic, Acute; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2009
Phenytoin-induced reduction of voriconazole serum concentration is not compensated by doubling the dosage.
    British journal of clinical pharmacology, 2009, Volume: 68, Issue:3

    Topics: Anticonvulsants; Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Middle Aged; Phenytoin; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Discovery of highly potent novel antifungal azoles by structure-based rational design.
    Bioorganic & medicinal chemistry letters, 2009, Oct-15, Volume: 19, Issue:20

    Topics: Antifungal Agents; Azoles; Binding Sites; Computer Simulation; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Hydrogen Bonding; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole

2009
The effects of an hsp90 inhibitor on the paradoxical effect.
    Japanese journal of infectious diseases, 2009, Volume: 62, Issue:5

    Topics: Animals; Antifungal Agents; Candida albicans; Echinocandins; Enzyme Inhibitors; Fungi; HSP90 Heat-Shock Proteins; Lipopeptides; Macrolides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2009
Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation.
    Transplantation proceedings, 2009, Volume: 41, Issue:7

    Topics: Antifungal Agents; Diabetes Mellitus; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Kidney Transplantation; Middle Aged; Mycoses; Paecilomyces; Polycystic Kidney Diseases; Postoperative Complications; Pyrimidines; Renal Replacement Therapy; Ribavirin; Treatment Outcome; Triazoles; Voriconazole

2009
Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report.
    Transplantation proceedings, 2009, Volume: 41, Issue:7

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Aspergillus; Endophthalmitis; Eye Enucleation; Humans; Liver Cirrhosis; Liver Transplantation; Male; Polymerase Chain Reaction; Pyrimidines; Triazoles; Vancomycin; Voriconazole; Young Adult

2009
Penetrating keratoplasty for invasive fungal keratitis resulting from a thorn injury involving Phomopsis species.
    Cornea, 2009, Volume: 28, Issue:10

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Ascomycota; Cataract; Cataract Extraction; Corneal Ulcer; Eye Infections, Fungal; Eye Injuries, Penetrating; Gardening; Humans; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Plant Diseases; Postoperative Care; Pyrimidines; Reoperation; Triazoles; Voriconazole

2009
Development and validation of a stability-indicating HPLC method for determination of voriconazole and its related substances.
    Journal of chromatographic science, 2009, Volume: 47, Issue:7

    Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Stability; Hydrolysis; Oxidation-Reduction; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2009
Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes.
    Journal of cutaneous pathology, 2009, Volume: 36 Suppl 1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Diagnosis, Differential; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycetoma; Opportunistic Infections; Pyrimidines; Scedosporium; Skin Diseases; Triazoles; Voriconazole

2009
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts

2010
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Mycoses; Pyrimidines; Time Factors; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2010
[Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus flavus; Caspofungin; Chemotherapy, Adjuvant; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Humans; Injections, Intraventricular; Lipopeptides; Male; Neuroaspergillosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2009
Scedosporium scleritis or keratitis or both: case series.
    Eye & contact lens, 2009, Volume: 35, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Keratitis; Keratoplasty, Penetrating; Male; Medical Records; Ophthalmic Solutions; Postoperative Complications; Pterygium; Pyrimidines; Scedosporium; Scleritis; Treatment Outcome; Triazoles; Voriconazole

2009
[Effects of voriconazole and vascular lesions in invasion of aspergillosis into the central nerve system].
    Rinsho shinkeigaku = Clinical neurology, 2009, Volume: 49, Issue:8

    Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Cerebral Infarction; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole

2009
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.
    Medical mycology, 2010, Volume: 48, Issue:3

    Topics: Anti-HIV Agents; Antifungal Agents; Cerebrospinal Fluid; Dideoxynucleosides; Drug Monitoring; HIV Infections; Humans; Interferon-gamma; Lamivudine; Male; Meningitis, Cryptococcal; Pyrimidines; Ritonavir; Serum; Triazoles; Voriconazole; Young Adult

2010
In vitro hepatic metabolism explains higher clearance of voriconazole in children versus adults: role of CYP2C19 and flavin-containing monooxygenase 3.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:1

    Topics: Adult; Aging; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Biocatalysis; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Kinetics; Liver; Microsomes, Liver; Middle Aged; Models, Biological; Oxygenases; Pyrimidines; Triazoles; Voriconazole; Young Adult

2010
Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Caspofungin; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2010
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:12

    Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; Lung Transplantation; Male; Middle Aged; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2009
Voriconazole concentrations and outcome of invasive fungal infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:7

    Topics: Adult; Aged; Antifungal Agents; Australia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
    Haematologica, 2010, Volume: 95, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Middle Aged; Prospective Studies; Pyrimidines; Registries; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
    Mycopathologia, 2010, Volume: 169, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Blood; Candida tropicalis; Candidiasis; Catheterization; Cell Adhesion; Cells, Cultured; Enzymes; Epithelial Cells; Equipment and Supplies; Fluconazole; Fungal Proteins; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Urine; Virulence Factors; Voriconazole

2010
Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:12

    Topics: Administration, Topical; Antifungal Agents; Candidiasis; Humans; Keratitis; Male; Middle Aged; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:6

    Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2010
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Female; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Pyrimidines; Tracheitis; Triazoles; Voriconazole

2010
Treatment with voriconazole in 3 eyes with resistant Acanthamoeba keratitis.
    American journal of ophthalmology, 2010, Volume: 149, Issue:1

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Topical; Adolescent; Antiprotozoal Agents; Contact Lenses; Cornea; Drug Resistance; Female; Humans; Keratoplasty, Penetrating; Middle Aged; Ophthalmic Solutions; Pyrimidines; Retrospective Studies; Triazoles; Visual Acuity; Voriconazole

2010
Pythium insidiosum keratitis in an Australian child.
    Clinical & experimental ophthalmology, 2009, Volume: 37, Issue:8

    Topics: Antifungal Agents; Australia; Biguanides; Child, Preschool; Corneal Transplantation; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Female; Genes, rRNA; Humans; Pyrimidines; Pythium; Triazoles; Voriconazole

2009
A 19-year-old man with progressive lung infiltrates.
    Cleveland Clinic journal of medicine, 2009, Volume: 76, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bronchoscopy; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult; Zygomycosis

2009
Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.
    Medical mycology, 2010, Volume: 48, Issue:3

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cervical Vertebrae; Drainage; Echinocandins; Granulomatous Disease, Chronic; Humans; Interferon-gamma; Itraconazole; Lipopeptides; Male; Osteomyelitis; Pyrimidines; Saudi Arabia; Thoracic Vertebrae; Treatment Outcome; Triazoles; Voriconazole

2010
Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Mycoses, 2011, Volume: 54, Issue:3

    Topics: Adolescent; Aged; Antifungal Agents; Chemoprevention; Drug Monitoring; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mycoses; Pyrimidines; Serum; Triazoles; Voriconazole

2011
Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive Candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Automation; Candida; Candidiasis; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Statistics as Topic; Triazoles; Voriconazole

2010
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
    Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Carcinoma, Squamous Cell; Child; Comorbidity; Dermatitis, Phototoxic; DNA Damage; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Middle Aged; Pyrimidines; Retrospective Studies; Skin Neoplasms; Triazoles; Voriconazole; Young Adult

2010
[Designing a tool to describe drug interactions and adverse events for learning and clinical routine].
    Annales pharmaceutiques francaises, 2009, Volume: 67, Issue:6

    Topics: Antifungal Agents; Audiovisual Aids; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Education, Pharmacy, Continuing; Immunosuppressive Agents; Leukocyte Count; Pharmacists; Pyrimidines; Software; Students, Pharmacy; Tacrolimus; Triazoles; Voriconazole

2009
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Mycoses, 2011, Volume: 54, Issue:3

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2011
Management of obstructive renal failure caused by bilateral renal aspergilloma in an immunocompetent newborn.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bladder Exstrophy; Humans; Infant, Newborn; Male; Nephrostomy, Percutaneous; Pyrimidines; Renal Insufficiency; Treatment Outcome; Triazoles; Ureterostomy; Voriconazole

2010
Primary cutaneous infection with Scedosporium apiospermum successfully treated with voriconazole.
    Mycoses, 2011, Volume: 54, Issue:4

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Arm; Biopsy; Dermatomycoses; Drug Resistance, Fungal; Histocytochemistry; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Microbial Sensitivity Tests; Microscopy; Middle Aged; Pyrimidines; Scedosporium; Skin; Treatment Outcome; Triazoles; Voriconazole

2011
Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:9

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Female; Humans; Immunocompromised Host; Male; Middle Aged; Pyrimidines; Time Factors; Triazoles; Voriconazole

2010
Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Chemical Analysis; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Transplantation; Transplantation, Homologous; Triazoles; Voriconazole; Young Adult

2010
Voriconazole pharmacokinetics in liver transplant recipients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Female; Genotype; Humans; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2010
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
    Bone marrow transplantation, 2010, Volume: 45, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2010
[Cerebral aspergilloma in an immunocompetent patient: radiological and histopathological findings].
    Neurologia (Barcelona, Spain), 2009, Volume: 24, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Brain; Central Nervous System Fungal Infections; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult

2009
How many steps along the path is too far?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1

    Topics: Antifungal Agents; Child; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole pharmacokinetics and pharmacodynamics in children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Linear Models; Male; Models, Biological; Mycoses; Proportional Hazards Models; Pyrimidines; Retrospective Studies; Statistics, Nonparametric; Triazoles; Voriconazole; Young Adult

2010
An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery.
    Current eye research, 2009, Volume: 34, Issue:11

    Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Disease Outbreaks; Drug Therapy, Combination; Endophthalmitis; Eye Evisceration; Eye Infections, Fungal; Female; Fusarium; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Retrospective Studies; Triazoles; Turkey; Visual Acuity; Vitrectomy; Voriconazole

2009
Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses.
    Medical mycology, 2010, Volume: 48, Issue:4

    Topics: Antifungal Agents; Biofilms; Calcineurin; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Gene Expression Regulation, Fungal; HSP90 Heat-Shock Proteins; Lipopeptides; Micafungin; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole

2010
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colorimetry; Confidence Intervals; Drug Therapy, Combination; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole

2010
Subcutaneous phaeohyphomycosis in a renal transplant recipient successfully treated with voriconazole.
    Acta dermato-venereologica, 2009, Volume: 89, Issue:6

    Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Kidney Transplantation; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Alternaria sinusitis in children with acute myeloid leukemia: case reports from the Childhood Acute Myeloid Leukemia Infection Research Group.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:2

    Topics: Adolescent; Alternaria; Amphotericin B; Antifungal Agents; Child, Preschool; Female; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2010
Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Colony Count, Microbial; Disease Models, Animal; Kidney; Male; Mice; Mycoses; Neutropenia; Pyrimidines; Sepsis; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
    Haematologica, 2010, Volume: 95, Issue:6

    Topics: Adolescent; Adult; Aged; Air Pollutants; Caspofungin; Cohort Studies; Construction Materials; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2010
Voriconazole-associated myositis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2009, Volume: 15, Issue:7

    Topics: Acute Disease; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Myositis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2009
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison.
    Cornea, 2010, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Beauveria; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Fungal; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Middle Aged; Mycoses; Pest Control; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole

2010
In vivo and in vitro investigations of fungal keratitis caused by Colletotrichum gloeosporioides.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2009, Volume: 25, Issue:6

    Topics: Aged, 80 and over; Antifungal Agents; Colletotrichum; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Keratitis; Natamycin; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Oral voriconazole for invasive fungal skull base infection.
    The Journal of laryngology and otology, 2010, Volume: 124, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Biopsy; Diagnosis, Differential; Exophthalmos; Female; Humans; Magnetic Resonance Imaging; Pyrimidines; Radiography; Skull Base; Triazoles; Voriconazole

2010
In vitro activities of azole antifungal agents against Propionibacterium acnes isolated from patients with acne vulgaris.
    Biological & pharmaceutical bulletin, 2010, Volume: 33, Issue:1

    Topics: Acne Vulgaris; Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Phytotherapy; Propionibacterium acnes; Pyrimidines; Triazoles; Voriconazole

2010
Management of endogenous cryptococcal endophthalmitis with voriconazole.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:6

    Topics: Aged, 80 and over; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Pyrimidines; Triazoles; Voriconazole

2009
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:1

    Topics: Adult; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Function Tests; Lymphocyte Depletion; Male; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Statistics as Topic; T-Lymphocytes; Triazoles; Voriconazole

2010
The effects of antifungal agents to conidial and hyphal forms of Aspergillus fumigatus.
    Medical mycology, 2010, Volume: 48, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Hyphae; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Spores, Fungal; Tetrazolium Salts; Triazoles; Voriconazole

2010
Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma.
    Medical mycology, 2010, Volume: 48, Issue:1

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Fungal Proteins; Humans; Itraconazole; Male; Middle Aged; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2010
Mycetoma of the foot.
    British journal of hospital medicine (London, England : 2005), 2009, Volume: 70, Issue:11

    Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Madurella; Magnetic Resonance Imaging; Mycetoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2009
Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
    Archives of dermatology, 2010, Volume: 146, Issue:3

    Topics: Adult; Antifungal Agents; Biopsy; Chronic Disease; Coccidioidomycosis; Diagnosis, Differential; Ear; Female; Follow-Up Studies; Forearm; Granulomatous Disease, Chronic; Humans; Male; Melanoma; Meningitis, Fungal; Photosensitivity Disorders; Pyrimidines; Skin Neoplasms; Time Factors; Triazoles; Voriconazole; Young Adult

2010
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2010
Current controversies in treating invasive zygomycosis.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Cunninghamella; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Mucormycosis; Pyrimidines; Triazoles; Voriconazole

2010
Impact of mold infections in explanted lungs on outcomes of lung transplantation.
    Transplantation, 2010, Jan-27, Volume: 89, Issue:2

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antifungal Agents; Female; Heart-Lung Transplantation; Humans; Incidence; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Retrospective Studies; Survival Rate; Survivors; Triazoles; Voriconazole

2010
The successful medical treatment of a case of Paecilomyces lilacinus keratitis.
    Cornea, 2010, Volume: 29, Issue:3

    Topics: Administration, Topical; Aged; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2010
Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp.
    Medical mycology, 2010, Volume: 48, Issue:5

    Topics: Adult; Antifungal Agents; Caspofungin; Cells, Cultured; Cunninghamella; Echinocandins; Enzyme-Linked Immunosorbent Assay; Humans; Interleukin-6; Interleukin-8; Lipopeptides; Microbial Viability; Neutrophils; Pyrimidines; Rhizopus; Tetrazolium Salts; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole

2010
[Porphyria cutanea tarda revealed by voriconazole].
    Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:1

    Topics: Aged; Alcoholism; Antifungal Agents; Cheilitis; Feces; Humans; Liver; Male; Photosensitivity Disorders; Porphyria Cutanea Tarda; Porphyrins; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Uroporphyrinogen Decarboxylase; Voriconazole

2010
Resolution of secondary pulmonary alveolar proteinosis following treatment of rhinocerebral aspergillosis.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3

    Topics: Aged; Amphotericin B; Antifungal Agents; Female; Humans; Magnetic Resonance Imaging; Neuroaspergillosis; Pulmonary Alveolar Proteinosis; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2010
Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Citrus paradisi; Colony Count, Microbial; Diet; Immunocompromised Host; Kidney; Liver; Male; Mice; Mycoses; Paecilomyces; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Pediatric blood & cancer, 2010, Jul-01, Volume: 54, Issue:7

    Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Pyrimidines; Triazoles; Voriconazole

2010
Antifungal management.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2010, Volume: 16, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cord Blood Stem Cell Transplantation; Echinocandins; Humans; Leukemia; Lung; Male; Middle Aged; Neutropenia; Postoperative Complications; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia.
    Medical mycology, 2010, Volume: 48, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Survival; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lipopeptides; Micafungin; Monocytes; Pyrimidines; Spores, Fungal; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole

2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:4

    Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Post-traumatic fungal keratitis caused by Carpoligna sp.
    Cornea, 2010, Volume: 29, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Base Sequence; Corneal Injuries; Corneal Ulcer; DNA, Fungal; Eye Infections, Fungal; Eye Injuries; Humans; Lacerations; Male; Mitosporic Fungi; Molecular Sequence Data; Natamycin; Polymerase Chain Reaction; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 28S; Triazoles; Voriconazole

2010
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:1

    Topics: Adult; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Pyrimidines; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole

2010
Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole.
    International ophthalmology, 2010, Volume: 30, Issue:6

    Topics: Administration, Topical; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Corneal Stroma; Eye Infections, Fungal; Female; Follow-Up Studies; Humans; Injections, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Critical Illness; Drug Monitoring; Female; Humans; Injections, Intravenous; Kidney; Kidney Function Tests; Liver; Liver Function Tests; Male; Middle Aged; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2010
Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Antifungal Agents; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Endpoint Determination; Fluconazole; Itraconazole; Lipopeptides; Pyrimidines; Time Factors; Triazoles; Voriconazole

2010
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2010
Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
    Therapeutic drug monitoring, 2010, Volume: 32, Issue:2

    Topics: Adult; Age Factors; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Pyrimidines; Saliva; Triazoles; Voriconazole

2010
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:5

    Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole

2010
[Infectious keratitis and cosmetic lenses: a five-case retrospective study].
    Journal francais d'ophtalmologie, 2010, Volume: 33, Issue:4

    Topics: Abscess; Acanthamoeba Keratitis; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Antifungal Agents; Benzamidines; Biguanides; Blindness; Contact Lenses; Corneal Opacity; Corneal Surgery, Laser; Female; Gentamicins; Humans; Keratitis; Middle Aged; Pseudomonas Infections; Pyrimidines; Retrospective Studies; Risk Factors; Serratia Infections; Staphylococcal Infections; Ticarcillin; Triazoles; Vancomycin; Voriconazole; Young Adult

2010
[Near-drowning and cerebral infections caused by fungi belonging to the Pseudallescheria / Scedosporium-complex].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2010, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Brain; Central Nervous System Infections; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Mycoses; Near Drowning; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Young Adult

2010
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
    Mycoses, 2011, Volume: 54, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2011
Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Chemoprevention; Cost-Benefit Analysis; Female; Hospitals; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
    The clinical respiratory journal, 2008, Volume: 2, Issue:4

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2008
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 7

    Topics: Aged; Antifungal Agents; Aspergillus niger; Female; Humans; Lung; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
    Transplantation proceedings, 2010, Volume: 42, Issue:2

    Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole

2010
Alternaria and paecilomyces keratitis associated with soft contact lens wear.
    Cornea, 2010, Volume: 29, Issue:5

    Topics: Adult; Alternaria; Antifungal Agents; Contact Lens Solutions; Contact Lenses, Hydrophilic; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Paecilomyces; Pyrimidines; Triazoles; Voriconazole; Young Adult

2010
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:2

    Topics: Africa; Americas; Antifungal Agents; Asia; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Europe; Fluconazole; Geography; Humans; Microbial Sensitivity Tests; Middle East; Pyrimidines; Triazoles; Voriconazole

2010
Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
    Mycopathologia, 2010, Volume: 170, Issue:3

    Topics: Acremonium; Amphotericin B; Antifungal Agents; Blood; Child; Fever; Fungemia; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Triazoles; Voriconazole

2010
Renal allograft loss due to overwhelming invasive Candida infection.
    Kidney international, 2010, Volume: 77, Issue:8

    Topics: Adult; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Humans; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
EUCAST breakpoints for antifungals.
    Drug news & perspectives, 2010, Volume: 23, Issue:2

    Topics: Antifungal Agents; Candida; Computer Simulation; Drug Resistance, Fungal; Europe; Fluconazole; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole

2010
Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).
    Medical mycology, 2010, Volume: 48, Issue:6

    Topics: Animals; Antifungal Agents; Chordata; Chrysosporium; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Reptiles; Triazoles; Voriconazole

2010
Truncated Afyap1 attenuates antifungal susceptibility of Aspergillus fumigatus to voriconazole and confers adaptation of the fungus to oxidative stress.
    Mycopathologia, 2010, Volume: 170, Issue:3

    Topics: Adaptation, Physiological; Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; Humans; Oxidative Stress; Pyrimidines; Sequence Deletion; Stress, Physiological; Transcription Factors; Triazoles; Voriconazole

2010
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2010, Volume: 45, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Functional Laterality; Fungemia; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole

2010
Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:1

    Topics: Aged; Animals; Antifungal Agents; beta-Cyclodextrins; Critical Illness; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Renal Dialysis; Renal Insufficiency; Triazoles; Voriconazole

2010
Intravenous voriconazole after toxic oral administration.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Administration, Oral; Antifungal Agents; Drug Eruptions; Humans; Injections, Intravenous; Liver; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Sphenoid Sinusitis; Triazoles; Voriconazole

2010
Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.
    The Journal of infectious diseases, 2010, Jun-15, Volume: 201, Issue:12

    Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Cytokines; Echinocandins; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Microbial Viability; Microscopy, Confocal; Oxidation-Reduction; Phagocytes; Pyrimidines; Respiratory Burst; Rhodamines; Staining and Labeling; Triazoles; Voriconazole

2010
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole

2010
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
    Pediatric pulmonology, 2010, Volume: 45, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole

2010
Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole.
    The Pediatric infectious disease journal, 2010, Volume: 29, Issue:5

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Male; Mycoses; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2010
Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis.
    American journal of ophthalmology, 2010, Volume: 149, Issue:6

    Topics: Acremonium; Adult; Aged; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Injections; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2010
Voriconazole for both successful treatment of disseminated Trichosporon asahii infection and subsequent cord blood transplantation in an infant with acute myelogenous leukemia.
    Bone marrow transplantation, 2011, Volume: 46, Issue:2

    Topics: Antifungal Agents; Cord Blood Stem Cell Transplantation; Female; Humans; Infant; Leukemia, Myeloid, Acute; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2011
[Susceptibility to fluconazole and voriconazole of Candida species isolated from intensive care units patients in Medellin, Colombia (2001-2007)].
    Revista iberoamericana de micologia, 2010, Sep-30, Volume: 27, Issue:3

    Topics: Antifungal Agents; Candida; Colombia; Fluconazole; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
AfMkk2 is required for cell wall integrity signaling, adhesion, and full virulence of the human pathogen Aspergillus fumigatus.
    International journal of medical microbiology : IJMM, 2010, Volume: 300, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cell Adhesion; Cell Wall; Disease Models, Animal; Glass; Humans; Hydrogen-Ion Concentration; Mice; Mitogen-Activated Protein Kinase Kinases; Plastics; Pyrimidines; Signal Transduction; Survival Analysis; Temperature; Triazoles; Virulence; Virulence Factors; Voriconazole

2010
Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients.
    Bone marrow transplantation, 2011, Volume: 46, Issue:3

    Topics: Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Pyrimidines; Tacrolimus; Transplantation, Homologous; Triazoles; Voriconazole

2011
Fatal peritonitis caused by Rhizopus microsporus.
    Medical mycology, 2010, Volume: 48, Issue:8

    Topics: Antifungal Agents; Colon; Crohn Disease; Fatal Outcome; Female; Humans; Intestinal Perforation; Middle Aged; Mucormycosis; Peritonitis; Pyrimidines; Rhizopus; Triazoles; Voriconazole

2010
[Primary cutaneous aspergillosis in an immunocompetent farmworker].
    Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:5

    Topics: Adult; Agricultural Workers' Diseases; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biopsy; Dermatomycoses; Dermis; Facial Dermatoses; Humans; Immunocompetence; Male; Neutrophils; Periodic Acid-Schiff Reaction; Pyrimidines; Triazoles; Voriconazole

2010
X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:5

    Topics: Antifungal Agents; Child; Granulomatous Disease, Chronic; Humans; Male; Photosensitivity Disorders; Pyrimidines; Serratia Infections; Skin Aging; Triazoles; Voriconazole

2010
Fusarium sepsis, voriconazole, and the skin.
    Cutis, 2010, Volume: 85, Issue:4

    Topics: Antifungal Agents; Fusarium; Humans; Mycoses; Pyrimidines; Sepsis; Skin; Triazoles; Voriconazole

2010
Characterization of yeasts colonizing in healthy individuals.
    Medical mycology, 2011, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Carrier State; Female; Fluconazole; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Taiwan; Triazoles; Voriconazole; Yeasts; Young Adult

2011
Cutaneous hyalohyphomycosis in a girdled lizard (Cordylus giganteus) caused by the Chrysosporium anamorph of Nannizziopsis vriesii and successful treatment with voriconazole.
    Veterinary dermatology, 2010, Volume: 21, Issue:4

    Topics: Animals; Antifungal Agents; Chrysosporium; Hyalohyphomycosis; Lizards; Pyrimidines; Triazoles; Voriconazole

2010
A case series of unilateral orbital aspergillosis in three cats and treatment with voriconazole.
    Veterinary ophthalmology, 2010, Volume: 13, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Cat Diseases; Cats; Eye Diseases; Pyrimidines; Triazoles; Voriconazole

2010
Identification of Paecilomyces variotii in clinical samples and settings.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:8

    Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole

2010
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Mass Spectrometry; Pyrimidines; Reference Standards; Triazoles; Voriconazole

2010
Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:11

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Fatal Outcome; Female; Heart Transplantation; Humans; Lung Transplantation; Middle Aged; Mycoses; Neoplasm Invasiveness; Neoplasm Metastasis; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole

2010
Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.
    Cornea, 2010, Volume: 29, Issue:9

    Topics: Acanthamoeba Keratitis; Administration, Oral; Adolescent; Antiprotozoal Agents; Chronic Disease; Corneal Stroma; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2010
Determination of voriconazole in human serum and plasma by micellar electrokinetic chromatography.
    Journal of pharmaceutical and biomedical analysis, 2010, Dec-15, Volume: 53, Issue:5

    Topics: Animals; Cattle; Chromatography, Micellar Electrokinetic Capillary; Humans; Male; Plasma; Pyrimidines; Reproducibility of Results; Serum; Triazoles; Voriconazole

2010
Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Experimental murine scedosporiosis: histopathology and azole treatment.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Brain; Kidney; Mice; Mycetoma; Pyrimidines; Scedosporium; Spleen; Treatment Outcome; Triazoles; Voriconazole

2010
In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and posaconazole by Clinical and Laboratory Standards Institute reference method and E-test.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole

2011
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jul-15, Volume: 51, Issue:2

    Topics: Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Hand; Humans; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2010
Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing.
    Medical mycology, 2011, Volume: 49, Issue:1

    Topics: Amphotericin B; Candida; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Pyrimidines; Triazoles; Voriconazole

2011
Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:6

    Topics: Antifungal Agents; Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Fluconazole; Humans; Itraconazole; Microsomes, Liver; Pyrimidines; Triazoles; Voriconazole

2010
Increasing the dose of voriconazole compensates for enzyme induction by phenytoin.
    British journal of clinical pharmacology, 2010, Volume: 69, Issue:6

    Topics: Administration, Oral; Adult; Anticonvulsants; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Humans; Phenytoin; Pyrimidines; Triazoles; Voriconazole

2010
In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Antifungal Agents; Dipodascus; Fluconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Rhodotorula; Saccharomyces cerevisiae; Triazoles; Trichosporon; Voriconazole

2010
Voriconazole-associated salt-losing nephropathy.
    Clinical and experimental nephrology, 2010, Volume: 14, Issue:4

    Topics: Aged; Antifungal Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Fluid Therapy; Humans; Hyponatremia; Kidney Diseases; Liver; Male; Neurophysins; Protein Precursors; Pyrimidines; Renin; Sodium; Sodium Chloride; Time Factors; Treatment Outcome; Triazoles; Vasopressins; Voriconazole; Water-Electrolyte Balance

2010
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Pediatric pulmonology, 2010, Volume: 45, Issue:7

    Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole

2010
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.
    Pediatric hematology and oncology, 2010, Volume: 27, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Case report 2: Fungal infections in chronic obstructive pulmonary disease.
    Mycoses, 2010, Volume: 53 Suppl 2

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillus fumigatus; Belgium; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography, Thoracic; Steroids; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Case-Control Studies; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Multivariate Analysis; Mycoses; Opportunistic Infections; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Sunlight; Triazoles; Voriconazole

2010
Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Europe; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; United States; Voriconazole

2010
Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
    Current eye research, 2010, Volume: 35, Issue:7

    Topics: Administration, Topical; Animals; Antifungal Agents; Aqueous Humor; Biological Availability; Biological Transport; Chromatography, High Pressure Liquid; Debridement; Epithelium, Corneal; Microbial Sensitivity Tests; Ophthalmic Solutions; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole

2010
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Pyrimidines; Reoperation; Retrospective Studies; Survivors; Time Factors; Tissue Donors; Triazoles; Valganciclovir; Voriconazole

2010
Using sweeping-micellar electrokinetic chromatography to determine voriconazole in patient plasma.
    Talanta, 2010, Jul-15, Volume: 82, Issue:2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Humans; Limit of Detection; Micelles; Molecular Structure; Pyrimidines; Triazoles; Voriconazole

2010
Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6

    Topics: Abscess; Antifungal Agents; Caspofungin; Echinocandins; Female; Forearm; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Lipopeptides; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Soft Tissue Infections; Treatment Outcome; Triazoles; Voriconazole

2010
Aspergillus endocarditis 2003-2009.
    Medical mycology, 2011, Volume: 49 Suppl 1

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Endocarditis; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Surgical Procedures, Operative; Triazoles; Voriconazole; Young Adult

2011
[Rhodotorula glutinis sepsis. A case report].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole

2010
Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2010, Volume: 35, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Hepatitis, Chronic; Humans; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2010
Successful topical application of caspofungin in the treatment of fungal keratitis refractory to voriconazole.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:7

    Topics: Administration, Topical; Antifungal Agents; Candidiasis; Caspofungin; Corneal Ulcer; Drug Resistance, Fungal; Echinocandins; Eye Infections, Fungal; Female; Humans; Lipopeptides; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2010
Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Male; Mice; Pyrimidines; Triazoles; Voriconazole

2010
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2010
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Fusarium; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.
    FEMS immunology and medical microbiology, 2010, Volume: 60, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; CD11b Antigen; Cells, Cultured; Echinocandins; Gene Expression; Gene Expression Profiling; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Interleukin-8; Lipopeptides; Neutrophils; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptors; Triazoles; Up-Regulation; Voriconazole

2010
Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Geotrichum; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Characterization of Candida parapsilosis complex isolates.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole

2011
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study).
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Guideline Adherence; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2010
Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring.
    Xenobiotica; the fate of foreign compounds in biological systems, 2010, Volume: 40, Issue:10

    Topics: Adult; Antifungal Agents; Drug Monitoring; Female; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2010
Persistent photopsia following course of oral voriconazole.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:4

    Topics: Administration, Oral; Antifungal Agents; Female; Histoplasmosis; Humans; Middle Aged; Ocular Physiological Phenomena; Pyrimidines; Treatment Outcome; Triazoles; Vision Disorders; Voriconazole

2010
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole

2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
    Bone marrow transplantation, 2011, Volume: 46, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
    The Journal of dermatological treatment, 2011, Volume: 22, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2011
Comparison and evaluation of a novel bioassay and high-performance liquid chromatography for the clinical measurement of serum voriconazole concentrations.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Assay; Candida; Child; Chromatography, High Pressure Liquid; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Serum; Triazoles; Voriconazole; Young Adult

2011
Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.
    The Journal of biological chemistry, 2010, Oct-08, Volume: 285, Issue:41

    Topics: Amino Acid Substitution; Anticonvulsants; Antidepressive Agents; Antifungal Agents; Brain; Catalytic Domain; Cholesterol; Cholesterol 24-Hydroxylase; Clotrimazole; Crystallography, X-Ray; Humans; Mutation, Missense; Piperidines; Protein Binding; Pyrimidines; Steroid Hydroxylases; Structure-Activity Relationship; Tranylcypromine; Triazoles; Voriconazole

2010
Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10

    Topics: Adult; Aged; Antifungal Agents; Biological Availability; Female; Humans; Lung Transplantation; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole; Young Adult

2010
Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Acetaminophen; Chemistry, Pharmaceutical; Crystallization; Dextrans; Dosage Forms; Indomethacin; Ketolides; Magnetic Resonance Spectroscopy; Pyrimidines; Solubility; Suspensions; Trehalose; Triazoles; Voriconazole

2010
Are disk diffusion and Etest methods reliable for detecting Candida glabrata and other species' susceptibility to fluconazole and voriconazole?
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4

    Topics: Antifungal Agents; Candida glabrata; Disk Diffusion Antimicrobial Tests; False Positive Reactions; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Triazoles; Voriconazole

2010
Generation of mutants in Candida albicans with reduced susceptibility to caspofungin: influence on other antifungal products.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole

2010
Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome.
    Southern medical journal, 2010, Volume: 103, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Humans; Itraconazole; Lung; Mycetoma; Pneumothorax; Pyrimidines; Scedosporium; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:4

    Topics: Animals; Anti-Infective Agents; Aza Compounds; Cell Count; Cell Survival; Chondroitin Sulfates; Complex Mixtures; Cornea; Cryopreservation; Culture Media, Serum-Free; Dextrans; Endothelium, Corneal; Fluoroquinolones; Gentamicins; Moxifloxacin; Organ Preservation Solutions; Pyrimidines; Quinolines; Swine; Tissue Preservation; Triazoles; Voriconazole

2010
An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.
    Pharmacology, 2010, Volume: 86, Issue:3

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Injections, Intravenous; Male; Nonlinear Dynamics; Pyrimidines; Rats; Rats, Wistar; Triazoles; Voriconazole

2010
Developing a safe antifungal treatment protocol to eliminate Batrachochytrium dendrobatidis from amphibians.
    Medical mycology, 2011, Volume: 49, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Anura; Chytridiomycota; Clinical Protocols; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Clinician ordering practices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory.
    Therapeutic drug monitoring, 2010, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Monitoring; Female; Humans; Laboratories; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pyrimidines; Referral and Consultation; Triazoles; Voriconazole

2010
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1->3)-beta-D-glucan detection in serum samples as an adjunct to diagnosis.
    Journal of medical microbiology, 2010, Volume: 59, Issue:Pt 12

    Topics: Antifungal Agents; beta-Glucans; Child; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteoglycans; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2010
Fungal spinal cord compression in metastatic synovial sarcoma.
    Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Fractures, Spontaneous; Humans; Lung Neoplasms; Mycoses; Neoplasm Recurrence, Local; Neoplasm Staging; Osteomyelitis; Pneumonectomy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Spinal Cord Compression; Spinal Cord Neoplasms; Triazoles; Voriconazole

2011
Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole

2010
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole

2010
Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Female; Fungal Proteins; Mice; Microbial Sensitivity Tests; Mutation; Pyrimidines; Triazoles; Voriconazole

2010
Cystoid macular edema secondary to fluconazole toxicity.
    Ocular immunology and inflammation, 2010, Volume: 18, Issue:6

    Topics: Administration, Oral; Aged; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Pyrimidines; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Voriconazole

2010
Increasing incidence of mucormycosis in University Hospital, Belgium.
    Emerging infectious diseases, 2010, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult

2010
Catheter-associated aspergillosis of the chest wall following allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Catheters; Child, Preschool; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Pyrimidines; Thoracic Wall; Transplantation, Homologous; Triazoles; Voriconazole

2011
Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Transplantation; Lipopeptides; Pyrimidines; Thyroid Gland; Thyroiditis; Triazoles; Voriconazole

2011
Fusarium keratitis 3 weeks after healed corneal cross-linking.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2010, Volume: 26, Issue:12

    Topics: Collagen; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fusarium; Humans; Keratoconus; Mycoses; Photosensitizing Agents; Pyrimidines; Riboflavin; Surgical Wound Infection; Tobramycin; Triazoles; Ultraviolet Rays; Voriconazole; Wound Healing; Young Adult

2010
Successful treatment of sellar aspergillus abscess.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:12

    Topics: Aged; Antifungal Agents; Brain Abscess; Caspofungin; Diagnosis, Differential; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Neuroaspergillosis; Neurosurgical Procedures; Pituitary Diseases; Pituitary Neoplasms; Pyrimidines; Triazoles; Voriconazole

2010
Ulcerated plaque under a ruby ring in an immunosuppressed patient.
    Dermatology online journal, 2010, Aug-15, Volume: 16, Issue:8

    Topics: Adenine Nucleotides; Aged; Antineoplastic Agents; Arabinonucleosides; Candida; Candidiasis, Cutaneous; Clofarabine; Cytarabine; Dermatologic Agents; Dermatomycoses; Fusarium; Humans; Immunocompromised Host; Itraconazole; Jewelry; Leukemia, Myeloid, Acute; Male; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole

2010
In vitro and in vivo antifungal susceptibilities of the Mucoralean fungus Cunninghamella.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Cunninghamella; Diabetes Mellitus, Experimental; Echinocandins; Itraconazole; Lipopeptides; Male; Mice; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Thiazoles; Triazoles; Voriconazole

2010
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Austria; Azoles; Denmark; Drug Resistance, Fungal; Environmental Microbiology; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2010
[Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:8

    Topics: Acidosis; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Micafungin; Multiple Myeloma; Pyrazines; Pyrimidines; Triazoles; Tumor Lysis Syndrome; Voriconazole; Zygomycosis

2010
[Species distribution and antifungal susceptibilities of yeast clinical isolates from three hospitals in Korea, 2001 to 2007].
    The Korean journal of laboratory medicine, 2010, Volume: 30, Issue:4

    Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Hospitals; Humans; Pyrimidines; Republic of Korea; Rhodotorula; Triazoles; Trichosporon; Voriconazole; Yeasts

2010
Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole

2011
Rapid detection of Acanthamoeba cysts in frozen sections of corneal scrapings with Fungiflora Y.
    The British journal of ophthalmology, 2010, Volume: 94, Issue:11

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Anti-Infective Agents, Local; Chlorhexidine; Coloring Agents; Corneal Diseases; Epithelium, Corneal; Eye Infections, Parasitic; Frozen Sections; Humans; Organic Chemicals; Pyrimidines; Triazoles; Voriconazole

2010
Oral voriconazole dose in children: one size does not fit all.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Oct-01, Volume: 51, Issue:7

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Mycoses; Pyrimidines; Triazoles; Voriconazole

2010
Trichosporon surgical wound infection in a renal allograft recipient successfully treated with voriconazole.
    Transplantation, 2010, Sep-15, Volume: 90, Issue:5

    Topics: Adult; Antifungal Agents; Biopsy; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; Male; Mycoses; Necrosis; Pyrimidines; Treatment Outcome; Triazoles; Trichosporon; Voriconazole

2010
Comparison of a glucose consumption based method with the CLSI M38-A method for testing antifungal susceptibility of Trichophyton rubrum and Trichophyton mentagrophytes.
    Chinese medical journal, 2010, Volume: 123, Issue:14

    Topics: Antifungal Agents; Econazole; Glucose; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Trichophyton; Voriconazole

2010
Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis.
    Medical mycology, 2011, Volume: 49, Issue:2

    Topics: Aged; Antifungal Agents; Hemoptysis; Humans; Immunocompromised Host; Kidney Transplantation; Lung Diseases, Fungal; Male; Mycetoma; Pseudallescheria; Pyrimidines; Sarcoidosis; Triazoles; Voriconazole

2011
Keratomycosis in a dog treated with topical 1% voriconazole solution.
    Veterinary ophthalmology, 2010, Volume: 13, Issue:5

    Topics: Administration, Topical; Animals; Antifungal Agents; Dog Diseases; Dogs; Eye Infections, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2010
Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Mycopathologia, 2011, Volume: 171, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Fusarium; Mice; Mycoses; Pyrimidines; Survival Rate; Triazoles; Voriconazole

2011
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2010
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspo
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Anidulafungin; Antifungal Agents; Blood Chemical Analysis; Caspofungin; Chromatography, Liquid; Echinocandins; Humans; Itraconazole; Lipopeptides; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole

2010
[Treatment of ABPA: a place for voriconazole and omalizumab?].
    Revue des maladies respiratoires, 2010, Volume: 27, Issue:7

    Topics: Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Humans; Omalizumab; Pyrimidines; Triazoles; Voriconazole

2010
[Rebound after ABPA treatment with voriconazole].
    Revue des maladies respiratoires, 2010, Volume: 27, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Female; Humans; Male; Middle Aged; Pyrimidines; Recurrence; Triazoles; Voriconazole

2010
Pulmonary aspergillosis in a non-neutropenic critical patient.
    The Journal of trauma, 2010, Volume: 69, Issue:4

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Burns, Inhalation; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Humans; Hydrogen Sulfide; Intensive Care Units; Lipopeptides; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole

2010
[Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis of Aspergillus fumigatus].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Female; Intravitreal Injections; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Random Allocation; Triazoles; Voriconazole

2010
Fast and reliable determination of voriconazole in human plasma by LC-APCI-MS/MS.
    Bioscience, biotechnology, and biochemistry, 2010, Volume: 74, Issue:10

    Topics: Aged; Atmospheric Pressure; Blood Chemical Analysis; Chromatography, Liquid; Female; Humans; Male; Pyrimidines; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole

2010
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fatal Outcome; Female; Fungemia; Humans; Immunocompromised Host; Molecular Sequence Data; Mycoses; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole; Young Adult

2011
In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.
    Tropical biomedicine, 2010, Volume: 27, Issue:2

    Topics: Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2010
Voriconazole plasma levels in children are highly variable.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:2

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Humans; Infant; Male; Plasma; Pyrimidines; Spectrophotometry; Triazoles; Voriconazole

2011
Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro?
    Clinical orthopaedics and related research, 2011, Volume: 469, Issue:5

    Topics: Anidulafungin; Antifungal Agents; Drug Carriers; Drug Implants; Echinocandins; Polymethyl Methacrylate; Pyrimidines; Solubility; Time Factors; Triazoles; Voriconazole

2011
Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.
    Mycopathologia, 2011, Volume: 171, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Fluconazole; Lung; Mice; Mice, Inbred BALB C; Mice, SCID; Pyrimidines; Rodent Diseases; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole; Yeasts

2011
Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Aged; Antifungal Agents; Female; Humans; Liver; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
[Clinical implication of therapeutic drug monitoring on voriconazole from the aspect of the analysis for CYP2C19 gene].
    The Japanese journal of antibiotics, 2010, Volume: 63, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Liver; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2010
Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings.
    International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:11

    Topics: Antifungal Agents; Drug Stability; Feasibility Studies; Humans; Microdialysis; Pyrimidines; Time Factors; Triazoles; Voriconazole

2010
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Chinese medical journal, 2010, Volume: 123, Issue:19

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
Severe Arthrographis kalrae keratomycosis in an immunocompetent patient.
    Cornea, 2011, Volume: 30, Issue:3

    Topics: Adult; Antifungal Agents; Candida albicans; Contact Lenses, Hydrophilic; Corneal Perforation; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Keratoplasty, Penetrating; Mitosporic Fungi; Mycoses; Pyrimidines; Reoperation; Triazoles; Voriconazole

2011
The treatment of pulmonary Wangiella dermatitidis infection with oral voriconazole.
    Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:3

    Topics: Administration, Oral; Aged, 80 and over; Antifungal Agents; Bronchoalveolar Lavage Fluid; Exophiala; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2011
Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
    Medical mycology, 2010, Volume: 48 Suppl 1

    Topics: Adult; Antifungal Agents; Cystic Fibrosis; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Random Amplified Polymorphic DNA Technique; Scedosporium; Triazoles; Voriconazole

2010
Human tissue distribution of voriconazole.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Adult; Aged; Aspergillosis; Autopsy; Brain; Female; Humans; Kidney; Liver; Lung; Male; Middle Aged; Myocardium; Pyrimidines; Spleen; Tissue Distribution; Triazoles; Voriconazole; Young Adult

2011
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole

2011
Successful treatment of systemic Geotrichum capitatum infection by liposomal amphotericin-B, itraconazole, and voriconazole in a Japanese man.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:22

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Geotrichosis; Humans; Itraconazole; Japan; Male; Middle Aged; Pyrimidines; Remission Induction; Triazoles; Voriconazole

2010
Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis.
    American journal of ophthalmology, 2010, Volume: 150, Issue:6

    Topics: Acremonium; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Injections; Pyrimidines; Risk Factors; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2010
Fatal dysrhythmia following initiation of lansoprazole during a long-term course of voriconazole.
    Journal of clinical pharmacology, 2011, Volume: 51, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Antifungal Agents; Aspergillosis; Drug Interactions; Fatal Outcome; Humans; Lansoprazole; Male; Pyrimidines; Tachycardia, Ventricular; Triazoles; Voriconazole

2011
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis.
    Cornea, 2011, Volume: 30, Issue:4

    Topics: Administration, Topical; Aged; Alternaria; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microscopy, Confocal; Mycoses; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole

2011
A case of bovine valve endocarditis caused by Engyodontium album.
    Medical mycology, 2011, Volume: 49, Issue:4

    Topics: Adult; Antifungal Agents; Arthritis, Juvenile; Ascomycota; Beauveria; DNA, Fungal; Endocarditis; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Mycoses; Prosthesis-Related Infections; Pyrimidines; Reoperation; Sequence Analysis, DNA; Triazoles; Voriconazole

2011
Impact of therapeutic drug monitoring of voriconazole in a pediatric population.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:6

    Topics: Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Mycoses; Plasma; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2011
Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Chemoprevention; Child; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole

2011
Clinical features and outcomes of four patients with invasive fungal sinusitis.
    Auris, nasus, larynx, 2011, Volume: 38, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].
    Brain and nerve = Shinkei kenkyu no shinpo, 2010, Volume: 62, Issue:12

    Topics: Administration, Oral; Aged, 80 and over; Amphotericin B; Antigens, Fungal; Cerebrospinal Fluid; Cryptococcus neoformans; Drug Therapy, Combination; Female; Humans; Liposomes; Meningitis, Cryptococcal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Clinical importance of the CYP2C19*17 variant allele for voriconazole.
    British journal of clinical pharmacology, 2011, Volume: 71, Issue:1

    Topics: Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Humans; Pharmaceutical Preparations; Pyrimidines; Triazoles; Voriconazole

2011
Aspergillus infection of supramid orbital implant and hyperostosis of orbital bone: report of a unique case.
    Orbit (Amsterdam, Netherlands), 2010, Volume: 29, Issue:6

    Topics: Adult; Aspergillosis; Aspergillus; Combined Modality Therapy; Device Removal; Follow-Up Studies; Humans; Hyperostosis; Male; Nylons; Orbital Fractures; Orbital Implants; Prosthesis-Related Infections; Pyrimidines; Radiography; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2010
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Treatment for fungal endophthalmitis resulting from keratitis.
    American journal of ophthalmology, 2011, Volume: 151, Issue:1

    Topics: Acremonium; Alternaria; Anterior Chamber; Antifungal Agents; Aspergillus; Corneal Ulcer; Endophthalmitis; Eye Infections, Fungal; Fusarium; Humans; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole

2011
In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms.
    Journal of Korean medical science, 2010, Volume: 25, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Caspofungin; Catheter-Related Infections; Catheterization, Central Venous; Drug Administration Routes; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2010
Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Opportunistic Infections; Periostitis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Radiography; Radionuclide Imaging; Triazoles; Voriconazole

2011
Resolution of recurrent fusarium arthritis after prolonged antifungal therapy.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:1

    Topics: Ankle Joint; Antifungal Agents; Arthritis, Infectious; Drug Therapy, Combination; Fusarium; Humans; Immunocompromised Host; Mycoses; Pyrimidines; Recurrence; Toe Joint; Triazoles; Voriconazole

2011
Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
    Mycopathologia, 2011, Volume: 171, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Tunisia; Voriconazole

2011
Pharmacokinetics of voriconazole in adult mallard ducks (Anas platyrhynchos).
    Medical mycology, 2011, Volume: 49, Issue:5

    Topics: Administration, Oral; Animals; Anseriformes; Antifungal Agents; Biological Assay; Chromatography, Liquid; Female; Injections, Intravenous; Male; Plasma; Pyrimidines; Triazoles; Voriconazole

2011
Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: Report of a case and a novel treatment.
    Ear, nose, & throat journal, 2010, Volume: 89, Issue:12

    Topics: Aged; Antifungal Agents; Combined Modality Therapy; Debridement; Female; Follow-Up Studies; Fungemia; Humans; Immunocompromised Host; Lung Transplantation; Mycoses; Paecilomyces; Pulmonary Fibrosis; Pyrimidines; Rhinitis; Severity of Illness Index; Treatment Outcome; Triazoles; Voriconazole

2010
Management of voriconazole hepatotoxicity in a lung transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:3

    Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Lung Transplantation; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.
    Mycopathologia, 2011, Volume: 171, Issue:6

    Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Pyrimidines; Triazoles; Voriconazole

2011
Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Survival Analysis; Triazoles; Voriconazole; Young Adult

2010
Modulators of very low voriconazole concentrations in routine therapeutic drug monitoring.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:1

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Enzyme Induction; Female; Genotype; Humans; Male; Medication Adherence; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2011
Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Recurrent Lecythophora mutabilis keratitis and endophthalmitis after deep anterior lamellar keratoplasty.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Microscopy, Acoustic; Middle Aged; Mycoses; Phialophora; Pyrimidines; Recurrence; Triazoles; Voriconazole

2011
Interaction of oxycodone and voriconazole-a case series of patients with cancer pain supports the findings of randomised controlled studies with healthy subjects.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:8

    Topics: Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Female; Humans; Male; Oxycodone; Pyrimidines; Triazoles; Voriconazole

2011
Effects of voriconazole co-administration on oxycodone-induced adverse events: a case in the retrospective survey.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antifungal Agents; Aspergillosis; Burkitt Lymphoma; Chronic Pain; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Mycoses; Oxycodone; Pyrimidines; Receptors, Opioid, mu; Retrospective Studies; Triazoles; Voriconazole

2011
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of ep
    Journal of clinical microbiology, 2011, Volume: 49, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: one stone two birds.
    Leukemia research, 2011, Volume: 35, Issue:5

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Immunosuppression Therapy; Invasive Pulmonary Aspergillosis; Leukemia; Pyrimidines; Radiography; Remission Induction; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole

2011
Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Mar-01, Volume: 52, Issue:5

    Topics: Adult; Aged; Alkaline Phosphatase; Antifungal Agents; Exostoses; Female; Fluorides; Heart Transplantation; Humans; Male; Middle Aged; Periostitis; Plasma; Pyrimidines; Transplantation; Triazoles; Voriconazole

2011
[Fatal outcome of invasive tracheal aspergillosis].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2011, Volume: 183, Issue:5

    Topics: Antifungal Agents; Bronchi; Carotid Artery, External; Caspofungin; Contrast Media; Echinocandins; Fatal Outcome; Hemoptysis; Humans; Image Processing, Computer-Assisted; Iohexol; Lipopeptides; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, Spiral Computed; Trachea; Tracheal Diseases; Triazoles; Voriconazole; Young Adult

2011
Severe acute hypokalaemia secondary to voriconazole. Uncommon pharmacological causes of hypokalaemia.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1

    Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Invasive; Drug Therapy, Combination; Humans; Hypokalemia; Linezolid; Lung Diseases, Fungal; Male; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Potassium Chloride; Pyrimidines; Triazoles; Voriconazole

2011
Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an effect not predicted by the MIC value alone.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Drug Interactions; Drug Resistance, Fungal; Fungal Proteins; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole as secondary antifungal prophylaxis in stem cell transplant recipients.
    Haematologica, 2011, Volume: 96, Issue:2

    Topics: Antifungal Agents; Humans; Leukemia; Mycoses; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole

2011
A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:3

    Topics: Aged; Antifungal Agents; Heart Transplantation; Humans; Male; Periostitis; Pyrimidines; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Triazoles; Voriconazole; Whole Body Imaging

2011
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:4

    Topics: Antifungal Agents; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2011
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
    AIDS (London, England), 2011, Feb-20, Volume: 25, Issue:4

    Topics: Anti-Retroviral Agents; Aspergillosis; Aspergillus; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Male; Nitriles; Pneumonia, Aspiration; Pyridazines; Pyrimidines; Ritonavir; Triazoles; Voriconazole

2011
Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
    Clinical pharmacokinetics, 2011, Volume: 50, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Bayes Theorem; Female; Humans; Liver Transplantation; Male; Middle Aged; Nonlinear Dynamics; Pyrimidines; Triazoles; Voriconazole

2011
The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
    Medical mycology, 2011, Volume: 49, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole

2011
Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:6

    Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2010
Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Biofilms; Drug Resistance, Fungal; Fungal Proteins; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Mutation; Pyrimidines; Triazoles; Voriconazole

2011
Cerebral phaeohyphomycosis caused by Bipolaris spicifera after heart transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:4

    Topics: Antifungal Agents; Ascomycota; Brain Abscess; Cerebral Phaeohyphomycosis; Heart Transplantation; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2011
[Fungal keratitis in an immunocompetent patient].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Corneal Opacity; Corneal Transplantation; Corneal Ulcer; Diagnostic Errors; Drug Resistance, Fungal; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Immunocompetence; Keratitis, Herpetic; Male; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2011
Antifungal use in hospitalized adults in U.S. academic health centers.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Mar-01, Volume: 68, Issue:5

    Topics: Academic Medical Centers; Adult; Antifungal Agents; Azoles; Caspofungin; Echinocandins; Humans; Lipopeptides; Multivariate Analysis; Practice Patterns, Physicians'; Pyrimidines; Regression Analysis; Triazoles; United States; Voriconazole

2011
Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Plankton; Pyrimidines; Triazoles; Voriconazole

2011
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patients.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1

    Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antifungal Agents; Female; Humans; International Normalized Ratio; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematology; Hospital Costs; Humans; Length of Stay; Lipopeptides; Male; Middle Aged; Models, Economic; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
Disseminated Rhizomucor pusillus causing early multiorgan failure during hematopoietic stem cell transplantation for severe aplastic anemia.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:3

    Topics: Amphotericin B; Anemia, Aplastic; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Mucormycosis; Multiple Organ Failure; Pyrimidines; Rhizomucor; Triazoles; Voriconazole

2011
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.
    International journal of hematology, 2011, Volume: 93, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2011
Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus.
    Journal of pharmaceutical sciences, 2011, Volume: 100, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Delayed-Action Preparations; Endophthalmitis; Eye; Humans; Intravitreal Injections; Microspheres; Pyrimidines; Rabbits; Triazoles; Voriconazole

2011
Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
    JPMA. The Journal of the Pakistan Medical Association, 2010, Volume: 60, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Child; Fever; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
A case of Candida haemulonii osteitis: clinical features, biochemical characteristics, and antifungal resistance profile.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:7

    Topics: Adult; Antifungal Agents; Candida; Candidiasis; Histocytochemistry; Humans; Male; Microbial Sensitivity Tests; Microscopy; Osteitis; Pyrimidines; Triazoles; United States; Vascular Surgical Procedures; Voriconazole

2011
Voriconazole-associated phototoxicity.
    Dermatology online journal, 2011, Feb-15, Volume: 17, Issue:2

    Topics: Antifungal Agents; Bone Marrow Transplantation; Dermatitis, Phototoxic; Humans; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Sunlight; Triazoles; Voriconazole

2011
A vascular graft infection by aspergillus treated without graft removal.
    Minerva chirurgica, 2011, Volume: 66, Issue:1

    Topics: Abscess; Adult; Anti-Bacterial Agents; Antifungal Agents; Aortic Aneurysm, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Combined Modality Therapy; Coronary Sinus; Coronary Vessels; Debridement; Drug Therapy, Combination; Fever; Heart Valve Prosthesis; Humans; Male; Postoperative Complications; Povidone-Iodine; Prosthesis-Related Infections; Pyrimidines; Replantation; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
    Medical mycology, 2011, Volume: 49, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole

2011
Voriconazole: may be an option for treatment of cryptococcal meningitis.
    Medical mycology, 2011, Volume: 49, Issue:3

    Topics: Animals; Antifungal Agents; Humans; Infant, Newborn; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2011
Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes.
    Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye, 2011, Mar-10, Volume: 42 Online

    Topics: Aged; Antifungal Agents; Candidiasis; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Male; Middle Aged; Postoperative Complications; Pseudophakia; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole

2011
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:7

    Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole

2011
Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
    Mycopathologia, 2011, Volume: 172, Issue:2

    Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Liver Cirrhosis; Mycoses; Nystatin; Paecilomyces; Pyrimidines; Skin Ulcer; Treatment Outcome; Triazoles; Voriconazole

2011
A 61 year-old female with a prior history of tuberculosis presenting with hemoptysis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Apr-01, Volume: 52, Issue:7

    Topics: Antifungal Agents; Emigrants and Immigrants; Female; Hemoptysis; Humans; Microscopy; Middle Aged; Mycetoma; Mycology; Pakistan; Pyrimidines; Radiography, Thoracic; Scedosporium; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; United States; Voriconazole

2011
Quantification of voriconazole in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry: application to a bioequivalence study.
    Arzneimittel-Forschung, 2011, Volume: 61, Issue:2

    Topics: Adult; Antifungal Agents; Area Under Curve; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Half-Life; Humans; Male; Pyrimidines; Quality Control; Reference Standards; Reproducibility of Results; Solutions; Solvents; Spectrometry, Mass, Electrospray Ionization; Therapeutic Equivalency; Triazoles; Voriconazole

2011
Highly activated oral bioavailability of tacrolimus on coadministration of oral voriconazole.
    International journal of clinical pharmacology and therapeutics, 2011, Volume: 49, Issue:4

    Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Drug Interactions; Female; Humans; Immunosuppressive Agents; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2011
Fatal mycotic aneurysms due to Scedosporium and Pseudallescheria infection.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:5

    Topics: Aneurysm, Infected; Antifungal Agents; Aorta; Cerebral Arteries; Fatal Outcome; Humans; Male; Middle Aged; Mycetoma; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Vascular Surgical Procedures; Voriconazole

2011
Mechanism of voriconazole-induced transient visual disturbance: reversible dysfunction of retinal ON-bipolar cells in monkeys.
    Investigative ophthalmology & visual science, 2011, Jul-07, Volume: 52, Issue:8

    Topics: Aminobutyrates; Animals; Antifungal Agents; Electroretinography; Infusions, Intravenous; Intravitreal Injections; Macaca fascicularis; Photic Stimulation; Photoreceptor Cells, Vertebrate; Pyrimidines; Retinal Bipolar Cells; Triazoles; Vision Disorders; Voriconazole

2011
Breakthrough lung Scedosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergillosis associated with monoclonal gammopathy of undetermined significance (MGUS).
    Medical mycology journal, 2011, Volume: 52, Issue:1

    Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mycetoma; Paraproteinemias; Pulmonary Aspergillosis; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2011
The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis.
    Cornea, 2011, Volume: 30, Issue:8

    Topics: Administration, Topical; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; Eye Infections, Fungal; Fusarium; Humans; Injections, Intraocular; Male; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
    The British journal of ophthalmology, 2011, Volume: 95, Issue:12

    Topics: Administration, Ophthalmic; Adult; Aged; Antifungal Agents; Aspergillosis; Corneal Ulcer; Eye Infections, Fungal; Female; Fusariosis; Humans; Injections, Intralesional; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.
    Irish medical journal, 2011, Volume: 104, Issue:2

    Topics: Antifungal Agents; Candidemia; Cross Infection; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole is effective as secondary antifungal prophylaxis in leukemia patients with prior pulmonary fungal disease: case series and review of literature.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Female; Humans; Leukemia; Lung Diseases, Fungal; Male; Middle Aged; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Oral voriconazole for neutropenia: a leukemia patient with probable pulmonary aspergillosis and scedosporidiosis.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1

    Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Leukemia; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2011
Treatment of microsporidia keratitis with topical voriconazole monotherapy.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:4

    Topics: Administration, Topical; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Humans; Male; Microsporidia; Microsporidiosis; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2011
Successful treatment of intra-abdominal Exophiala dermatitidis infection in a dog.
    The Veterinary record, 2011, Feb-26, Volume: 168, Issue:8

    Topics: Abdomen; Abdominal Abscess; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Exophiala; Female; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2011
Fungal endophthalmitis successfully treated with intravitreal voriconazole injection.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:8

    Topics: Adult; Antifungal Agents; Cord Blood Stem Cell Transplantation; Endophthalmitis; Eye Infections, Fungal; Female; Humans; Intravitreal Injections; Leukemia, Erythroblastic, Acute; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole toxicity related to polymorphisms in CYP2C19.
    Internal medicine journal, 2011, Volume: 41, Issue:4

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Hallucinations; Humans; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2011
The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.
    Infection, 2011, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Central Nervous System Fungal Infections; Child; Child, Preschool; Female; Humans; Infant; Male; Middle Aged; Pyrimidines; Retrospective Studies; Scedosporium; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Lupus-like lesions in a 28-month-old boy with chronic granulomatous disease on long-term voriconazole prophylaxis.
    Journal of cutaneous pathology, 2011, Volume: 38, Issue:8

    Topics: Antibiotic Prophylaxis; Antifungal Agents; Child, Preschool; Granulomatous Disease, Chronic; Humans; Lupus Erythematosus, Discoid; Male; Pyrimidines; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole

2011
Transcriptional profiling of azole-resistant Candida parapsilosis strains.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7

    Topics: Antifungal Agents; Azoles; Candida; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Profiling; Microbial Sensitivity Tests; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole

2011
Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:5

    Topics: Administration, Oral; Administration, Topical; Aged; Alternaria; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Keratitis; Lipopeptides; Pyrimidines; Triazoles; Voriconazole

2011
Oral Candida isolates among HIV-infected subjects in Nigeria.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:3

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole

2011
Scopulariopsis brevicaulis abscess in a child treated for myeloblastic leukaemia.
    The Lancet. Infectious diseases, 2011, Volume: 11, Issue:5

    Topics: Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Lung Abscess; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2011
Design, synthesis and molecular docking studies of novel triazole as antifungal agent.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:7

    Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Propanols; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole

2011
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole

2011
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Denmark; Drug Resistance, Fungal; Female; Hospitals; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Pyrimidines; Respiratory System; Respiratory Tract Infections; Treatment Outcome; Triazoles; Voriconazole

2011
Diagnosis and treatment of fungal infection after liver transplantation.
    Chinese medical journal, 2011, Volume: 124, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2011
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:7

    Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Pharmacokinetics of voriconazole during continuous venovenous hemofiltration.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:3

    Topics: Aged; Antifungal Agents; Area Under Curve; Hemofiltration; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Voriconazole

2011
Eumycetoma of the hand caused by Leptosphaeria tompkinsii and refractory to medical therapy with voriconazole.
    Mycopathologia, 2011, Volume: 172, Issue:4

    Topics: Antifungal Agents; Ascomycota; Debridement; DNA, Fungal; Hand; Histocytochemistry; Humans; Male; Middle Aged; Molecular Sequence Data; Mycetoma; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; United Kingdom; Voriconazole

2011
Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2

    Topics: Antifungal Agents; Candida; Candidemia; Cross Infection; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2011
Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Animals; Antifungal Agents; Ascomycota; Chromoblastomycosis; Itraconazole; Male; Mice; Mice, Nude; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2011
Antifungal susceptibility of ocular fungal pathogens recovered from around the world against itraconazole, voriconazole, amphotericin B, and caspofungin.
    Medical mycology, 2012, Volume: 50, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Eye Infections, Fungal; Fungi; Fusarium; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
An accidental mass.
    Lancet (London, England), 2011, May-21, Volume: 377, Issue:9779

    Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
    Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:9

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Fungal; Female; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Rabbits; Triazoles; Vitreous Body; Voriconazole

2011
[Intralobar pulmonary sequestration with aspergillosis in an asymptomatic 39-year-old man].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:22

    Topics: Adult; Bronchopulmonary Sequestration; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Radiography; Thoracotomy; Treatment Outcome; Triazoles; Voriconazole

2011
Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Antifungal Agents; Exophiala; Genotype; Humans; Microbial Sensitivity Tests; Phaeohyphomycosis; Pyrimidines; Triazoles; Voriconazole

2011
Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction.
    Mycoses, 2011, Volume: 54, Issue:6

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Interactions; Genotype; Half-Life; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Triazoles; Vincristine; Voriconazole

2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole

2011
Isolated cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic stem cell transplantation.
    Journal of infection in developing countries, 2011, May-28, Volume: 5, Issue:5

    Topics: Adult; Antifungal Agents; Aspergillosis; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Stem Cell Transplantation; Treatment Outcome; Triazoles; Voriconazole

2011
Cutaneous fusariosis developing in a post-irradiation site.
    Dermatology online journal, 2011, May-15, Volume: 17, Issue:5

    Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole

2011
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
    Veterinary microbiology, 2011, Aug-26, Volume: 152, Issue:1-2

    Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:4

    Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole; Young Adult

2011
Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.
    Ophthalmology, 2011, Volume: 118, Issue:9

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Infant; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Diseases; Paranasal Sinus Diseases; Pyrimidines; Retrospective Studies; Tomography, X-Ray Computed; Triazoles; Voriconazole; Young Adult

2011
Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection.
    Bone marrow transplantation, 2012, Volume: 47, Issue:4

    Topics: Adult; Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mucormycosis; Pyrimidines; Radiography; Remission Induction; Transplantation, Homologous; Triazoles; Voriconazole

2012
Natamycin and voriconazole in fungal keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:6

    Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Keratitis; Natamycin; Ophthalmic Solutions; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Voriconazole-associated severe hyponatremia.
    Medical mycology, 2012, Volume: 50, Issue:1

    Topics: Aged; Antifungal Agents; Aspergillosis; Drug Monitoring; Female; Humans; Hyponatremia; Male; Middle Aged; Pyrimidines; Serum; Triazoles; Voriconazole

2012
Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation.
    Mycoses, 2011, Volume: 54, Issue:6

    Topics: Aerobiosis; Anaerobiosis; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Deep skin infection of Scedosporium apiospermum in a patient with refractory idiopathic thrombocytopenic purpura.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:12

    Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lymphangitis; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mycetoma; Purpura, Thrombocytopenic, Idiopathic; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2011
Pseudallescheria boydii infection of a prosthetic hip joint--an uncommon infection in a rare location.
    The American journal of the medical sciences, 2011, Volume: 342, Issue:3

    Topics: Antifungal Agents; Female; Hip Prosthesis; Humans; Middle Aged; Mycetoma; Prosthesis-Related Infections; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2011
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
[A case of lung scedosporiosis successfully treated with monitoring of plasma voriconazole concentration level].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2011, Volume: 49, Issue:5

    Topics: Aged; Antifungal Agents; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2011
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole

2011
In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fungi; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2011
Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.
    Drug development and industrial pharmacy, 2012, Volume: 38, Issue:1

    Topics: Administration, Topical; Animals; Antifungal Agents; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Carriers; Drug Stability; Emulsions; Guinea Pigs; Hydrogen-Ion Concentration; Oleic Acid; Permeability; Plant Oils; Polyethylene Glycols; Polysorbates; Pyrimidines; Rheology; Solubility; Surface-Active Agents; Triazoles; Voriconazole; Water; Waxes

2012
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2

    Topics: Antifungal Agents; Candida; Caspofungin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Delayed recalcitrant fungal endophthalmitis secondary to Curvularia.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2011, Volume: 46, Issue:2

    Topics: Abscess; Aged; Amphotericin B; Ascomycota; Cataract Extraction; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Eye Enucleation; Eye Infections, Fungal; Female; Humans; Mycoses; Pyrimidines; Recurrence; Triazoles; Vitrectomy; Vitreous Body; Voriconazole

2011
Role of voriconazole in combined acanthamoeba and fungal corneal ulcer.
    Contact lens & anterior eye : the journal of the British Contact Lens Association, 2011, Volume: 34, Issue:6

    Topics: Amebiasis; Amebicides; Antifungal Agents; Corneal Ulcer; Eye Infections, Fungal; Eye Infections, Parasitic; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
The effect of enteral nutrition supplements on serum voriconazole levels.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2012, Volume: 18, Issue:1

    Topics: Adolescent; Antifungal Agents; Enteral Nutrition; Food-Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pyrimidines; Suspensions; Triazoles; Voriconazole

2012
[Cutaneous neutrophils infiltrates. Case 4. Pseudo-tumoral cutaneous alternariosis].
    Annales de pathologie, 2011, Volume: 31, Issue:3

    Topics: Aged, 80 and over; Alternaria; Antifungal Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinoma, Verrucous; Combined Modality Therapy; Dacarbazine; Dermatomycoses; Diagnosis, Differential; Ependymoma; Fatal Outcome; Folliculitis; Frontal Lobe; Hand Dermatoses; Humans; Immunocompromised Host; Keratosis; Male; Neutrophils; Pyrimidines; Skin Neoplasms; Staining and Labeling; Temozolomide; Triazoles; Voriconazole

2011
Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Immunologic Deficiency Syndromes; Infant; Injections, Intravenous; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2011
Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Fusariosis; Fusarium; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
    Mycopathologia, 2011, Volume: 172, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole

2011
Targeted disruption of nonribosomal peptide synthetase pes3 augments the virulence of Aspergillus fumigatus.
    Infection and immunity, 2011, Volume: 79, Issue:10

    Topics: Animals; Animals, Outbred Strains; Antifungal Agents; Aspergillus fumigatus; Cell Line; Fungal Proteins; Gene Deletion; Macrophages; Mice; Moths; Peptide Synthases; Phenotype; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Virulence; Voriconazole

2011
Cutaneous alternariosis microscopically mimicking blastomycosis.
    Journal of cutaneous pathology, 2011, Volume: 38, Issue:11

    Topics: Alternaria; Alternariosis; Antifungal Agents; Blastomycosis; Combined Modality Therapy; Dermatologic Surgical Procedures; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Knee; Male; Middle Aged; Pyrimidines; Skin; Triazoles; Voriconazole

2011
Pigmented fruiting bodies and birefringent crystals in a surgical wound: A clue to Aspergillus niger infection.
    Journal of cutaneous pathology, 2011, Volume: 38, Issue:8

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Crystallization; Debridement; Fruiting Bodies, Fungal; Humans; Male; Opportunistic Infections; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2011
Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:4

    Topics: Antifungal Agents; Candida glabrata; Drug Synergism; Echinocandins; Humans; Lipopeptides; Macrophages; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole

2011
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
    Archives of dermatology, 2011, Volume: 147, Issue:7

    Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole

2011
Cytotoxicity of voriconazole on cultured human corneal endothelial cells.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Corneal; Flow Cytometry; Humans; Membrane Proteins; Necrosis; Phosphoproteins; Propidium; Pyrimidines; Triazoles; Voriconazole; Zonula Occludens-1 Protein

2011
Intravitreal voriconazole for the treatment of Aspergillus chorioretinitis.
    International ophthalmology, 2011, Volume: 31, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillosis; Chorioretinitis; Diagnosis, Differential; Eye Infections, Fungal; Follow-Up Studies; Humans; Intravitreal Injections; Male; Microscopy, Acoustic; Pyrimidines; Triazoles; Visual Acuity; Voriconazole

2011
Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents -- a report of two cases.
    Annals of the Academy of Medicine, Singapore, 2011, Volume: 40, Issue:6

    Topics: Adult; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fluconazole; Humans; Lipopeptides; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Trichosporonosis; Voriconazole; Young Adult

2011
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
    Infection, 2012, Volume: 40, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.
    Bone marrow transplantation, 2012, Volume: 47, Issue:5

    Topics: Amphotericin B; Antibodies, Monoclonal; Antifungal Agents; Eurotiales; Fatal Outcome; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Lung Diseases, Fungal; Male; Pyrimidines; Triazoles; Voriconazole

2012
A case of pseudomembranous colitis after voriconazole therapy.
    Yonsei medical journal, 2011, Volume: 52, Issue:5

    Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
    International journal of dermatology, 2012, Volume: 51, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fusariosis; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Voriconazole

2012
Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child, Preschool; Echinocandins; Fatal Outcome; Female; Heart Defects, Congenital; Humans; Immunocompromised Host; Lipopeptides; Mediastinitis; Mycoses; Peritoneal Dialysis; Peritonitis; Postoperative Complications; Pyrimidines; Spleen; Triazoles; Trichoderma; Voriconazole

2011
Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
    Clinical therapeutics, 2011, Volume: 33, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Bone Marrow Transplantation; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lansoprazole; Liver; Male; Mutation; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2011
Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates.
    Mycopathologia, 2011, Volume: 172, Issue:6

    Topics: Antifungal Agents; Blood; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; Romania; Triazoles; Voriconazole; Yeasts

2011
The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute.
    Orthopedics, 2011, Aug-08, Volume: 34, Issue:8

    Topics: Antifungal Agents; Bone Cements; Bone Substitutes; Calcium Sulfate; Chromatography, High Pressure Liquid; Drug Carriers; In Vitro Techniques; Microbial Sensitivity Tests; Polymethyl Methacrylate; Pyrimidines; Solubility; Solvents; Time Factors; Triazoles; Voriconazole

2011
Aspergillus fumigatus spondylodiskitis in renal transplant patient: voriconazole experience.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:4

    Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Back Pain; Discitis; Diskectomy; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Tuberculosis, Pulmonary; Voriconazole

2011
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:4

    Topics: Antifungal Agents; Drug Therapy, Combination; Echinocandins; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts

2011
Curvularia lunata endophthalmitis.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:5

    Topics: Antifungal Agents; Ascomycota; Cataract Extraction; Endophthalmitis; Eye Infections, Fungal; Humans; Itraconazole; Male; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2011
Successful management of an intracranial phaeohyphomycotic fungal granuloma in a dog.
    Journal of the American Veterinary Medical Association, 2011, Aug-15, Volume: 239, Issue:4

    Topics: Animals; Antifungal Agents; Cerebral Phaeohyphomycosis; Dog Diseases; Dogs; Fluconazole; Granuloma; Male; Pyrimidines; Triazoles; Voriconazole

2011
In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Drug Synergism; Fungi; Fusarium; Ibuprofen; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Broth microdilution and time-kill testing of Caspofungin, voriconazole, amphotericin B and their combinations against clinical isolates of Candida krusei.
    Mycopathologia, 2012, Volume: 173, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole

2012
In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis.
    Mycopathologia, 2012, Volume: 173, Issue:1

    Topics: Antifungal Agents; Candida; Humans; Microbial Sensitivity Tests; Pyrimidines; Stomatitis, Denture; Triazoles; Voriconazole

2012
In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:11

    Topics: Aminopyridines; Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2011
Dosing voriconazole in an obese patient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:7

    Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Mycoses; Obesity; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2011
Polyhexamethylene biguanide and calcineurin inhibitors as novel antifungal treatments for Aspergillus keratitis.
    Investigative ophthalmology & visual science, 2011, Sep-21, Volume: 52, Issue:10

    Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Biguanides; Calcineurin Inhibitors; Corneal Ulcer; Cyclosporine; Disinfectants; Drug Synergism; Eye Infections, Fungal; Immunosuppressive Agents; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Prospective Studies; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2011
Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Eye Infections, Fungal; Female; Humans; Hyphae; Immunocompetence; Male; Maxilla; Middle Aged; Mucormycosis; Nose Diseases; Orbit; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole

2012
Pharmacokinetics of sulfobutylether-β-cyclodextrin (SBECD) in subjects on hemodialysis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:3

    Topics: Adult; Antifungal Agents; beta-Cyclodextrins; Case-Control Studies; Excipients; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Prognosis; Pyrimidines; Renal Dialysis; Tissue Distribution; Triazoles; Voriconazole

2012
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:5

    Topics: Amino Acid Sequence; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Binding Sites; Catalytic Domain; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Triazoles; Voriconazole

2011
[Chromoblastomycosis caused by Fonsecaea monophora].
    Medical mycology journal, 2011, Volume: 52, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Ascomycota; Base Sequence; Chromoblastomycosis; Humans; Hyperthermia, Induced; Japan; Male; Middle Aged; Philippines; Pyrimidines; RNA, Fungal; RNA, Ribosomal; Treatment Outcome; Triazoles; Voriconazole

2011
Voriconazole-induced periostitis.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:2

    Topics: Adult; Bone and Bones; Endophthalmitis; Female; Humans; Periostitis; Pyrimidines; Radionuclide Imaging; Time Factors; Triazoles; Voriconazole; Whole Body Imaging

2012
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
    Clinical oral investigations, 2012, Volume: 16, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia

2012
Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:3

    Topics: Antifungal Agents; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole

2011
Acremonium keratomycosis in a cat.
    Veterinary ophthalmology, 2011, Volume: 14 Suppl 1

    Topics: Acremonium; Animals; Antifungal Agents; Cat Diseases; Cats; Cornea; Corneal Diseases; Eye Infections, Fungal; Female; Miconazole; Pyrimidines; Triazoles; Voriconazole

2011
Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
    Mycoses, 2012, Volume: 55, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Biological Specimen Banks; DNA, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole

2012
[Subacute infectious endocarditis of unusual etiology: peculiarities of diagnostics and treatment].
    Klinicheskaia meditsina, 2011, Volume: 89, Issue:4

    Topics: Adult; Endocarditis; Female; Humans; Prototheca; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
[Mucormycosis: retrospective evaluation of 12 cases].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Brain Diseases; Diabetes Complications; Female; Hematologic Diseases; Humans; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Nose Diseases; Orbital Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
Tenosynovitis caused by a pseudallescheria boydii infection and symptoms of reflex sympathetic dystrophy after a dog bite.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:7

    Topics: Animals; Antifungal Agents; Bites and Stings; Diagnosis, Differential; Dogs; Humans; Male; Middle Aged; Mycoses; Pseudallescheria; Pyrimidines; Reflex Sympathetic Dystrophy; Tenosynovitis; Triazoles; Voriconazole

2011
Voriconazole-induced QT interval prolongation and torsades de pointes.
    Pediatrics international : official journal of the Japan Pediatric Society, 2011, Volume: 53, Issue:5

    Topics: Adolescent; Antifungal Agents; Child; Electrocardiography; Endocarditis; Female; Humans; Long QT Syndrome; Male; Pulmonary Aspergillosis; Pyrimidines; Torsades de Pointes; Triazoles; Trichosporonosis; Voriconazole

2011
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
    Veterinary microbiology, 2012, Mar-23, Volume: 155, Issue:2-4

    Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
Fluorosis because of prolonged voriconazole therapy in a teenager with acute myelogenous leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Adolescent; Antifungal Agents; Fluorides; Fusariosis; Humans; Leukemia, Myeloid, Acute; Male; Periostitis; Pyrimidines; Triazoles; Voriconazole

2011
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Trends in zygomycosis in children.
    Mycoses, 2012, Volume: 55, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Humans; Incidence; Male; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; United States; Voriconazole; Zygomycosis

2012
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
    The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:9

    Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole

2011
Post-traumatic Pseudallescheria apiosperma osteomyelitis: positive outcome of a young immunocompetent male patient due to surgical intervention and voriconazole therapy.
    Mycoses, 2011, Volume: 54 Suppl 3

    Topics: Adolescent; Antifungal Agents; Bone Transplantation; Fractures, Open; Humans; Immunocompetence; Male; Microbial Sensitivity Tests; Mycoses; Osteomyelitis; Pseudallescheria; Pyrimidines; Tibial Fractures; Transplantation, Autologous; Treatment Outcome; Triazoles; Voriconazole

2011
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
    AIDS (London, England), 2011, Oct-23, Volume: 25, Issue:16

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antifungal Agents; Atazanavir Sulfate; Drug Resistance, Multiple, Viral; Humans; Male; Middle Aged; Mycetoma; Oligopeptides; Pyridines; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:7

    Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Incidence; Infant; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Analysis; Taiwan; Triazoles; Voriconazole; Young Adult

2012
A painful thigh lesion in an immunocompromised 11-year-old boy.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:11

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Humans; Hyphae; Immunocompromised Host; Lung Neoplasms; Male; Pyrimidines; Pythiosis; Pythium; Sarcoma, Ewing; Thigh; Triazoles; Voriconazole

2011
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
    Mycoses, 2012, Volume: 55, Issue:2

    Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole

2012
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Comorbidity; Early Diagnosis; Female; Galactose; Hospital Units; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Italy; Leukocyte Count; Male; Mannans; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2011
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Coccidioides; Coccidioidomycosis; Cohort Studies; Exostoses; Female; Fluconazole; Fluorides; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Periostitis; Pyrimidines; Triazoles; United States; Voriconazole

2012
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Codon; Culture Media; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Mycological Typing Techniques; Pyrimidines; Time Factors; Triazoles; Voriconazole

2012
SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genetic Complementation Test; Genotype; Humans; Microbial Sensitivity Tests; Organisms, Genetically Modified; Pyrimidines; Real-Time Polymerase Chain Reaction; Sterol Regulatory Element Binding Proteins; Transcription, Genetic; Triazoles; Voriconazole

2012
Penicillium marneffei infection presenting as vulv-ulcer in an HIV-infected woman.
    European journal of medical research, 2011, Sep-12, Volume: 16, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Diagnosis, Differential; Female; HIV; HIV Infections; Humans; Mycoses; Penicillium; Pyrimidines; Triazoles; Ulcer; Voriconazole; Vulvar Diseases; Young Adult

2011
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2012
Subcutaneous dematiaceous fungal infection.
    Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Chromoblastomycosis; Combined Modality Therapy; Costa Rica; Diagnosis, Differential; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Kidney Transplantation; Leg; Male; Phaeohyphomycosis; Pneumonia; Pyrimidines; Soil Microbiology; Triazoles; Voriconazole

2011
Treatment of refractory coccidioidomycosis with voriconazole or posaconazole.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Volume: 53, Issue:11

    Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Salvage Therapy; Southwestern United States; Treatment Outcome; Triazoles; Voriconazole

2011
Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
    Orthopedics, 2011, Nov-09, Volume: 34, Issue:11

    Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Drug Substitution; Female; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Lung Transplantation; Periostitis; Postoperative Complications; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2011
[Pulmonary aspergillosis and HIV infection: about two cases].
    Revue de pneumologie clinique, 2012, Volume: 68, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; HIV Infections; Humans; Lung Diseases, Fungal; Male; Middle Aged; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Radiography; Risk Factors; Triazoles; Voriconazole

2012
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
    Haematologica, 2012, Volume: 97, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Population pharmacokinetics of voriconazole in adults.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Bayes Theorem; Case-Control Studies; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole

2012
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole

2012
Voriconazole serum levels measured by high-performance liquid chromatography: a monocentric study in treated patients.
    Medical mycology, 2012, Volume: 50, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole; Young Adult

2012
Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).
    Mycopathologia, 2012, Volume: 173, Issue:5-6

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Therapy, Combination; Lung; Lung Diseases, Fungal; Mice; Mice, SCID; Pyrimidines; Severe Combined Immunodeficiency; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2012
[Careful: skins cancers and voriconazole].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:11

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Drug Eruptions; Female; Humans; Male; Melanoma; Photosensitizing Agents; Pyrimidines; Skin Aging; Skin Neoplasms; Triazoles; Voriconazole; Young Adult

2011
Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole.
    Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:4

    Topics: Adult; Antifungal Agents; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Liver Transplantation; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2011
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2012
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Therapy, Combination; Fatal Outcome; Fungemia; Humans; Leukemia, Myeloid, Acute; Male; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole; Young Adult

2012
Mevalonate governs interdependency of ergosterol and siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Feb-21, Volume: 109, Issue:8

    Topics: Amphotericin B; Animals; Aspergillus fumigatus; Biomass; Biosynthetic Pathways; Enoyl-CoA Hydratase; Ergosterol; Ferric Compounds; Gene Deletion; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Gene Silencing; Genes, Fungal; Hydroxamic Acids; Hydroxymethylglutaryl CoA Reductases; Iron Deficiencies; Ligases; Lovastatin; Mevalonic Acid; Mice; Microbial Sensitivity Tests; Oxidative Stress; Pulmonary Aspergillosis; Pyrimidines; Siderophores; Triazoles; Up-Regulation; Virulence; Voriconazole

2012
Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.
    Xenobiotica; the fate of foreign compounds in biological systems, 2012, Volume: 42, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A; Female; Humans; Inhibitory Concentration 50; Kinetics; Male; Microsomes, Liver; Pyrimidines; Substrate Specificity; Tacrolimus; Testosterone; Triazoles; Voriconazole

2012
Ventricular bigeminy associated with voriconazole, methadone and esomeprazole.
    International journal of clinical pharmacy, 2011, Volume: 33, Issue:6

    Topics: Adult; Analgesics, Opioid; Antifungal Agents; Arrhythmias, Cardiac; Drug Interactions; Esomeprazole; Female; Humans; Methadone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proton Pump Inhibitors; Pyrimidines; Triazoles; Ventricular Dysfunction; Voriconazole

2011
A case report of voriconazole therapy failure in a homozygous ultrarapid CYP2C19*17/*17 patient comedicated with carbamazepine.
    British journal of clinical pharmacology, 2012, Volume: 74, Issue:1

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Homozygote; Humans; Middle Aged; Pyrimidines; Treatment Failure; Triazoles; Voriconazole

2012
Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
    Mycoses, 2011, Volume: 54 Suppl 4

    Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Skin; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Invasive pulmonary aspergillosis in a patient with seminomatous testicular cancer.
    Mycoses, 2011, Volume: 54 Suppl 4

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Pyrimidines; Testicular Neoplasms; Treatment Outcome; Triazoles; Voriconazole

2011
[Invasive aspergillosis: new tools for a targeted medical management].
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:12

    Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Clinical Trials as Topic; Comorbidity; Disease Management; Female; France; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Rapid simultaneous determination of voriconazole and its N-oxide in human plasma using an isocratic high-performance liquid chromatography method and its clinical application.
    Clinical biochemistry, 2012, Volume: 45, Issue:1-2

    Topics: Acetonitriles; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chromatography, High Pressure Liquid; Female; Humans; Male; Middle Aged; Models, Chemical; Oxides; Plasma; Pyrimidines; Reproducibility of Results; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole

2012
Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus.
    Mycopathologia, 2012, Volume: 173, Issue:4

    Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Drug Therapy, Combination; Echinocandins; Humans; Male; Mice; Pyrimidines; Triazoles; Voriconazole

2012
A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features.
    Medical mycology, 2012, Volume: 50, Issue:6

    Topics: Aged, 80 and over; Animals; Aspergillosis; Aspergillus; Bronchial Diseases; Bronchoscopy; Diabetes Mellitus; Female; Humans; Hydrogen Peroxide; Immunocompromised Host; Lung; Mice; Pyrimidines; Triazoles; Voriconazole

2012
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Female; Fluconazole; Fungal Proteins; Genotype; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mutation, Missense; Phenylalanine; Pyrimidines; Sterol 14-Demethylase; Survival Rate; Triazoles; Tyrosine; Voriconazole

2012
Chronic granulomatous disease in an adult recognized by an invasive aspergillosis.
    The American journal of the medical sciences, 2012, Volume: 343, Issue:2

    Topics: Antifungal Agents; Aspergillus; Diagnosis, Differential; Germany; Granulomatous Disease, Chronic; Humans; Infusions, Parenteral; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Phagocytes; Pyrimidines; Respiratory Insufficiency; Tachypnea; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation.
    Colloids and surfaces. B, Biointerfaces, 2012, Apr-01, Volume: 92

    Topics: Administration, Cutaneous; Animals; Drug Carriers; Drug Delivery Systems; Elasticity; Liposomes; Male; Mice; Mice, Hairless; Pyrimidines; Skin; Skin Absorption; Triazoles; Voriconazole

2012
New species of Madurella, causative agents of black-grain mycetoma.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:3

    Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Fungal Proteins; Humans; Leg; Madurella; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mycetoma; Phylogeny; Pyrimidines; RNA Polymerase II; Sequence Analysis, DNA; Sudan; Triazoles; Tubulin; Voriconazole

2012
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
Efficacy of intrathecal administration of liposomal amphotericin B combined with voriconazole in a murine model of cryptococcal meningitis.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Colony Count, Microbial; Cryptococcus neoformans; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Meningitis, Cryptococcal; Mice; Pyrimidines; Triazoles; Voriconazole

2012
Effects of the CYP2B6*6 allele on catalytic properties and inhibition of CYP2B6 in vitro: implication for the mechanism of reduced efavirenz metabolism and other CYP2B6 substrates in vivo.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:4

    Topics: Alkynes; Alleles; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Biotransformation; Bupropion; Catalysis; Clopidogrel; Cyclopropanes; Cytochrome P-450 CYP2B6; Cytochromes b5; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Pyrimidines; Substrate Specificity; Ticlopidine; Triazoles; Voriconazole

2012
A case of fluconazole, voriconazole-resistant Cryptococcus neoformans isolated from and immunocompetent patient.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:6

    Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Immunocompetence; Male; Pyrimidines; Triazoles; Voriconazole; Young Adult

2011
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:4

    Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Colony Count, Microbial; Cortisone; Cyclophosphamide; Disease Models, Animal; Guinea Pigs; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2012
Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Feb-01, Volume: 54, Issue:3

    Topics: Aged, 80 and over; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus; Cardiac Surgical Procedures; Caspofungin; Coronary Care Units; Disease Outbreaks; Echinocandins; Female; Humans; Incidence; Lipopeptides; Male; Middle Aged; Pyrimidines; Spores, Fungal; Triazoles; Voriconazole

2012
How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole

2012
Future directions in mucormycosis research.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1

    Topics: Antifungal Agents; Aspergillus; Biomedical Research; Early Diagnosis; Genome, Fungal; Humans; Immunocompromised Host; Mucormycosis; Pyrimidines; Rhizopus; Risk Factors; Triazoles; Voriconazole

2012
Administration of voriconazole in patients with renal dysfunction.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Fast and simple LC-MS/MS method for quantifying plasma voriconazole.
    Clinica chimica acta; international journal of clinical chemistry, 2012, Apr-11, Volume: 413, Issue:7-8

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Pyrimidines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole

2012
Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats.
    Drug and chemical toxicology, 2012, Volume: 35, Issue:3

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antifungal Agents; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Creatinine; Dose-Response Relationship, Drug; gamma-Glutamyltransferase; Injections, Intraperitoneal; Kidney; Liver; Microscopy, Electron, Transmission; Molecular Structure; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; Toxicity Tests; Triazoles; Voriconazole

2012
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bacterial Typing Techniques; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole

2012
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:6

    Topics: Antifungal Agents; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Plasma; Pyrimidines; Triazoles; Voriconazole

2012
A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Medical mycology, 2012, Volume: 50, Issue:6

    Topics: Aminolevulinic Acid; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Photochemotherapy; Pyrimidines; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2012
Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Echinocandins; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Humans; Lipopeptides; Micafungin; Pyrimidines; RNA, Messenger; Transcriptome; Treatment Outcome; Triazoles; Voriconazole

2012
The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Adolescent; Agrobacterium tumefaciens; Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Gene Transfer Techniques; Humans; Lung; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Plasmids; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole

2012
Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
    FEMS yeast research, 2012, Volume: 12, Issue:4

    Topics: Ambroxol; Antifungal Agents; Biofilms; Candida; Colorimetry; Drug Synergism; Fungemia; Humans; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole

2012
Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model.
    Cornea, 2012, Volume: 31, Issue:3

    Topics: Administration, Topical; Animals; Anterior Chamber; Anti-Bacterial Agents; Antifungal Agents; Aqueous Humor; Cornea; Models, Animal; Ofloxacin; Photosensitizing Agents; Pyrimidines; Random Allocation; Riboflavin; Swine; Triazoles; Ultraviolet Rays; Voriconazole

2012
Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Fluconazole; Humans; Male; Meningitis, Cryptococcal; Meningoencephalitis; Microbial Sensitivity Tests; Organophosphates; Pyrimidines; Triazoles; Voriconazole

2012
Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Mycopathologia, 2012, Volume: 174, Issue:2

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Taiwan; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2012
Purpureocillium lilacinum as a cause of cavitary pulmonary disease: a new clinical presentation and observations on atypical morphologic characteristics of the isolate.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:5

    Topics: Aged, 80 and over; Antifungal Agents; DNA, Fungal; Female; Humans; Hypocreales; Lung Diseases, Fungal; Microscopy; Molecular Sequence Data; Mycoses; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2012
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Longitudinal Studies; Mathematical Computing; Microbial Sensitivity Tests; Models, Statistical; Mutation; Netherlands; Promoter Regions, Genetic; Pyrimidines; Sequence Analysis, DNA; Tandem Repeat Sequences; Triazoles; Voriconazole

2012
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole

2012
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:8

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    European review for medical and pharmacological sciences, 2012, Volume: 16, Issue:1

    Topics: Adult; Antifungal Agents; Cardiac Pacing, Artificial; Cardiopulmonary Resuscitation; Electric Countershock; Electrocardiography; Electrolytes; Female; Humans; Long QT Syndrome; Mitral Valve Insufficiency; Nephrotic Syndrome; Pyrimidines; Rheumatic Heart Disease; Torsades de Pointes; Triazoles; Voriconazole

2012
Non-clinical safety assessment and toxicokinetics of voriconazole and anidulafungin in the juvenile rat: a combination study design in support of a Paediatric Investigation Plan.
    Regulatory toxicology and pharmacology : RTP, 2012, Volume: 63, Issue:1

    Topics: Administration, Oral; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Drug Combinations; Drug Evaluation, Preclinical; Echinocandins; Female; Injections, Subcutaneous; Male; Pyrimidines; Rats; Rats, Inbred F344; Research Design; Sex Factors; Toxicity Tests; Triazoles; Voriconazole

2012
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
    Enfermedades infecciosas y microbiologia clinica, 2012, Volume: 30, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole

2012
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
    The European respiratory journal, 2012, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult

2012
Aspergillus-associated cerebral aneurysm successfully treated by endovascular and surgical intervention with voriconazole in lupus nephritis patient.
    Journal of Korean medical science, 2012, Volume: 27, Issue:3

    Topics: Antifungal Agents; Female; Humans; Immunosuppressive Agents; Intracranial Aneurysm; Lupus Nephritis; Middle Aged; Neuroaspergillosis; Pyrimidines; Stents; Surgical Instruments; Triazoles; Voriconazole

2012
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2012, Volume: 49, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Comorbidity; Drug Utilization; Female; Health Services; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Quality of Life; Radiography, Thoracic; Retrospective Studies; Severity of Illness Index; Socioeconomic Factors; Spirometry; Triazoles; Voriconazole

2012
Toxicity of voriconazole on corneal endothelial cells in an animal model.
    The British journal of ophthalmology, 2012, Volume: 96, Issue:6

    Topics: Animals; Anterior Chamber; Antifungal Agents; Cell Count; Corneal Endothelial Cell Loss; Endothelium, Corneal; Injections, Intraocular; Microscopy, Electron, Scanning; Models, Animal; Pyrimidines; Rabbits; Triazoles; Voriconazole

2012
Gastrointestinal basidiobolomycosis in a child; an unusual fungal infection mimicking fistulising Crohn's disease.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:3

    Topics: Antifungal Agents; Child, Preschool; Colectomy; Crohn Disease; Diagnosis, Differential; Entomophthorales; Humans; Intestinal Diseases; Male; Pyrimidines; Triazoles; Voriconazole; Zygomycosis

2012
Intracameral and topical voriconazole for fungal corneal endoexudates.
    Cornea, 2012, Volume: 31, Issue:4

    Topics: Administration, Topical; Adult; Aged; Anterior Chamber; Antifungal Agents; Aspergillosis; Corneal Stroma; Corneal Ulcer; Exudates and Transudates; Eye Infections, Fungal; Humans; Injections, Intraocular; Male; Middle Aged; Pyrimidines; Triazoles; Visual Acuity; Voriconazole; Young Adult

2012
Monitoring trough voriconazole plasma concentrations in haematological patients: real life multicentre experience.
    Mycoses, 2012, Volume: 55, Issue:6

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hematologic Diseases; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Scedosporium apiospermum keratomycosis in a dog.
    Veterinary ophthalmology, 2012, Volume: 15, Issue:6

    Topics: Animals; Antifungal Agents; Ascomycota; Dog Diseases; Dogs; Keratitis; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Effect of process variables on morphology and aerodynamic properties of voriconazole formulations produced by thin film freezing.
    International journal of pharmaceutics, 2012, Jun-15, Volume: 429, Issue:1-2

    Topics: Administration, Inhalation; Antifungal Agents; Crystallization; Dioxanes; Dry Powder Inhalers; Excipients; Freezing; Nanostructures; Particle Size; Polymers; Povidone; Powders; Pyrimidines; Solvents; Technology, Pharmaceutical; Triazoles; Voriconazole

2012
Systemic mycosis in a California sea lion (Zalophus californianus) with detection of cystofilobasidiales DNA.
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:1

    Topics: Animals; Antifungal Agents; Basidiomycota; DNA, Fungal; Fatal Outcome; Itraconazole; Male; Mycoses; Pyrimidines; Sea Lions; Triazoles; Voriconazole

2012
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidemia; Female; Humans; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2012
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:7

    Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole

2012
Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
    International journal of hematology, 2012, Volume: 95, Issue:5

    Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Pyrimidines; Tacrolimus; Triazoles; Voriconazole; Young Adult

2012
Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy.
    Clinics (Sao Paulo, Brazil), 2012, Volume: 67, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Debridement; Humans; Male; Middle Aged; Negative-Pressure Wound Therapy; Pyrimidines; Sternotomy; Treatment Outcome; Triazoles; Voriconazole

2012
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
    Le infezioni in medicina, 2012, Volume: 20, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole

2012
Recurrent fungal iris granuloma in a 10-year-old child.
    Ocular immunology and inflammation, 2012, Volume: 20, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Granuloma; Humans; Iris Diseases; Pyrimidines; Recurrence; Treatment Outcome; Triazoles; Voriconazole

2012
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:7

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Immunocompromised Host; Immunosuppression Therapy; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole

2012
Risk factors for voriconazole hepatotoxicity at 12 weeks in lung transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2012, Volume: 12, Issue:7

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Liver; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole; Young Adult

2012
Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Colorimetry; Culture Media; Drug Combinations; Echinocandins; Humans; Microbial Sensitivity Tests; Protein Binding; Pyrimidines; Serum Albumin; Tetrazolium Salts; Time Factors; Triazoles; Voriconazole

2012
Paecilomyces lilacinus endophthalmitis following cataract surgery: a therapeutic challenge.
    Klinische Monatsblatter fur Augenheilkunde, 2012, Volume: 229, Issue:4

    Topics: Aged; Antifungal Agents; Cataract Extraction; Endophthalmitis; Humans; Male; Mycoses; Paecilomyces; Pyrimidines; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2012
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
    Klinische Padiatrie, 2012, Volume: 224, Issue:3

    Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Treatment of dematiaceous fungal keratitis in a dog.
    Journal of the American Veterinary Medical Association, 2012, May-01, Volume: 240, Issue:9

    Topics: Administration, Topical; Animals; Antifungal Agents; Cornea; Corneal Ulcer; Dog Diseases; Dogs; Eye Infections, Fungal; Keratitis; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Voriconazole-induced phototoxicity in children.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:7

    Topics: Chemoprevention; Child; Child, Preschool; Dermatitis, Phototoxic; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Neoplasms; Pyrimidines; Retrospective Studies; Risk Assessment; Triazoles; Voriconazole

2012
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
    Mycoses, 2012, Volume: 55 Suppl 2

    Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole

2012
In vitro antifungal activity of Indian liposomal amphotericin B against clinical isolates of emerging species of yeast and moulds, and its comparison with amphotericin B deoxycholate, voriconazole, itraconazole and fluconazole.
    Mycoses, 2013, Volume: 56, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole; Yeasts

2013
Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia.
    Il Giornale di chirurgia, 2012, Volume: 33, Issue:3

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Colectomy; Emergencies; Enterocolitis, Necrotizing; Female; Humans; Ileostomy; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:8

    Topics: Antifungal Agents; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole

2012
The first Korean case of candidemia due to Candida dubliniensis.
    Annals of laboratory medicine, 2012, Volume: 32, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2012, Volume: 81, Issue:3

    Topics: Administration, Inhalation; Animals; Antifungal Agents; Area Under Curve; Crystallization; Dry Powder Inhalers; Excipients; Freezing; Lung; Male; Mice; Mice, Inbred ICR; Particle Size; Povidone; Pyrimidines; Solubility; Tissue Distribution; Triazoles; Voriconazole

2012
Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:7

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Middle Aged; Mutation, Missense; Neuroaspergillosis; Pyrimidines; Spain; Triazoles; Voriconazole

2012
Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.
    Cornea, 2013, Volume: 32, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Eye Infections, Fungal; Female; Fusarium; Humans; Keratitis; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Treatment Failure; Triazoles; Visual Acuity; Voriconazole; Young Adult

2013
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult

2012
Effects of anidulafungin and voriconazole, singly and in combination, on cytokine/chemokine production by human monocyte-derived macrophages infected with Candida glabrata or activated by lipopolysaccharide.
    Chemotherapy, 2012, Volume: 58, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Chemokines; Cytokines; Echinocandins; Humans; Lipopolysaccharides; Macrophages; Pyrimidines; Triazoles; Voriconazole

2012
In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2012, Volume: 73, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Coccidioidal endophthalmitis in immunocompetent person, California, USA.
    Emerging infectious diseases, 2012, Volume: 18, Issue:6

    Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Eye Infections, Fungal; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Ultrasonography; Voriconazole

2012
Editorial commentary: Antifungal therapeutic drug monitoring progress: getting it right the first time.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Plasma; Pyrimidines; Triazoles; Voriconazole

2012
Pseudomembranous necrotizing tracheobronchial aspergillosis: an analysis of 16 cases.
    Chinese medical journal, 2012, Volume: 125, Issue:7

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Bronchoscopy; Caspofungin; Echinocandins; Female; Humans; Itraconazole; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Azoles; Base Sequence; Biological Transport; Candida glabrata; Drug Resistance, Multiple, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Mutation, Missense; Pyrimidines; Saccharomyces cerevisiae; Sequence Analysis, DNA; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole

2012
In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Anidulafungin; Antifungal Agents; Aspergillus; Azoles; Drug Combinations; Echinocandins; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2012, Volume: 10, Issue:3

    Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole

2012
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    The Kaohsiung journal of medical sciences, 2012, Volume: 28, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Fatal bronchial invasion of Scopulariopsis brevicaulis in an acute monocytic leukemia patient.
    Diagnostic microbiology and infectious disease, 2012, Volume: 73, Issue:4

    Topics: Adult; Amphotericin B; Bronchi; Caspofungin; DNA, Fungal; DNA, Ribosomal; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Genes, rRNA; Histocytochemistry; Humans; Leukemia, Monocytic, Acute; Lipopeptides; Lung; Lung Diseases, Fungal; Molecular Sequence Data; Pyrimidines; Radiography, Thoracic; RNA, Fungal; RNA, Ribosomal, 18S; Scopulariopsis; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole

2012
Poly-lactide-co-glycolide nanoparticles containing voriconazole for pulmonary delivery: in vitro and in vivo study.
    Nanomedicine : nanotechnology, biology, and medicine, 2013, Volume: 9, Issue:1

    Topics: Animals; Antifungal Agents; Drug Carriers; Female; In Vitro Techniques; Lactic Acid; Lung; Male; Mice; Microscopy, Electron, Scanning; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Triazoles; Voriconazole

2013
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
    The Journal of infectious diseases, 2012, Aug-01, Volume: 206, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Bioreactors; Cell Culture Techniques; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Simulation; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Endothelial Cells; Epithelial Cells; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Biological; Pulmonary Artery; Pyrimidines; Respiratory Mucosa; Triazoles; Voriconazole

2012
Aspergillus endocarditis in a native valve without prior cardiac surgery.
    General thoracic and cardiovascular surgery, 2012, Volume: 60, Issue:11

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Endocarditis; Humans; Male; Pyrimidines; Triazoles; Ultrasonography; Voriconazole

2012
Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review.
    Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Drug Resistance, Multiple, Fungal; Etoposide; Fatal Outcome; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Itraconazole; Leukemia, Myeloid, Acute; Mitoxantrone; Neutropenia; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Premedication; Pyrimidines; Recurrence; Salvage Therapy; Transplantation, Homologous; Triazoles; Voriconazole

2013
Fungal malignant otitis externa: pitfalls, diagnosis, and treatment.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2012, Volume: 33, Issue:5

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Female; Humans; Male; Mycoses; Otitis Externa; Pseudomonas aeruginosa; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.
    Investigative ophthalmology & visual science, 2012, Jul-03, Volume: 53, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Corneal Ulcer; Disease Models, Animal; Disease Outbreaks; Drug Resistance, Fungal; Epithelium, Corneal; Eye Infections, Fungal; Fusariosis; Fusarium; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microscopy, Confocal; Natamycin; Pyrimidines; Triazoles; Virulence; Voriconazole

2012
Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:9

    Topics: Adult; Amino Acid Substitution; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cell Membrane; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Gene Expression Profiling; Humans; Mice; Microbial Sensitivity Tests; Middle Aged; Mutant Proteins; Oxidoreductases; Pyrimidines; Sterols; Triazoles; Virulence; Voriconazole

2012
A lung mass: when the history helps the diagnosis.
    BMJ case reports, 2011, Oct-04, Volume: 2011

    Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bone Marrow Transplantation; Child; Combined Modality Therapy; Diagnosis, Differential; Humans; Lymphadenitis; Male; Osteomyelitis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
    Medical mycology, 2013, Volume: 51, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cohort Studies; Demography; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Length of Stay; Lipopeptides; Lung; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Time Factors; Triazoles; Voriconazole

2013
Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cyclophosphamide; Deoxycholic Acid; Drug Combinations; Echinocandins; Endothelial Cells; Heart; Immunosuppression Therapy; Intercellular Adhesion Molecule-1; Kidney; Lipopeptides; Lung; Male; Mice; Nephrosis; Neuroaspergillosis; P-Selectin; Pyrimidines; Triazoles; Voriconazole

2012
[Quantitative evaluation method of the informational value of initial symptoms based on Bayesian theory].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:6

    Topics: Antifungal Agents; Bayes Theorem; Chemical and Drug Induced Liver Injury; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Pharmacists; Probability; Pyrimidines; Symptom Assessment; Triazoles; Voriconazole

2012
[Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010].
    Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2012, Volume: 29, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Candida; Chile; Cohort Studies; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2012
Craniocerebral maduromycosis.
    Journal of neurosurgery. Pediatrics, 2012, Volume: 10, Issue:1

    Topics: Adolescent; Antifungal Agents; Bone Diseases; Brain Diseases; Female; Humans; India; Madurella; Magnetic Resonance Imaging; Mycetoma; Naphthalenes; Parietal Lobe; Pyrimidines; Scalp; Seizures; Terbinafine; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2012, Volume: 106, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Caspofungin; CD4 Lymphocyte Count; Echinocandins; Female; Fluconazole; Histoplasma; Histoplasmosis; Humans; Itraconazole; L-Lactate Dehydrogenase; Lipopeptides; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Intra-articular injection of voriconazole for Fusarium solani arthritis after bone marrow transplantation.
    The Journal of infection, 2012, Volume: 65, Issue:4

    Topics: Adolescent; Antifungal Agents; Arthritis; Bone Marrow Transplantation; Fusariosis; Fusarium; Histocytochemistry; Humans; Immunocompromised Host; Injections, Intra-Articular; Male; Microscopy; Pyrimidines; Skin; Triazoles; Voriconazole

2012
Azole preexposure affects the Aspergillus fumigatus population in patients.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Multigene Family; Polymorphism, Single Nucleotide; Pyrimidines; Triazoles; Voriconazole

2012
Benefit of polyhexamethylene biguanide in Fusarium keratitis.
    Ophthalmic research, 2012, Volume: 48, Issue:4

    Topics: Adult; Antifungal Agents; Benzamidines; Biguanides; Contact Lenses, Hydrophilic; Corneal Ulcer; Disinfectants; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fungi; Fusariosis; Fusarium; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Natamycin; Pyrimidines; Triazoles; Voriconazole

2012
Pseudallescheria boydii infection of the brain.
    Surgical infections, 2012, Volume: 13, Issue:3

    Topics: Administration, Oral; Antifungal Agents; Brain Abscess; Burns; Central Nervous System Fungal Infections; Explosions; Humans; Infusions, Intravenous; Middle Aged; Pseudallescheria; Pyrimidines; Triazoles; Voriconazole

2012
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
    Medical mycology, 2013, Volume: 51, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
    Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:5

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Pancreatitis; Pyrimidines; Triazoles; Voriconazole

2012
A retrospective analysis of voriconazole pharmacokinetics in Japanese pediatric and adolescent patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis; Candidemia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Japan; Male; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
The efficacy of voriconazole in 24 ocular Fusarium infections.
    Infection, 2013, Volume: 41, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
[Photo quiz: Deep-seated mycosis].
    Medical mycology journal, 2012, Volume: 53, Issue:2

    Topics: Antifungal Agents; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Middle Aged; Polymerase Chain Reaction; Pulmonary Aspergillosis; Pyrimidines; RNA, Fungal; Scedosporium; Sputum; Triazoles; Voriconazole

2012
Voriconazole inhibits biofilm formation in different species of the genus Candida.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:10

    Topics: Antifungal Agents; Biofilms; Candida; Candidiasis; Humans; Pyrimidines; Staining and Labeling; Tetrazolium Salts; Triazoles; Voriconazole

2012
Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
    Medical mycology, 2013, Volume: 51, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Drug Synergism; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole

2013
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interactions; Drug Monitoring; Female; Glucocorticoids; Humans; Male; Middle Aged; Mitosporic Fungi; Mycoses; Nucleic Acid Synthesis Inhibitors; Phenytoin; Pyrimidines; Retrospective Studies; Rifampin; Treatment Outcome; Triazoles; Voltage-Gated Sodium Channel Blockers; Voriconazole

2012
Remarkably efficient inhaled antifungal monotherapy for invasive pulmonary aspergillosis.
    The European respiratory journal, 2012, Volume: 40, Issue:1

    Topics: Administration, Inhalation; Aged; Antifungal Agents; Humans; Male; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2012
Development and validation of a fast HPLC/photodiode array detection method for the measurement of voriconazole in human serum samples. A reference laboratory experience.
    Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31, Issue:1

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole

2013
Multiple fungal brain abscesses in a child with acute lymphoblastic leukemia.
    Mycopathologia, 2012, Volume: 174, Issue:5-6

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus niger; Brain Abscess; Child, Preschool; Female; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole

2012
Clinical images: voriconazole-induced periostitis deformans.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Female; Humans; Middle Aged; Periostitis; Pyrimidines; Triazoles; Voriconazole

2012
Voriconazole is delivered from antifungal-loaded bone cement.
    Clinical orthopaedics and related research, 2013, Volume: 471, Issue:1

    Topics: Antifungal Agents; Bone Cements; Compressive Strength; Dose-Response Relationship, Drug; Drug Delivery Systems; Pyrimidines; Triazoles; Voriconazole

2013
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
    Medical mycology, 2013, Volume: 51, Issue:2

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Monitoring of voriconazole plasma concentrations in immunocompromised paediatric patients.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:11

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Immunocompromised Host; Infant; Male; Plasma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2012
Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:11

    Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Chi-Square Distribution; Female; Humans; Incidence; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2012
Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis.
    Transplantation, 2012, Aug-27, Volume: 94, Issue:4

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Voriconazole

2012
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole

2012
The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation.
    Statistics in medicine, 2012, Dec-30, Volume: 31, Issue:30

    Topics: Antifungal Agents; Bias; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Data Interpretation, Statistical; Humans; Likelihood Functions; Models, Theoretical; Normal Distribution; Pharmacokinetics; Pyrimidines; Reproducibility of Results; Research Design; Triazoles; Voriconazole

2012
VFEND® (voriconazole)-associated hypoglycaemia without identified drug interaction.
    Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Enterocolitis; Glucose; Humans; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Male; Middle Aged; Pyrimidines; Severity of Illness Index; Syncope; Treatment Outcome; Triazoles; Voriconazole

2013
Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2012, Volume: 31, Issue:11

    Topics: Adult; Antifungal Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Humans; Incidence; Logistic Models; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Risk Factors; Skin Neoplasms; Time Factors; Transplantation; Triazoles; Voriconazole

2012
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole

2012
Sarcoid-like reaction in Cryptococcus neoformans infection.
    BMJ case reports, 2012, Jul-27, Volume: 2012

    Topics: Administration, Oral; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Diagnosis, Differential; Female; Humans; Itraconazole; Middle Aged; Pyrimidines; Radiography, Thoracic; Sarcoidosis; Triazoles; Voriconazole

2012
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Debridement; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2012
Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:10

    Topics: Adolescent; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Cluster Analysis; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Granulomatous Disease, Chronic; Humans; Itraconazole; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Failure; Triazoles; Voriconazole; Young Adult

2012
Are epidemiologic cut-off values predictors of the in vivo efficacy of azoles in experimental aspergillosis?
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:2

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus niger; Disease Models, Animal; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.
    Blood, 2012, Sep-20, Volume: 120, Issue:12

    Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole

2012
Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.
    The British journal of dermatology, 2013, Volume: 168, Issue:1

    Topics: Adult; Antibodies, Antinuclear; Antifungal Agents; Aspergillosis; Drug Eruptions; Female; Humans; Light; Male; Middle Aged; Patch Tests; Photosensitivity Disorders; Pyrimidines; Sunlight; Triazoles; Voriconazole

2013
In vitro pharmacokinetic/pharmacodynamic modeling of voriconazole activity against Aspergillus species in a new in vitro dynamic model.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Pyrimidines; Triazoles; Voriconazole

2012
Treatment of granulomatous amoebic encephalitis with voriconazole and miltefosine in an immunocompetent soldier.
    The American journal of tropical medicine and hygiene, 2012, Volume: 87, Issue:4

    Topics: Acanthamoeba; Adult; Amebiasis; Animals; Encephalitis; Granuloma; Humans; Immunocompetence; Male; Military Personnel; Phosphorylcholine; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Chemical research in toxicology, 2012, Sep-17, Volume: 25, Issue:9

    Topics: Animals; Benzodiazepines; Biomarkers; Carbamazepine; Cell Survival; Chemical and Drug Induced Liver Injury; Chemokines; Chromans; Clozapine; Cytokines; Diclofenac; Drug Synergism; Female; Glutathione; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; In Vitro Techniques; Ketoconazole; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Olanzapine; Pyrimidines; Thiazolidinediones; Triazoles; Troglitazone; Voriconazole

2012
Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    European journal of clinical pharmacology, 2013, Volume: 69, Issue:3

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2013
Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven
    FEMS yeast research, 2012, Volume: 12, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Candidemia; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia; Pyrimidines; Tertiary Care Centers; Triazoles; Voriconazole

2012
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
    Revista iberoamericana de micologia, 2013, Jan-03, Volume: 30, Issue:1

    Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evaluation; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Pregnancy; Puerperal Disorders; Pyrimidines; Recurrence; Species Specificity; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.
    Pediatric blood & cancer, 2013, Volume: 60, Issue:1

    Topics: Adolescent; Age Factors; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Male; Pyrimidines; Triazoles; Voriconazole

2013
Utilization of omeprazole to augment subtherapeutic voriconazole concentrations for treatment of Aspergillus infections.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Administration Routes; Drug Administration Schedule; Drug Monitoring; Drug Synergism; Humans; Magnetic Resonance Imaging; Male; Omeprazole; Pyrimidines; Triazoles; Voriconazole; Young Adult

2012
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Mice; Mice, Inbred ICR; Mutation, Missense; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Voriconazole-associated phototoxic effects and lentigo formation in an African American man.
    Archives of dermatology, 2012, Volume: 148, Issue:8

    Topics: Antifungal Agents; Coccidioidomycosis; Dermatitis, Phototoxic; Drug Eruptions; Humans; Lentigo; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial.
    The British journal of ophthalmology, 2012, Volume: 96, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Eye Infections, Fungal; Fusariosis; Fusarium; Humans; Keratitis; Natamycin; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole

2012
Evaluation of the effect of obesity on voriconazole serum concentrations.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:12

    Topics: Adult; Aged; Antifungal Agents; Cohort Studies; Female; Humans; Male; Middle Aged; Obesity; Pyrimidines; Retrospective Studies; Serum; Time Factors; Triazoles; Voriconazole

2012
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report].
    No shinkei geka. Neurological surgery, 2012, Volume: 40, Issue:9

    Topics: Amphotericin B; Humans; Liposomes; Magnetic Resonance Imaging; Male; Meningitis, Cryptococcal; Middle Aged; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole

2012
Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro.
    Investigative ophthalmology & visual science, 2012, Sep-19, Volume: 53, Issue:10

    Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amphotericin B; Animals; Antifungal Agents; Drug Therapy, Combination; Enzyme Inhibitors; Guanidines; Humans; In Vitro Techniques; Keratitis; Methylene Blue; Mice; Mice, Inbred C57BL; Photochemotherapy; Photosensitizing Agents; Polymers; Pyrimidines; Riboflavin; Triazoles; Ultraviolet Therapy; Voriconazole

2012
Management of recurrent Paecilomyces lilacinus keratitis.
    Clinical & experimental optometry, 2013, Volume: 96, Issue:3

    Topics: Aged; Humans; Keratitis; Male; Mycoses; Paecilomyces; Pyrimidines; Recurrence; Triazoles; Voriconazole

2013
Co-isolation of Vahlkampfia and acanthamoeba in acanthamoeba-like keratitis in a Spanish population.
    Cornea, 2013, Volume: 32, Issue:5

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Adult; Antifungal Agents; Antiprotozoal Agents; Benzamidines; Biguanides; Cell Line; Disinfectants; DNA, Protozoan; Drug Therapy, Combination; Female; Gene Amplification; Genotyping Techniques; Humans; Incidence; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Retrospective Studies; RNA, Ribosomal, 18S; Schizopyrenida; Spain; Triazoles; Voriconazole; Young Adult

2013
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
    Ugeskrift for laeger, 2012, Aug-27, Volume: 174, Issue:35

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole

2012
Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.
    Mycopathologia, 2012, Volume: 174, Issue:5-6

    Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Fungal Capsules; Humans; Melanins; Microbial Sensitivity Tests; Pimenta; Plant Extracts; Pyrimidines; Triazoles; Voriconazole

2012
The use of group sequential designs with common competing risks tests.
    Statistics in medicine, 2013, Mar-15, Volume: 32, Issue:6

    Topics: Blood Platelets; Clinical Trials as Topic; Computer Simulation; Cord Blood Stem Cell Transplantation; Fluconazole; Humans; Kidney Diseases; Pyrimidines; Research Design; Risk; Sample Size; Statistics as Topic; Triazoles; Voriconazole

2013
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Antifungal Agents; Australia; Cryptococcosis; Cryptococcus gattii; Drug Resistance, Fungal; Europe; Fluconazole; Humans; India; Itraconazole; Microbial Sensitivity Tests; North America; Pyrimidines; South Africa; South America; Triazoles; Voriconazole

2012
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
    Infection, 2012, Volume: 40, Issue:6

    Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole

2012
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12

    Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole

2012
Better hospital nutrition needed to prevent and treat Aspergillus infections.
    Medical mycology, 2013, Volume: 51, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole

2013
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
    Journal of clinical pharmacy and therapeutics, 2013, Volume: 38, Issue:1

    Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2013
Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2012, Sep-06, Volume: 17, Issue:36

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fever; Fungal Proteins; Germany; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pyrimidines; Sequence Analysis; Treatment Outcome; Triazoles; Voriconazole

2012
Successful salvage therapy of refractory HIV-related cryptococcal meningitis with the combination of liposomal amphotericin B, voriconazole, and recombinant interferon-γ.
    Diagnostic microbiology and infectious disease, 2012, Volume: 74, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; HIV Infections; Humans; Interferon-gamma; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2012
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2012, Volume: 53, Issue:8

    Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole

2012
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2013, Volume: 42, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole

2013
Disseminated subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a patient with Wegener's granulomatosis.
    Acta dermato-venereologica, 2013, Volume: 93, Issue:3

    Topics: Aged; Antifungal Agents; Biopsy; DNA, Fungal; Exophiala; Female; Granulomatosis with Polyangiitis; Humans; Immunocompromised Host; Immunosuppressive Agents; Phaeohyphomycosis; Pyrimidines; Ribotyping; Risk Factors; Skin; Treatment Outcome; Triazoles; Voriconazole

2013
Mixed Acanthamoeba and multidrug-resistant Achromobacter xyloxidans in late-onset keratitis after laser in situ keratomileusis.
    Journal of cataract and refractive surgery, 2012, Volume: 38, Issue:10

    Topics: Acanthamoeba Keratitis; Achromobacter denitrificans; Adult; Antifungal Agents; Corneal Stroma; Corneal Ulcer; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Polymerase Chain Reaction; Postoperative Complications; Pyrimidines; Surgical Flaps; Tomography, Optical Coherence; Triazoles; Voriconazole

2012
Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Animals; Antifungal Agents; Body Burden; C-Reactive Protein; Colony Count, Microbial; Cortisone; Drug Combinations; Galactose; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung; Mannans; Organ Size; Pulmonary Aspergillosis; Pyrimidines; Rats; Respiratory Function Tests; Serum Amyloid P-Component; Survival; Triazoles; Voriconazole

2012
2D solid-state NMR analysis of inclusion in drug-cyclodextrin complexes.
    Molecular pharmaceutics, 2012, Nov-05, Volume: 9, Issue:11

    Topics: Adenine; Carbon Radioisotopes; Cyclodextrins; Diflunisal; Fluorine Radioisotopes; Hydrogen; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Organophosphonates; Phosphorus; Pyrimidines; Triazoles; Voriconazole

2012
Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biofilms; Caspofungin; Colorimetry; Coloring Agents; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Tetrazolium Salts; Triazoles; Voriconazole

2012
Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12

    Topics: Amino Acid Sequence; Amphotericin B; Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Pyrimidines; Saccharomyces cerevisiae; Steroid Isomerases; Sterols; Triazoles; Voriconazole

2012
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:12

    Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts

2012
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
    Annals of clinical microbiology and antimicrobials, 2012, Oct-04, Volume: 11

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole

2012
Voriconazole hepatotoxicity in severe liver dysfunction.
    The Journal of infection, 2013, Volume: 66, Issue:1

    Topics: Adult; Aged; Amphotericin B; Analysis of Variance; Antifungal Agents; Aspergillosis; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Liver; Liver Function Tests; Male; Middle Aged; Observation; Pyrimidines; Triazoles; Voriconazole

2013
Voriconazole stability in cement spacers.
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:11

    Topics: Antifungal Agents; Arthroplasty, Replacement, Hip; Biofilms; Bone Cements; Candida glabrata; Candidiasis; Caspofungin; Device Removal; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Therapy, Combination; Echinocandins; Hip Prosthesis; Humans; Infusions, Intravenous; Lipopeptides; Male; Middle Aged; Prostheses and Implants; Prosthesis-Related Infections; Pyrimidines; Triazoles; Voriconazole

2012
The surgical management of rhinocerebral mucormycosis.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2013, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult

2013
Relapsing cerebral aspergilloma associated with pregnancy.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Central Nervous System Fungal Infections; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Pregnancy; Pregnancy Complications, Infectious; Pyrimidines; Recurrence; Seizures; Triazoles; Voriconazole

2013
Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans.
    The AAPS journal, 2013, Volume: 15, Issue:1

    Topics: Adult; Humans; Male; Microdialysis; Middle Aged; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
    World journal of gastroenterology, 2012, Oct-07, Volume: 18, Issue:37

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole

2012
Pustules and sinus tracts involving the right arm of an elderly patient--quiz case. Diagnosis: eumycetoma.
    Archives of dermatology, 2012, Volume: 148, Issue:10

    Topics: Aged, 80 and over; Antifungal Agents; Humans; Male; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2012
Simultaneous cutaneous infection due to Paecilomyces lilacinus and Alternaria in a heart transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:6

    Topics: Alternaria; Alternariosis; Antifungal Agents; Dermatomycoses; Heart Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Paecilomyces; Pyrimidines; Triazoles; Voriconazole

2012
Successful treatment of a severe case of fusariomycosis in a beluga whale (Delphinapterus leucas leucas).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2012, Volume: 43, Issue:3

    Topics: Animals; Animals, Zoo; Antifungal Agents; Drug Administration Schedule; Extremities; Fusarium; Male; Mycoses; Pyrimidines; Triazoles; Voriconazole; Whales

2012
Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.
    Clinical nephrology, 2012, Volume: 78, Issue:5

    Topics: Adult; Antiviral Agents; Aspergillosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Pyrimidines; Triazoles; Voriconazole

2012
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage Fluid; Child; Child, Preschool; Czech Republic; Databases, Factual; Echinocandins; Female; Galactose; Humans; Leukemia; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Neutrophils; Pyrimidines; Retrospective Studies; Slovakia; Triazoles; Voriconazole; Young Adult

2013
Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in h
    Clinical chemistry and laboratory medicine, 2013, Volume: 51, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Chromatography, Liquid; Drug Monitoring; Humans; Itraconazole; Liquid-Liquid Extraction; Pyrimidines; Tandem Mass Spectrometry; Triazoles; Voriconazole

2013
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:4

    Topics: Animals; Antifungal Agents; China; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Penicillium; Pyrimidines; Rats; Terbinafine; Triazoles; Voriconazole

2013
Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Adolescent; Analysis of Variance; Antifungal Agents; Aspergillosis; Aspergillus; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Pharmacodynamics of anidulafungin against clinical Aspergillus fumigatus isolates in a nonneutropenic murine model of disseminated aspergillosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Echinocandins; Female; Fungal Proteins; Humans; Mice; Mutation; Neutrophils; Promoter Regions, Genetic; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2013
Voriconazole for Candida endophthalmitis.
    Ophthalmology, 2012, Volume: 119, Issue:11

    Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Male; Pyrimidines; Tomography, Optical Coherence; Treatment Outcome; Triazoles; Urine; Voriconazole

2012
Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:2

    Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Mice; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2013
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
    Annals of laboratory medicine, 2012, Volume: 32, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole

2012
Successful monitoring and treatment of intraocular dissemination of acanthamoeba.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2012, Volume: 130, Issue:11

    Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba; Acanthamoeba Keratitis; Animals; Antigens, Protozoan; Diagnosis, Differential; DNA, Protozoan; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole

2012
Ochroconis gallopavum infection in a lung transplant recipient: report of a case.
    Transplantation proceedings, 2012, Volume: 44, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Bronchiolitis Obliterans; Disease Progression; Drug Administration Schedule; Enterobacter cloacae; Enterococcus; Fatal Outcome; Humans; Imipenem; Lung Transplantation; Male; Opportunistic Infections; Phaeohyphomycosis; Pyrimidines; Respiratory Tract Infections; Skin; Sputum; Tobramycin; Treatment Outcome; Triazoles; Voriconazole

2012
Treatment of iatrogenic fungal infections: a black mold defines a new gray zone in medicine.
    Annals of internal medicine, 2013, Feb-05, Volume: 158, Issue:3

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Arthritis; Centers for Disease Control and Prevention, U.S.; Drug Contamination; Fungi; Humans; Iatrogenic Disease; Injections, Spinal; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Referral and Consultation; Spinal Diseases; Spinal Puncture; Triazoles; United States; Voriconazole

2013
A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Antifungal Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Itraconazole; Limit of Detection; Naproxen; Observer Variation; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole

2013
Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; China; Chromoblastomycosis; DNA, Fungal; Female; Hospitals, Teaching; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Naphthalenes; Pyrimidines; Sequence Analysis, DNA; Terbinafine; Treatment Outcome; Triazoles; Voriconazole

2013
Case report of exposure to voriconazole in the second and third trimesters of pregnancy.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Adult; Aspergillosis; Aspergillus flavus; Female; Humans; Pregnancy; Pregnancy Trimester, Third; Pyrimidines; Triazoles; Voriconazole

2013
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Drug Evaluation; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Middle Aged; Pyrimidines; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Meningitis outbreak challenges hospital pharmacies.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Dec-01, Volume: 69, Issue:23

    Topics: Amphotericin B; Antifungal Agents; Drug Contamination; Drug Monitoring; Drug Therapy, Combination; Humans; Meningitis, Fungal; Pharmacy Service, Hospital; Pyrimidines; Triazoles; Voriconazole; Workforce

2012
In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Microbial Sensitivity Tests; Point Mutation; Promoter Regions, Genetic; Pyrimidines; Tandem Repeat Sequences; Triazoles; Voriconazole

2013
Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections.
    Annals of internal medicine, 2013, Feb-05, Volume: 158, Issue:3

    Topics: Anti-Inflammatory Agents; Antifungal Agents; Disease Outbreaks; Drug Contamination; Follow-Up Studies; Humans; Iatrogenic Disease; Injections, Epidural; Leukocyte Count; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Prospective Studies; Pyrimidines; Spinal Puncture; Statistics, Nonparametric; Triazoles; Virginia; Voriconazole

2013
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Ciprofloxacin shows synergism with classical antifungals against Histoplasma capsulatum var. capsulatum and Coccidioides posadasii.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Antifungal Agents; Caspofungin; Ciprofloxacin; Coccidioides; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Histoplasma; Lipopeptides; Microbial Sensitivity Tests; Mycelium; Pyrimidines; Triazoles; Voriconazole

2013
Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
    The Journal of international medical research, 2012, Volume: 40, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Invasive Pulmonary Aspergillosis; Liver Failure, Acute; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2012
Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:3

    Topics: Antifungal Agents; beta-Thalassemia; Bone Marrow Transplantation; Child; Humans; Male; Prognosis; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2013
Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4

    Topics: Animal Structures; Animals; Antiprotozoal Agents; Chagas Disease; Disease Models, Animal; Female; Histocytochemistry; Mice; Mice, Inbred BALB C; Parasitemia; Pyrimidines; Survival Analysis; Triazoles; Trypanosoma cruzi; Voriconazole

2013
Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency.
    Pharmacogenomics, 2012, Volume: 13, Issue:16

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cytochrome P-450 CYP2C19; Genetic Association Studies; Granulomatous Disease, Chronic; Humans; Male; Pharmacogenetics; Pyrimidines; Triazoles; Voriconazole

2012
Corneal stromal abscessation in two horses treated with intracorneal and subconjunctival injection of 1% voriconazole solution.
    Veterinary ophthalmology, 2013, Volume: 16, Issue:6

    Topics: Abscess; Animals; Antifungal Agents; Eye Diseases; Horse Diseases; Horses; Injections, Intraocular; Male; Pyrimidines; Triazoles; Voriconazole

2013
STB5 is a negative regulator of azole resistance in Candida glabrata.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Amino Acid Sequence; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida glabrata; DNA-Binding Proteins; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Oxidative Stress; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Alignment; Transcription Factors; Triazoles; Voriconazole

2013
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole

2013
Combination antifungal therapy for invasive pulmonary aspergillosis.
    BMJ case reports, 2012, Dec-14, Volume: 2012

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
[Photo quiz: basic mycology].
    Medical mycology journal, 2012, Volume: 53, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Pyrimidines; Triazoles; Voriconazole

2012
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report.
    Transplantation proceedings, 2013, Volume: 45, Issue:2

    Topics: Air Microbiology; Antifungal Agents; Cardiomyopathy, Dilated; Cyclonic Storms; Environmental Exposure; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2013
Coordinated roles of pregnane X receptor and constitutive androstane receptor in autoinduction of voriconazole metabolism in mice.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Animals; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Gene Expression Regulation; Hepatocytes; Host Specificity; Humans; Ketoconazole; Liver; Membrane Proteins; Mice; Mice, Transgenic; Oxidoreductases, N-Demethylating; Pregnane X Receptor; Primary Cell Culture; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; RNA, Messenger; Species Specificity; Triazoles; Voriconazole

2013
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole

2013
Prothioconazole and prothioconazole-desthio activities against Candida albicans sterol 14-α-demethylase.
    Applied and environmental microbiology, 2013, Volume: 79, Issue:5

    Topics: Antifungal Agents; Candida albicans; Enzyme Inhibitors; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole

2013
Prevalence of yeast other than Candida albicans in denture wearers.
    Journal of prosthodontics : official journal of the American College of Prosthodontists, 2013, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Dentures; DNA Fingerprinting; Female; Fluconazole; Humans; Male; Microbial Interactions; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Oral Hygiene; Polymerase Chain Reaction; Prospective Studies; Pyrimidines; RNA, Fungal; RNA, Ribosomal; RNA, Transfer; Triazoles; Voriconazole

2013
Voriconazole-induced bradycardia without QT interval prolongation: a possible non-concentration-dependent adverse effect.
    Intensive care medicine, 2013, Volume: 39, Issue:3

    Topics: Antifungal Agents; Bradycardia; Electrocardiography; Female; Humans; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2013
Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Resistance, Fungal; Galactose; Immunocompromised Host; Kidney; Male; Mannans; Mice; Microbial Sensitivity Tests; Predictive Value of Tests; Pyrimidines; Triazoles; Voriconazole

2013
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2013
Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange.
    Therapeutic drug monitoring, 2013, Volume: 35, Issue:1

    Topics: Antifungal Agents; Antiphospholipid Syndrome; Critical Illness; Humans; Male; Middle Aged; Plasma Exchange; Plasmapheresis; Pyrimidines; Triazoles; Voriconazole

2013
Quantification of voriconazole in human bronchoalveolar lavage fluid using high-performance liquid chromatography with fluorescence detection.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2013, Jan-15, Volume: 913-914

    Topics: Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Drug Stability; Humans; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Triazoles; Voriconazole

2013
Mohs micrographic surgery for the treatment of localized cutaneous alternariosis.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:2

    Topics: Alternariosis; Antifungal Agents; Humans; Male; Middle Aged; Mohs Surgery; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2013
Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole

2013
Scedosporium apiospermum soft tissue infection as the initial presentation of acute myeloid leukemia: a case report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7

    Topics: Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Decitabine; Diagnosis, Differential; Disease Progression; Fatal Outcome; Female; Humans; Leg Ulcer; Leukemia, Myeloid, Acute; Mycoses; Pancytopenia; Pyrimidines; Scedosporium; Soft Tissue Infections; Triazoles; Voriconazole

2013
Evaluation of intravenous voriconazole in patients with compromised renal function.
    BMC infectious diseases, 2013, Jan-16, Volume: 13

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Triazoles; Voriconazole; Young Adult

2013
Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Arabidopsis; Arabidopsis Proteins; Biosynthetic Pathways; Brassinosteroids; Drug Resistance; Fragaria; Genetic Variation; Metabolome; Phenotype; Pyrimidines; Sterol 14-Demethylase; Sterols; Triazoles; Voriconazole

2013
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole

2012
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:4

    Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole

2013
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
    Die Pharmazie, 2012, Volume: 67, Issue:12

    Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole

2012
[Combination antifungal therapy in hematopoietic stem cell transplantation patients].
    Harefuah, 2012, Volume: 151, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Child; Dermatomycoses; Drug Therapy, Combination; Fusariosis; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lung Diseases, Fungal; Male; Nasopharyngeal Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Effects of a defective endoplasmic reticulum-associated degradation pathway on the stress response, virulence, and antifungal drug susceptibility of the mold pathogen Aspergillus fumigatus.
    Eukaryotic cell, 2013, Volume: 12, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytosol; Drug Resistance, Fungal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoplasmic Reticulum-Associated Degradation; Fungal Proteins; Gene Deletion; Gene Expression Regulation, Fungal; Mice; Proteasome Endopeptidase Complex; Protein Folding; Pyrimidines; Survival Analysis; Triazoles; Ubiquitin-Protein Ligases; Virulence; Voriconazole

2013
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:4

    Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
    Mycoses, 2013, Volume: 56, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
[Endophthalmitis in course of candidosis--a case report].
    Klinika oczna, 2012, Volume: 114, Issue:3

    Topics: Adult; Antifungal Agents; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Pyrimidines; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole

2012
[Favorable outcome in a case of complicated fungal keratitis].
    Journal francais d'ophtalmologie, 2013, Volume: 36, Issue:3

    Topics: Abscess; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Diabetes Complications; Eye Injuries; Female; Fusariosis; Fusarium; Humans; Keratitis; Lens Implantation, Intraocular; Middle Aged; Phacoemulsification; Pyrimidines; Triazoles; Voriconazole; Wound Infection

2013
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
Software for dosage individualization of voriconazole for immunocompromised patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Adult; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Models, Theoretical; Pyrimidines; Software; Triazoles; Voriconazole

2013
A 56-year-old man with undifferentiated fever in the ICU and endobronchial plaques.
    Chest, 2013, Feb-01, Volume: 143, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Colectomy; Fever; Humans; Intensive Care Units; Intestinal Diseases; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
    The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012
Reflections on the approach to treatment of a mycologic disaster.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Cladosporium; Humans; Mucormycosis; Mycoses; Pyrimidines; Rhizopus; Rhodotorula; Triazoles; Voriconazole

2013
Schizophyllum commune: a new organism in eye infection.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Administration, Topical; Adult; Amphotericin B; Antifungal Agents; Cornea; Corneal Transplantation; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Keratitis; Male; Molecular Sequence Data; Mycoses; Polymerase Chain Reaction; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
    The Indian journal of medical research, 2012, Volume: 136, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole

2012
Voriconazole suppresses the growth of Leishmania species in vitro.
    Parasitology research, 2013, Volume: 112, Issue:5

    Topics: Animals; Antiprotozoal Agents; Fluconazole; Inhibitory Concentration 50; Ketoconazole; Leishmania; Parasitic Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole

2013
Selection of the antifungal agent decides prognosis of invasive aspergillosis: case report of a successful outcome with voriconazole.
    International ophthalmology, 2014, Volume: 34, Issue:1

    Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Humans; Male; Orbital Diseases; Prognosis; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole

2014
Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.
    Pharmacotherapy, 2013, Volume: 33, Issue:3

    Topics: Adolescent; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Administration Schedule; Genotype; Humans; Injections, Intravenous; Male; Obesity; Pyrimidines; Triazoles; Voriconazole

2013
Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Drug Monitoring; Humans; Hyponatremia; Invasive Pulmonary Aspergillosis; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Post-operative endophthalmitis due to Fusarium dimerum.
    The Southeast Asian journal of tropical medicine and public health, 2012, Volume: 43, Issue:6

    Topics: Administration, Ophthalmic; Administration, Oral; Administration, Topical; Antifungal Agents; Cataract Extraction; Drug Therapy, Combination; Endophthalmitis; Female; Fusarium; Humans; Lens Implantation, Intraocular; Middle Aged; Postoperative Complications; Prednisolone; Pyrimidines; Triazoles; Voriconazole

2012
EUCAST technical note on voriconazole and Aspergillus spp.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2013
Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Triazoles; Voriconazole

2013
Experimental models of disseminated scedosporiosis with cerebral involvement.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:2

    Topics: Animals; Antifungal Agents; Blood-Brain Barrier; Brain; Central Nervous System Fungal Infections; Disease Models, Animal; Dose-Response Relationship, Drug; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Scedosporium; Survival Analysis; Triazoles; Voriconazole

2013
Native aortic valve fungal endocarditis.
    BMJ case reports, 2013, Feb-20, Volume: 2013

    Topics: Administration, Oral; Adult; Antifungal Agents; Aortic Valve; Candida albicans; Candidiasis; Diagnosis, Differential; Echocardiography, Transesophageal; Endocarditis; Follow-Up Studies; Heart Valve Diseases; Humans; Male; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.
    Clinical orthopaedics and related research, 2013, Volume: 471, Issue:10

    Topics: Animals; Antifungal Agents; Cell Line; Cell Proliferation; Cell Survival; Fibroblasts; Mice; Mycoses; Osteoblasts; Pilot Projects; Pyrimidines; Triazoles; Voriconazole

2013
Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations.
    Infection, 2013, Volume: 41, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System Fungal Infections; Colitis, Ulcerative; Histocytochemistry; Humans; Male; Microscopy; Middle Aged; Psychosurgery; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.
    BMC infectious diseases, 2013, Feb-26, Volume: 13

    Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2013
Aspergillus petrous apicitis associated with cerebral and peritubular abscesses in an immunocompetent man.
    The Journal of laryngology and otology, 2013, Volume: 127, Issue:4

    Topics: 14-alpha Demethylase Inhibitors; Abscess; Aged; Antifungal Agents; Aspergillus; Cranial Nerve Diseases; Delayed Diagnosis; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Neuroaspergillosis; Petrositis; Pyrimidines; Radiography; Skull Base; Triazoles; Voriconazole

2013
Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis.
    Progress in transplantation (Aliso Viejo, Calif.), 2013, Volume: 23, Issue:1

    Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Early Diagnosis; Heart Transplantation; Humans; Immunoenzyme Techniques; Male; Membrane Glycoproteins; Meningitis, Fungal; Middle Aged; Neuroaspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    American journal of hematology, 2013, Volume: 88, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Female; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Recurrence; Remission Induction; Retrospective Studies; Rhizopus; Triazoles; Voriconazole

2013
Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:11

    Topics: Adolescent; Antifungal Agents; Caspofungin; Child; Child, Preschool; Coccidioidomycosis; Echinocandins; Female; Humans; Infant; Lipopeptides; Male; Pyrimidines; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole

2013
Elements of style in managing coccidioidomycosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:11

    Topics: Antifungal Agents; Caspofungin; Coccidioidomycosis; Echinocandins; Female; Humans; Lipopeptides; Male; Pyrimidines; Triazoles; Voriconazole

2013
Disseminated paracoccidioidomycosis.
    The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Male; Paracoccidioidomycosis; Pyrimidines; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole

2013
Voriconazole induced bradycardia.
    Pediatric hematology and oncology, 2013, Volume: 30, Issue:7

    Topics: Antifungal Agents; Aspergillosis; Bradycardia; Child; Child, Preschool; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Triazoles; Voriconazole

2013
Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:7

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Consolidation Chemotherapy; Economics, Pharmaceutical; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Heart Transplantation; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Risk Factors; Skin Neoplasms; Triazoles; Voriconazole; Young Adult

2013
Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.
    BMC infectious diseases, 2013, Mar-06, Volume: 13

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Genes, Fungal; Humans; Kuwait; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Statistics, Nonparametric; Triazoles; Voriconazole

2013
Localized Histoplasma capsulatum osteomyelitis of the fibula in an immunocompetent teenage boy: a case report.
    BMC infectious diseases, 2013, Mar-11, Volume: 13

    Topics: Antifungal Agents; Child; Fibula; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Male; Osteomyelitis; Pyrimidines; Radiography; Triazoles; Voriconazole

2013
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:6

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dermatomycoses; Drugs, Chinese Herbal; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Opportunistic Infections; Postoperative Complications; Pyrimidines; Scedosporium; Skin Ulcer; Transplantation Conditioning; Transplantation, Autologous; Triazoles; Voriconazole; Young Adult

2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.
    Mycopathologia, 2013, Volume: 175, Issue:3-4

    Topics: Aged; Antifungal Agents; Humans; Lung; Male; Mycetoma; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole

2013
Preemptive treatment with voriconazole in lung transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus fumigatus; Cohort Studies; Female; Humans; Incidence; Lung Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult

2013
A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms.
    Drug metabolism and pharmacokinetics, 2013, Volume: 28, Issue:5

    Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Monitoring; Half-Life; Humans; Male; Neurotoxicity Syndromes; Pyrimidines; Triazoles; Voriconazole

2013
Intracranial blastomycosis presenting as an enhancing cerebellopontine mass.
    Turkish neurosurgery, 2013, Volume: 23, Issue:2

    Topics: Adult; Antifungal Agents; Blastomyces; Blastomycosis; Cerebellar Diseases; Cerebellar Neoplasms; Cerebellopontine Angle; Craniotomy; Humans; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Necrosis; Positron-Emission Tomography; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Candida; Candidiasis; Fluconazole; Lepidoptera; Pyrimidines; Triazoles; Voriconazole

2013
In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Pyrimidines; Triazoles; Voriconazole

2013
Candida krusei arthritis in an adolescent with acute myelogenous leukemia.
    The Pediatric infectious disease journal, 2013, Volume: 32, Issue:10

    Topics: Adolescent; Antifungal Agents; Arthritis, Infectious; Candida; Candidiasis; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Pyrimidines; Triazoles; Voriconazole

2013
Outcomes of persons with blastomycosis involving the central nervous system.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2

    Topics: Amphotericin B; Azoles; Biopsy; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Humans; Magnetic Resonance Imaging; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2013
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole

2013
Excavated pneumonia: an unusual suspect.
    Intensive care medicine, 2013, Volume: 39, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole

2013
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2013
Correlation of CYP2C19 phenotype with voriconazole plasma concentration in children.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:5

    Topics: Adolescent; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C19; Female; Humans; Infant; Male; Phenotype; Polymorphism, Single Nucleotide; Pyrimidines; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole

2013
Rapid high performance liquid chromatographic assay for determination of voriconazole concentration in human plasma.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96 Suppl 2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole

2013
Disseminated Ochroconis gallopava infection in a heart transplant patient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:3

    Topics: Antifungal Agents; Ascomycota; Brain; Fatal Outcome; Heart Transplantation; Humans; Lung; Male; Middle Aged; Mycoses; Peritoneum; Pyrimidines; Triazoles; Voriconazole

2013
Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1.
    Molecular pharmacology, 2013, Volume: 84, Issue:1

    Topics: Antifungal Agents; Azoles; Binding Sites; Cholesterol; Cholesterol 24-Hydroxylase; Clotrimazole; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Humans; Protein Binding; Pyrimidines; Steroid Hydroxylases; Sterol 14-Demethylase; Triazoles; Voriconazole

2013
Compassionate use of voriconazole in newborn infants diagnosed with severe invasive fungal sepsis.
    European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:6

    Topics: Antifungal Agents; Compassionate Use Trials; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Pyrimidines; Sepsis; Triazoles; Voriconazole

2013
A 76-year-old man with a right lung adenocarcinoma and invasive Aspergillosis.
    Mycopathologia, 2013, Volume: 176, Issue:1-2

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antifungal Agents; Aspergillus fumigatus; Histocytochemistry; Humans; Invasive Pulmonary Aspergillosis; Lung; Lung Neoplasms; Male; Microscopy; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole

2013
Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Boston; Carcinoma, Squamous Cell; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Male; Neoplasm Staging; Prognosis; Pyrimidines; Risk Factors; Skin Neoplasms; Survival Rate; Survivors; Triazoles; Voriconazole; Whole-Body Irradiation; Young Adult

2014
[Isolation of Scedosporium apiospermum (teleomorph: Pseudallescheria apiosperma) from an acute myeloid leukemia patient].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:2

    Topics: Antifungal Agents; Bronchoalveolar Lavage Fluid; Caspofungin; Echinocandins; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Lung; Male; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Base Sequence; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Polyenes; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Analysis, DNA; Triazoles; Tunisia; Voriconazole

2013
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Resolution of Coccidioides immitis endophthalmitis with an aggressive surgical and medical therapeutic approach.
    Seminars in ophthalmology, 2013, Volume: 28, Issue:4

    Topics: Antifungal Agents; Coccidioides; Coccidioidomycosis; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Visual Acuity; Vitrectomy; Voriconazole

2013
Determination of voriconazole serum concentration by bioassay, a valid method for therapeutic drug monitoring for clinical laboratories.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Antifungal Agents; Candida; Drug Monitoring; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2013
Exacerbation of myasthenia gravis with voriconazole.
    Muscle & nerve, 2013, Volume: 47, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Blepharoptosis; Computer Simulation; Disease Progression; Female; Humans; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Pyrimidines; Triazoles; Voriconazole

2013
Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:4

    Topics: Aged; Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Drug Resistance, Fungal; Female; Genes, Fungal; Genotype; Hospitals; Humans; Male; Middle Aged; Molecular Typing; Mycological Typing Techniques; Netherlands; Pyrimidines; Residence Characteristics; Selection, Genetic; Sequence Analysis, DNA; Surveys and Questionnaires; Treatment Failure; Triazoles; Voriconazole; Young Adult

2013
Voriconazole resistance in Aspergillus fumigatus: should we be concerned?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:4

    Topics: Air Microbiology; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Humans; Male; Molecular Typing; Pyrimidines; Residence Characteristics; Triazoles; Voriconazole

2013
In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.
    Annals of laboratory medicine, 2013, Volume: 33, Issue:3

    Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Triazoles; Voriconazole

2013
cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Germany; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Prevalence; Pyrimidines; Triazoles; Voriconazole

2013
Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:3

    Topics: Antifungal Agents; Consensus; Drug Monitoring; Humans; Japan; Pyrimidines; Triazoles; Voriconazole

2013
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:9

    Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Chlorhexidine; Colorimetry; Drug Combinations; Fluoroquinolones; HeLa Cells; Humans; Macrophages; Mice; Moxifloxacin; Ophthalmic Solutions; Parasitic Sensitivity Tests; Pyrimidines; Quinolines; Triazoles; Voriconazole

2013
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Geography; Humans; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Reference Values; Triazoles; Voriconazole

2013
Relapse of fungal meningitis associated with contaminated methylprednisolone.
    The New England journal of medicine, 2013, Jun-27, Volume: 368, Issue:26

    Topics: Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Contamination; Humans; Injections, Epidural; Male; Meningitis, Fungal; Methylprednisolone; Methylprednisolone Acetate; Pyrimidines; Recurrence; Saccharomycetales; Triazoles; Voriconazole

2013
Management of a case of Candida endogenous endophthalmitis in a neonate.
    Ocular immunology and inflammation, 2014, Volume: 22, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Candida tropicalis; Candidemia; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Infant, Newborn; Intravitreal Injections; Pyrimidines; Triazoles; Vancomycin; Voriconazole

2014
Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant.
    Journal of medical economics, 2013, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Female; Health Services; Hematopoietic Stem Cell Transplantation; Hospitalization; Humans; Itraconazole; Male; Middle Aged; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2013
Association of sustained high plasma trough concentration of voriconazole with the incidence of hepatotoxicity.
    Clinica chimica acta; international journal of clinical chemistry, 2013, Sep-23, Volume: 424

    Topics: Adolescent; Aged; Aged, 80 and over; Antifungal Agents; Child; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Liver; Liver Function Tests; Logistic Models; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
    BioMed research international, 2013, Volume: 2013

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesiveness; Animals; Antifungal Agents; Aspergillus fumigatus; beta-Cyclodextrins; Candida albicans; Cornea; Drug Delivery Systems; Drug Stability; Eye; Gels; Goats; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Microbial Sensitivity Tests; Permeability; Pyrimidines; Rheology; Temperature; Triazoles; Viscosity; Voriconazole

2013
Rhizopus keratitis following corneal trauma.
    JAMA ophthalmology, 2013, Volume: 131, Issue:6

    Topics: Administration, Ophthalmic; Administration, Oral; Antifungal Agents; Bacteriological Techniques; Corneal Injuries; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Eye Infections, Fungal; Eye Injuries, Penetrating; Humans; Male; Middle Aged; Mucormycosis; Pyrimidines; Rhizopus; Treatment Outcome; Triazoles; Voriconazole

2013
Steady-state pharmacokinetics and metabolism of voriconazole in patients.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:11

    Topics: Administration, Oral; Adult; Antifungal Agents; Biotransformation; Humans; Plasma; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
    Annals of transplantation, 2013, May-23, Volume: 18

    Topics: Adolescent; Antifungal Agents; Hepatoblastoma; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Liver Transplantation; Male; Opportunistic Infections; Pyrimidines; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
    The Journal of antibiotics, 2013, Volume: 66, Issue:11

    Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole

2013
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Adult; Antifungal Agents; Bronchoalveolar Lavage Fluid; Female; Humans; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Pilot Projects; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Echinocandins; Fungal Proteins; Humans; Microbial Sensitivity Tests; Pyrimidines; Serum; Triazoles; Voriconazole

2013
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:12

    Topics: Antifungal Agents; Drug Synergism; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole

2013
Voriconazole: skeletal fluorosis.
    Prescrire international, 2013, Volume: 22, Issue:139

    Topics: Antifungal Agents; Bone Diseases; Fluoride Poisoning; Humans; Pyrimidines; Triazoles; Voriconazole

2013
Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Diagnostic microbiology and infectious disease, 2013, Volume: 77, Issue:1

    Topics: Antifungal Agents; Candida; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2013
[Severe corneal infection by Colletotrichum gloeosporioides in a farmer].
    Medicina clinica, 2014, Feb-04, Volume: 142, Issue:3

    Topics: Aged; Agricultural Workers' Diseases; Antifungal Agents; Colletotrichum; Corneal Transplantation; Corneal Ulcer; Diagnosis, Differential; Eye Infections, Fungal; Humans; Keratitis, Herpetic; Male; Pyrimidines; Triazoles; Voriconazole

2014
Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10

    Topics: Antifungal Agents; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Trichosporon; Voriconazole

2013
Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.
    Mycoses, 2014, Volume: 57, Issue:2

    Topics: Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Liver; Male; Mice; Pyrimidines; Spleen; Sporothrix; Sporotrichosis; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole

2014
Photo quiz. Generalized pain in a 20-year-old man with chronic granulomatous disease.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:4

    Topics: Antifungal Agents; Bone and Bones; Chemoprevention; Fluoride Poisoning; France; Granulomatous Disease, Chronic; Hand; Humans; Male; Pain; Periostitis; Pyrimidines; Radiography; Triazoles; Voriconazole; Young Adult

2013
Differential expression of ATP-binding cassette and/or major facilitator superfamily class efflux pumps contributes to voriconazole resistance in Aspergillus flavus.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:4

    Topics: Antifungal Agents; Aspergillus flavus; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Drug Resistance, Fungal; Fungal Proteins; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Oligomycins; Protein Isoforms; Pyrimidines; RNA, Fungal; RNA, Messenger; Triazoles; Voriconazole

2013
Successful treatment of acute thyroiditis due to Aspergillus spp. in the context of disseminated invasive aspergillosis in a kidney transplant patient.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Volume: 33, Issue:4

    Topics: Acute Disease; Antifungal Agents; Aspergillosis; Female; Humans; Kidney Transplantation; Middle Aged; Postoperative Complications; Pyrimidines; Remission Induction; Thyroiditis; Triazoles; Voriconazole

2013
Aspergillosis sinusitis with cranio-orbital spread in an apparently immunocompetent patient.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2013, Volume: 74 Suppl 1

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Brain; Combined Modality Therapy; Debridement; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Ophthalmoplegia; Orbit; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2013
Microcalorimetry assay for rapid detection of voriconazole resistance in Aspergillus fumigatus.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Antifungal Agents; Aspergillus fumigatus; Calorimetry; Drug Resistance, Fungal; Microbial Sensitivity Tests; Pyrimidines; Thermodynamics; Time Factors; Triazoles; Voriconazole

2013
Subacute exogenous Rhizoctonia solani endophthalmitis following cataract extraction with intraocular lens implantation.
    Journal of cataract and refractive surgery, 2013, Volume: 39, Issue:10

    Topics: Acute Disease; Antifungal Agents; Cataract Extraction; Combined Modality Therapy; Device Removal; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mycoses; Postoperative Complications; Pyrimidines; Rhizoctonia; Triazoles; Vitrectomy; Voriconazole

2013
Acute chiasmal abscess resulting from perineural extension of invasive sino-orbital aspergillosis in an immunocompetent patient.
    World neurosurgery, 2014, Volume: 81, Issue:1

    Topics: Abscess; Antifungal Agents; Aspergillosis; Cranial Sinuses; Debridement; Humans; Immunocompetence; Immunohistochemistry; Itraconazole; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Optic Chiasm; Optic Nerve; Orbital Diseases; Pyrimidines; Triazoles; Visual Fields; Voriconazole

2014
Scleral and intraocular amoebic dissemination in Acanthamoeba keratitis.
    Cornea, 2013, Volume: 32, Issue:12

    Topics: Acanthamoeba Keratitis; Adult; Antifungal Agents; Cryotherapy; Female; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Pyrimidines; Retrospective Studies; Scleritis; Treatment Outcome; Triazoles; Voriconazole

2013
Spray-dried voriconazole-cyclodextrin complexes: solubility, dissolution rate and chemical stability.
    Carbohydrate polymers, 2013, Oct-15, Volume: 98, Issue:1

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Carbohydrate Conformation; Drug Stability; Molecular Docking Simulation; Pyrimidines; Solubility; Temperature; Triazoles; Voriconazole

2013
Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:1

    Topics: Acremonium; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Mycoses; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2014
Intermolecular interaction of voriconazole analogues with model membrane by DSC and NMR, and their antifungal activity using NMR based metabolic profiling.
    Bioorganic & medicinal chemistry, 2013, Nov-01, Volume: 21, Issue:21

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antifungal Agents; Calorimetry, Differential Scanning; Candida albicans; Carboxylic Acids; Esters; Hydroxybenzoate Ethers; Lipid Bilayers; Magnetic Resonance Spectroscopy; Metabolome; Microbial Sensitivity Tests; Pyrimidines; Transition Temperature; Triazoles; Voriconazole

2013
Extensive proteomic remodeling is induced by eukaryotic translation elongation factor 1Bγ deletion in Aspergillus fumigatus.
    Protein science : a publication of the Protein Society, 2013, Volume: 22, Issue:11

    Topics: Actin Cytoskeleton; Antifungal Agents; Aspergillus fumigatus; Fungal Proteins; Gene Expression Regulation, Fungal; Gene Targeting; Genetic Complementation Test; Glutathione Transferase; Glycerolphosphate Dehydrogenase; Homeodomain Proteins; HSP70 Heat-Shock Proteins; Humans; Oxidation-Reduction; Oxidative Stress; Peptide Elongation Factor 1; Phenotype; Protein Biosynthesis; Proteomics; Pyrimidines; Triazoles; Voriconazole

2013
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2014, Volume: 122, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole

2014
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
    Journal of medical virology, 2014, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult

2014
In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:12

    Topics: Adult; Aged; Cohort Studies; Dermatitis, Phototoxic; Female; France; Humans; Male; Middle Aged; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole; Young Adult

2013
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
    The Southeast Asian journal of tropical medicine and public health, 2013, Volume: 44, Issue:3

    Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    JAMA ophthalmology, 2013, Volume: 131, Issue:11

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Antiprotozoal Agents; Benzamidines; Biguanides; Chlorhexidine; Disinfectants; Humans; Parasitic Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2013
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole

2013
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole

2013
An enantioselective synthesis of voriconazole.
    The Journal of organic chemistry, 2013, Nov-15, Volume: 78, Issue:22

    Topics: Molecular Structure; Pyrimidines; Stereoisomerism; Triazoles; Voriconazole

2013
Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus niger; Belgium; Female; Humans; Incidence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole

2014
Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia.
    BMJ case reports, 2013, Oct-10, Volume: 2013

    Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Female; Fusariosis; Humans; Immune Reconstitution Inflammatory Syndrome; Immunocompromised Host; Leukemia, Myeloid, Acute; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2013
Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients.
    Bone marrow transplantation, 2014, Volume: 49, Issue:1

    Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fusariosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lipopeptides; Logistic Models; Male; Mycoses; Neutrophils; Prospective Studies; Pyrimidines; Retrospective Studies; Risk; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2014
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
    Journal de mycologie medicale, 2013, Volume: 23, Issue:4

    Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Drug Substitution; Fatal Outcome; Female; Fluconazole; Fungemia; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Scedosporium; Triazoles; Voriconazole; Young Adult

2013
Skin infection caused by Scedosporium apiospermum in immunocompromised patients. Report of two cases.
    Dermatology online journal, 2013, Oct-16, Volume: 19, Issue:10

    Topics: Abscess; Aged; Antifungal Agents; Dermatomycoses; Humans; Immunocompromised Host; Male; Naphthalenes; Pyrimidines; Scedosporium; Terbinafine; Triazoles; Voriconazole

2013
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
    International journal of medical sciences, 2013, Volume: 10, Issue:12

    Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole

2013
Ulcerative tracheobronchitis due to Aspergillus.
    Journal of bronchology & interventional pulmonology, 2013, Volume: 20, Issue:4

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Asthma; Biopsy; Bronchitis; Bronchoscopy; Critical Care; Humans; Incidental Findings; Male; Pyrimidines; Respiration, Artificial; Respiratory Mucosa; Tracheitis; Tracheostomy; Treatment Failure; Treatment Outcome; Triazoles; Ulcer; Voriconazole

2013
Fungal peritonitis associated with Curvularia geniculata and Pithomyces species in a patient with vulvar cancer who was successfully treated with oral voriconazole.
    The Journal of antibiotics, 2014, Volume: 67, Issue:2

    Topics: Antifungal Agents; Antineoplastic Agents; Ascomycota; Diabetic Nephropathies; Female; Humans; Immunocompromised Host; Medroxyprogesterone; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole; Vulvar Neoplasms

2014
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens.
    Seminars in ophthalmology, 2014, Volume: 29, Issue:4

    Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole

2014
Successful treatment of Fusarium keratitis after photo refractive keratectomy.
    Indian journal of ophthalmology, 2013, Volume: 61, Issue:11

    Topics: Adult; Antifungal Agents; Cornea; Diagnosis, Differential; Eye Infections, Fungal; Female; Follow-Up Studies; Fusariosis; Fusarium; Humans; Keratitis; Myopia; Ophthalmic Solutions; Photorefractive Keratectomy; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole

2013
A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1

    Topics: Antifungal Agents; Humans; Itraconazole; Pyrimidines; Triazoles; Voriconazole

2014
Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:3

    Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Leukemia; Male; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2014
[Fungal keratitis caused by Scedosporium apiospermum: first report from Turkey].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4

    Topics: Antifungal Agents; Conjunctiva; Cornea; Disease Progression; Drug Resistance, Fungal; Drug Therapy, Combination; Eye Foreign Bodies; Eye Infections, Fungal; Eye Injuries; Female; Humans; Keratitis; Keratoplasty, Penetrating; Middle Aged; Natamycin; Pyrimidines; Scedosporium; Treatment Refusal; Triazoles; Turkey; Voriconazole

2013
[Three cases of fungemia caused by Blastoschizomyces capitatus].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Caspofungin; Child; Echinocandins; Female; Fungemia; Humans; Immunocompromised Host; Lipopeptides; Lymphoma, B-Cell; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Saccharomycetales; Triazoles; Voriconazole; Young Adult

2013
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole

2014
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
    BMJ case reports, 2013, Nov-18, Volume: 2013

    Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole

2013
In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method.
    TheScientificWorldJournal, 2013, Volume: 2013

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Turkey; Voriconazole

2013
Acute meningitis caused by Cladosporium sphaerospermum.
    The American journal of the medical sciences, 2013, Volume: 346, Issue:6

    Topics: Aged; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cladosporium; Drug Therapy, Combination; Humans; Male; Meningitis, Fungal; Pyrimidines; Taiwan; Treatment Outcome; Triazoles; Voriconazole

2013
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2013, Volume: 19, Issue:8

    Topics: Aged; Alkaline Phosphatase; Antifungal Agents; Arthralgia; Diagnosis, Differential; Disease Progression; Female; Granulomatosis with Polyangiitis; Hip Joint; Humans; Periostitis; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2013
Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
    Parasitology research, 2014, Volume: 113, Issue:2

    Topics: Acanthamoeba; Amebiasis; Amebicides; Chlorhexidine; Humans; Parasitic Sensitivity Tests; Peru; Pyrimidines; Triazoles; Voriconazole

2014
Perplexity of a fungus in the sinus.
    The American journal of medicine, 2014, Volume: 127, Issue:1

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Ascomycota; Benzenesulfonates; Brain Abscess; Central Nervous System Fungal Infections; Chronic Disease; Coloring Agents; Debridement; Epidural Abscess; Frontal Lobe; Frontal Sinus; Humans; Lactic Acid; Male; Phenols; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole

2014
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Pyrimidines; Remission Induction; Retrospective Studies; Secondary Prevention; Tertiary Care Centers; Triazoles; Voriconazole

2014
Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey.
    BMC infectious diseases, 2013, Nov-26, Volume: 13

    Topics: Amphotericin B; Antifungal Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Turkey; Voriconazole

2013
[Photo quiz: Deep-seated mycosis].
    Medical mycology journal, 2013, Volume: 54, Issue:4

    Topics: Adolescent; Antifungal Agents; Disease Susceptibility; Emericella; Granulomatous Disease, Chronic; Humans; Lung; Lung Diseases, Fungal; Male; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2013
Disseminated pulmonary penicilliosis in a rheumatoid arthritis patient.
    Journal of thoracic imaging, 2014, Volume: 29, Issue:2

    Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Echinocandins; Humans; Hydrocortisone; Lipopeptides; Lung; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2014
Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Mycopathologia, 2014, Volume: 177, Issue:1-2

    Topics: Animals; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Caspofungin; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Galactose; Humans; Lipopeptides; Male; Mannans; Microbial Sensitivity Tests; Neutropenia; Pulmonary Aspergillosis; Pyrimidines; Rats; Rats, Sprague-Dawley; Treatment Outcome; Triazoles; Voriconazole

2014
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole

2014
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole

2014
Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.
    Mycopathologia, 2014, Volume: 177, Issue:1-2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Cataract Extraction; Disease Outbreaks; Endophthalmitis; Eye Infections, Fungal; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Voriconazole

2014
Atypical lentigines in a man with mixed African American and white race/ethnicity receiving long-term voriconazole therapy.
    JAMA dermatology, 2014, Volume: 150, Issue:3

    Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Black or African American; Dermatomycoses; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Lentigo; Male; Pyrimidines; Risk Assessment; Sarcoidosis, Pulmonary; Triazoles; Voriconazole; White People

2014
Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype.
    The Journal of infectious diseases, 2014, Jun-15, Volume: 209, Issue:12

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Female; Hallucinations; Homozygote; Humans; Liver; Male; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult

2014
Bullous phototoxicity from voriconazole.
    The Journal of emergency medicine, 2014, Volume: 46, Issue:3

    Topics: Adult; Antifungal Agents; Dermatitis, Phototoxic; Drug Eruptions; Female; Foot Dermatoses; Humans; Pyrimidines; Skin Diseases, Vesiculobullous; Sunbathing; Triazoles; Voriconazole

2014
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Cancer, 2014, Apr-15, Volume: 120, Issue:8

    Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Costs; Echinocandins; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Voriconazole

2014
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4

    Topics: Antifungal Agents; Candida; Fluconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2014
Voriconazole-induced periostitis in two post-transplant patients.
    Journal of radiology case reports, 2013, Volume: 7, Issue:8

    Topics: Antifungal Agents; Female; Heart Transplantation; Humans; Male; Middle Aged; Opportunistic Infections; Periostitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Factors affecting voriconazole plasma concentrations in patients with invasive fungal infections.
    International journal of clinical pharmacology and therapeutics, 2014, Volume: 52, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; Humans; Male; Middle Aged; Mycoses; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole

2014
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S.
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Approval; Echinocandins; Female; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Off-Label Use; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult

2014
Antibiotics sensitivity of Candida clinical and food-borne isolates.
    Acta biochimica Polonica, 2013, Volume: 60, Issue:4

    Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole

2013
In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina.
    Biochemical and biophysical research communications, 2014, Apr-11, Volume: 446, Issue:3

    Topics: Animals; Cholesterol; Cholesterol 24-Hydroxylase; Cytokines; Electroretinography; Enzyme Inhibitors; Homeostasis; Hydroxycholesterols; Male; Microglia; Nerve Tissue Proteins; Neuroglia; Pyrimidines; Rats; Rats, Wistar; Retina; Steroid Hydroxylases; Triazoles; Up-Regulation; Voriconazole

2014
Utilizing hardware culture in a case of atypical keratitis.
    Seminars in ophthalmology, 2014, Volume: 29, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Contact Lenses, Hydrophilic; Corneal Ulcer; Drug Therapy, Combination; Equipment Contamination; Eye Infections, Fungal; Humans; Male; Mycological Typing Techniques; Natamycin; Pyrimidines; Triazoles; Voriconazole; Young Adult

2014
Chronic granulomatous invasive fungal sinusitis: an evolving approach to management.
    International forum of allergy & rhinology, 2014, Volume: 4, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Granuloma; Humans; Male; Pyrimidines; Sinusitis; Triazoles; Voriconazole

2014
A computational exploration of imprinted polymer affinity based on voriconazole metabolites.
    The Analyst, 2014, Apr-07, Volume: 139, Issue:7

    Topics: Adsorption; Binding Sites; Computer Simulation; Cross-Linking Reagents; Methacrylates; Models, Molecular; Molecular Conformation; Molecular Imprinting; Particle Size; Polymerization; Polymers; Pyrimidines; Spectrophotometry, Ultraviolet; Surface Properties; Thermodynamics; Triazoles; Voriconazole

2014
Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease.
    Journal of the American Academy of Dermatology, 2014, Volume: 70, Issue:3

    Topics: Biopsy, Needle; Child; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Immunohistochemistry; Lung Diseases, Fungal; Lupus Erythematosus, Discoid; Male; Photosensitivity Disorders; Prognosis; Pyrimidines; Recurrence; Severity of Illness Index; Sunlight; Triazoles; Voriconazole

2014
Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus; Echinocandins; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Triazoles; Voriconazole

2014
Aspergillus spondylodiscitis in an immunocompetent patient following spinal anesthesia.
    Orthopaedic surgery, 2014, Volume: 6, Issue:1

    Topics: Adult; Anesthesia, Spinal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cesarean Section; Debridement; Discitis; Female; Humans; Immunocompetence; Pregnancy; Puerperal Infection; Pyrimidines; Triazoles; Voriconazole

2014
Phototoxic dermatoses in pediatric BMT patients receiving voriconazole.
    Pediatric blood & cancer, 2014, Volume: 61, Issue:7

    Topics: Allografts; Antifungal Agents; Bone Marrow Transplantation; Child; Female; Humans; Male; Photosensitivity Disorders; Pyrimidines; Retrospective Studies; Skin Neoplasms; Sunlight; Sunscreening Agents; Triazoles; Voriconazole

2014
Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei.
    The American journal of the medical sciences, 2014, Volume: 348, Issue:3

    Topics: Adult; Antifungal Agents; Candida albicans; Caspofungin; Cell Proliferation; Cells, Cultured; Echinocandins; Humans; Immunologic Factors; Leukocytes, Mononuclear; Lipopeptides; Male; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2014
A high-definition view of endogenous fungal endophthalmitis.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4

    Topics: Antifungal Agents; Caspofungin; Echinocandins; Endophthalmitis; Fundus Oculi; Humans; Lipopeptides; Male; Middle Aged; Ophthalmoscopy; Photography; Pyrimidines; Tomography, Optical Coherence; Triazoles; Voriconazole

2014
Coccidioidomycosis in a Pacific walrus (Odobenus rosmarus divergens).
    Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians, 2014, Volume: 45, Issue:1

    Topics: Animals; Antifungal Agents; Coccidioidomycosis; Female; Pyrimidines; Triazoles; Voriconazole; Walruses

2014
The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex.
    Journal of medical microbiology, 2014, Volume: 63, Issue:Pt 7

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cyclosporine; Drug Synergism; Echinocandins; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2014
Aspergilloma and massive haemoptysis.
    BMJ case reports, 2014, Apr-16, Volume: 2014

    Topics: Adult; Aneurysm, False; Angiography; Antifungal Agents; Embolization, Therapeutic; Female; Hemoptysis; Humans; Ill-Housed Persons; Mycetoma; Pulmonary Artery; Pulmonary Aspergillosis; Pyrimidines; Severity of Illness Index; Substance Abuse, Intravenous; Tomography, X-Ray Computed; Triazoles; Voriconazole

2014
Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium.
    JAMA ophthalmology, 2014, Volume: 132, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cell Count; Chondroitin Sulfates; Colony Count, Microbial; Complex Mixtures; Cornea; Culture Media, Serum-Free; Dextrans; Drug Combinations; Drug Contamination; Endothelium, Corneal; Gentamicins; Humans; Microbial Sensitivity Tests; Organ Preservation; Organ Preservation Solutions; Pyrimidines; Tissue Donors; Treatment Outcome; Triazoles; Voriconazole

2014
Tumorlike cardiac fungal mycetoma caused by Scedosporium apiospermum presenting as symptomatic ventricular tachycardia.
    Circulation, 2014, May-13, Volume: 129, Issue:19

    Topics: Adult; Antifungal Agents; Heart; Hemodynamics; Humans; Male; Mycetoma; Mycoses; Pyrimidines; Scedosporium; Tachycardia, Ventricular; Treatment Outcome; Triazoles; Voriconazole

2014
Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?
    Environmental monitoring and assessment, 2014, Volume: 186, Issue:9

    Topics: Adaptation, Physiological; Agriculture; Antifungal Agents; Aspergillus; Azoles; Environmental Monitoring; Fungicides, Industrial; Humans; Itraconazole; Microbial Sensitivity Tests; Portugal; Pyrimidines; Triazoles; Voriconazole; Wine

2014
Alopecia and nail changes associated with voriconazole therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antifungal Agents; Cross-Sectional Studies; Disease Outbreaks; Female; Humans; Male; Methylprednisolone; Michigan; Middle Aged; Mycoses; Nails; Prevalence; Triazoles; Voriconazole

2014
Multiple Aspergillus brain abscesses after liver transplantation.
    Transplantation, 2014, Jun-27, Volume: 97, Issue:12

    Topics: Antifungal Agents; Brain Abscess; Female; Humans; Liver Transplantation; Magnetic Resonance Imaging; Middle Aged; Neuroaspergillosis; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2014
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:6

    Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult

2015
Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:10

    Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Suction; Treatment Outcome; Triazoles; Voriconazole

2014
Experimental treatment of Curvularia infection.
    Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Immunocompromised Host; Male; Mice; Mycoses; Treatment Outcome; Triazoles; Voriconazole

2014
Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
    Mycoses, 2014, Volume: 57, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Canada; Female; Fusariosis; Fusarium; Humans; Male; Middle Aged; Prospective Studies; Registries; Survival Analysis; Treatment Outcome; Triazoles; United States; Voriconazole; Young Adult

2014
Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.
    BMC microbiology, 2014, Jul-05, Volume: 14

    Topics: Amphotericin B; Animals; Antifungal Agents; Biofilms; Biological Assay; Candida albicans; Candidemia; Drug Resistance, Fungal; Gene Expression Profiling; Genetic Variation; Humans; Lepidoptera; Pyrimidines; Survival Analysis; Triazoles; Virulence; Voriconazole

2014
Cysticidal activity of antifungals against different genotypes of Acanthamoeba.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Antifungal Agents; Cysts; Humans; Parasitic Sensitivity Tests; Triazoles; Voriconazole

2014
Experimental therapy with azoles against Candida guilliermondii.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Antifungal Agents; Azoles; Candida; Microbial Sensitivity Tests; Triazoles; Voriconazole

2014
[Cladophilaphora bantiana brain abscess treated with voriconazole in an immunocompetent patient].
    Mikrobiyoloji bulteni, 2014, Volume: 48, Issue:3

    Topics: Adult; Antifungal Agents; Ascomycota; Brain Abscess; Central Nervous System Fungal Infections; Cerebral Phaeohyphomycosis; Frontal Lobe; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Parietal Lobe; Pyrimidines; Triazoles; Voriconazole

2014
Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.
    Journal of clinical microbiology, 2014, Volume: 52, Issue:10

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Brazil; Calmodulin; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Prevalence; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole

2014
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:12

    Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Molecular Sequence Data; Mutation, Missense; Sequence Analysis, DNA; Triazoles; Voriconazole

2014
[Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2014, Volume: 88, Issue:4

    Topics: Antifungal Agents; Drugs, Generic; Humans; Itraconazole; Lung; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2014
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Drug Resistance, Fungal; Female; Fluconazole; Fungemia; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Romania; Saccharomyces cerevisiae; Triazoles; Voriconazole; Yeasts; Young Adult

2015
Last generation triazoles for imported eumycetoma in eleven consecutive adults.
    PLoS neglected tropical diseases, 2014, Volume: 8, Issue:10

    Topics: Adolescent; Adult; Antifungal Agents; beta-Glucans; Child; Exophiala; Fluorodeoxyglucose F18; Fusarium; Humans; Madurella; Magnetic Resonance Imaging; Male; Mycetoma; Positron-Emission Tomography; Proteoglycans; Retrospective Studies; Skin; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2014
Keratitis caused by Absidia corymbifera in an immunocompetent male with no corneal injuries.
    Archivos de la Sociedad Espanola de Oftalmologia, 2015, Volume: 90, Issue:3

    Topics: Absidia; Administration, Ophthalmic; Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Drug Therapy, Combination; Humans; Immunocompetence; Male; Middle Aged; Mucormycosis; Ophthalmic Solutions; Staining and Labeling; Triazoles; Voriconazole

2015
Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
    Mycoses, 2015, Volume: 58, Issue:3

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Pyrimidines; Triazoles; Voriconazole

2015
Successful long-term management of invasive cerebral fungal infection following liver transplantation.
    Mycoses, 2015, Volume: 58, Issue:3

    Topics: Antifungal Agents; Aspergillus; Aspergillus flavus; Brain Diseases; Central Nervous System Fungal Infections; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Middle Aged; Neuroaspergillosis; Radiography; Scedosporium; Triazoles; Voriconazole

2015
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Mycoses, 2015, Volume: 58, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole

2015
Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis.
    Mycoses, 2015, Volume: 58, Issue:5

    Topics: Aged; Antifungal Agents; Brain; Brain Abscess; Delayed-Action Preparations; Humans; Male; Neuroaspergillosis; Tablets; Treatment Outcome; Triazoles; Voriconazole

2015
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
    Mycoses, 2015, Volume: 58, Issue:5

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole

2015
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole

2015
Multi-triazole-resistant Aspergillus fumigatus infections in Australia.
    Mycoses, 2015, Volume: 58, Issue:6

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Australia; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation, Missense; Retrospective Studies; Triazoles; Voriconazole

2015
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:5

    Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole

2016
Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence.
    PLoS pathogens, 2015, Volume: 11, Issue:4

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Crosses, Genetic; Drug Resistance, Multiple, Fungal; Fungal Proteins; Genes, Mating Type, Fungal; Genetic Loci; Hydroxymethylglutaryl CoA Reductases; Itraconazole; Larva; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mixed Function Oxygenases; Moths; Mutation; Sterol 14-Demethylase; Survival Analysis; Triazoles; Virulence; Voriconazole

2015
Azole Antifungal Agents To Treat the Human Pathogens Acanthamoeba castellanii and Acanthamoeba polyphaga through Inhibition of Sterol 14α-Demethylase (CYP51).
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: 14-alpha Demethylase Inhibitors; Acanthamoeba castellanii; Amebiasis; Amebicides; Antifungal Agents; Azoles; Cell Proliferation; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole

2015
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015, Volume: 21, Issue:8

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA Mutational Analysis; Drug Resistance, Fungal; Female; Fungal Proteins; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Promoter Regions, Genetic; Triazoles; Turkey; Voriconazole; Young Adult

2015
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole

2015
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole

2015
In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection.
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Larva; Lepidoptera; Microbial Sensitivity Tests; Survival Analysis; Triazoles; Voriconazole

2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2015
Contribution of a Simple Bioassay in Effective Therapeutic Drug Monitoring of Posaconazole and Voriconazole.
    Therapeutic drug monitoring, 2015, Volume: 37, Issue:5

    Topics: Antifungal Agents; Biological Assay; Blood Proteins; Calibration; Drug Monitoring; Humans; Protein Binding; Triazoles; Voriconazole

2015
Azole resistance in canine and feline isolates of Aspergillus fumigatus.
    Comparative immunology, microbiology and infectious diseases, 2015, Volume: 42

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cat Diseases; Cats; Cytochrome P-450 Enzyme System; Dog Diseases; Dogs; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2015
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Agar; Animals; Antifungal Agents; Culture Media; Disease Models, Animal; Drosophila melanogaster; Female; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Survival Analysis; Triazoles; Virulence; Voriconazole

2015
Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Mucormycosis; Nitriles; Pyridines; Species Specificity; Triazoles; Voriconazole

2015
Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.
    Diagnostic microbiology and infectious disease, 2016, Volume: 84, Issue:1

    Topics: Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Kidney; Male; Mice; Proteoglycans; Treatment Outcome; Triazoles; Voriconazole

2016
Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Alleles; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Candida glabrata; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nitriles; Protein Isoforms; Pyridines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole

2016
Aspergillus Mediastinitis after Orthotopic Heart Transplantation: A Case Report.
    Texas Heart Institute journal, 2015, Volume: 42, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Combined Modality Therapy; Debridement; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Mediastinitis; Middle Aged; Reoperation; Surgical Flaps; Surgical Wound Infection; Time Factors; Treatment Outcome; Triazoles; Voriconazole

2015
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mycological Typing Techniques; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Voriconazole

2016
In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Coordination Complexes; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Triazoles; Voriconazole

2016
Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Amino Acid Substitution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bacterial Typing Techniques; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Epidemiological Monitoring; Fungal Proteins; Gene Expression; Genotype; Humans; Italy; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Mutation; Promoter Regions, Genetic; Triazoles; Voriconazole

2016
Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Cytomegalovirus Infections; Drug Resistance, Fungal; Fungal Proteins; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Transplant Recipients; Triazoles; United States; Voriconazole

2016
A combination approach to treating fungal infections.
    Scientific reports, 2015, Nov-23, Volume: 5

    Topics: Antifungal Agents; Candida albicans; Cell Line, Tumor; Cell Survival; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Epithelial Cells; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Tobramycin; Triazoles; Voriconazole

2015
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Mycopathologia, 2016, Volume: 181, Issue:3-4

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Quantification of the Triazole Antifungal Compounds Voriconazole and Posaconazole in Human Serum or Plasma Using Liquid Chromatography Electrospray Tandem Mass Spectrometry (HPLC-ESI-MS/MS).
    Methods in molecular biology (Clifton, N.J.), 2016, Volume: 1383

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Voriconazole

2016
Isavuconazole: a role for the newest broad-spectrum triazole.
    Lancet (London, England), 2016, Feb-20, Volume: 387, Issue:10020

    Topics: Antifungal Agents; Female; Humans; Male; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole

2016
Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Fungal; Humans; Immunocompromised Host; Male; Mice; Mycoses; Neutropenia; Scopulariopsis; Species Specificity; Survival Analysis; Triazoles; Virulence; Voriconazole

2016
Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
    Mycoses, 2016, Volume: 59, Issue:5

    Topics: Animals; Anti-Allergic Agents; Antifungal Agents; ATP-Binding Cassette Transporters; Candida; Chlorobenzenes; Drug Resistance, Microbial; Ergosterol; Fluconazole; Fungicides, Industrial; Gene Expression Regulation, Fungal; Humans; Itraconazole; Malathion; Microbial Sensitivity Tests; Promethazine; Rhodamines; Sterol 14-Demethylase; Triazoles; Voriconazole

2016
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
    Mycoses, 2016, Volume: 59, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen.
    Journal de mycologie medicale, 2016, Volume: 26, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; Caspofungin; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Environmental Microbiology; Humans; Iran; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Opportunistic Infections; Triazoles; Voriconazole

2016
In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Benzoxazoles; Caspofungin; Drug Combinations; Drug Synergism; Echinocandins; Fungal Proteins; Gene Expression; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; TOR Serine-Threonine Kinases; Triazoles; Voriconazole

2016
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES].
    La Revue du praticien, 2015, Volume: 65, Issue:10

    Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2015
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole

2016
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Antifungal Agents; Drug Interactions; Hospitalization; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole

2016
Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects.
    JAMA dermatology, 2016, 07-01, Volume: 152, Issue:7

    Topics: Aged; Antifungal Agents; Chronic Disease; Dermatitis, Phototoxic; Exophiala; Female; Follow-Up Studies; Humans; Meningitis, Fungal; Phaeohyphomycosis; Retreatment; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole

2016
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:1

    Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Intensive Care Units; Itraconazole; Microbial Sensitivity Tests; Species Specificity; Triazoles; Turkey; Voriconazole

2016
Voriconazole Dosing in Obese Patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 07-15, Volume: 63, Issue:2

    Topics: Antifungal Agents; Humans; Obesity; Pyrimidines; Triazoles; Voriconazole

2016
Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
    Mycoses, 2016, Volume: 59, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Male; Microbial Sensitivity Tests; Mycological Typing Techniques; Phenotype; Sequence Analysis, DNA; Triazoles; Trichosporon; Trichosporonosis; Voriconazole

2016
Fungal infection of cystic fibrosis patients - single center experience.
    Pneumonologia i alergologia polska, 2016, Volume: 84, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts

2016
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1

    Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole

2016
Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity.
    ChemMedChem, 2016, 07-19, Volume: 11, Issue:14

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; HEK293 Cells; Hemolysis; Heterocyclic Compounds, 2-Ring; Humans; Itraconazole; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Structure-Activity Relationship; Thiazoles; Triazoles; Voriconazole

2016
Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Anemia, Aplastic; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Central Nervous System; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocephalus; Immunocompromised Host; Immunosuppression Therapy; Laminectomy; Lipopeptides; Magnetic Resonance Imaging; Opportunistic Infections; Recurrence; Transplantation, Autologous; Treatment Outcome; Triazoles; Trichosporon; Trichosporonosis; Ventriculoperitoneal Shunt; Voriconazole

2016
Comment on: Utility of voriconazole therapeutic drug monitoring: a meta-analysis.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:11

    Topics: Antifungal Agents; Drug Monitoring; Humans; Pyrimidines; Triazoles; Voriconazole

2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
    Mycoses, 2017, Volume: 60, Issue:2

    Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole

2017
Aspergillus fumigatus carrying TR34/L98H resistance allele causing complicated suppurative otitis media in Tanzania: Call for improved diagnosis of fungi in sub-Saharan Africa.
    BMC infectious diseases, 2016, 09-02, Volume: 16

    Topics: Adolescent; Adult; Alleles; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Fungal; Female; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Otitis Media, Suppurative; Tanzania; Triazoles; Voriconazole; Young Adult

2016
Antimold Prophylaxis May Reduce the Risk of Invasive Fusariosis in Hematologic Patients with Superficial Skin Lesions with Positive Culture for Fusarium.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:12

    Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antifungal Agents; Female; Fusariosis; Fusarium; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intertrigo; Leukemia; Male; Middle Aged; Onychomycosis; Prospective Studies; Skin; Triazoles; Voriconazole; Young Adult

2016
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole

2017
Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Fungal Proteins; Fusarium; Microbial Sensitivity Tests; Triazoles; Voriconazole

2017
A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
    Clinical chemistry and laboratory medicine, 2017, May-01, Volume: 55, Issue:6

    Topics: Antifungal Agents; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Fluconazole; Humans; Itraconazole; Limit of Detection; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Triazoles; Voriconazole

2017
Tintelnotia, a new genus in Phaeosphaeriaceae harbouring agents of cornea and nail infections in humans.
    Mycoses, 2017, Volume: 60, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Cornea; Echinocandins; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratitis; Lipopeptides; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Phylogeny; Terbinafine; Triazoles; Voriconazole

2017
Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:6

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzylisoquinolines; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Female; Humans; Itraconazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Voriconazole

2017
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2017, Volume: 17, Issue:9

    Topics: Antifungal Agents; Biomarkers; Cytochrome P-450 CYP3A; Drug Interactions; Female; Follow-Up Studies; Genotype; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Polymorphism, Single Nucleotide; Postoperative Complications; Prognosis; Retrospective Studies; Risk Factors; Tacrolimus; Triazoles; Voriconazole

2017
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5

    Topics: Animals; Antibiotic Prophylaxis; Antifungal Agents; Disease Models, Animal; Immunosuppression Therapy; Lung Diseases, Fungal; Mice; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles; Voriconazole

2017
Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.
    Therapeutic drug monitoring, 2017, Volume: 39, Issue:2

    Topics: Antifungal Agents; Azoles; Drug Monitoring; Female; Humans; Itraconazole; Lung Transplantation; Male; Middle Aged; Plasma; Retrospective Studies; Tablets; Transplant Recipients; Triazoles; Voriconazole

2017
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:3

    Topics: Acute Kidney Injury; Acyclovir; Aged; Alternaria; Alternariosis; Antibiotic Prophylaxis; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Graft vs Host Disease; Hand; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Levofloxacin; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Paranasal Sinuses; Phaeohyphomycosis; Pneumonia; Prednisone; Primary Myelofibrosis; Respiratory Insufficiency; Spores, Fungal; Transplantation, Homologous; Triazoles; Voriconazole

2017
Triazole Resistance in
    Chinese medical journal, 2017, Mar-20, Volume: 130, Issue:6

    Topics: Antifungal Agents; Aspergillus fumigatus; China; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Promoter Regions, Genetic; Tandem Repeat Sequences; Triazoles; Voriconazole

2017
    BMJ case reports, 2017, Mar-22, Volume: 2017

    Topics: Aged; Antifungal Agents; Aspergillosis; Brain; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Triazoles; Voriconazole

2017
Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Antifungal Agents; Ascomycota; Caspofungin; Dihydroorotate Dehydrogenase; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Oxidoreductases Acting on CH-CH Group Donors; Scedosporium; Triazoles; Voriconazole

2017
New pharmacological opportunities for the treatment of invasive mould diseases.
    The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1

    Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole

2017
Changing epidemiology of candidaemia in Australia.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole

2017
Clinical effectiveness of early posaconazole suspension pre-emptive therapy in lung transplant recipients: The Alfred's experience.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cohort Studies; Drug Monitoring; Female; Humans; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Transplant Recipients; Treatment Outcome; Triazoles; Voriconazole

2017
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jul-15, Volume: 65, Issue:2

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2017
Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Sterol 14-Demethylase; Triazoles; Voriconazole

2017
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    PloS one, 2017, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult

2017
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:4

    Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult

2017
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9

    Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2017
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2017
Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon.
    Mycoses, 2017, Volume: 60, Issue:11

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cameroon; Genetic Variation; Genotype; Geography; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Phylogeny; Soil Microbiology; Triazoles; Voriconazole

2017
Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
    Therapeutic drug monitoring, 2017, Volume: 39, Issue:5

    Topics: Acetonitriles; Adult; Antifungal Agents; Calibration; Chromatography, Liquid; Drug Monitoring; Female; Fluconazole; Humans; Indicators and Reagents; Isotope Labeling; Itraconazole; Nitriles; Plasma; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole

2017
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole

2017
Assessment of carvacrol for control of avian aspergillosis in intratracheally challenged chickens in comparison to voriconazole with a reference on economic impact.
    Journal of applied microbiology, 2017, Volume: 123, Issue:5

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chickens; Cymenes; Eugenol; Microbial Sensitivity Tests; Monoterpenes; Poultry Diseases; Real-Time Polymerase Chain Reaction; Spores, Fungal; Thymol; Triazoles; Voriconazole

2017
Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.
    Mycopathologia, 2017, Volume: 182, Issue:11-12

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Methylene Blue; Microbial Sensitivity Tests; Photochemotherapy; Photosensitizing Agents; Scedosporium; Triazoles; Voriconazole

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11

    Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole

2017
Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study.
    Annals of clinical microbiology and antimicrobials, 2017, Sep-11, Volume: 16, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adult; Antifungal Agents; Colorado; Drug Compounding; Drug Monitoring; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2017
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Antifungal Agents; Biofilms; Calcineurin Inhibitors; Candida parapsilosis; Drug Synergism; Exophiala; Humans; Itraconazole; Microbial Sensitivity Tests; Phaeohyphomycosis; Tacrolimus; Triazoles; Voriconazole

2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
    The Journal of infectious diseases, 2018, 03-13, Volume: 217, Issue:7

    Topics: Acetamides; Animals; Antifungal Agents; Aspergillus flavus; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Invasive Pulmonary Aspergillosis; Mice; Piperazines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2018
Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Ear; Genotype; Hospitals, University; Humans; Itraconazole; Lepidoptera; Microsatellite Repeats; Respiratory System; Triazoles; Voriconazole

2017
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
    Mycoses, 2018, Volume: 61, Issue:3

    Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2018
Persistent CNS toxicity in a patient receiving posaconazole tablets after discontinuation of voriconazole due to supratherapeutic serum levels.
    The Journal of antimicrobial chemotherapy, 2018, 01-01, Volume: 73, Issue:1

    Topics: Antifungal Agents; Brain Diseases; Humans; Male; Middle Aged; Serum; Tablets; Triazoles; Voriconazole

2018
Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates.
    BMC infectious diseases, 2017, 11-21, Volume: 17, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Hospitals, University; Humans; Immunocompromised Host; Iran; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole

2017
Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
    Acta biochimica Polonica, 2017, Volume: 64, Issue:4

    Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Polymorphism, Genetic; Triazoles; Voriconazole

2017
The challenges of treating aspergillus abdominal aneurysm after hematopoietic cell transplant: Rapid voriconazole metabolizer.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:3

    Topics: Aneurysm, Infected; Antifungal Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Triazoles; Voriconazole

2019
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
    Microbial pathogenesis, 2018, Volume: 115

    Topics: Adolescent; Antifungal Agents; Candida; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Fluconazole; Humans; Kluyveromyces; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Nitriles; Opportunistic Infections; Pichia; Pyridines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole

2018
Comparative evaluation of different gradient diffusion tests for detection of azole resistance in Aspergillus fumigatus.
    Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Reproducibility of Results; Triazoles; Voriconazole

2018
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Endophthalmitis; Eye; Female; Fusarium; Humans; Hyphae; Immunocompromised Host; Leukemia, Myeloid, Acute; Treatment Outcome; Triazoles; Vitrectomy; Voriconazole

2018
Posaconazole-Induced Pseudohyperaldosteronism.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Aged; Antifungal Agents; Heart Failure; Histoplasmosis; Humans; Hydroxysteroid Dehydrogenases; Hyperaldosteronism; Hypertension; Hypokalemia; Mineralocorticoid Excess Syndrome, Apparent; Triazoles; Voriconazole

2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2018
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Acetaminophen; Analgesics; Antifungal Agents; Aspirin; Candida; Candida albicans; Candida glabrata; Candidiasis; Dipyrone; Drug Resistance, Fungal; Fluconazole; Humans; Ibuprofen; Itraconazole; Meloxicam; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Insight into the Significance of Aspergillus fumigatus cyp51A Polymorphisms.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:6

    Topics: Amino Acid Substitution; Animals; Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Microbial Sensitivity Tests; Moths; Point Mutation; Polymorphism, Single Nucleotide; Triazoles; Voriconazole

2018
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study.
    Journal de mycologie medicale, 2018, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2018
Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7

    Topics: Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC/PDA: role of azole metabolic rate.
    Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:1

    Topics: Antifungal Agents; Azoles; Chromatography, High Pressure Liquid; Humans; Itraconazole; Serum; Triazoles; Voriconazole

2018
Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis.
    BMC infectious diseases, 2018, 06-04, Volume: 18, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Exophiala; Female; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Osteomyelitis; Phaeohyphomycosis; Triazoles; Voriconazole

2018
A vexing case of bone pain in a renal transplant recipient: Voriconazole-induced periostitis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:5

    Topics: Antifungal Agents; Drug Substitution; Graft Rejection; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Middle Aged; Periostitis; Transplant Recipients; Triazoles; Voriconazole

2018
Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole

2018
Quantification of Serum Voriconazole, Isavuconazole, and Posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
    Current protocols in toxicology, 2018, Volume: 76, Issue:1

    Topics: Antifungal Agents; Chromatography, Liquid; Humans; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole

2018
Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Candida glabrata; Drug Resistance, Fungal; Ergosterol; Fluconazole; Fungal Proteins; Humans; Itraconazole; Lanosterol; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Sterol 14-Demethylase; Triazoles; Voriconazole

2018
Treatment of Suspected Invasive Fungal Infection in War Wounds.
    Military medicine, 2018, 09-01, Volume: 183, Issue:suppl_2

    Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries

2018
Diagnosis and Treatment of Invasive Aspergillus fumigatus Wound Infection Following Subtotal Colectomy for Perforated Toxic Megacolon in an Immunosuppressed Patient.
    Wounds : a compendium of clinical research and practice, 2018, Volume: 30, Issue:10

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colectomy; Debridement; Female; Humans; Immunocompromised Host; Megacolon, Toxic; Postoperative Complications; Surgical Wound Infection; Treatment Outcome; Triazoles; Voriconazole

2018
Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Triazoles; Voriconazole

2019
Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.
    Drug testing and analysis, 2019, Volume: 11, Issue:4

    Topics: Analgesics, Opioid; Animals; Antifungal Agents; Ketoconazole; Male; Methadone; Nitriles; Pyridines; Rats, Sprague-Dawley; Triazoles; Voriconazole

2019
Impact of Antifungal Compounds on Viability and Anti-
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Cell Survival; Deoxycholic Acid; Doxorubicin; Drug Combinations; Fluconazole; Humans; Killer Cells, Natural; Microbial Sensitivity Tests; Polyethylene Glycols; Triazoles; Voriconazole

2019
Isavuconazole: Case Report and Pharmacokinetic Considerations.
    Chemotherapy, 2018, Volume: 63, Issue:5

    Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Bronchoalveolar Lavage Fluid; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Half-Life; Humans; Immunocompromised Host; Nitriles; Pyridines; Tandem Mass Spectrometry; Triazoles; Voriconazole; Young Adult

2018
Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
    Medical mycology, 2019, Oct-01, Volume: 57, Issue:7

    Topics: Antifungal Agents; DNA, Fungal; Fluconazole; Fungi; Humans; Italy; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
    Mycoses, 2019, Volume: 62, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole

2019
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.
    Critical care (London, England), 2018, 12-22, Volume: 22, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole

2018
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
    AAPS PharmSciTech, 2019, Jan-02, Volume: 20, Issue:1

    Topics: Antifungal Agents; Bone Density Conservation Agents; Drug Interactions; Female; Fluconazole; Forecasting; Humans; Itraconazole; Middle Aged; Models, Biological; Tamoxifen; Triazoles; Voriconazole

2019
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.
    BMC infectious diseases, 2019, Feb-11, Volume: 19, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole

2019
The Evolution of Azole Resistance in
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Amino Acid Sequence; Antifungal Agents; Azoles; Candida albicans; Fluconazole; Fungal Proteins; Itraconazole; Mutation; Protein Binding; Sterol 14-Demethylase; Triazoles; Voriconazole

2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Scientific reports, 2019, 03-07, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult

2019
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
    Future microbiology, 2019, Volume: 14

    Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Triazoles; Voriconazole

2019
Why do lung transplant patients discontinue triazole prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole

2019
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center.
    Annals of clinical microbiology and antimicrobials, 2019, Mar-20, Volume: 18, Issue:1

    Topics: Academic Medical Centers; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2019
Antifungal Drugs Influence Neutrophil Effector Functions.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Interleukin-8; Neutrophils; Nitriles; Phagocytosis; Pyridines; Triazoles; Voriconazole

2019
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
    Xenobiotica; the fate of foreign compounds in biological systems, 2020, Volume: 50, Issue:3

    Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole

2020
When medicine transforms art.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:4

    Topics: Adult; Antifungal Agents; Art; Coccidioidomycosis; Color; Female; Humans; Lung; Tomography, X-Ray Computed; Triazoles; Vision Disorders; Voriconazole

2019
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom.
    Journal of medical economics, 2020, Volume: 23, Issue:1

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Health Expenditures; Health Resources; Health Services; Hospitalization; Humans; Invasive Fungal Infections; Models, Economic; Nitriles; Prescription Fees; Pyridines; Quality-Adjusted Life Years; State Medicine; Survival Analysis; Triazoles; Uncertainty; United Kingdom; Voriconazole

2020
Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.
    Scientific reports, 2019, 07-01, Volume: 9, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Aspergillus fumigatus; Benzamides; Cell Line; Drug Synergism; Humans; Pulmonary Alveoli; Pulmonary Aspergillosis; Triazoles; Voriconazole

2019
Isavuconazole and voriconazole inhibition of sterol 14α-demethylases (CYP51) from Aspergillus fumigatus and Homo sapiens.
    International journal of antimicrobial agents, 2019, Volume: 54, Issue:4

    Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Aspergillus fumigatus; Cytochrome P450 Family 51; Humans; Inhibitory Concentration 50; Nitriles; Protein Binding; Pyridines; Recombinant Proteins; Sterols; Triazoles; Voriconazole

2019
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2019
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis.
    Transplantation, 2019, Volume: 103, Issue:12

    Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole

2019
    Journal of medical microbiology, 2019, Volume: 68, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Triazoles; Voriconazole

2019
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis.
    Mycoses, 2020, Volume: 63, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2020
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
    Medical mycology, 2020, Jul-01, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole

2020
Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2020
Simultaneous quantitation of five triazole anti-fungal agents by paper spray-mass spectrometry.
    Clinical chemistry and laboratory medicine, 2020, 04-28, Volume: 58, Issue:5

    Topics: Antifungal Agents; Dried Blood Spot Testing; Drug Monitoring; Fluconazole; Humans; Isotope Labeling; Laboratories; Limit of Detection; Paper; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole

2020
[Cryptic Aspergillus species - a case report of chronic cavitary pulmonary Aspergillus lentulus infection in a heart transplant recipient].
    Klinicka mikrobiologie a infekcni lekarstvi, 2019, Volume: 25, Issue:2

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Heart Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Triazoles; Voriconazole

2019
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Journal of infection in developing countries, 2018, 09-30, Volume: 12, Issue:9

    Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2018
Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms.
    BMC microbiology, 2020, 02-07, Volume: 20, Issue:1

    Topics: Aspergillus; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Azoles; Biofilms; Drug Synergism; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Itraconazole; Microbial Sensitivity Tests; Plankton; Triazoles; Voriconazole; Vorinostat

2020
Novel Application of Pentabromobenzyl Column for Simultaneous Determination of Eight Antifungal Drugs Using High-performance Liquid Chromatography.
    Combinatorial chemistry & high throughput screening, 2020, Volume: 23, Issue:10

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Clotrimazole; Humans; Hydrocarbons, Brominated; Imidazoles; Ketoconazole; Liquid-Liquid Extraction; Molecular Structure; Thiophenes; Triazoles; Voriconazole

2020
In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
    Diagnostic microbiology and infectious disease, 2020, Volume: 97, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Nitriles; Public Health Surveillance; Pyridines; Triazoles; Voriconazole

2020
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Journal de mycologie medicale, 2020, Volume: 30, Issue:2

    Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole

2020
COVID-19 associated pulmonary aspergillosis.
    Mycoses, 2020, Volume: 63, Issue:6

    Topics: Aged; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coronavirus Infections; COVID-19; Female; Galactose; Germany; Hemorrhage; Hospitals, Teaching; Humans; Intensive Care Units; Lung Diseases; Male; Mannans; Metapneumovirus; Middle Aged; Nitriles; Pandemics; Paramyxoviridae Infections; Pneumonia, Viral; Pulmonary Aspergillosis; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; Thorax; Tomography, X-Ray Computed; Triazoles; Voriconazole

2020
Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Heart Transplantation; Humans; Male; Nitriles; Osteomyelitis; Pyridines; Triazoles; Voriconazole

2020
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    JAMA dermatology, 2020, 07-01, Volume: 156, Issue:7

    Topics: Aged; Antifungal Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Incidence; Itraconazole; Lung Transplantation; Male; Middle Aged; Pulmonary Aspergillosis; Skin Neoplasms; Triazoles; United States; Voriconazole

2020
Isavuconazole Is as Effective as and Better Tolerated Than Voriconazole for Antifungal Prophylaxis in Lung Transplant Recipients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 08-02, Volume: 73, Issue:3

    Topics: Antifungal Agents; Humans; Lung; Nitriles; Pyridines; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole

2021
Central nervous system blastomycosis clinical characteristics and outcomes.
    Medical mycology, 2021, Jan-04, Volume: 59, Issue:1

    Topics: Adult; Antifungal Agents; Azoles; Blastomyces; Blastomycosis; Central Nervous System Fungal Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Tennessee; Treatment Outcome; Triazoles; Voriconazole

2021
Revision of EUCAST breakpoints: consequences for susceptibility of contemporary Danish mould isolates to isavuconazole and comparators.
    The Journal of antimicrobial chemotherapy, 2020, 09-01, Volume: 75, Issue:9

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; Denmark; Drug Resistance, Fungal; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole

2020
    Antimicrobial agents and chemotherapy, 2020, 08-20, Volume: 64, Issue:9

    Topics: Antifungal Agents; Ascomycota; Fungi; Microbial Sensitivity Tests; Nitriles; Pyridines; Thiazoles; Triazoles; Voriconazole

2020
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report.
    Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6

    Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole

2020
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain.
    Mycoses, 2021, Volume: 64, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Clinical Laboratory Techniques; Cost-Benefit Analysis; Diagnosis, Differential; Fungi; Hospitalists; Humans; Mucormycosis; Nitriles; Pyridines; Spain; Standard of Care; Triazoles; Voriconazole

2021
Antifungal susceptibility profile and molecular identification of Cyp51C mutations in clinical and environmental isolates of Aspergillus flavus from Argentina.
    Mycoses, 2021, Volume: 64, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Argentina; Aspergillosis; Aspergillus flavus; Cytochrome P450 Family 51; Drug Resistance, Fungal; Environmental Microbiology; Environmental Monitoring; Genes, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Mutation; Triazoles; Voriconazole

2021
Dementia-Like Symptoms Associated With Posaconazole.
    Journal of pharmacy practice, 2022, Volume: 35, Issue:1

    Topics: Antifungal Agents; Dementia; Humans; Triazoles; Voriconazole

2022
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
    Current drug metabolism, 2020, Volume: 21, Issue:13

    Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole

2020
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
    Molecular biology reports, 2020, Volume: 47, Issue:11

    Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole

2020
Isavuconazole as Salvage Therapy for Refractory Pediatric Coccidioidal Meningitis.
    The Pediatric infectious disease journal, 2021, 03-01, Volume: 40, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Child; Coccidioides; Coccidioidomycosis; Deoxycholic Acid; Drug Combinations; Humans; Meningitis, Fungal; Nitriles; Pyridines; Salvage Therapy; Triazoles; Voriconazole

2021
Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum.
    Mycopathologia, 2021, Volume: 186, Issue:1

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Reproducibility of Results; Triazoles; Voriconazole

2021
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles.
    Mycoses, 2021, Volume: 64, Issue:10

    Topics: Antifungal Agents; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Ergosterol; Fungal Proteins; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole; Whole Genome Sequencing

2021
Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.
    Scientific reports, 2021, 03-24, Volume: 11, Issue:1

    Topics: Antifungal Agents; Aspergillus; Calmodulin; Fungal Proteins; Humans; Iran; Microbial Sensitivity Tests; Nitriles; Onychomycosis; Pyridines; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Tubulin; Voriconazole

2021
Voriconazole-induced periostitis.
    Reumatismo, 2021, Apr-19, Volume: 73, Issue:1

    Topics: Adult; Antifungal Agents; Female; Humans; Periostitis; Radiography; Triazoles; Voriconazole

2021
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
    Medical mycology, 2021, Sep-03, Volume: 59, Issue:9

    Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Bird Diseases; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Falconiformes; Female; Male; Triazoles; Voriconazole

2021
Clinical utility of antifungal susceptibility testing in patients with fungal rhinosinusitis.
    Indian journal of medical microbiology, 2021, Volume: 39, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Mycoses; Sinusitis; Triazoles; Voriconazole

2021
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
    Medical mycology, 2021, Oct-04, Volume: 59, Issue:10

    Topics: Animals; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Nitriles; Pyridines; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole

2021
Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
    Antimicrobial agents and chemotherapy, 2021, 08-17, Volume: 65, Issue:9

    Topics: Antifungal Agents; Disk Diffusion Antimicrobial Tests; Itraconazole; Madurella; Microbial Sensitivity Tests; Triazoles; Voriconazole

2021
Antifungal drugs work together to treat germs causing fungal infections.
    Future microbiology, 2021, Volume: 16

    Topics: Anidulafungin; Antifungal Agents; Candida auris; Candidiasis, Invasive; Drug Resistance, Fungal; Drug Therapy, Combination; Humans; Nitriles; Pyridines; Triazoles; Voriconazole

2021
In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:3

    Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Europe; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; North America; Opportunistic Infections; Triazoles; Voriconazole

2021
The effect of biosynthesized selenium nanoparticles on the expression of CYP51A and HSP90 antifungal resistance genes in Aspergillus fumigatus and Aspergillus flavus.
    Biotechnology progress, 2022, Volume: 38, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Itraconazole; Microbial Sensitivity Tests; Nanoparticles; Selenium; Triazoles; Voriconazole

2022
Broad-spectrum azoles and flucloxacillin: a dangerous match.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2022, Volume: 41, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Drug Interactions; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Middle Aged; Nitriles; Pyridines; Staphylococcal Infections; Staphylococcus aureus; Triazoles; Voriconazole

2022
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
    Expert review of pharmacoeconomics & outcomes research, 2022, Volume: 22, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Canada; Cost-Benefit Analysis; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Pyridines; Triazoles; Voriconazole

2022
Antifungal activity and mechanism of action of 2-chloro-N -phenylacetamide: a new molecule with activity against strains of Aspergillus flavus.
    Anais da Academia Brasileira de Ciencias, 2021, Volume: 93, Issue:suppl 3

    Topics: Antifungal Agents; Aspergillus flavus; Microbial Sensitivity Tests; Molecular Docking Simulation; Triazoles; Voriconazole

2021
Interaction between flucloxacillin and azoles: Is isavuconazole next?
    Mycoses, 2021, Volume: 64, Issue:12

    Topics: Antifungal Agents; Azoles; Drug Interactions; Floxacillin; Humans; Nitriles; Pyridines; Triazoles; Voriconazole

2021
Azole resistance in Aspergillus fumigatus isolates from respiratory specimens in Lyon University Hospitals, France: prevalence and mechanisms involved.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:6

    Topics: Antifungal Agents; Aspergillus fumigatus; Cross-Sectional Studies; Cytochrome P-450 Enzyme System; France; Fungal Proteins; Hospitals, University; Humans; Itraconazole; Microbial Sensitivity Tests; Nitriles; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Pyridines; Respiratory Tract Infections; Retrospective Studies; Triazoles; Tubulin; Voriconazole

2021
Evaluation of Voriconazole and Posaconazole Dosing in Patients With Thermal Burn Injuries.
    Journal of burn care & research : official publication of the American Burn Association, 2022, 07-01, Volume: 43, Issue:4

    Topics: Adult; Antifungal Agents; Azoles; Burns; Humans; Retrospective Studies; Triazoles; Voriconazole

2022
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance.
    Medical mycology, 2021, Dec-08, Volume: 60, Issue:1

    Topics: Animals; Antifungal Agents; Aspergillosis; Clinical Decision Rules; Invasive Fungal Infections; Triazoles; Voriconazole

2021
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
    Clinical pharmacology in drug development, 2022, Volume: 11, Issue:6

    Topics: Antifungal Agents; Carcinoma, Non-Small-Cell Lung; Crizotinib; Fluconazole; Humans; Itraconazole; Lung Neoplasms; Triazoles; Voriconazole

2022
A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest, 2022, Volume: 161, Issue:1

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Atrial Fibrillation; Bronchoscopy; COVID-19; Dexamethasone; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mucormycosis; Nitriles; Obesity; Oxygen Inhalation Therapy; Pulmonary Aspergillosis; Pyridines; Respiration, Artificial; SARS-CoV-2; Smoking; Tomography, X-Ray Computed; Triazoles; Voriconazole

2022
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Antifungal Agents; Aspergillus; Azoles; Candida; Candida albicans; Drug Resistance, Fungal; Exophiala; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Morpholines; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Voriconazole

2022
Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:6

    Topics: Adult; Fluconazole; Humans; Leukemia, Promyelocytic, Acute; Male; Papilledema; Pseudotumor Cerebri; Tretinoin; Triazoles; Voriconazole; Young Adult

2022
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report.
    Medicine, 2022, Jan-28, Volume: 101, Issue:4

    Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole

2022
Itraconazole and Voriconazole: The Complexity of Dose Adjustments.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-31, Volume: 75, Issue:3

    Topics: Antifungal Agents; Humans; Itraconazole; Triazoles; Voriconazole

2022
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9

    Topics: Adult; Antifungal Agents; Azoles; Chemical and Drug Induced Liver Injury; Echinocandins; Fungi; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Retrospective Studies; Triazoles; Voriconazole

2022
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignanci
    Therapeutic drug monitoring, 2022, 10-01, Volume: 44, Issue:5

    Topics: Antifungal Agents; Azoles; Child; Humans; Invasive Fungal Infections; Neoplasms; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole

2022
Triazole-resistant
    Emerging microbes & infections, 2022, Volume: 11, Issue:1

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; China; Drug Resistance, Fungal; Fermentation; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Triazoles; Voriconazole

2022
Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center.
    Transplantation and cellular therapy, 2022, Volume: 28, Issue:8

    Topics: Adult; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Receptors, Chimeric Antigen; Triazoles; Voriconazole

2022
Horizontal Gene Transfer of Triazole Resistance in Aspergillus fumigatus.
    Microbiology spectrum, 2022, 06-29, Volume: 10, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Fungal Proteins; Fungi; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole

2022
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:9

    Topics: Adult; Antifungal Agents; Bayes Theorem; China; Hematologic Neoplasms; Humans; Models, Biological; Triazoles; Voriconazole

2022
In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122

    Topics: Antifungal Agents; Candida; Candida glabrata; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles; Voriconazole

2022
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients.
    Medical mycology, 2022, Sep-02, Volume: 60, Issue:9

    Topics: Animals; Antifungal Agents; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole

2022
Voriconazole-induced severe skin allergy and neurological adverse event in a liver failure patient: A case report.
    Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:10

    Topics: Adult; Antifungal Agents; Humans; Hypersensitivity; Liver Failure; Male; Triazoles; Voriconazole

2022
Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains.
    International journal of antimicrobial agents, 2023, Volume: 61, Issue:3

    Topics: Antifungal Agents; Aspergillus; Azoles; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole

2023
In vitro activity of isavuconazole against clinically relevant Trichosporon species: a comparative evaluation of EUCAST broth microdilution and MIC Test Strip methods.
    The Journal of antimicrobial chemotherapy, 2023, 03-02, Volume: 78, Issue:3

    Topics: Antifungal Agents; Fluconazole; Microbial Sensitivity Tests; Triazoles; Trichosporon; Voriconazole

2023
In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus.
    Journal de mycologie medicale, 2023, Volume: 33, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Auranofin; Itraconazole; Microbial Sensitivity Tests; Triazoles; Voriconazole

2023
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.
    Scientific reports, 2023, 04-25, Volume: 13, Issue:1

    Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Nitriles; Prospective Studies; Triazoles; Voriconazole

2023
A case of drug-induced myopathy in alcoholic cirrhosis caused by voriconazole.
    European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:9

    Topics: Aged; Antifungal Agents; Humans; Liver Cirrhosis, Alcoholic; Micafungin; Triazoles; Voriconazole

2023
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
    Medical mycology, 2023, Jun-05, Volume: 61, Issue:6

    Topics: Animals; Antifungal Agents; COVID-19; Pulmonary Aspergillosis; Retrospective Studies; Triazoles; Voriconazole

2023
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
    Medical mycology, 2023, Aug-02, Volume: 61, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole

2023
HPLC-MS/MS Method Validation for Antifungal Agents in Human Serum in Clinical Application.
    Clinical laboratory, 2023, Sep-01, Volume: 69, Issue:9

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Itraconazole; Tandem Mass Spectrometry; Triazoles; United States; Voriconazole

2023
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia.
    Scientific reports, 2023, 11-01, Volume: 13, Issue:1

    Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles; Voriconazole

2023
Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
    Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Monitoring; Itraconazole; Methanol; Reproducibility of Results; Tandem Mass Spectrometry; Triazoles; Voriconazole

2024